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Abstract 
Inositol pyrophosphates and inorganic polyphosphate (polyP) represent two of 
the most phosphate-rich molecules in the cell. However, the synthesis, 
metabolism and function of these “high-energy” molecules are not well 
understood. This work develops the amoeba, Dictyostelium discoideum, as a 
genetic model to study both classes of molecule. By applying improved 
polyacrylamide gel electrophoresis (PAGE) techniques, unlabelled inositol 
pyrophosphates and polyP extracted from D. discoideum have been visualised 
for the first time. 
 
Deletion of a range of inositol phosphate kinases reveals a complex synthetic 
pathway of the inositol pyrophosphates in the amoeba. Surprisingly, strains 
lacking the majority of inositol pyrophosphates do not display a dramatic 
phenotype. However, these cells retain low levels of inositol pyrophosphates. In 
fact, this work identified at least four enzymes capable of synthesising inositol 
pyrophosphates in the amoeba, including the novel inositol phosphate kinases 
IPKA and IPKB. In vitro, both IPKA and IPKB act as specific IP7 kinases. 
However, in vivo both enzymes are catalytically flexible and are able to 
phosphorylate other substrates. 
 
In addition, PAGE technology allows the detection of polyP extracted from D. 
discoideum, revealing the unprecedented increase of polyP during development. 
Deletion of the Polyphosphate kinase (PPK)1 gene confirms this to be the only 
PPK in the amoeba. Deletion of PPK has a negative effect on the fitness of the 
amoeba, a phenotype underpinned by the ability of polyP to regulate primary 
metabolism. The ppk1-null strain fails to accumulate polyP during development 
and is defective in spore germination. Loss of polyP during the development of 
ppk1 is partially compensated by an increase in inositol pyrophosphates. These 
observations support a model in which there is a functional interplay between 
inositol pyrophosphates, polyP and primary metabolism.  
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NMR Nuclear magnetic resonance 
NP40 Nonidet P-40 
nt Nucleotide 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PASK Poly acidic, serine (S) and lysine (K)  
PCR Polymerase chain reaction 
PDK1 Phosphoinositides dependent kinase 1 
PH Pleckstrin homology 
PHB Poly-(R)-3-hydroxybutryrate  
Pi Inorganic phosphate 
PI Phosphatidyl inositol 
PI(3)K Phosphatidyl inositol 3 kinase 
PIKK Phosphoinositides 3-kinase-related 
PIP Phosphatidyl inositol phosphate 
PiUS Inorganic phosphate uptake stimulator 
PKC Protein kinase C 
PLC Phospholipase C 
PLD Phospholipase D 
polyP Inorganic polyphosphate 
PP-IPs Inositol pyrophosphates 
PPIP5K Diphosphopentakisphosphate kinase 
PPK Polyphosphate kinase 
PtdIns Phosphatidyl inositol  
PVDF Polyvinylidene fluoride  
PX Phox Homology 
RNA Ribonucleic acid 
RNAi Ribonucleic acid interference 
RPKM Reads per kilobase per million mapped reads  
RT Room temperature 
RTK Receptor tyrosine kinase 
SAX Strong anion exchange 
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SC (media) Synthetic complete media 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SM Slime mold 
SSC Saline Sodium Citrate 
T Thymine 
TAE Tris acetate EDTA buffer 
TBE Tris borate EDTA buffer 
TBS Tris buffered saline 
TBST Tris buffered saline tween 
TE Tris EDTA 
TiO2 Titanium oxide 
Top1 Topoisomerase 1 
µM micro Molar 
V Volts 
VTC Vacuolar transport complex 
WT Wild type 
YPD Yeast extract peptone dextrose 
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.1. Introduction 
1.1 Inositol 
The six-carbon inositol sugar is the key building block upon which a very large 
family of signalling molecules is based. The majority of inositol found in 
biological systems is in the myo-inositol form, in which the six-carbon ring is 
arranged in its chair formation. Myo-inositol has a single axis of symmetry 
through positions 2 and 5, making positions 1 and 3 as well as 4 and 6 
enantiomeric (Figure 1.1). In its unphosphorylated state each carbon possesses 
a single hydroxyl group. The hydroxyl on position 2 is axial, perpendicular to the 
ring, whilst the remaining five hydroxyls are all equatorial, roughly in the same 
plain as the ring itself. Inositol is synthesised from glucose in a single 
isomerisation reaction conserved from archae to mammalian cells (Michell 
2011)(Figure 1.2), forming a very stable, metabolically inert molecule. The 
stability of this molecule makes it an ideal canvas to be decorated with 
phosphates, generating the so-called inositol phosphates.  
The unique stereochemical environment of each position allows an expansive 
repertoire of distinct inositol phosphates to be formed, with over 40 different 
soluble inositol phosphate species having been identified in living cells (Irvine 
and Schell 2001). The array of phospho-inositol species is further expanded by 
the phosphorylated inositol lipids, known as the phosphoinositides (Di Paolo 
and De Camilli 2006, Balla 2013). Greater complexity still is derived from the 
addition of more than one phosphate to a single carbon. These soluble 
molecules are characterised by their high phosphate content and the presence 
of one or more high-energy phospho-anhydride bonds. These molecules are 
termed diphosphoinositol phosphates although they are more commonly 
referred to as inositol pyrophosphates, as they will be referred to hereafter. 
Representatives of each inositol phosphate subfamily are depicted in Figure1.3.  
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Figure 1.1 Structure of myo-inositol 
Myo-inositol exists in the chair formation. The hydroxyl group on position 2 is 
axial, whilst all others are equatorial. This gives myo inositol a single axis of 
symmetry, through carbons 2 and 5, making positions 1,3 and 4,6 enantiomeric. 
Figure 1.2 Enzymatic conversion of glucose-6P to inositol 
Inositol is synthesised from glucose-6P by the inositol-3-phosphate synthase 
(IPS), which converts glucose-6P to inositol-3P. IPS requires NAD+ and the rtwo-
step eaction proceeds via oxidation followed by reduction. The so-called inositol 
monophosphatase (IMPase or IMPA) dephosphorylates inositol-3P to inositol. 
Carbon, white circle; phosphorus, red circle; and oxygen, green circle. Figure 
and figure legend adapted from (Livermore, Azevedo et al. 2016).  
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Figure 1.3 Illustrating representative members of three subfamilies of 
inositol phosphate-derived molecules 
This figure represents (from left to right) the phosphoinositides, depicted by 
PI(4,5)P2; the soluble inositol phosphates, depicted by I(1,4,5)P3; and the inositol 
pyrophosphates, as depicted by IP7 or 5PP-IP5. Highlighted in yellow are the 
three distinct classes of phosphate bond, which are important for the function of 
each family of molecule. The phosphodiester bond (left) provides a structural 
link between the inositol phosphate head group and its diacyl glycerol anchor.. 
The phosphoester bond (centre) attaches the phosphate group to the inositol 
ring, providing the unique signalling properties of both the inositol phosphates 
and the phosphoinositides. The phosphoanhydride bond of the PP-IPs (right) 
provides these molecules with their ‘high-energy’ properties. This bond allows 
these molecules to partake in phosphotransfer reactions. Carbon, white circle; 
phosphorus, red circle; and oxygen, green circle. Figure and figure legend 
adapted from (Livermore, Azevedo et al. 2016).  
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1.1.1 Phosphoinositides 
The best-characterised inositol phosphate species are without doubt the lipid 
bound or phosphoinositides. This family of molecules is linked through a 
phosphodiester bond on position 1 of the inositol ring to the diacyl glycerol 
group (Figure 1.3, left). The phosphoinositides are derived from the reversible 
phosphorylation of phosphatidyl inositol (PtdIns or PI)(see Table 1.1). This 
precursor molecule can be variably phosphorylated at positions 3,4 and 5 of the 
inositol ring, giving rise to a family of molecules that has eight members, 
including PI, in eukaryotic cells (Di Paolo and De Camilli 2006). 
 
The phosphoinositides make up a very small proportion of the total lipids in the 
cell, approximately 10% of total lipids, of which the majority is PI (Balla 2013). 
Nevertheless, they are involved in, and indeed regulate, a huge array of cellular 
functions from membrane and vesicular trafficking to nuclear signalling (Balla 
2013). The subcellular localisation of each individual member of this family is 
tightly controlled by activity of a range of kinases and phosphatases. Thus the 
identity of membranes is in part defined by their phosphoinositide composition. 
It is their presence throughout the membranes of the cell that allows these 
molecules to take part in such a wide array of cellular functions, a small number 
of which will be discussed below. 
 
The negative charge of the phosphate group and distinct arrangements around 
the inositol ring allows proteins to recognise and discern between individual 
phosphoinositides and anchor themselves at particular membranes. A number 
of protein folds have been identified which specifically recognise the 
phosphoinositide family of lipids, including the PH, PX and FYVE domains (Balla 
2013). The repertoire of protein modules described to interact with 
phosphoinositides is continuing to expand and now includes unstructured 
domains, which fold upon interaction with the head group. Consequently, the 
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range of functions in which phosphoinositides have been implicated is 
expanding too. 
 
A phosphoinositide of particular importance is PI(4,5)P2  (Figure 1.3). Primarily 
found at the plasma membrane, it is synthesised by the phosphorylation of 
PI(4)P and can be metabolised by dephosphorylation to either PI(4)P or PI(5)P, 
or by the cleavage by phospholipases, such as phospholipase C (PLC), in 
response to a stimulus. This cleavage of PI(4,5)P2  yields another family of 
signalling molecules, the inositol phosphates, which will be covered in more 
detail later.  
 
Alongside the role of PI(4,5)P2 in transmitting a signal across the membrane, via 
the inositol phosphates, this lipid executes a pleiotropy of functions. The 
presence of PI(4,5)P2 at the plasma membrane has been shown to be essential 
for the proper functioning of a range of ion channels (Hilgemann, Feng et al. 
2001, Suh and Hille 2005). PI(4,5)P2 regulates actin nucleation, organising 
cytoskeletal components (Rohatgi, Ho et al. 2000) and thus controlling cell 
shape and cell motility (Pollard and Borisy 2003). In addition many proteins 
regulating endocytosis possess domains which bind to PI(4,5)P2, defining the 
role for this lipid in controlling membrane trafficking and specifically endocytic 
events (Godlee and Kaksonen 2013). 
 
In addition to the actions briefly described above, PI(4,5)P2 can also be 
phosphorylated by the phosphoinositides-(3)-kinases (PI(3)Ks) to form 
PI(3,4,5)P3. This phosphorylation occurs transiently in response to growth factor 
stimulus, receptor tyrosine kinase (RTK) or G protein coupled receptor (GPCR) 
activation. PI(3,4,5)P3 and can mediate a range of effects from chemotaxis to cell 
proliferation and survival. 
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In fact the localisation of PI(3,4,5)P3 at the leading edge of the amoeba D. 
discoideum has been described to be responsible for polarised motility during 
chemotaxis (Iijima, Huang et al. 2002). However, the role of PI(3,4,5)P3 in D. 
discoideum is controversial as genetic ablation of PI(3,4,5)P3 signalling does not 
impair the ability of the amoeba to respond to chemoattractants (Hoeller and 
Kay 2007, Hoeller, Bolourani et al. 2013, Nichols, Veltman et al. 2015). 
 
Regardless of the controversy over the role of PI(3,4,5)P3 in D. discoideum 
chemotaxis, in mammals this phosphoinositide plays a key role in signalling 
through the protein kinase Akt (Vanhaesebroeck, Stephens et al. 2012). Akt, also 
known as protein kinase B, is a serine, threonine kinase, which contains a PH 
domain with high affinity for both PI(3,4)P2 and PI(3,4,5)P3. The production of 
PI(3,4,5)P3 at the plasma membrane in response to a stimulus results in the 
recruitment of Akt. Once recruited by PI(3,4,5)P3, Akt can be phosphorylated 
and activated by phosphoinositides dependent kinase 1(PDK1) (Alessi, James et 
al. 1997, Stokoe, Stephens et al. 1997) and mammalian target of rapamycin 
(mTORC2)(Sarbassov, Guertin et al. 2005). Once activated, Akt phosphorylates 
a range of substrates including those involved in the insulin signalling pathway 
(glycogen synthase kinase 3), apoptotic pathway (BCL 2) and cell cycle 
regulators (p21 and p27) (Vanhaesebroeck, Stephens et al. 2012). Thus 
PI(3,4,5)P3 is crucial to regulating these diverse process through its dual role in 
Akt activation, promoting its recruitment to the plasma membrane, as well as 
being required for the activity of the activating kinase PDK1 (Alessi, James et al. 
1997), which phosphorylates Akt.  
 
Aside from PI(4,5)P2 and  PI(3,4,5)P3, other members of the phosphoinositides 
family have numerous and varied functions in other cellular compartments (Di 
Paolo and De Camilli 2006, Balla 2013). However, these molecules and the 
proteins that regulate them fall outside the scope of this work and will not be 
covered in further detail here. In addition, the nuclear signalling properties 
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displayed by the phosphoinositides (Blind, Suzawa et al. 2012, Shah, Jones et 
al. 2013) will not be covered in this work for the same reasons.  
1.1.2 Inositol phosphates 
While much research has elucidated the roles of inositol lipids in cellular 
processes, of which only a very small amount has been covered above, 
comparatively little is known about the functions of the much larger family of 
soluble inositol phosphates. There are, however, a number of well-studied 
examples, the most famed being the role of the second messenger I(1,4,5)P3. 
I(1,4,5)P3, abbreviated hereafter to IP3, can be derived from the phospholipase C 
(PLC)-dependent cleavage of the lipid PIP2. In 1983 it was first demonstrated 
that this cleavage of PIP2 induces a transient increase in IP3 resulting in Ca2+ 
release from internal stores (Streb, Irvine et al. 1983). In this classical example, 
IP3 acts as the archetypal second messenger, acutely increasing in response to 
a stimulus, diffusing through the cytosol and binding to the IP3Receptor to 
induce Ca2+ release from internal stores (Berridge 1993). 
 
PLC, the enzyme that liberates IP3 from its di-acyl glycerol (DAG) tail, comes in 
several flavours. These can be activated by either GPCR stimulation and 
heterotrimeric G proteins or by activated RTKs. Once activated the membrane 
associated enzyme cleaves PIP2 at the plasma membrane, releasing two second 
messengers: IP3 and DAG. The soluble IP3 diffuses through the cytosol and 
binds to the large membrane protein IP3Receptor. The IP3Receptor, localised to 
the membrane of the endoplasmic reticulum (ER), has an IP3 binding site in its N 
terminal region. Once bound by IP3, the IP3Receptor oligomerises, with four 
subunits coming together to form a Ca2+ channel, allowing the efflux of Ca2+ from 
the ER (Berridge 1993).  
 
Whilst the soluble IP3 diffuses through the cytosol, DAG, the other product of 
PIP2 cleavage, diffuses through the plasma membrane. DAG, a second 
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messenger in its own right, is able to activate protein kinase C, leading to the 
phosphorylation of a wide range of substrates (Reyland 2009).   
 
Since the initial description of IP3 acting as a second messenger, much work 
focused on defining the pathways in which other inositol phosphates act. Whilst 
the levels of both I(1,3,4,5)P4 and I(1,3,4)P3 increase in response to stimulus, 
these are primarily metabolites of I(1,4,5)P3 brought about by the 
phosphorylation by IP3-3-Kinase (IP3-3K) and subsequent dephosphorylation by 
a 5-phosphatase rather than signalling molecules in their own right (Irvine and 
Schell 2001).  
 
In fact, the search for other inositol phosphate receptors has also largely been 
fruitless and it has been proposed that the only other member of this family that 
could be termed a second messenger is I(3,4,5,6)P4 (Shears, Ganapathi et al. 
2012). I(3,4,5,6)P4 is a concentration-dependent inhibitor of Cl- channels, in 
particular acting on the ClC3 channel (Mitchell, Wang et al. 2008). This species 
is increased in response to PLC activation in a manner dependent on the activity 
of another, unrelated, IP3 kinase, ITPK1 (Shears 2009).  I(3,4,5,6)P4 is thereby 
able to influence a range of cellular processes dependent upon ClC3 channels, 
from neural development to inflammation (Shears 2009). 
 
Whilst attention has been paid to the roles of inositol phosphates as second 
messengers, in particular focusing on IP3, the most abundant forms of inositol 
phosphates in mammalian cells are in fact inositol pentakisphosphates, IP5 and 
inositol hexakisphosphate, IP6. Perhaps unsurprisingly these were the first 
inositol phosphate species to be identified. The accumulation of IP6, also known 
as phytic acid, in seeds was the first description of the inositol phosphates 
almost a century ago (Posternak 1921). Subsequently, IP5 was the first inositol 
phosphate to be described in animal cells, with its identification in chicken 
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erythrocytes (Johnson and Tate 1969). The synthetic pathway of these “higher” 
inositol phosphates is summarised in Figure 1.4. 
 
The “higher” inositol” phosphates, whilst not considered classical second 
messengers, have been implicated in a wide range of cellular processes. IP5 
has, for example, been demonstrated to play a role in the oxygen affinity of 
haemoglobin (Coates 1975) and as a modulator of Wnt signalling (Gao and 
Wang 2007). The synthesis of IP5 and IP6 has also been shown to regulate 
neuronal development, with the intracellular ratio of these two molecules altering 
in response to stimulation in both differentiated PC12 cells and primary neurons 
(Loss, Wu et al. 2013). IP6,, meanwhile, has been implicated in processes 
including protein kinase C activation (Efanov, Zaitsev et al. 1997) and mRNA 
transport (York, Odom et al. 1999). An additional interesting role for IP6 emerged 
with the surprise identification of a single IP6 molecule deep within the structure 
of RNA editing enzyme Adar2 (Macbeth, Schubert et al. 2005). This raised the 
possibility that the highly charged IP6 might function as a protein folding 
cofactor, independent of any classical signalling role. It is not clear how 
widespread this phenomenon is, nor whether other highly polar molecules might 
perform the same role in vivo, but it appears that Adar2 is not unique in its use 
of IP6 as a protein folding cofactor (J.D. York personal communication). 
1.2 Inositol pyrophosphates 
Whilst IP6 was for many years considered to the most highly phosphorylated 
form of inositol, two independent studies in D. discoideum and mammalian cells 
demonstrated otherwise in 1993 (Menniti, Miller et al. 1993, Stephens, 
Radenberg et al. 1993). It was noted that species more polar than IP6 could be 
detected by high-pressure liquid chromatography (HPLC) analysis of 
radiolabelled 3H-inositol. This indicated the existence of inositol phosphate 
species containing more than six phosphates. Given that the inositol sugar  
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Figure 1.4 Simplified synthetic pathway of inositol pyrophosphates 
This simplified pathway depicts the possible routes of inositol pyrophosphate 
synthesis in yeast (S. cerevisiae), amoeba (D.discoideum) and mammalian cells, 
starting from myo-inositol. S. cerevisiae exclusively synthesises inositol 
phosphates  via the lipid pathway (York, Odom et al. 1999), whereas D. 
discoideum synthesises IP6, via the cytosolic route (Stephens and Irvine 1990) 
The enzymology of this pathway is not well characterised. This figure highlights 
the major metabolic pathway as supported by yeast genetic studies (York, 
Odom et al. 1999, Saiardi, Sciambi et al. 2002, Seeds, Bastidas et al. 2005). 
Multiple PP-IP4 isoforms can be synthesised in vitro by IP6K (5PP-IP4 is shown 
here). P indicates a single phosphate (PO42−) group; R and R′ represent fatty 
acid chains; dashed arrows represent multiple steps of modification that are not 
shown in detail; kinases catalysing each step are indicated in red (mammalian) 
and blue (S. cerevisiae). Figure and figure legend adapted from (Wilson, 
Livermore et al. 2013).  
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Table 1.1 Phosphoinositide and inositol phosphate nomenclature 
Common name IUPAC nomenclature Alternative name Common Isomeric forms 
Lipid    
PI PtdIns -  
PIP PtdInsP - 
PI(3)P 
PI(4)P 
PI(5)P 
PIP2 PtdInsP2 - 
PI(4,5)P2 
PI(3,4)P2 
PI(3,5)P2 
PIP3 PtdInsP3 - PI(3,4,5)P2 
Soluble    
IP3 
Inositol trisphosphate 
(InsP3) - 
I(1,4,5)P3 
I(1,3,4)P3 
IP4 Inositol tetrakisphosphate (InsP4) - 
I(1,3,4,5)P4 
I(3,4,5,6)P4 
I(1,4,5,6)P4 
IP5 Inositol pentakisphosphate (InsP5) - I(1,3,4,5,6)P5 
IP6 Inositol hexakisphosphate (InsP6) 
Phytic acid  
IP7/PP-IP5 
Diphosphoinositol 
pentakisphosphate 
(PP-InsP5) 
InsP7 
1 PP-IP5 
5 PP-IP5 
IP8/(PP)2-IP4 
Bisdiphosphoinositol 
tetrakisphosphate [(PP)2-
InsP4] 
InsP8 
1,5 PP-IP4 (yeast, 
mammalian) 
5,6 PP-IP4 (D. 
discoideum) 
PP-IP4 
 
 
Diphosphoinositol 
tetrakisphosphate PP- InsP4 
(1/3)PP-IP4 
5 PP-IP4 
(PP)2-IP3 Bisdiphosphoinositol trisphosphate (PP)2-InsP3  
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contains six carbons itself, the arrangement of seven or more phosphates 
around the ring necessitates the formation of a high-energy phosphoanhydride 
bond linking a beta phosphate to the ring (Figure 1.3). In fact, it is this presence 
of at least one beta phosphate that characterises the so-called inositol 
pyrophosphates or, to use the correct IUPAC nomenclature, diphosphoinositol 
polyphosphates (see Table 1.1 for disambiguation of nomenclature). 
1.2.1 Inositol pyrophosphates: structure and synthesis 
The most common form of inositol pyrophosphate in yeast and mammalian cells 
is the IP6-derived PP-IP5, hereafter referred to as IP7 (see Table 1.1). Other 
members of this family include (PP)2-IP4, hereafter referred to as IP8. 
Pyrophosphates can also be synthesised from IP6 precursors such as IP5 
(Figure 1.4)(Table 1.1) and even less phosphorylated inositol species (Seeds, 
Bastidas et al. 2005). Whilst IP6 is present at concentrations of up to 10-60 µM 
in mammalian cells, IP7 usually exists at a concentration less than 10% of that, 
between 0.5 and 1.3 µM (Albert, Safrany et al. 1997, Shears 2001). The social 
amoeba D. discoideum, which will be the focus of this work, is exceptional in 
possessing extremely high levels of IP6, up to 0.7 mM (Albert, Safrany et al. 
1997). Furthermore the inositol pyrophosphates have also been described to 
increase up to ~1.5 mM during the starvation-induced development of this 
amoeba (Laussmann, Pikzack et al. 2000). 
 
Two distinct classes of enzymes are able to synthesise inositol pyrophosphates 
by adding a beta phosphate to the inositol ring (Figure 1.4). These are the 
IP6Kinases (IP6K) and the PPIP5Kinases (PPIP5K). Each enzyme displays a 
specific activity towards a single position on the ring, with IP6Ks placing a 
pyrophosphate on position 5 (Draskovic, Saiardi et al. 2008) and PPIP5Ks 
placing a pyrophosphate on position 1 (Wang, Falck et al. 2012). These gene 
families are conserved from yeast (where they are called Kcs1 and Vip1 
respectively) to mammals (Figure 1.4).   
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The IP6Ks are members of the inositol phosphate kinase family and possess the 
characteristic PxxxDxKxG inositol phosphate-binding motif (Figure 7.1). Yeast 
possess a single IP6K, Kcs1, whilst mammalian genomes encode three isoforms 
of IP6K, IP6K1-3. All of these kinases are able to phosphorylate IP6 to IP7 as well 
as IP5 to PP-IP4 in vitro (Saiardi, Erdjument-Bromage et al. 1999, Saiardi, Nagata 
et al. 2001, Draskovic, Saiardi et al. 2008). The substrate selectivity varies 
between isoforms and organism, for instance the mammalian IP6K1 has a five-
fold higher affinity for IP6 over IP5, whilst the IP6K2 has a 20-fold higher affinity 
for IP6 (Saiardi, Erdjument-Bromage et al. 1999). Kcs1 is a non-essential gene in 
yeast, although the kcs1Δ yeast does display a range of phenotypes affecting its 
general fitness (Saiardi, Caffrey et al. 2000). In mouse, each individual gene has 
been deleted in isolation to generate single knockouts IP6K1-/-, IP6K 2-/- and 
IP6K3-/- discussed in more detail later. Some of the phenotypes observed in 
yeast have been reproduced in these knockout mice, however all of these mice 
retain functional IP6K and likely IP7. The close proximity of IP6K1 and IP6K2 on 
the same locus of the same arm of chromosome 9 in mice (chromosome 3 in 
humans) makes the generation of a double knockout mouse by traditional 
methods impractical. 
 
The IP6Ks, in contrast to other members of the inositol phosphate kinase family, 
are notable for their very high Km for ATP of between 1.0 and 1.4 mM, 
comparable to the intracellular concentration of ATP (Wundenberg and Mayr 
2012, Wilson, Livermore et al. 2013). This makes these kinases exquisitely 
sensitive to changes in ATP concentration, the significance of which will be 
explored in more detail later.  
   
Surprisingly, phylogenetic analysis suggests that the IP6Ks are in fact the most 
ancient members of the inositol phosphate kinase family (Bennett, Onnebo et al. 
2006). This is counter intuitive considering that the synthesis of their preferred 
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substrate, IP6, requires the activity of other inositol phosphate kinases, in 
particular IPMK (Figure 1.4). Nevertheless, this theory is supported by the 
recently published structure of the E. histolytica IP6K (Wang, DeRose et al. 
2014). This enzyme displays hybrid kinase activity, phosphorylating not only IP6 
to IP7 but also IP3 to IP4. The catalytic flexibility displayed by this evolutionarily 
ancient kinase is explained by the partial separation of the substrate binding 
determinants for IP3 and IP6. This separation was demonstrated by a 55° rotation 
of the smaller IP3 in the active site. Based on these observations, single point 
mutations in the binding determinants of hsIP6K2, were shown to induce a 50-
fold increase in IP3K activity in hsIP6K2. Thus this evidence supports a model in 
which the IP6Ks were the first inositol phosphate kinases to arise and that 
subsequent mutations gave rise to first the flexible IPMK, then the more recently 
evolved and highly specific IP3-3K. 
 
The second class of enzyme capable of synthesising inositol pyrophosphates is 
PPIP5K. This enzyme was first characterised in yeast as Vip1 in 2007 (Mulugu, 
Bai et al. 2007). Yeast possess a single Vip1, whilst mammalian genomes 
encode two PPIP5Ks. These large enzymes (~130 kDa) are remarkable for their 
domain structure, which includes both a kinase domain and an acid-
phosphatase domain. The kinase domain has a unique protein fold, unlike other 
inositol phosphate kinases, and is able to add a pyrophosphate moiety to 
position 1 on the ring(Wang, Falck et al. 2012). In vitro PPIP5K is able to 
phosphorylate both IP6 and IP7, however the physiological preference appears to 
be towards IP7 generated by IP6K. In yeast, kcs1Δ possesses no detectable IP7, 
whilst vip1Δ  has increased levels of IP7. The most likely explanation for this 
result is that Vip1 acts predominantly an IP7 kinase in vivo and its deletion 
results in an increase in its substrate.  
 
The deletion of Vip1 has relatively limited effect on the fitness of the vip1Δ 
mutant. This is in stark contrast to the severe effect in the kcs1Δ, adding further 
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to the hypothesis that PPIP5K/Vip1 is primarily an IP7 kinase. However, deletion 
of Asp1, the Schizosaccharomyces pombe homologue to Vip1, renders the 
mutant temperature sensitive (Feoktistova, McCollum et al. 1999). 
 
The structure of the PPIP5K kinase domain displays a number of unique 
properties. The addition of a further negative charge onto the already highly 
polar IP7 is not an energetically favourable event. As such the positively charged 
residues in the binding site make numerous contacts with the substrate to 
neutralise the charge and facilitate the addition of an eighth phosphate to the 
already densely phosphorylated IP7 (Wang, Falck et al. 2012). Furthermore, a 
second, less constrained binding site exists on the surface of PPIP5K (Wang, 
DeRose et al. 2014). This second binding pocket has been hypothesized to act 
as a substrate capture site, rather than having an allosteric effect. It is proposed 
that substrate transiently occupies the surface-binding site, before being flipped 
100° into the active site where it is phosphorylated. 
 
The PPIP5K enzymes are further complicated by the presence of an additional 
acidic-phosphatase domain. The phosphatase domain from the PPIP5K 
homologue (Asp1) of the fission yeast, S. pombe, has recently been shown to 
possess very specific activity towards pyrophosphate moieties at position 1 of 
the ring (Wang, Nair et al. 2015). Both the phosphatase domain alone and full-
length protein were able to dephosphorylate (1PP) IP7 and (1,5PP) IP8, but not 
other isomeric forms of IP7. This remarkable activity indicates that the product of 
the PPIP5K kinase domain is specifically destroyed by the phosphatase domain 
of the very same protein. 
 
Aside from the PPIP5K phosphatase domain, additional inositol pyrophosphate 
phosphatases exist in the form of the DIPPs. These phosphatases also display a 
greater hydrolase activity towards position 1 of the inositol ring although they 
are able to dephosphorylate other positions on the ring. Four DIPPs have been 
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identified in mammals, whilst the yeast genome encodes a single homologue 
(Ddp1). These enzymes are members of the Nudix (nucleoside diphosphate 
linked moiety X) family of hydrolases and are highly promiscuous. They are able 
to cleave the phosphoanhydride bond of a wide range substrates, including 
nucleotide analogues such as Ap6A and, interestingly, for this work, inorganic 
polyphosphate (polyP), a property shared by both the mammalian and yeast 
homologues (Lonetti, Szijgyarto et al. 2011).    
 
1.2.2 Inositol pyrophosphates: fluctuations and turnover 
In most circumstances the steady state levels of the inositol pyrophosphates 
remain remarkably constant. Relatively few examples of modulation of the level 
of inositol pyrophosphates have been described. The most extreme example, as 
mentioned previously, is the increase in inositol pyrophosphates that occurs 
during the development of the social amoeba D. discoideum. Upon deprivation 
of nutrients the myxamoeba undergoes a 25-fold increase in the level of inositol 
pyrophosphates (Laussmann, Pikzack et al. 2000). This extreme event occurs 
over the course of 24 h or more and is a markedly different phenomena to the 
acute increase associated with second messengers. More rapid changes could 
be observed with direct treatment of pre-starved cells with cyclic AMP (cAMP), 
the key modulator of the developmental response in D. discoideum (Williams 
2010). This treatment induced a rapid change in both IP7 and IP8 within 60 s. 
However, as well as being pre-starved, these cells had also been treated with 
caffeine and a PIKK (phosphoinositides 3-kinase-related) family inhibitor to 
supress endogenous cAMP production. 
  
The pharmacological treatment of a variety of mammalian cells with NaF is also 
able to induce an increase in the level of inositol pyrophosphates. This treatment 
points to a rapid turnover of these molecules, with approximately 50% of the IP6 
and up to 20% of the IP5 pool converted to inositol pyrophosphates each hour 
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(Menniti, Miller et al. 1993). This indicates that, whilst the concentration of these 
molecules does not vary dramatically, they are rapidly turned over. Thus 
maintaining their concentration requires significant investment of energy. Further 
evidence of this comes from primary hepatocytes where the IP7 pool was shown 
to turnover ten times in a 40 min period. This can be compared to just 10% of 
the IP6 pool in the same time period (Glennon and Shears 1993). 
 
The physiological relevance of NaF-induced increases in inositol 
pyrophosphates is unclear. NaF is well known as a pan-phosphatase inhibitor, 
able to inhibit the action of DIPPs (although it’s ability to inhibit the phosphatase 
domain of PPIP5K is not known) (Caffrey, Safrany et al. 2000). The effect of NaF 
may, therefore, be solely explained by its inhibitory action on phosphatases. 
However, the effect of NaF on levels of inositol pyrophosphates is not 
conserved in yeast, despite the fact that Ddp1p is also sensitive to NaF 
inhibition (Lonetti, Szijgyarto et al. 2011).  
  
Physiological modulations of the level of inositol pyrophosphates during the cell 
cycle have been described in rat mammary tumour cells (Barker, Wright et al. 
2004) and yeast (Banfic, Bedalov et al. 2012). In rat cells, IP7 was reported to 
peak during G1 phase, when the levels of inositol pyrophosphates doubled in 
comparison to any other stage of the cell cycle. Meanwhile in yeast, the peak in 
inositol pyrophosphates was found to occur during S phase. Neither the 
significance of these divergent results, nor the role of these fluctuations during 
the cell cycle, are well understood.  
 
Alongside the effects described above, starvation has also been described to 
modulate the levels of inositol pyrophosphates in mammalian and yeast cells. 
Overnight serum starvation of mouse embryonic fibroblasts (MEFs) results in a 
depletion of the level of IP7. This decrease can be reverted by treatment with 
insulin-like growth factor 1 (IGF-1) (Chakraborty, Koldobskiy et al. 2010). 
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Meanwhile, phosphate starvation has been reported to stimulate both an 
increase (Lee, Mulugu et al. 2007) and decrease (Boer, Crutchfield et al. 2010) in 
the levels of inositol pyrophosphates. 
 
In plants, which possess homologues to PPIP5K, but not IP6K, jasmonate 
signalling can induce the synthesis of IP8 (Laha, Johnen et al. 2015).  Whilst the 
source of IP7 in plants remains unclear, IP8 is synthesised in a manner 
dependent upon the activity of the PPIP5K homologue, VIH2. Treatment of 
Arabidopsis thaliana with the plant hormone methyl jasmonate, a hormone 
involved in the plant pathogen response, induces a 2-fold increase in IP8 (Laha, 
Johnen et al. 2015). This increase is dependent upon VIH2, disruption of this 
gene causes aberrant jasmonate perception and decreased resilience to 
pathogens. 
 
That there are so few examples of fluctuations of the levels of inositol 
pyrophosphates suggests that these molecules are not classical second 
messengers and that they act in an alternative fashion. The rapid turnover and 
substantial energetic investment in a stable steady state concentration hints at a 
role in some kind of homeostatic control. In fact, of the few examples identified 
in which the level of inositol pyrophosphates change, most occur in response to 
some form of starvation, suggesting a potential link to metabolic homeostasis. 
1.2.3 Roles of inositol pyrophosphates 
The evolutionary conservation of these molecules indicates an important role in 
eukaryotic physiology. This view is further supported by the wide-ranging 
cellular processes in which the inositol pyrophosphates have been implicated. 
From vesicular trafficking to maintenance of telomere length and epigenetic 
control of transcription, the inositol pyrophosphates are exceptionally diverse in 
their influences. 
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A role in vesicular trafficking was first identified through the fragmented vacuole 
of the yeast kcs1Δ (Saiardi, Caffrey et al. 2000). The biogenesis of the yeast 
vacuole is dependent on both endocytic and Golgi trafficking, providing the first 
suggestions that vesicle fusion or trafficking might be regulated in some way by 
the presence of inositol pyrophosphates. Further genetic studies localised the 
trafficking defect to the endocytic pathway (Saiardi, Sciambi et al. 2002).  
 
The role of inositol pyrophosphates in controlling telomere length was indicated 
by the altered telomere lengths in strains with aberrant levels of inositol 
pyrophosphates (Saiardi, Resnick et al. 2005, York, Armbruster et al. 2005). 
Cells synthesising increased levels of inositol pyrophosphates showed a 
decrease in length of telomeres, whilst cells lacking inositol pyrophosphates had 
longer telomeric regions (Saiardi, Resnick et al. 2005). This effect was mediated 
through the phosphoinositide 3-related-kinases Tel1 and possibly Mec1 
pathways involved in DNA damage repair in yeast. 
 
Further roles for the inositol pyrophosphates in the nucleus were indicated by 
the altered methylation of histones in mammalian cells lacking IP6K1 (Burton, 
Azevedo et al. 2013). A yeast two-hybrid screen identified IP6K1 as an 
interaction partner of the histone demethylase, Jumonji domain-containing 2C 
(JMJD2C). Investigation of this interaction in HeLa cells and ip6k-/- MEFs 
revealed that this interaction recruited IP6K1 to chromatin. Furthermore, 
synthesis of IP7 by IP6K was able to regulate the activity of JMJD2C and thus 
the level of histone methylation. This effect is dependent on the catalytic activity 
of IP6K, but not due to direct effect of IP7 on JMJD2C as IP7 isomers are unable 
to alter JMJD2C demethylase activity in in vitro assays. Transcription of genes 
controlled by JMJD2C activity is altered by the presence or absence of IP6K1, 
indicating that inositol pyrophosphate signalling plays a role in transcription by 
acting on histone modifying enzymes via an as yet unidentified mechanism. 
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The role of inositol pyrophosphates in control of transcription is further 
demonstrated by the failure of yeast lacking inositol pyrophosphates to mount 
an environmental stress response (ESR) (Worley, Luo et al. 2013). The 
kcs1Δvip1Δ show defective transcriptional response to a range of stresses, 
manifesting in a failure to repress stress genes during logarithmic growth as well 
as a failure to induce stress genes upon osmotic, heat or oxidative stress. The 
effect of inositol pyrophosphates on the ESR response also occurs at the level 
of chromatin modification. Cells lacking inositol pyrophosphates are deficient in 
the activity of the histone deactelyase (HDAC) Rpd3L, leading to a failure to 
regulate transcriptional response downstream of the environmental stress 
pathway (Worley, Luo et al. 2013). The inhibition of Rpd3L by the inositol 
pyrophosphates has been suggested to be direct, due to the binding of inositol 
pyrophosphates to an IP4 binding pocket previously identified in Rpd3L’s human 
homologue, HDAC3 (Watson, Fairall et al. 2012). 
 
Such a breadth of effects, across a disparate array of cellular processes 
suggests a more basic regulatory function of inositol pyrophosphates. One 
intuitive hypothesis postulates that the diverse influences of the inositol 
pyrophosphates are underpinned by an influence on primary metabolism 
(Bennett, Onnebo et al. 2006, Shears 2009). 
 
In recent years evidence supporting this attractive hypothesis (detailed in Figure 
1.5) has emerged from both yeast and mammalian models. In yeast, the kcs1Δ 
strain, which lacks detectable IP7, is unable to grow on nonfermentable carbon 
sources and yet has three-fold higher levels of ATP (Szijgyarto, Garedew et al. 
2011). This remarkable effect on energy homeostasis occurs in spite of the fact 
that the mitochondria of this strain are dysfunctional. Instead this increase in   
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Figure 1.5 Influence of inositol pyrophosphates in primary metabolism 
Primary metabolic influences exerted by inositol pyrophosphates (shown as IP7). 
This figure shows three, probably connected, features that link inositol 
pyrophosphates to metabolism. This can be observed at the molecular level, 
through control of phosphate homoeostasis (Norbis, Boll et al. 1997, Illies, 
Gromada et al. 2007, Chakraborty, Koldobskiy et al. 2010, Lonetti, Szijgyarto et 
al. 2011); at a cellular level through an effect on primary metabolism (Szijgyarto, 
Garedew et al. 2011) and at the level of the organism, by regulating insulin 
signalling (Illies, Gromada et al. 2007, Chakraborty, Koldobskiy et al. 2010)levels. 
Figure and figure legend adapted from (Wilson, Livermore et al. 2013). 
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ATP stems from the dramatic shift to glycolytic ATP-production. Moreover, the 
adenylate energy charge (AEC), a measure of amount of metabolically available 
energy stored in the adenylate pool, of these cells is also increased. 
Overexpression of the human IP6K1 in this strain correspondingly reduces the 
level of ATP, indicating that this is a likely to be a direct effect of IP7 rather than 
of Kcs1p itself. Mouse embryonic fibroblasts (MEFs) lacking the IP6K1 display a 
similar increase in the levels of ATP as well as defective mitochondria, indicating 
that this phenomenon is not specific to yeast. 
 
The concept of inositol pyrophosphates as metabolic regulators gains support 
from the properties of the main synthesising enzyme, IP6K. IP6K has a Km for 
ATP of between 1.0 and 1.4 mM (Voglmaier, Bembenek et al. 1996, Saiardi, 
Erdjument-Bromage et al. 1999, Saiardi, Caffrey et al. 2000), a value very close 
to that of intracellular concentrations of ATP. The other inositol phosphate 
kinases typically have a Km for ATP between 20 and 100 µM (Wundenberg and 
Mayr 2012), making IP6Ks unusually sensitive to cellular ATP levels. This 
observation prompted the “energostat” model for inositol pyrophosphate control 
of metabolism (Wundenberg and Mayr 2012). This model postulates that any 
slight fluctuation in cellular ATP will be reflected by a subtle, but finely tuned 
change in IP6K activity and thus the level of IP7. These subtle changes in the 
level of inositol pyrophosphates then exert their effects on a range of cellular 
functions as described above. This beautifully explains both remarkably 
constant steady state levels of inositol pyrophosphates and the extraordinary 
range of phenotypes with which they are associated. Importantly, the 
“energostat” model makes no assumptions regarding the mode of action, 
explored further below. 
 
In light of this role as a regulator of basic cell metabolism, a range of phenotypic 
effects of can be explained.  In the pathogenic yeast Cryptococcus neoformans, 
cells lacking inositol pyrophosphates are less able to sustain an infection than 
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their WT counterparts. This pathogenic defect is underpinned by the metabolic 
control exerted by the inositol pyrophosphates (Lev, Li et al. 2015). The kcs1Δ of 
C. neoformans displays a similar growth defect to the S. cerevisiae strain on 
non-fermentable carbon sources. In addition, the activity of Kcs1 was required 
for infection of mouse lungs, as infection with kcs1Δ strain resulted in a reduced 
fungal load. It is hypothesised that this infection defect was due to the observed 
metabolic defect of the kcs1Δ strain, impairing its proliferation in the low carbon 
environment of the lung and precluding its utilisation of alterative carbon 
sources (Lev, Li et al. 2015). 
 
Considering the inositol pyrophosphates as metabolic regulators can also aid in 
the interpretation of the IP6K1-/- knockout mouse phenotype. This mouse 
displays a dramatic metabolic phenotype, with decreased insulin secretion 
(Bhandari, Juluri et al. 2008), hypersensitive to insulin and resistance to obesity 
even when fed a high fat diet (Chakraborty, Koldobskiy et al. 2010). This link to 
organismal energetic metabolism is consistent with the increase in insulin 
release by exocytosis from pancreatic beta cells overexpressing IP6K1 (Illies, 
Gromada et al. 2007). Similarly knock down of IP6K1 in these cells reduces their 
rate of exocytosis. These observations are all consistent with a link to metabolic 
homeostasis at the organismal level (Figure 1.5). 
 
Conversely, the IP6K2-/- knockout mouse does not exhibit any metabolic 
phenotype or insulin sensitivity. Rather this mouse is resistant to ionising 
radiation and exhibits an upregulation of DNA-repair pathways (Morrison, Haney 
et al. 2009). Overexpression of IP6K2 in a range of cancer cell lines increases 
their susceptibility to cell stressors, including cisplatin and staurosporin (Nagata, 
Luo et al. 2005). Meanwhile RNAi of IP6K2, but neither IP6K1 nor IP6K3 
diminishes staurosporin-induced apoptosis. The effect on apoptosis is IP6K2 
specific and associated with the translocation of IP6K2 from the nucleus to the 
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mitochondria, although these localisation studies were performed with 
overexpressed, tagged IP6K2, not endogenous protein (Nagata, Luo et al. 2005).  
 
Recently, characterisation of the IP6K3-/- knock out mouse has revealed a 
defect in coordination and motor function (Fu, Xu et al. 2015). IP6K3 is 
particularly abundant in the Purkinje cells of the cerebellum and its deletion 
results in a reduction in the number of synapses formed by these cells. 
However, this phenotype is dependent upon the kinase itself, rather than its 
inositol pyrophosphate products. IP6K3 interacts with components of the 
cytoskeleton, spectrin and adducin, independently of its kinase function. 
Deletion of IP6K3 abrogates the interaction between these cytoskeletal proteins, 
culminating in changes in cell morphology, reduced synapse formation and a 
coordination defect in the rotor rod (Fu, Xu et al. 2015). 
1.2.4 Inositol pyrophosphates: mechanism of action 
The inositol pyrophosphates are clearly influential in many cellular processes, 
however the molecular mechanism by which these influences are exerted is 
controversial. To date two modes of action have been proposed for the inositol 
pyrophosphates (Figure 1.6). The first, and most classical, is through binding of 
IP7 to PH domain-containing proteins. This mechanism postulates that IP7 
competes with the normal ligand for the PH domain, PIP3, and disrupts the 
membrane localisation of effector molecules. The first described example of this 
came from work in D. discoideum where IP7 competes with PIP3 for the PH 
domain of the cytosolic regulator of adenylate cyclase (crac) (Luo, Huang et al. 
2003). Thus the presence of IP7 has an inhibitory effect on the membrane 
localisation of crac. Deletion of the IP6K in these cells ablated IP7. Expression of 
a GFP-tagged fusion protein of the crac PH domain (PHcrac) displays an 
increased membrane localisation in response to cAMP in mutant compared to 
WT cells. IP7 is able to inhibit the localisation of the PHcrac to liposomes 
containing PIP3 with an IC50 of 50 nM.  
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Figure 1.6 Mechanism of action of inositol pyrophosphates 
The allosteric mechanism of action (A); where inositol pyrophosphates bind to 
an effector protein. This  has been suggested for the S. cerevisiae protein Pho81 
(Lee, Mulugu et al. 2007) as well as PH domains of the D. discoideum protein 
Crac (Luo, Huang et al. 2003) and the mammalian Akt (Chakraborty, Koldobskiy 
et al. 2010). Pyrophosphorylation of proteins (B); inositol pyrophosphates 
transfer their β-phosphate to target proteins (Saiardi, Bhandari et al. 2004). A 
pre-phosphorylated serine residue (Bhandari, Saiardi et al. 2007) in a negatively 
charged local environment (shown in red) can be pyrophosphorylated, in the 
presence of divalent cations. Figure and figure legend adapted from (Wilson, 
Livermore et al. 2013). 
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In fact IP7 is able to competitively inhibit binding of mammalian PH domains to 
PIP3, including the PH domain of Akt (PHAkt) (Luo, Huang et al. 2003). In IP6K1 -
/- MEFs there is an increased localisation of Akt to the membrane in response to 
IGF-1 treatment. Similarly, the proposed mechanism places IP7 as a competitive 
inhibitor of PIP3 for to the PH domain of Akt (Chakraborty, Koldobskiy et al. 
2010). This study describes the inhibition of PDK1 phosphorylation of Akt by IP7 
with an IC50 of ~ 1µM in the presence of PIP3 and 20 nM in the absence of PIP3. 
However, since the cellular concentration of IP7 in mammalian cells is typically 
0.5 – 1.3 µM, it seems likely that Akt would be constitutively bound and inhibited 
by IP7. This observation poses significant problems, as the membrane 
localisation of Akt upon PIP3 production would require Akt to first release IP7 
before binding PIP3 at the membrane. 
 
In fact alternative studies of the PH domain of PDK1 measured its affinity for IP7 
to be less than that for IP6 (Komander, Fairservice et al. 2004). Given that in most 
cells the concentration of IP6 is far in excess of that of IP7, it is unlikely that 
physiological concentrations of IP7 will bind to PDK1. Finally, structural and 
spectral analysis of a PH domain bound to IP3 suggests that positions 4 and 5 of 
the inositol ring are crucial to binding (Hyvönen, Macias et al. 1995). Therefore 
placing a pyrophosphate moiety at position 5, as is the case for the most 
commonly occurring form of IP7 seems likely to disrupt the ability of the PH 
domain to bind IP7. 
 
The alternative mode of action for the inositol pyrophosphates depends more 
directly on the energy stored in the pyrophosphate moiety. Inositol 
pyrophosphates are able to take part in phosphotransfer reactions, donating 
their beta phosphate to target proteins (Saiardi, Bhandari et al. 2004). This 
process occurs in a non-enzymatic manner and involves the transfer of the beta 
phosphate onto a pre-phosphorylated serine located in acidic, serine-rich 
regions in a process termed pyrophosphorylation (Bhandari, Saiardi et al. 2007). 
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The evidence supporting this mode of action comes largely from the transfer of 
radioactivity from 32P-labelled IP7 (synthesised by incubating IP6 with IP6k and 
32P ATP) to target proteins. Nsr1 was identified as the most abundant 
phosphoprotein in yeast extract treated with radio labelled IP7. Nsr1, a ribosomal 
RNA processing enzyme, along with YGR130c, a protein of unknown function, 
are both phosphorylated by IP7 in vitro. Both proteins contain a serine-rich, 
acidic region, a property shared by all targets of IP7 phosphorylation to date. 
 
Numerous targets have been identified, offering insight into the mechanism by 
which previously discussed roles of inositol pyrophosphates, including 
trafficking and primary metabolism, may be exerted. In mammalian cells, the β 
subunit of the AP-3 clathrin accessory protein (AP3B1) is a target of IP7 
mediated pyrophosphorylation (Azevedo, Burton et al. 2009). In vitro 
pyrophosphorylation of AP3B1 inhibits the interaction of the clathrin adaptor 
with its binding partner, motor protein KIF3a. By using release of Gag-containing 
vesicles as a measure of AP3B1-KIF3a trafficking, it was revealed that cells with 
reduced levels of IP7 release more virus-like particles. The influence of AP3B1-
KIF3a trafficking in cells indicates that the pyrophosphorylation-dependent 
inhibition of binding between these two proteins also occurs in vivo. 
  
The metabolic phenotype of the kcs1Δ yeast, with dysfunctional mitochondria 
and yet elevated ATP, is dependent upon the upregulation of glycolytic genes, 
as shown by increased expression of GAPDH, PGK1 and alcohol 
dehydrogenase (ADH1) in this strain (Szijgyarto, Garedew et al. 2011). In fact the 
expression of these genes is regulated by inositol pyrophosphates via 
pyrophosphorylation. The expression of glycolytic genes in yeast is dependent 
upon the Gcr1, Gcr2 and Rap1 transcription factors. Gcr1 is  
pyrophosphorylated by IP7, disrupting the interaction between Gcr1 and Gcr2 
and inhibiting expression of glycolytic genes in WT cells. In kcs1Δ cells, lacking 
IP7 there is more binding between Gcr1 and Gcr2, leading to increased 
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expression of glycolytic genes and elevated ATP (Szijgyarto, Garedew et al. 
2011). 
 
Despite the demonstration that numerous proteins, in a range of model 
organisms, can be modified in this way, direct biophysical evidence that this 
modification occurs in vivo remains absent. 
1.2.5 Inositol pyrophosphates: concluding remarks 
Regardless of their mode of action, the inositol pyrophosphates represent a 
fascinating and potentially rather large family of molecules. They exert an 
influence over a diverse array of cellular process and represent a substantial 
energetic investment from the cell. Nevertheless, much remains to be 
understood about how these molecules function and why they merit such 
investment. The work described here, which has sought to address these 
fundamental problems, has in no small part been informed by the yeast model. 
Whilst this model organism has proved exceptionally powerful, further analysis 
of the true physiological function and mode of action of these molecules will 
require additional models to supplement the pioneering work to date. The 
amoeba, D. discoideum, the organism in which the inositol pyrophosphates 
were discovered, offers an attractive system in which to probe these questions, 
as will be described in more detail in section 1.5 
1.3 Inorganic polyphosphate (polyP) 
1.3.1 PolyP: structure and synthesis 
Inorganic polyphosphate (polyP) represents perhaps the simplest widely 
conserved polymer in biology (Figure 1.7). This molecule consists of chains of 
phosphate residues, ranging from tens to hundreds in length. Each phosphate is 
linked to the next by a “high-energy” phosphoanhydride bond, analogous to 
those found in ATP and inositol pyrophosphates (Kornberg 1995). Inorganic 
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polyphosphate has been identified across all kingdoms, from bacteria to 
mammals and, despite years of neglect, has recently begun to attract increased 
interest (Azevedo and Saiardi 2014). 
 
The synthetic route from ATP to polyP has been elucidated in bacteria and some 
lower eukaryotes, however, the enzyme(s) responsible for its synthesis in 
mammalian cells remain elusive. Interestingly, polyP can also be synthesised in 
an abiotic manner, in conditions of extreme heat (Kulaev 1975). The fact that 
polyP can be synthesised in the absence of any organism has fuelled 
speculation that this molecule may have acted as a primitive energy source in 
prebiotic evolution. This proposed ancient role, although speculative, led to the 
coining of the faintly disparaging description of polyP as a “molecular fossil” 
(Kornberg 1995). 
 
Regardless of the origins of polyP, four unrelated enzymes or enzyme 
complexes have been described to show polyphosphate kinase activity in 
modern organisms. The best characterised of these is the bacterial 
polyphosphate kinase (PPK), that is widely distributed across bacterial 
genomes. PPK1 was purified to homogeneity in 1990, revealing a 69 kDa protein 
functioning as part of a tetramer (Ahn and Kornberg 1990). Subsequent 
crystallisation of E. coli PPK1 refined this model to consist of a dimeric complex, 
in which each monomer possesses a positively charged channel that is 
predicted to interact with the elongating polyP chain (Zhu, Huang et al. 2005). 
Activation of PPK1 requires the autophosphorylation of histidine residues and, 
whilst PPK1 shows no structural similarities to other histidine kinases, it does 
share structural features with the eukaryotic enzyme phospholipase D (PLD), 
another enzyme activated by histidine phosphorylation (Kumble, Ahn et al. 1996, 
Zhu, Huang et al. 2005). Interestingly, the PPK1 enzyme can also be driven in 
reverse in conditions of high ADP and polyP, driving the synthesis of ATP, using 
polyP as a phosphate donor (Ahn and Kornberg 1990).  
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Figure 1.7 polyP structure and endo- and exo-polyphosphatase enzymatic 
site of action 
This figure shows a schematic of the polyP polymer, where ‘n’ can range 
between tens and several hundreds. Endopolyphosphatases cleave internal 
polyP bonds, generating two shorter polyP chains. Exopolyphosphatases cleave 
the terminal phosphoanhydride bond, generating free phosphate and shortening 
the polymer by one phosphate at a time. Phosphorus, red circle; and oxygen, 
green circle. Figure and figure legend adapted from (Livermore, Azevedo et al. 
2016). 
  
O
P
O
O
P
O
P O
O
PO
O
O
P
O
O
P
O
P O
O
PO
O
O
P
O
P O
O{ {
n
endo-polyphosphatase 
(Ppx1)
exo-polyphosphatase 
(Ppn1, Ddp1)
	   49 
A second polyphosphate kinase has been described in prokaryotic systems, the 
so-called PPK2 (Zhang, Ishige et al. 2002). This enzyme was identified by 
purification of activity found in lysates of ppk1 null P. aeruginosa. Isolation of the 
protein by serial fractionation, followed by mass spectrometry revealed a 40.8 
kDa protein. The protein, dubbed PPK2, is encoded by a 1074 bp gene 
widespread amongst prokaryotes. Characterisation of this protein reveals a 
number of differences in activity from PPK1. PPK2 is equally able to synthesise 
polyP using either ATP or GTP as substrate, in contrast to PPK1, which 
exclusively utilises ATP. This enzyme is also highly efficient in polyP-driven 
synthesis of GTP from GDP. Whilst this activity does not appear to extend to 
polyP-driven synthesis of ATP, the potency of GTP synthesis is far in excess of 
PPK2’s polyP synthesising activity (75 fold)(Ishige, Zhang et al. 2002). Therefore, 
whilst this enzyme is capable of synthesising polyP it is possible that its 
physiological role is in fact to maintain cellular levels of GTP by utilising polyP. 
Homology searches have found this gene to be widely distributed in prokaryotic 
genomes, however no eukaryotic homologues have been identified (Zhang, 
Ishige et al. 2002).  
 
In 2009 a eukaryotic polyphosphate kinase was identified in yeast (Hothorn, 
Neumann et al. 2009). This enzyme, Vtc4p, is part of the vacuolar transport 
chaperone (VTC) complex. This protein was identified when crystalisation of the 
VTC complex revealed a chain of electron density “winding through the tunnel 
domain” of the crystal. This VTC complex is predominantly located on the 
vacuolar membrane but can also be found on both the nuclear and plasma 
membrane. In each case the complex is orientated such that the catalytic 
domain faces the cytosol. The synthesis of polyP by this complex is coupled 
with its translocation across the membrane and in fact accumulation of polyP in 
the cytosol exerts a toxic effect on the cell (Gerasimaitė, Sharma et al. 2014).  
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Complexes homologous to the VTC complex have been identified in other 
simple eukaryotic systems, including the Trypanosome (Fang, Rohloff et al. 
2007). Ablation of the TbVT1 protein, the trypanosome Vtc4 homologue, by 
RNAi results in a decrease in polyP in these cells. Despite the conservation of 
the VTC complex between yeast and trypanosomes, no such complex can be 
found in the genomes of multicellular higher eukaryotes. To date, although polyP 
has been widely reported in mammalian cells (Morrissey, Choi et al. 2012), no 
polyphosphate kinase has been identified. 
 
One of the few other eukaryotes to possess an annotated polyphosphate kinase 
is the amoeba, D. discoideum. The genome of this amoeba encodes a bacterial-
like PPK enzyme, known as DdPPK1. This gene, most likely acquired by 
horizontal gene transfer from bacteria, encodes a 1053 amino acid protein, 
which is homologous to the E. coli PPK1 (Zhang, Gómez-García et al. 2005). D. 
discoideum is also notable for the presence of a second polyphosphate kinase 
in its genome. This second enzyme complex, described as DdPPK2, is a 
tetrameric complex of three actin-related proteins (Gómez-García and Kornberg 
2004). In a remarkably unique enzymatic process, this complex synthesises 
polyP as it polymerises itself to form actin-like fibrils. The conservation of 
homologous proteins in mammalian cells has led to some speculation that this 
enzymatic activity may be conserved in higher eukaryotes (Hooley, Whitehead et 
al. 2008). The synthesis of polyP in D. discoideum will be explored in more detail 
in section 1.5 and Chapter 5. 
 
PolyP is degraded by polyphosphatases, of which there are two classes, 
exopolyphosphatases, which degrade polyP by removing the terminal 
phosphate from the chain, and endopolyphosphatases, which cleave the 
internal bonds of the chain (Figure 1.7). The best-characterised 
exopolyphosphatase is the yeast protein Ppx1p, a member of the superfamily of 
phosphoesterases. This enzyme is able to processively cleave the terminal 
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phosphate from a polyP chain, degrading as far as the pyrophosphate moiety 
(Wurst and Kornberg 1994). Although the polyP kinase is yet to be identified in 
mammalian cells, a PPX homologue has been annotated in the form of h-Prune. 
 
Endopolyphosphatases represent the second class of polyphosphatases. The 
yeast protein PPN1 is encoded by a 2025 bp gene, however the gene product 
must be proteolytically cleaved before it is active (Shi and Kornberg 2005). The 
catalytically active form of PPN1 resides in the vacuole and comprises a 
homotetramer of 35 kDa subunits. Each subunit is derived from the cleavage of 
the so-called prePPN1, a 78 kDa precursor protein (Shi and Kornberg 2005). The 
exact post translational processing required to generate an active PPN1 is 
unclear, hence comparatively little is known about this protein other than its 
cellular localisation to the vacuole. Despite being best known as an 
endopolyphosphatase it appears that in certain conditions, PPN1 can also act 
as an exopolyphosphatase(Andreeva, Trilisenko et al. 2015). 
 
Whilst PPN1 is limited to yeast (Azevedo and Saiardi 2014), a second, more 
widespread, endopolyphosphatases has already been introduced in the form of 
the DIPPs and Ddp1. This enzyme has already been introduced for its ability to 
degrade the inositol pyrophosphates, however this highly promiscuous enzyme 
is also able to degrade polyP (Lonetti, Szijgyarto et al. 2011). As noted 
previously, DIPPs are widely conserved between yeast (Ddp1) and mammalian 
cells (DIPPS 1-4).  The ability of a single enzyme to degrade both the inositol 
pyrophosphates and polyP is notable and the links between these phosphate-
rich molecules will be explored in more detail later. 
1.3.2 PolyP: fluctuations and turnover 
PolyP is highly abundant in many bacteria as well as the yeast S. cerevisiae, 
where up to 20% of the dry mass is made up of polyP. Absolute quantification 
of polyP is challenging as the variable chain length of the polymer means that 
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concentration must be expressed in terms of free phosphate. By this measure, 
polyP is estimated to be in the millimolar range in both yeast and bacteria. 
Meanwhile the levels observed in mammalian cells are far lower, 20-120µM, with 
chain length of polymers also generally reduced (Kumble and Kornberg 1995). 
Nevertheless, several examples of accumulation of polyP have been described 
in bacteria. Nutrient starvation, osmotic stress and nitrogen starvation have all 
been shown to induce rapid accumulation of polyP in E. coli (Ault-Riché, Fraley 
et al. 1998). In yeast, phosphate starvation causes a rapid decrease in polyP, 
which can be restored upon addition of phosphate to the media (Trilisenko, 
Andreeva et al. 2003). 
1.3.3 Roles of polyphosphate 
Despite the unflattering term “molecular fossil”, polyP has been implicated in a 
wide range of cellular functions. There are several descriptions of enzymes that 
are able to utilise the energy stored in the phosphoanhydride bonds of polyP to 
drive biochemical processes. PPK for instance can be driven in reverse using 
polyP to reconstitute ATP by transferring a phosphate onto ADP (Ahn and 
Kornberg 1990). Furthermore, certain bacterial glucokinase enzymes are able to 
use polyP in place of ATP to phosphorylate glucose (Hsieh, Shenoy et al. 1993). 
More recently, the human mitochondrial protein C5orf33 has been shown to 
possess NAD kinase activity and is able to use both ATP and polyP to 
phosphorylate NAD, generating NADP+ (Ohashi, Kawai et al. 2012). 
 
In light of the large amounts of energy stored in a polyP polymer, its utility in 
both regenerating ATP and use by some enzymes to drive biochemical 
reactions, it is tempting to consider polyP as an energy source. In cells where 
polyP levels can exceed the steady state level of ATP, as is the case in the 
stationary phase of E. coli growth, this is a particularly attractive hypothesis. 
However, whilst there is no doubt that polyP is able to drive certain biochemical 
processes, in reality the turnover of ATP is so rapid that it could only be 
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sustained for a matter of seconds by physiological levels of polyP (Kornberg, 
Rao et al. 1999). Therefore, it does seem likely that in polyP acts as a major 
source of energy under most normal conditions.  
  
Aside from acting as an energy source, another intuitive role of polyP is its ability 
to act as a reservoir of free phosphate (Pi) and thus a Pi buffer. The synthesis 
and degradation of polyP allows the rapid and tuneable regulation of free Pi. The 
availability of free phosphate is of upmost importance for primary metabolism 
and synthesis of ATP. The extremely anionic nature of polyP also makes it a 
strong chelator of divalent cations. In the cell this is primarily Mg2+, however Ca2+ 
can be chelated with similar efficiency by polyP. Thus the synthesis or 
degradation of polyP can also have a dramatic effect on the cellular availability 
of these cations (Kornberg 1995). 
 
This polymer has also been shown to play a role in more specific functions, 
including the virulence of numerous human pathogens. Deletion of PPK1 in the 
opportunistic pathogen Pseudomonas aeruginosa renders the bacteria unable to 
form biofilms. This ppk null strain is defective in production of virulence factors 
and less able to sustain infections (Rashid, Rumbaugh et al. 2000). In fact, 
numerous pathogenic bacteria with reduced levels of polyP, including 
Salmonella and Shigella species, have been shown to show similar reduction in 
pathogenicity (Moreno and Docampo 2013).  
 
The effect of polyP on pathogenicity has also been documented in certain 
eukaryotic pathogens including Trypanosoma brucei. PolyP accumulates in an 
organelle known as the acidocalcisome in Trypanosomes. Acidocalcisomes are 
acidic, calcium and phosphate-rich organelles that were first described in 
Trypanosomes. Subsequently, orthologous compartments have been identified 
from bacteria to man (Docampo and Moreno 2011). Failure to accumulate polyP 
in the acidocalcisomes results in Trypanosomes with reduced pathogenicity 
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(Moreno and Docampo 2013). Despite conservation between prokaryotic or 
eukaryotic microorganisms the role of polyP in pathogenicity is not well 
understood.  
 
In mammalian cells, the dense granules of platelets share many properties with 
the acidocalcisome. It is perhaps unsurprising therefore that the dense granule 
is also rich in polyphosphate (Ruiz, Lea et al. 2004). Patients displaying dense 
granule storage disorders, commonly associated with bleeding conditions, have 
lower levels of polyP in platelets (Hernández-Ruiz, Sáez-Benito et al. 2009).  
 
Platelet activation induces the release of the contents of the dense granules, 
including polyP into the plasma. The release of polyP into the plasma has been 
shown to play an important role in the clotting cascade, directly activating 
plasma protease factor XII (Müller, Mutch et al. 2009). These and other studies 
have placed polyP as a potent modulator of platelet function and blood clotting, 
although the mechanism by which polyP exerts these effects is again unclear 
(Morrissey, Choi et al. 2012). 
 
Whilst the molecular mechanism by which polyP exerts its influence on both 
virulence and blood clotting is unclear, some molecular interactions of polyP 
have been described. In fact, surprisingly, this highly charged polymer has also 
been implicated in the formation of membrane pores in both prokaryotic and 
eukaryotic cells. 
 
The presence of non-proteic membrane channels is well documented in 
bacteria. These channels control cation membrane transport and are comprised 
of the polyester, poly-(R)-3-hydroxybutryrate (PHB) and polyP-Ca2+ (Azevedo 
and Saiardi 2014). In mammalian cells, polyP is associated with the membrane 
mitochondria permeability transition pore (mPTP) a multiprotein pore complex 
found in the inner leaflet of the mitochondrial membrane (Seidlmayer, Blatter et 
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al. 2012). The function of the mPTP is poorly understood, as is the role of polyP 
in its formation and maintenance. It is postulated that the presence of polyP is 
important for the ion conductance of these pores (Abramov, Fraley et al. 2007), 
indicating a further role for control of the cellular levels of ions by polyP. 
 
In addition to its role in mitochondrial ion transport, polyP metabolism has been 
linked to primary metabolism by a genome-wide screen in yeast (Freimoser, 
Hürlimann et al. 2006). This screen found that in yeast, 225 genes were involved 
with the maintenance of polyP levels. In each case, deletion of the identified 
gene alters polyP levels. This was most commonly associated with alterations in 
primary metabolism (Freimoser, Hürlimann et al. 2006), offering further evidence 
linking polyP to the energy status of cells. 
 
Recent work has illuminated some of the molecular interactions of polyP, 
potentially offering insight into how this polymer exerts its varied effects. In fact, 
polyP is able to act as a primordial protein-folding chaperone, showing an 
exceptional ability to protect protein folding in bacteria exposed to extreme 
denaturing conditions (Gray, Wholey et al. 2014). In response to treatment with 
protein unfolding stresses, for example hypochlorus acid (HOCl), E. coli 
accumulate polyP. The accumulation of polyP functions to prevent protein 
aggregation and protect against protein unfolding. Mutants with reduced polyP 
are less resistant to HOCl treatment and display higher levels of protein 
aggregation (Gray, Wholey et al. 2014). In vitro, polyP is able to act as a general 
molecular chaperone, stabilising the folding and thermal stability of numerous 
proteins, both prokaryotic and eukaryotic in origin. It is hypothesised that this 
remarkable property of polyP may be due to its ability to perform the role of 
molecular scaffold and stabilise secondary motifs. An alternative hypothesis is 
that the ionic interaction of the negatively charged phosphate residues, as well 
as the positive charge of associated cations, may exert a stabilising effect (Gray, 
Wholey et al. 2014).  
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This potentially universal property of polyP may offer insight into many of the 
functions described above. Whilst so far this role has only been described in 
prokaryotic cells, the simplicity and conservation of polyP structure is coherent 
with a similar role in eukaryotic cells. 
 
In addition to its ability to act as a protein-folding chaperone, polyP is also able 
to post translationally modify proteins (Skorko 1989, Azevedo, Livermore et al. 
2015). This process, termed polyphosphorylation, sees the addition of chains of 
polyphosphate to lysine residues attached in a non-enzymatic manner. 
Surprisingly this modification affects the pyrophosphorylation target Nsr1p as 
well as its interacting partner Top1p. The functionality of Top1p, its ability to 
relax supercoiled DNA, is negatively regulated by polyphosphorylation. Despite 
the non-enzymatic nature of this modification, regulation occurs via both the 
abundance of polyP and degradation of the modification. Polyphosphorylation 
of Nsr1p and Top1p varies according to the abundance of polyP and treatment 
with Ppx1 degrades the modification. Thus Ppx1 is not only an 
exopolyphosphatase, but also a protein polyphosphatase (Azevedo, Livermore 
et al. 2015). 
 
Although no consensus sequence has been identified for this modification, both 
targets characterised to date are modified in a highly acidic region, enriched in 
serines and lysines. These domains, termed poly acidic, serine (S) and lysine (K) 
(PASK) domains are commonly found in nuclear proteins. It interesting to note, 
therefore that, contrary to previous reports, a large pool of polyP is located in 
the yeast nucleus, approximately 20% of the total amount. Thus, the abundance 
of effector (polyP) and potential targets (PASK domain containing proteins) in 
the nucleus could indicate that this modification represents a major regulatory 
mechanism in nuclear signalling (Azevedo, Livermore et al. 2015). 
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The results described above are indicative of a recent resurgence of interest in 
this molecule, which although ancient in origin is utterly contemporary in its 
biological significance. Once more, the yeast model has been an exceptionally 
powerful tool to study the polyP. In the absence of a mammalian polyP kinase to 
date, yeast represents one of very few genetic models to study polyP function in 
eukaryotic cells.  Nevertheless, the VTC complex responsible for polyP 
synthesis in yeast is not conserved in higher eukaryotes and thus the 
development of additional genetic models will be essential to shed further light 
on the role of this fascinating molecule. 
1.4 Links between inositol pyrophosphates and 
inorganic polyphosphate (polyP) 
As introduced throughout this chapter thus far, numerous links exist between 
the structure, metabolism and functions of the inositol pyrophosphates and 
polyP. This should, perhaps, not come as a surprise given that they represent 
two of the most phosphate rich molecules in the cell. As a result, their 
involvement with phosphate metabolism and homeostasis is to be expected. A 
number of the concepts and phrasing introduced in this section draw from the 
recently published review “Phosphate, inositol and polyphosphates” (Livermore, 
Azevedo et al. 2016). 
 
In yeast the cellular levels of inositol pyrophosphate and polyP are intimately 
coupled (Auesukaree, Tochio et al. 2005). The kcs1Δ yeast strain possesses 
almost undetectable levels of inositol pyrophosphates and a dramatically 
reduced level of polyP. Similarly the vip1Δ strain has elevated levels of IP7 and 
correspondingly elevated levels of polyP (Lonetti, Szijgyarto et al. 2011). The 
mechanism by which this link is maintained is unknown. 
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In yeast, the Pho regulon represents a key pathway for phosphate sensing in S. 
cerevisiae. This regulon, consisting of numerous genes controls the transcription 
of hundreds of genes in response to phosphate abundance. A cyclin CDK 
complex, Pho80-Pho85 phosphorylates the Pho4 transcription factor (Kaffman, 
Herskowitz et al. 1994), causing its export from the nucleus (O'Neill, Kaffman et 
al. 1996). In conditions of phosphate starvation, the Pho80-Pho85 complex is 
inhibited by Pho81, resulting in the accumulation of Pho4 in the nucleus and a 
dramatic transcriptional response. Genetic perturbations to the Pho-regulon 
modulate levels of polyP, but do not affect the levels on inositol 
pyrophosphates. However, 1PP-IP5, synthesised by Vip1p, is able to 
allosterically inhibit the Pho80-Pho85-Pho81 complex, altering the transcription 
of hundreds of genes (Lee, Mulugu et al. 2007). Whilst the Pho-regulon is 
restricted to S. cerevisiae, the interplay between inositol pyrophosphates and 
polyP metabolism is striking. 
1.4.1 Phosphate metabolism 
Phosphorus, present in its phosphate (PO43-) form, is one of the most abundant 
elements in living cells. Its importance can be inferred from the range of 
molecules and functions with which it is associated. Phosphate plays a crucial 
structure role in the backbone of nucleic acids DNA and RNA. Its covalent 
attachment to proteins represents the most common signalling modality 
(Manning, Whyte et al. 2002), found from prokaryotic to eukaryotic cells. 
Furthermore, the energy stored in the phosphate-phosphate phosphoanhydride 
bond, present in ATP, inositol pyrophosphates and polyP, is the most common 
energy store in biology. Life as we know it depends upon phosphate (Elias, 
Wellner et al. 2012). 
 
Thus, it is evident that the cellular abundance of Pi must be tightly controlled. A 
number of specific transporters regulate free phosphate uptake, controlling its 
	   59 
concentration in this way (Dick, Dos-Santos et al. 2014). However, both polyP 
and inositol pyrophosphates feed into this control.  
 
As described above, the synthesis and degradation of polyP offers a rapid 
buffering system for free Pi. In turn the inositol pyrophosphates are able to 
regulate the level of polyP in yeast cells. In fact, links between phosphate 
metabolism and inositol pyrophosphates are conserved throughout biology. For 
example, IP6K2 was first identified as a regulator of phosphate uptake in 
Xenopus laevis oocytes before even IP6K was cloned. Injection of mammalian 
cDNA into the Xenopus oocyte was shown to induce the uptake of phosphate 
from the media, thus the gene was called Pi Uptake Stimulator (PiUS)(Norbis, 
Boll et al. 1997). It was noted at the time that this gene does not encode a 
transmembrane domain and therefore seemed unlikely to be a canonical 
phosphate transporter. Nevertheless, the mechanism by which phosphate 
uptake is achieved remains unknown. However, identification of PiUS as an 
enzyme, IP6K2 (Schell, Letcher et al. 1999), capable of synthesising IP7 seems 
to suggest a role for the inositol pyrophosphates in the control of Pi uptake. 
 
In addition, IP6K3 was one of only seven genes identified by genome-wide 
associated study (GWAS) to affect the level of phosphate in human blood serum 
(de Boer, Rue et al. 2009). Taken together these data point towards a strong 
relationship between inositol pyrophosphates and phosphate homeostasis at 
both the cellular and organismal level. 
1.5 Inositol pyrophosphates and inorganic 
polyphosphate in D. discoideum 
Having introduced, in a general way, the structure, synthesis and functions of 
the inositol pyrophosphates and polyP it is now necessary to examine the 
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current understanding of these molecules in the chosen model for this work, the 
social amoeba (myxamoeba) D. discoideum.  
 
D. discoideum is a member of the Dictystelid family of social amoeba, so-called 
due to their fascinating ability to grow and divide in a unicellular, amoeboid 
manner in conditions of high nutrients. Upon deprivation of nutrients, these cells 
undergo a remarkable developmental process during which cells first aggregate 
in their thousands, forming a motile “slug” or “grex”, before culminating in a 
fruiting body (sporocarp) (Figure 1.8). The sporocarp consists of two major cell 
types, the spore cells, which are able to germinate upon availability of nutrients 
and the stalk cells, which perish during the formation of the fruiting body in an 
act of extraordinary cellular altruism.  
 
D. discoideum was developed as a laboratory model in the 1930s, with much 
early work focusing on transition to multicellularity and cell fate determination 
(Williams 2010). Since then the amoeba has become an influential model in to 
study chemotaxis and many other cellular processes (Williams 2010).  
 
The D. discoideum genome is haploid and approximately 35 Mb in length, 
comprising six chromosomes ranging between 4 and 8 Mb. At 78% A+T, the 
genome is remarkably A+T rich and has one of the highest A+T biases of any 
known organism. Introns are present in many, but not all, genes and are 
generally <100 base pairs in length. Few genes have more than 3 introns 
(Eichinger and Noegel 2003). 
 
Wild, soil dwelling amoeba are only able to grow when provided with bacteria as 
a food source, thus the majority of the work in this organism has used the 
axenic (AX) strains. Axenic strains are able to grow in rich liquid media, either as 
adherent cells or in shaking culture. It is these axenic strains, most commonly 
AX2, that have been used to study many cellular processes, including   
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Figure 1.8 D. discoideum lifecycle 
D. discoideum exist as unicellular amoeba during vegetative growth. Upon 
deprivation of nutrients, cells begin to aggregate in response to cAMP. 
Aggregating cells form multicellular mounds, which then develop into motile 
slugs, or “grex”, consisting of tens to hundreds of thousands of cells. These 
slugs ultimately mature, into fruiting bodies, consisting of spore cells (~80%) 
and stalk cells (~20%). Stalk cells die during the formation of the fruiting body, 
whilst spore cells are able to germinate into unicellular amoeba upon availability 
of nutrients (Williams 2010).  
  
8 h
16 hr
25 hr
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cell-fate determination (Kay, Flatman et al. 1999), chemotaxis (Kay, Langridge et 
al. 2008) and transcriptional regulation (Corrigan and Chubb 2014). It was the 
AX2 strain of D. discoideum that the inositol pyrophosphates were first identified 
in 1993 (Stephens, Radenberg et al. 1993). 
1.5.1 Inositol pyrophosphates in D. discoideum 
As described above this organism played an important role in the discovery of 
the inositol pyrophosphates. Both the discovery and dramatic physiologic 
accumulation of inositol pyrophosphates in D. discoideum have already been 
discussed. However, these do not represent the sole contributions of D. 
discoideum to field. In fact, it was in this organism that the direct, stepwise 
phosphorylation of myo-inositol to IP6 was first described (Stephens and Irvine 
1990). This study outlined the precise metabolic pathway leading to production 
of IP6 in D. discoideum, progressing via phosphorylation on position 3, followed 
by position 6, then 4, then 1, then 5 and finally position 2. The presence of other 
isomers of IP5, aside from the I(1,3,4,5,6)P5 was shown to be due to rapid 
dephosphorylation of IP6 rather than an alternative route of synthesis.  
 
This work was corroborated by the observation that the deletion of the single 
PLC gene in the D. discoideum induced only a slight decrease in the level of 
I(1,4,5)P3 detected (Drayer, Van der Kaay et al. 1994), suggesting that normal 
levels of inositol phosphates are obtained by a pathway independent of lipid 
phosphoinositides and PLC activity. In fact the I(1,4,5)P3 is obtained by the 
dephosphorylation of the I(1,3,4,5,6)P5 formed via the pathway described above 
(Dijken, Haas et al. 1995). This dephosphorylation activity could also be 
detected in a single enzyme purified from rat liver cells and attributed to an 
enzyme now known as MIPP (Dijken, Haas et al. 1995). These often overlooked 
data are in direct contrast to yeast, where the PLC1 gene is required for 
synthesis of higher inositol phosphates and plc1Δ yeast contain no detectable 
IP6 (York, Odom et al. 1999). With at least 13 PLC genes encoded in mammalian 
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cells, it is not known whether a true plc-null mammalian cell would possess 
soluble inositol phosphates. 
 
Another difference noted between structure and synthesis of inositol 
pyrophosphates between D. discoideum and S. cerevisiae is the isomeric form 
of IP8 (Table 1.1). The in vitro activities of Kcs1p and Vip1p point towards yeast 
possessing the 1,5(PP)2-IP4 isomer of IP8. However, NMR analysis of D. 
discoideum IP8 defines this as the either the 4,5(PP)2-IP4 or 5,6(PP)2-IP4 isomer 
(Laussmann, Eujen et al. 1996, Albert, Safrany et al. 1997). This is to date, the 
only in vivo purified IP8 that has been analysed by NMR. Nevertheless, the NMR 
data is validated by the presence of a very strong kinase activity towards 6PP-
IP5 in D. discoideum extract. The identity of this kinase is unclear, however, a 
partial purification was able to identify that a 40 kDa protein was responsible for 
this activity (Laussmann, Reddy et al. 1997). 
 
It is possible that the recombinant E. coli purified kinases used to define the 
isomers synthesised by Kcs1p and Vip1p behave differently to their 
endogenously expressed counterparts. Alternatively, it may represent a genuine 
difference between the isomeric form of IP8 found in the amoeba. The effect of 
such a difference to the physiology of these molecules would likely depend on 
the mode of action in which they are involved. Phosphotransfer reactions would 
be unlikely to be affected by placing the pyrophosphate on a different position 
on the ring, whilst allosteric interactions and receptor binding could be 
dramatically affected. 
 
Finally, the most recent work on the inositol pyrophosphates in D. discoideum, 
now over ten years old, identified these molecules as regulators of the 
developmental response (Luo, Huang et al. 2003). An IP6K null strain, hereafter 
referred to as ip6k* was generated in this study. This strain possesses no 
detectable inositol pyrophosphates, as determined by HPLC. The speed of 
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aggregation of this mutant strain is slightly increased. This increased speed of 
aggregation is due to the absence of IP7-mediated inhibition of crac localisation 
to the membrane. IP7 achieves this inhibition by competing for the binding of the 
PH-domain of crac with PIP3 as described previously (Luo, Huang et al. 2003).  
 
It is interesting to note once again, that genetic deletion of PIP3 signalling does 
not impair the ability of D. discoideum to respond to cAMP (Hoeller and Kay 
2007, Hoeller, Bolourani et al. 2013, Nichols, Veltman et al. 2015). This 
observation suggests PIP3 plays a negligible role in directed chemotaxis in the 
amoeba and raises uncertainty about the mechanism of action of IP7 proposed 
by Luo et al. (Luo, Huang et al. 2003) 
1.5.2 PolyP in D. discoideum 
The amoeba has also been influential as a model to study polyP. The first 
description of this polymer in D. discoideum was by Gezelius and colleagues in 
the 1970s (Gezelius 1974). This work described a low abundance of polyP in the 
amoeba, before undergoing a five-fold increase during development. The 
presence of polyP in the spore was later confirmed by 31P NMR analysis, 
alongside substantial levels of IP6 (Klein, Cotter et al. 1988). 
 
D. discoideum was also the first eukaryotic organism in which a polyphosphate 
kinase was identified. As described in section 1.3, the amoeba possesses a 
bacterial-like PPK1 as well as a tetrameric complex known as DdPPK2, 
unrelated to the bacterial PPK2. 
 
The PPK1 gene was likely acquired through a horizontal gene transfer event 
from the bacteria on which this amoeba feeds. The PPK1 enzyme shows 30% 
identity and 51% similarity to its E. coli counterpart (Zhang, Gómez-García et al. 
2007), however the homology is limited to the C terminal portion of the 
amoeboid enzyme. The 
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compared to just 688 aa in E. coli. The N terminal portion of the PPK1 enzyme 
represents a novel protein fold with no clear homologues and no annotated 
function. It is, however, required for enzymatic activity (Zhang, Gómez-García et 
al. 2007). 
 
A knock out strain of PPK1 has been generated previously (Zhang, Gómez-
García et al. 2005). This strain was found to show defects in development, 
predation and cytokinesis. The mutant strain grows slower on bacterial lawns, 
but not in rich axenic media. This defect was shown to stem from a defect in 
phagocytosis as demonstrated by reduced uptake of bacteria. Furthermore, this 
mutant is slower to form fruiting bodies, but displays no defect in spore 
germination. The PPK1 mutant also displays a defect in cytokinesis, with 
significantly more multinucleate cells in the mutant compared to WT (Zhang, 
Gómez-García et al. 2007). 
 
An additional, interesting link between polyP and predator-prey relationship was 
observed by examining the growth of the amoeba on an alternative bacterial 
substrate, P. aeruginosa (Zhang, Gómez-García et al. 2005). This bacterial strain 
does not support D. discoideum growth, however deletion of the PPK1 gene in 
the bacteria allows the amoeba, both WT and PPK1 null, to grow on this 
bacteria, suggesting polyP is important to the fitness of P. aeruginosa. 
 
Despite genetic disruption of the PPK1 gene the amoeba strain generated by 
Zhang et al. retains approximately 5% of WT polyP kinase activity and residual 
levels of polyP, estimated at between 20-50% of WT (Zhang, Gómez-García et 
al. 2005). The presence of polyP in this strain can be attributed to the presence 
of additional polyP kinase, the PPK2 complex. This complex was purified from 
WT AX2M1 membranes (Gómez-García and Kornberg 2004). The polyP-
synthesising properties of this actin-related complex are inhibited by addition of 
phalloidin and are concurrent with the formation of actin-like filaments. The 
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genes encoding this remarkable enzyme complex were not cloned, nor deleted, 
making it difficult to estimate the relative contribution of these enzymes to 
cellular polyP concentrations. 
 
 As in Trypanosomes, D. discoideum accumulates polyP in an organelle 
analogous to the acidocalcisome (Marchesini, Ruiz et al. 2002). Hyposmotic 
stress causes the interaction of this organelle with the contractile vacuole, 
indicating a functional linkage between the two organelles and a possible role 
for polyP in the osmotic regulation of the amoeba (Marchesini, Ruiz et al. 2002). 
1.6 Rationale 
Having outlined the current understanding of both inositol pyrophosphates and 
polyP, the aim of this project is to develop D. discoideum as a model to further 
study both these molecules. Whilst the amoeba is of great historical significance 
in the inositol pyrophosphate field it has been somewhat neglected in recent 
years in favour of the yeast model. Study of inositol pyrophosphates in yeast 
offers numerous advantages including ease of genetic manipulation and that 
cells can be readily labelled with 3H-inositol. Consequently, this organism has 
been exceptionally informative and influential in the field to date.  
 
However, the simplicity of the yeast model is not without its downsides. The 
yeast genome encodes just four inositol phosphate kinases (Table 3.1). Whilst 
these are well conserved in mammalian systems, the mammalian genome 
encodes additional inositol phosphate kinase, such as ITPK1, that do not feature 
in the yeast genome. The D. discoideum genome encodes seven inositol 
phosphate kinases, including a homologue to mammalian ITPK1 (Table 3.1). 
 
Furthermore, in yeast, the synthesis of inositol phosphates (and therefore 
inositol pyrophosphates) is entirely dependent upon the phospholipase C-
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medicated cleavage of PIP2. It remains unclear if this is the case in higher 
eukaryotes, including mammals. Certainly in D. discoideum the situation is 
rather different. A direct, step-wise phosphorylation of inositol appears to be the 
primary route of synthesis in the amoeba as demonstrated by the lack of 
phenotype of the plc1 strain. However, the enzymes responsible for these 
activities have not been identified. 
 
Whilst the amoeba is evolutionarily distant from both yeast and mammalian 
cells, its genome size and conservation of kinases, positions it as an ideal 
intermediate between these two systems. Alongside these advantages, are 
numerous technical considerations making the amoeba an attractive model. 
Axenic strains can be grown in high quantities with ease, making biochemistry 
straightforward. Furthermore, the developmental life cycle allows the effect of 
these molecules on a robust and reproducible developmental process to be 
studied. Finally, the high rate of homologous recombination in D. discoideum 
allows the relatively simple deletion of genes (Williams 2010).  
 
Perhaps the most important technical consideration, however, is the high level 
of inositol pyrophosphates and their precursor IP6 in these cells. Whilst the 
amoeba is not readily labelled with 3H-inositol (Saiardi lab observation), recent 
technological developments in PAGE technology have allowed the resolution 
and detection of unlabelled inositol pyrophosphates (Losito, Szijgyarto et al. 
2009). This technique has been applied to in vitro studies, however the high 
levels of inositol phosphates in the amoeba offer the potential to analyse the 
inositol phosphate profile in unlabelled cell extracts for the first time (Pisani, 
Livermore et al. 2014)(See Chapter 3, Figure 3.1). 
 
This improved PAGE technology also allows the resolution and detection of 
unlabelled polyP (Lonetti, Szijgyarto et al. 2011). As described above, D. 
discoideum is one of the few eukaryotic models in which a polyphosphate 
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kinase has been identified. Thus applying PAGE technology to polyP 
metabolism in D. discoideum is an equally attractive aim. 
 
Together these characteristics make the amoeba an ideal model organism in 
which to study the synthesis and metabolism of the inositol pyrophosphates and 
polyP as well as the relationship between these phosphate-rich molecules. 
Therefore the aim of this project will be employ a genetic and biochemical 
approach to better characterise the synthesis, functions and interactions of 
these molecules in D. discoideum. 
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2. Materials and Methods 
2.1 Bacteria 
2.1.1 Bacterial growth media 
E. coli was grown in LB (Luria-Bertani) media [1% Bacto-tryptone 
(FormediumTM), 0.5% yeast extract (FormediumTM), 10 mM NaCl] at 37°C, 220 
rpm or on agar plates(LB media supplemented with 2%) agar. Transformed 
bacteria were selected on ampicillin at 100 µg/ml (stock 100 mg/ml in H2O).  
Blue white screening of colonies was performed by supplementing LB agar 
plates with 20 µg/ml X-Gal (stock 20 mg/ml in DMF, stored at -20°C and 
protected from light) and 0.1 mM Isopropyl β-D-1-thiogalactopyranosid (IPTG) 
(stock 0.1 M in H2O, filter sterilised). These plates will be referred to as IPTG, X-
gal, Amp LB plates hereafter. 
Glycerol stocks were prepared by mixing in a 1:1 ratio saturated bacterial 
culture, with 50% sterile glycerol. Stocks were stored at -80°C. 
2.1.2 E. coli strains 
E. coli  
DH5α: F- endA1 glnV44 thi-1 relA1 gyrA96 deoR nupG lacZdeltaM15 hsdR17 
DH5α: NEB® 5-alpha Competent E. coli (High Efficiency) 
K. aerogenes 
2.1.3 Competent cells 
Chemical competent E. coli were prepared using a protocol modified from 
(Hanahan 1983). DH5α E. coli were streaked on an LB agar plate. A single 
colony was picked and grown overnight in LB media. The culture was diluted to 
an O.D.600 of 0.01 and incubated at 37°C, 220 rpm until an O.D.600 of 0.6 was 
reached. The bacteria were placed on ice for 15 min and collected by 
centrifugation at 2800 rpm for 10 min. Bacteria were resuspended in 0.4 vol of 
	   70 
ice cold TfbI and incubated on ice for an additional 15 min. Cells were collected 
by centrifugation (as above) and resuspended in 0.04 volumes of ice cold TfbII. 
Aliquots of 200 µl were frozen in dry ice and ethanol bath, then stored at -80°C. 
 
TfbI 
Compound Final Concentration 
Potassium Acetate 30 mM 
Rubidium chloride 100 mM 
Calcium chloride 10 mM 
Manganese chloride 50 mM 
Glycerol 15% (v/v) 
  
The pH was adjusted to 5.8 using dilute acetic acid. The buffer was filter 
sterilised and stored at 4°C. 
 
TfbII 
Compound Final Concentration 
MOPS 10 mM 
Rubidium chloride 10 mM 
Calcium chloride 75 mM 
Glycerol 1% (v/v) 
 
The pH was adjusted to 6.5 using dilute sodium hydroxide. The buffer was filter 
sterilised and stored at 4°C. 
2.1.4 E. coli transformation 
100 µl chemical competent cells were mixed with 100 ng plasmid DNA or 7µg 
ligation mixture. Cells were incubated on ice for 30 min before heat shock at 
42°C for 45 s. Cells were then chilled on ice before incubation at 37°C, 220 rpm 
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for 45 min  in pre-warmed LB media. Transformants were selected on LB agar 
plates containing 100 µg/ml ampicillin overnight. 
Ligations using Promega Ltd., PGEM T- easy cloning vectors vector were 
selected using IPTG, X-gal, Amp LB plates. 
2.2 Manipulation of nucleic acids 
All routine nucleic acid manipulations were performed using either Qiagen Ltd. or 
Promega Ltd. kits according to manufacturer’s instructions. Restriction enzymes 
were purchased from New England Biolabs, Inc (NEB). T4 DNA ligase was 
purchased from either Roche Diagnostics or TaKaRa Co., Ltd. Small scale DNA 
purification were made using Qiagen Ltd. Mini kits, according to manufacturer’s 
instructions. Large scale DNA purifications were performed using Promega Ltd. 
PureYieldTM plasmid Midiprep kit according to manufacturer’s instructions. 
Qiagen QiaquickTM Gel Extraction Kit and QiaquickTM PCR Purification Kits were 
used for purification of DNA from agarose gels and PCR product respectively. 
2.2.1 Agarose gel electrophoresis 
DNA fragments were resolved in 0.7-1% agarose gels containing 1x TAE buffer 
(40 mM Tris Acetate, 1 mM EDTA) and 0.1 µg/ml ethidium bromide. Gels were 
run in 1x TAE buffer at 30-90 V. A 1 kb DNA ladder (NEB) was loaded as a size 
marker. DNA samples were mixed with 6x DNA loading buffer (either: 10 mM 
Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 50% (vol/vol) glycerol and 0.005% orange 
G or 10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 50% (vol/vol) glycerol and 
0.005% bromophenol blue) prior to loading. 
RNA fragments were resolved in 1% agarose gels containing 1% MOPS, made 
with DEPC treated water. These gels were supplemented with 5% (vol/vol) 37% 
formaldehyde. Gels were run in 1x MOPS at 60 V. RNA samples were mixed 
with an equal volume of RNA loading buffer (75% (vol/vol) formamide, 20% 
(vol/vol) 37% formaldehyde and 5% DNA and 0.001% ethidium bromide), they 
were then boiled for 5 min, before loading on the gel. 
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2.2.2 Restriction enzymes 
Restriction digests were performed according to manufacturer’s instructions. 
Typically reactions were performed in 40 µl volumes, including 4 µl 10x buffer 
(NEB), 10-20 units of enzyme (NEB) and 1-3 µg DNA. Reactions were incubated 
at 37°C from 2-4 h. 
2.2.3 DNA ligations 
Digested plasmid vectors (typically 50 ng) were mixed with inserts at a 1:3 molar 
ratio in a reaction volume of 10-15 µl, containing 5 units of DNA ligase 
(Roche/TaKaRa). Reactions were incubated at 16°C overnight or for 1 h at room 
temperature (RT).  
PCR products were ligated into Promega Ltd., PGEM T- easy cloning vectors 
without prior digestion using a Promega Ltd., T4 DNA ligase. 
2.2.4 Polymerase Chain Reaction (PCR) 
Oligonucleotide primers were purchased from Integrated DNA Technologies, 
Inc. and resuspended in nuclease free water at a concentration of 100 
picomoles/µl. TaKaRa Ex Taq DNA polymerase was used to amplify DNA for 
both cloning purposes and for colony PCR. Reactions were performed in a PTC-
200 DNA Engine (MJ Research). 
 
PCR reaction mixtures were optimised for each reaction, but a typical 50 µl 
reaction mix was as follows: 
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Reaction Component Volume (µ l) Final Concentration 
Template (genomic 
DNA) 
0.1 - 
10 x Reaction Buffer 
(TaKaRa) 
5 1x 
dNTPs 4 800 µM 
Primer (forward) 10 
pM/µl 
1 1 pM/µl 
Primer (reverse) 10 
pM/µl 
1 1 pM/µl 
Enzyme 0.5 0.1 U/µl 
H2O 38.4 - 
 
PCR cycling conditions were optimised for each reaction, but a cycle was as 
follows: 
1. Denaturing: 95°C, 5 min 
2. Denaturing: 95°, 30 s 
3. Annealing: at Tm of primers, -3-5°C (approximately 68°C), 30 s 
4. Extension: 72°C, 1 min per kb 
5. Repeat steps 2-4, 30 times 
6. Final extension: 72°C, 10 min   
 
2.2.5 Colony PCR 
• Bacterial 
Colony PCR was used to identify bacterial clones containing recombinant 
plasmids after ligation. Where possible, one primer was specific to the insert. 
Individual bacterial clones were picked from agar plates in 20 µl sterile H2O and 
1 µl was used in 10 µl reactions. A standard 10 µl reaction mix was as follows: 
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Reaction Component Volume (µ l) Final Concentration 
Template (Cells) 1 - 
10 x Reaction Buffer 
(TaKaRa) 
1 1x 
DNTPs 0.8 800 µM 
Primer (forward) 10 
pM/µl 
0.05 1 pM/µl 
Primer (reverse) 10 
pM/µl 
0.05 1 pM/µl 
TaKaRa Ex Taq 0.05 0.1 U/µl 
H2O 7.05 - 
 
• D. discoideum 
Crude genomic preparation of individual D. discoideum clones were prepared by 
scraping a p2 tip through a colony and placing in 20 µl crude genomic extraction 
buffer for 5 min. 
Reaction Component Volume (µ l) Final Concentration 
10 x Reaction Buffer 
(TaKaRa) 
2 1x 
10% NP-40 1 1 pM/µl 
Proteinase K 0.1 0.1 U/µl 
H2O 17 - 
 
Genomic preparations were incubated at: 
1. 55°C for 45 min 
2. 95°C for 10 min 
Crude genomic DNA was then used as a template in 10 µl PCR reactions to 
identify clones in which homologous recombination had occurred. Reactions 
included either one primer within the inserted resistance gene or within the 
region to excised by recombination. A typical 10 µl reaction was as follows: 
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Reaction Component Volume (µ l) Final Concentration 
Template (Crude 
genomic DNA) 
1 - 
10 x Reaction Buffer 
(TaKaRa) 
1 1x 
dNTPs 0.8 800 µM 
Primer (forward) 10 
pM/µl 
0.05 1 pM/µl 
Primer (reverse) 10 
pM/µl 
0.05 1 pM/µl 
TaKaRa Ex Taq 0.05 0.1 U/µl 
H2O 7.05 - 
 
2.2.6 DNA sequencing 
DNA samples were sent for sequencing by MWG Eurofins. 
2.2.7 DNA extraction from D. discoideum 
D. discoideum pellets from 2 x 107 cells from vegetative cultures were 
resuspended in 1 ml cold RLB. Samples were spun at 5 k x g for 5 min at 4°C. 
The pellet was then resuspended in 50 µl RLB, before adding 350 µl GPA, 
mixing by pipette and then GPB 350 µl GPB. Finally, 3 µl of 20 mg/ml Proteinase 
K was added and samples were incubated overnight at 55°C. 500 µl of phenol 
(pH 8.0) was then added, samples were mixed by pipette and spun at 16k x g 
for 10 min. The aqueous upper phase was transferred to a fresh tube and an 
additional 500 µl phenol (pH 8.0) added. Samples were mixed and centrifuged 
as before. The aqueous phase was then transferred to a fresh tube and mixed 
with 2 vol of 100% ice cold ethanol and 0.1 vol 3 M sodium acetate. Samples 
were incubated at -20°C for > 4 h, before being centrifuged for 10 min at 16k x 
g. Pellets were washed in 70% ethanol, centrifuged again and then resuspended 
in 50-100 µl TE (10 mM TrisHCl pH 7.4, 1 mM EDTA) depending on pellet size. 
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RLB 
Compound Final Concentration 
Sucrose 0.32 M 
TrisHCl pH 7.4 10 mM 
Magnesium chloride  5 mM 
Triton X-100 1% 
 
GPA 
Compound Final Concentration 
TrisHCl pH 7.4 10 mM 
EDTA  10 mM 
 
GPB 
Compound Final Concentration 
TrisHCl pH 7.4 10 mM 
SDS  0.7% 
 
2.2.8 RNA extraction from D. discoideum 
Pellets of 2 x 107 cells from vegetative cultures were harvested and washed in 1 
ml 20 mM Potassium phosphate buffer pH 6.2 (KK2). Cell pellets were 
resuspended in 500 µl RNA lysis buffer, before adding 500 µl phenol (pH 4.3). 
Mixtures were incubated at RT on a rotary shaker for 20 min. Samples were 
centrifuged in a benchtop microcentrifuge at 16k x g for 5 min. The upper, 
aqueous phase was transferred to a fresh microcentrifuge tube before adding 
200 µl chloroform. Samples were centrifuged at 16k x g for 5 min. The upper, 
aqueous phase was again transferred to a fresh tube, before adding 1 ml of 
100% ethanol. Samples were incubated at -20°C for 20 min and then 
centrifuged at 16k x g for 5 min. Supernatant was removed and RNA pellets 
were resuspended in RNase free H2O. 
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RNA Lysis Buffer 
Compound Final Concentration 
Tris HCl pH 7.4 50 mM 
Sodium chloride 100 mM 
Sodium dodecyl sulfate (SDS)  1% 
EDTA 10 mM 
DEPC H2O  
 
2.2.9 cDNA synthesis 
RNA was diluted to 1 µg/µl and mixed with 50 ng/µl random hexamers (pdN6), 
10 mM dNTP mix in a final volume of 13.75 µl. Samples were incubated at 65°C 
for 5 min, then on ice for 2 min. 4 µl of 5x first strand buffer (InvitrogenTM), 1 µl 
0.1 M DTT and 1 µl RNaseOUTTM were added along with 0.25 µl Superscript III 
reverse transcriptase (InvitrogenTM). Samples were then incubated at 25°C for 5 
min and 50°C for 1 h, before inactivating the reverse transcriptase at 70°C for 15 
min. 
2.2.10 Southern blotting 
Genomic DNA was purified from D. discoideum cells as described above. DNA 
was digested with 10-20 units restriction enzymes (NEB) in 40 µl reactions 
containing 4 µl 10 x buffer (NEB), 5-10 µg of gDNA overnight at 37°C. Digested 
DNA was run on 0.7 % agarose gel at 30 V. The gel was then treated in 0.125 M 
HCl solution for 10 min, before neutralisation in 1.5 M NaCl, 0.5M NaOH for 30 
min. Finally the gel was incubated in 1.5 M NaCl, 0.5 M TrisHCl 7.5 for 60 min. 
DNA was then transferred overnight onto Hybond membrane (Amersham) using 
10 x SSC (1.5 M NaCl, 0.15 M tri Sodium citrate). Radiolabelled probe was 
generated using fragments of DNA digested from the deletion construct, 
labelled using HiPrime labelling kit (Roche Diagnostics) and dCTP32 from Perkin 
Elmer. Membranes were incubated with probe overnight at 65°C in Church 
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phosphate buffer (0.5 M NaPO3 pH 7.2, 7% SDS, 1 mM EDTA). The membrane 
was then washed for 15 min with 1x SSC and 0.1% SDS and then for another 
15 min with 0.1x SSC and 0.1% SDS. The membrane was then exposed to 
photographic film overnight at -80°C. 
2.2.11 Northern blotting 
RNA was purified from cells and resolved by agarose electrophoresis as 
described above. RNA was transferred onto membrane as described for 
Southern blotting. Probes to the coding region of were synthesised as for 
Southern blotting using HiPrime labelling kit (Roche Diagnostics) and dCTP32 
from Perkin Elmer to label double stranded DNA. Hybridisation of the probe with 
membrane was performed overnight at 65°C in 1 % BSA, 0.5 M NaPO4 pH 7.2, 
1 mM EDTA, 7% SDS. The membrane was then washed twice for 30 min with 
40 mM NaPO4 pH 7.2, 1 mM EDTA and 5% SDS. Finally the membrane was 
washed a further two times for 30 min each with 40 mM NaPO4 pH 7.2, 1 mM 
EDTA, 1% SDS, 30-60. All washes were at 65°C. The membrane was then 
exposed to photographic film overnight. 
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2.3 D. discoideum 
2.3.1 Media 
D. discoideum was grown in HL5 media for all purposes except where noted. 
HL5 media was composed of: 
 
HL5 
Compound Final concentration (g/L) 
Glucose 14 
Yeast extract (FormediumTM) 7 
Proteose peptone No 2 (BactoTM) 14 
Sodium phosphate (dibasic) 
anhydrous 
0.5 
Potassium phosphate (monobasic) 
anhydrous 
0.5 
 
HL5 was adjusted to pH 6.5 with phosphoric acid. 
HL5 was supplemented with penicillin/streptomycin at a working concentration 
of 10 U/ml and 10 µg/ml respectively. Transformant cells were selected with 
either Blasticidin (10 µg/ml)(Calbiochem) or G418 (5-20 µg/ml)(InvivoGen). 
HL5 was also supplemented with 0.2 M sorbitol where indicated (spore 
germination experiments). 
 
For certain purposes, including clonal selection, D. discoideum was grown on 
bacterial (K. aerogenes) lawn. These bacteria were grown on slime mould (SM) 
plates. 
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• SM 
Compound Final Concentration (g/L) 
Glucose 10 g/L 
Yeast extract (FormediumTM) 5 g/L 
Proteose peptone No 2 (BactoTM) 10 g/L 
Potassium phosphate (monobasic) 
anhydrous 
1 
Potassium phosphate (dibasic) 
anhydrous 
1.9 
Magnesium sulfate, heptahydrate 1 
 
All other media were obtained from FormediumTM, including SIH and SIH without 
potassium phosphate. 
2.3.2 Buffers 
• KK2  
20 mM potassium phosphate pH 6.2. 
2.3.3 D. discoideum strains 
AX2 Axenic strain 
NC4 wild isolate strain 
2.3.4 Axenic strains growth 
Axenic strains were grown at 22°C in HL5 media either adherent to uncoated 
NunclonTM 92 mm dishes or in shaking (120 rpm) flasks. Cells grown in shaking 
culture were diluted every 1-2 days such that cell density did not exceed 5 x 106 
cells per ml. For clonal selection AX2 strain were grown on SM plates on K. 
aerogenes. D. discoideum were diluted to a density of ~1 x 103 cells/ml and 
mixed with ~100 µl of saturated K. aerogenes culture. 
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Stocks of cells were made from vegetative cultures (density ~2 x 106 cells/ml), 
that were centrifuged at 2 k rpm for 2 min. Pellets were cooled on ice for 5 min 
before resuspending in ice cold HL5. An equal volume of ice cold HL5 
supplemented with 20% DMSO was then added, giving a final concentration of 
10% DMSO. Cells were frozen at -20°C for 1-2 h, before transfer to -80°C. 
2.3.5 Wild isolate growth 
NC4 cells were grown on SM plates and K. aerogenes as described above. 
2.3.6 Mutant construction 
Mutants were constructed using the TMO1 deletion vector (Muramoto, Cannon 
et al. 2012). 
Regions of DNA flanking the gene of interest were amplified by PCR from AX2 
genomic DNA as described above. Table 2.1 indicates the primers used to 
amplify targeting arms. 
Knockout plasmids TMO1-IP6K-Bsr, TMO1-PPIP5K-Bsr, TMO1-IPMK-Bsr, 
TMO1-PPK1-Bsr were generated by inserting these sequences into the plasmid 
TMO1, with the 5’ sequence inserted between the NotI and EcoRI sites and the 
3’ sequence between the HindIII and KpnI sites. The resultant plasmids were 
then digested using BssHII and used to transform AX2 cells by electroporation, 
see below.  
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Table 2.1 Primers for deletion constructs 
Gene Primer Primer sequence Product 
length 
Restriction 
site 
IP6K 
5’ arm 
Forward 
GCAGCGGCCGCCTCAATCCACCCACACTCAC 
 
1050 
NotI 
5’ arm 
Reverse 
GCAGAATTCGTTGTTGTTGGGCTTCTTGG 
 
EcoRI 
3’ arm 
Forward 
GCGAAGCTTGCGGTAGTAAACCTCAACCTTC 
 
835 
HindIII 
3’ arm 
Reverse 
GCAGGTACCCTCTTCACTGGTGACACCTATGC 
 
KpnI 
PPIP
5K 
5’ arm 
Forward 
GCAGCGGCCGCGTAGTCAGCAAATTTACCAC 
 
1069 
NotI 
5’ arm 
Reverse 
GCAGAATTCCTATCTACAATTGGCCATTC 
 
EcoRI 
3’ arm 
Forward 
GCGAAGCTTGATATATTACGTGTTAATGG 
 
832 
HindIII 
3’ arm 
Reverse 
GCAGGTACCTCAAATGGTCAAATTGCTGG 
 
KpnI 
IPMK 
5’ arm 
Forward 
GCAGCGGCCGCTTACCACCAGCCAATAAGGC 
 
901 
NotI 
5’ arm 
Reverse 
GCAGAATTCAATTCTAATTCTTTACCACC 
 
EcoRI 
3’ arm 
Forward 
GCGAAGCTTGATAGAATCTATGAAGATGG 
749 
HindIII 
3’ arm 
Reverse 
GCAGGTACCTTAACCAATTTGAAACTATG 
 
KpnI 
PPK 
5’ arm 
Forward 
GCAGCGGCCGCGACAAACCCCCCAGACAAT
GG  
1042 
NotI 
5’ arm 
Reverse 
GCAGAATTCCATTTGCTAATGGTGGTGCATC EcoRI 
3’ arm 
Forward 
GCGAAGCTTCGTCGTGTCGAAGTAATGGTTCC 
925 
HindIII 
3’ arm 
Reverse 
GCAGGTACCGGACGCCACCTTTAACTCG KpnI 
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2.3.7 Blasticidin Resistance excision 
The Blasticidin Resistance gene was excised from the ppip5k strain using the 
pDex-Cre-NLS plasmid (dictybase stock centre, dictybase.org). This 
extrachromasomal vector was introduced into ppip5k by H50 electroporation as 
described below. The overexpression of a nuclear targeted Cre recombinase 
cleaved the loxP sites engineered into the TMO1 vector either side of the BSR 
gene, excising it from the genome. Cells were selected under G418 (described 
below) and scored for sensitivity to Blasticidin. 
2.3.8 Electroporation 
D. discoideum were electroporated by two methods, E-buffer protocol and H50 
protocol 
• E-buffer 
Each electroporation required 2x107 from vegetative cultures. These were 
centrifuged at 2 k rpm for 2 min before resuspension in 5 ml ice cold E-Buffer. 
Cells were centrifuged again and resuspended in 1 ml of E buffer per 
electroporation. 10-25 µg digested DNA (deletion construct) was added per 
electroporation and mixed by inversion. Cells were transferred to ice-cold 0.2 
cm electroporation cuvettes (Bio-rad Laboratories, Inc.) and placed in a Bio-rad 
Inc. genepulser and exposed to a single pulse of 0.65 kV at 25 µF. Cuvettes 
were then placed on ice before transferal of cells into a 92 mm dish and mixing 
with 16 µl Healing Solution. After 15 min, 12 ml of room temperature HL5 was 
added. Cells were allowed to grow overnight without selection. Transformant 
cells were selected by addition of 10 µg/ml Blasticidin (Calbiochem). Cells were 
selected for 6-9 days and media changed every 2-3 days. 
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E buffer 
Component Final concentration 
Sucrose 50 mM 
Potassium phosphate pH 6.1 10 mM 
 
Healing buffer 
Component Final concentration 
Magnesium chloride 100 mM 
Calcium chloride 100 mM 
 
• H50 
Cells were centrifuged at 2 k rpm for 2 min and washed twice in cold H50 buffer. 
Cells were resuspended in H50 buffer at a concentration of 5x107 cells per ml 
and incubated on ice for 5 min before transferral to an ice cold 0.1 cm 
electroporation cuvettes (Bio-rad Laboratories, Inc.) and electroporated with two 
pulses, with 5 s in between pulses. Each pulse was 0.85 kV and 25 µF. Cells 
were then iced for 5 min and allowed to recover in HL5 in a 92 mm dish 
overnight. G418 selection (5-20 µg/ml) was added the following day. Cells were 
selected for 4-6 days and media changed every 2-3 days. 
 
H50 
Component Final concentration 
HEPES 20 mM 
Potassium chloride 50 mM 
Sodium chloride 10 mM 
Magnesium sulfate 1 mM 
Sodium bicarbonate 5 mM 
Sodium phosphate (monobasic) 1 mM 
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2.3.9 Clonal selection 
After 6-9 days selection (Blasticidin) or 4-6 days selection (G418) cells were 
transferred from 92 mm dishes and diluted to 1x103 cells per ml. 5-50 µl of this 
dilution was then plated on SM plates along with 100 µl saturated K. aerogenes 
culture. These plates were allowed to grow at 22°C for 4- 5 days until individual 
colonies of D. discoideum had cleared plaques in the bacterial lawn. Clones 
were then selected for either screening or amplification with a P2 tip (see above, 
Section 2.2). 
2.3.10 Starvation 
Cells were starved by transferring cells from vegetative cultures onto KK2 2% 
agar plates in either 35 or 92 mm dishes. 1x 107 cells were plated on a 35 mm 
plate, whilst 8x107 cells were plated on a 92 mm plate. Cells were allowed to 
develop for between 1 and 48 h on KK2 agar plates.  Cells were collected after 1 
h, ~8 h when cells were beginning to aggregate, 16 h, when cells had coalesced 
to form slugs and after >24 h when fruiting bodies were fully formed. Cells were 
harvested either by dislodging with KK2 and a P100 pipette or, at later time 
points, with a plastic scraper. 
2.3.11 Cell extract preparation 
3x 107 cells from vegetative cultures were centrifuged at 2k rpm for 2 min. Cells 
were washed once in KK2, then transferred to a 1.5 ml microcentrifuge tube. 
Cells were centrifuged again at 2k rpm for 1 min and resuspended in 80 µl ice-
cold Cell Lysis Buffer. Samples were transferred to a 100 µl volume dounce 
homogenizer (on ice). Cells were agitated with ten strokes in the dounce and 
incubated on ice for 5 min. Lysates were then transferred to a fresh tube and 
centrifuged in a refrigerated centrifuge at 4°C at 16k rpm for 15 min. 
Supernatant was collected and protein concentration measured using Bio-rad 
DC protein assay. Extracts were stored on ice and used in in vitro assays 
immediately. 
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Cell Lysis Buffer 
Component Final concentration 
Tris HCl pH 7.0 20 mM 
Sodium chloride 150 mM 
EGTA 1 mM 
EDTA 1 mM 
CHAPS 0.1% 
DTT (added fresh) 5mM 
Mammalian Protease Inhibitor 
Cocktail 
(Sigma P8340) (added fresh) 
1x 
 
2.3.12 Potassium cyanide and BHAM treatment 
Cells from vegetative cultures were transferred to 92 mm dishes and allowed to 
adhere, at a confluence of ∼50%. Once cells were adherent, media were 
replaced with fresh HL5, supplemented with 100 µM potassium cyanide (KCN) 
and 20 µM benzohydroxamate (BHAM). Cells were harvested at indicated time 
points. 
2.3.13 Fruiting body images 
Cells were allowed to develop and form fruiting bodies on KK2 agar plates for 
48 h. Images were then taken on an camera mounted on an adjustable zoom 
dissecting microscope. Images were taken at the same magnification.  
2.3.14 Spore preparation 
Cells were developed for 48 h on KK2 agar plates as described above. Spores 
were obtained using protocols adapted from (Chiew, Reimers et al. 1985, 
Dynes, Clark et al. 1994). Fruiting bodies were harvested by scraping cells from 
plates and then incubated in 0.5 % NP40 for 3 min before spinning and washing 
three times in either KK2 or H2O. If used for spore germination or whole fruiting 
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body extraction these cells were pelleted and resuspended in KK2, counted and 
either inoculated at indicated spore concentration or used in phenol chloroform 
extraction as described. Pure spore preparations were obtained by passing 
fruiting body preparations through 114 grade Whatman filter paper after washes 
to remove stalk cells. Spore cells were then collected and resuspended in KK2, 
counted and used for phenol chloroform extraction. 
2.3.15 Spore germination 
Spore germination was assayed using a protocol adapted from (Van Dijken and 
Van Haastert 2001). Spores were prepared as described above, counted and 
diluted at a density of 1.5 x 106 spores/ml in either HL5, HL5 supplemented with 
0.2 M sorbitol or SIH without phosphate. Cells were then counted and scored as 
either spore, swollen spore or amoeba at indicated time points. 
 
2.3.16 Immunofluorescence 
Cells from vegetative cultures were transferred to 4 well plates and allowed to 
adhere to 13 mm glass coverslips. Cells were either allowed to recover in HL5, 
or media removed and replaced with KK2 for 1-5 h. Cells were fixed with either 
ice-cold methanol of formaldehyde: 
 
• Methanol 
Media was replaced with ice-cold methanol for 15 min. Methanol was then 
removed and cells were washed three times in KK2.  
 
• Formaldehyde 
Media was replaced with 4% formaldehyde. Formaldehyde was then removed 
and cells were washed three times in KK2.  
 
Coverslips were stained by either: 
• DAPI staining 
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Inverted on a solution of 2 mg/ml DAPI in KK2 for 10 min. Coverslips were 
washed in KK2 and mounted on a slide using ProLong Gold Mounting Media 
(ThermoFisher). Coverslips were then imaged on a 2012 model Leica TCS SPE 
confocal microscope mounted on a semi-automated, inverted Leica DMI4000 
stand. Samples were imaged using a 408 nm laser and emission measured 
between 440-480 nm. 
• PolyP binding domain (PPBD) 
Coverslips were blocked for 10 min at room temperature with 1% BSA, 1 mM 
EDTA and 1 mM EGTA. Coverslips were inverted on 20 µl of 100 µg/ml PPBD in 
KK2, with 1% BSA overnight. Coverslips were then washed in 0.05% Triton X 
100, KK2 and again in KK2. After washes, coverslips were incubated with 7.5 
µg/ml anti Xpress (InvitrogenTM) with 1% BSA in KK2 overnight. Coverslips were 
then washed in 0.05% Triton X 100, KK2 and again in KK2. After washes, 
coverslips were incubated with α-mouse (goat) conjugated to alexa 488 at 
1:5,000, KK2 with 1% BSA plus 1:2,500 Hoechst for 4 h. Coverslips were then 
washed in 0.05% Triton X 100, KK2, then in KK2 and finally in H2O, before being 
mounted using ProLong Gold Mounting Media (ThermoFisher). Coverslips were 
then imaged on a 2012 model Leica TCS SPE confocal microscope mounted on 
a semi-automated, inverted Leica DMI4000 stand. 
2.3.17 Electron microscopy 
Spores were prepared as described above. Spore pellets were then fixed in 2% 
glutaraldehyde/2% Paraformaldehyde (both EM grade) in 0.1 M Sodium 
cacodylate at room temperature for 30 min. Cells were centrifuged and washed 
in 0.1 M Sodium cacodylate. Spores were centrifuged and resuspended in 0.7% 
low gelling point agarose in 0.1 M Sodium cacodylate. Pellets were incubated 
on ice for 10 min to allow agarose to set. The pellet was then cut from tube and 
cut into smaller blocks (1-2mm x 1-2mm) to increase surface area to volume 
ratio and assist infiltration. The cut pellet was then washed twice in 0.1 M 
Sodium cacodylate. Samples were subjected to a secondary fix in 1% osmium 
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tetroxide/1.5% Potassium ferricyanide at 4°C for 1 h. Samples were washed 
three times in 0.1 M Sodium cacodylate and incubated in 1% tannic acid in 0.05 
M Sodium cacodylate for 45 min at room temperature. Samples were washed 
twice in 0.05 M Sodium cacodylate and then once in ddH2O. Samples were 
sequentially dehydrated in increasing EtOH concentrations, for 5 min in 70%, 5 
min in 90% and 2 x 10 min in 100%. 
  
Samples were incubated in 1:1 mix of propylene oxide:Epon resin for 90 min on 
rotary mixer, before an overnight incubation in 100% Epon on rotary mixer at 
room temp. Finally, samples were incubated in fresh 100% Epon for 2 h and 
transferred to embedding moulds in fresh Epon and baked overnight at 60 
degrees to polymerise resin. 
  
 Samples were cut into 70 nm thick “ultrathin” sections were cut on a Leica UC7 
ultramicrotome using a Diatome ultra 45 degree diamond knife, and transferred 
onto formvar coated slot grids. Sections were stained on grids using Reynolds 
lead citrate for 10 min, before washing five times in ddH2O. 
  
• Imaging 
Samples were imaged on an FEI Tecnai G2 Spirit 120kv transmission electron 
microscope, using an Olympus SIS Morada CCD camera. 
2.4 S. cerevisiae 
2.4.1 Media 
Growth without selection was performed in either YPD (FormediumTM) or SC (see 
below). Selection was performed in SC URA-. 
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• YPD 
YPB Broth (FormediumTM) 
• YPD agar 
YPB Broth (FormediumTM) 
Agar 20 g/L 
 
• SC media 
Compound Final Concentration (g/L) 
Glucose 10 g/L 
Yeast Nitrogen Base without amino 
acids (Sigma) 
6.9 g/L 
Complete Synthetic Media (CSM) 
(MPBiomedicals) 
0.79 g/L 
 
• SC media URA-­‐	  
Compound Final Concentration (g/L) 
Glucose 10 g/L 
Yeast Nitrogen Base without amino 
acids (Sigma) 
6.9 g/L 
CSM-URA amino acid (MPBiomedicals) 0.77 g/L 
 
• SC media URA- agar 
Compound Final Concentration (g/L) 
Glucose 10 g/L 
Yeast Nitrogen Base without amino 
acids (Sigma) 
6.9 g/L 
CSM-URA amino acid (MPBiomedicals) 0.77 g/L 
Agar 20 g/L 
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2.4.2 Strains 
DDY1810: MATa, leu, ura3-52, trp1, prb1-1122, pep4-3, pre1-451 
2.4.3 Transformation 
• High efficiency 
Yeast colonies were inoculated in 10 ml YPD media and grown overnight at 
30°C, 200 rpm shaking to an OD600 of ~0.4-0.8. Cells were centrifuged at 2000 
rpm for 3 min and washed once in sterile water. Cell pellets were resuspended 
in 100 µl TE/LiAc (10 mM TrisHCl pH 7.6, 1 mM EDTA, 100 mM lithium acetate). 
0.1 µg of plasmid DNA and 0.1 mg pre-boiled salmon sperm carrier DNA. 600 µl 
of PEG/LiAc was added (40% PEG 3350, 100 mM lithium acetate, 10 mM Tris-
HCl pH 7.6, 1 mM EDTA). Cells were vortexed for 10 sec and incubated at 30°C, 
200 rpm for 30 min. 70 µl DMSO was added and cells heat shocked at 42°C for 
15 min. Cells were then incubated on ice for 2 min and resuspended in 300 µl 
sterile water. 120 µl of yeast were transferred to URA- agar plates and incubated 
for 3-4 days. 
• Quick transformation 
Cells were picked from YPD agar plates and transferred to 1 ml sterile water. 
Cells ere centrifuges at 3 k rpm for 2 min and resuspended in 33% PEG (w/v), 
100 mM LiAc and 0.1 mg pre-boiled salmon sperm carrier DNA. 0.1 µg of 
plasmid DNA was added to each transformation and vortexed. Cells were 
incubated at 42°C for 30 min before centrifugation at 2 k rpm, 3 min. Cells were 
resuspended in 400 µl sterile water. 200 µl of mixture was URA- agar plates and 
incubated for 3-4 days. 
2.4.4 Growth rescue 
Yeast cells were grown to an OD600 of 0.8, and then serial dilutions were 
prepared in sterile H2O and 10 µl dropped onto URA- minimal media plates. 
Plates were incubated at 30°C for 3-4 days. 
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2.4.5 Protein extraction 
Yeast cells were grown to an OD600 of 0.8, centrifuged at 2000 rpm for 3 min, 
washed once in ice-cold water and resuspended in New Lysis Buffer (NLB). 1/3 
vol of glass beads were added and samples were vortexed for 5 min at 4°C. 
Extracts were centrifuged at 16 k x g at 4°C and supernatant was transferred to 
new tube for further use. 
 
NLB 
Component Final concentration 
Tris pH8.0 50 mM 
Sodium chloride 10 mM 
EDTA 7 mM 
DTT 5 mM 
Protease inhibitor cocktail (Sigma 
P8215) 
1x 
 
2.5 Molecular biology: Proteins 
2.5.1 SDS-PAGE 
The NuPAGETM (InvitrogenTM) system was used with 4-12% Bis-tris gels 
(InvitrogenTM) in MOPS SDS running buffer (InvitrogenTM). Molecular weight 
marker (PAGE rulerTM)(ThermoFisher) was used. Gels were run at 120-180 mV 
according to manufacturers instructions. 
2.5.2 Immunoblot analysis 
Proteins were transferred to Polyvinylidene Fluoride (PVDF) membrane (Bio-Rad) 
that had been equilibrated in methanol. Transfer was in 1 x Tris-Glycine transfer 
buffer (25 mM Tris, 192 mM glycine), using the InvitrogenTM transfer cell for 90 
min at 100 mV at 4°C. PVDF membranes were blocked in 5 % (w/v) skimmed 
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milk powder in Tris-buffered saline-Tween 20 (TBST; 137 mM NaCl, 2.7 mM 
KCl, 19 mM Tris base, 0.1% Tween 20) for 30 min – 1 h at room temperature. 
Membranes were incubated with primary antibody (Table 2.2), α-GST (rabbit) at 
1:7000 in 3% skimmed milk in TBST for 1 h at room temperature or overnight at 
4°C with rotation. Membranes were washed three times in TBST from 10 min 
before incubation with secondary antibody Table 2.2), α-rabbit (mouse), at 
1:100,000 in 3% skimmed milk in TBST for 1 h at room temperature with 
rotation. Membranes were washed three times in TBST for 10 min. Membranes 
were incubated with LuminataTM Crescendo Western HRP Substrate (MilliporeTM) 
as per manufacturer’s instructions. Luminescence was detected by exposing 
membranes to photographic film (GE Healthcare).   
2.5.3 Glutathione Sepharose Transferase (GST) pull down 
GST tagged proteins were pulled down from yeast cell extract prepared from ~ 
1 L of cells at an OD600 of ~1.7. Cells were centrifuged at 2.5k rpm for 5 min and 
washed once in ice-cold water. Cell pellets were resuspended in one vol. NLB 
(supplemented with 1x yeast PIC and 5 mM DTT). Cells were lysed in a Bead 
BeaterTM homogeniser (Bio Spec Products Ltd.) with acid washed glass beads 
for 5 min. Extracts were kept ice-cold throughout. Cell extract was recovered 
and beads washed once with 0.5 vol NLB. Extract was then centrifuged at 16k x 
g at 4°C for 10 min. GST beads Glutathione Sepharose High Performance beads 
(GE healthcare) were equilibrated in NLB (plus 1x yeast PIC; 5 mM DTT) and at a 
ratio of 1:3. 500 µl of GST bead preparation (125 µl beads, 375 µl NLB) was 
added to cell extract and rotated at 4°C for 1.5 h. Samples were centrifuged at 1 
k rpm for 30 sec and cell extract was removed. GST beads were washed three 
times with NLB supplemented with 1x yeast PIC; 5 mM DTT and 0.5% Triton X. 
GST beads were washed once in NLB supplemented with 1x yeast PIC and 5 
mM DTT and then resuspended in 375 µl NLB supplemented with 1x yeast PIC 
and 5 mM DTT. GST beads were stored at 4°C for up to 3 days. 
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2.5.4 Silver Stain 
Proteins were resolved by SDS PAGE as described above. Gels were then fixed 
in fixative 1 (40 % methanol, 10 % acetic acid) for 30 min. Gels were then 
transferred to fixative 2 (10% ethanol, 5% acetic acid) for 15 min, after which 
fixative 2 was replaced for an additional 15 min incubation. Gels were 
transferred to Oxidizer solution (3.4 mM potassium dichromate, 3.2 mM nitric 
acid). Gels were then washed 3-4 times in milliQ water until the yellow colour of 
the gel had been removed. Subsequently gels were incubated in 12 mM Silver 
nitrate solution for 20 min. Gels were washed once in milliQ before addition of 
developer solution (0.28 M sodium carbonate, 0.05% formaldehyde) for 5 min. 
Developer solution was replaced once before transfer of gel to stop solution (5% 
acetic acid) for 5 min. 
2.5.5 In vitro assays 
• Cell extract 
Cell extract was prepared as described above. Cell extract activity assays were 
performed in either 25 µl or 40 µl volumes, rotating, for between 30 min and 3 h 
at 37°C.  
• 10x Reaction Buffer 
Component Final concentration 
HEPES pH6.8 200 mM 
Potassium chloride 1 M 
Magnesium chloride 60 mM 
DTT 10 mM 
 
A typical 40 µl reaction mixture was as follows: 
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Reaction Component Volume (µ l) Final Concentration 
Cell extract 5 - 
10x Buffer 4 1x 
Substrate 10 mM 
IP3/IP5/IP6/IP7 
1.5 400 µM 
Sodium fluoride (10mM) 4 1 mM 
ATP, Mg salt (10 mM) 6 1.5 mM 
Phosphocreatine 
(100mM) 
1 2.5 mM 
Creatine phosphokinase 
500 U/ml 
1 12.5 U/ml 
 
• GST tagged enzymes 
GST tagged enzymes were pulled down on GST beads as described above. 
Enzyme activity assays were performed in 40 µl volumes, rotating for 3 h at 
37°C. A typical 40 µl reaction mixture was as follows: 
Reaction Component Volume (µ l) Final Concentration 
GST beads (1:3 beads: 
buffer) 
20 - 
10x Buffer 4 1x 
Substrate 10 mM 
IP3/IP5/IP6/IP7 
1.5 400 µM 
Sodium fluoride (10mM) 4 1 mM 
ATP, Mg salt (10 mM) 6 1.5 mM 
Phosphocreatine 
(100mM) 
1 2.5 mM 
Creatine phosphokinase 
500 U/ml 
1 12.5 U/ml 
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2.5.6 Fast Protein Liquid Chromatography (FPLC) 
Cell extracts were prepared as described above from 1.5 x108 cells in 500 µl 
lysis buffer in a 2 ml dounce. Cell extract was then loaded on an AKTA FPLC 
system and fractionated by either Heparin column or DEAE column. 
• HiTrapTM Heparin HP, 1 ml (GE Healthcare) 
After loading, column was washed with wash buffer (25 mM HEPES, 50 mM 
KCl, 1 mM EDTA, 0.05% CHAPS). A 10 min gradient with elution buffer (25 mM 
HEPES, 1.5 M KCl, 1 mM EDTA and 0.05% CHAPS). 0.5 ml extracts were 
collected and used in in vitro reactions as described. 
• HiTrapTM DEAE FF, 1 ml (GE Healthcare) 
After loading, column was washed with wash buffer (25 mM HEPES, 50 mM 
KCl, 1 mM EDTA, 0.05% CHAPS). A 10 min gradient with elution buffer (25 mM 
HEPES, 1.5 M KCl, 1 mM EDTA and 0.05% CHAPS). 0.5 ml extracts were 
collected and used in in vitro reactions as described. 
2.6 Molecular biology: Phosphate 
2.6.1 Perchloric acid extraction 
• D. discoideum 
The inositol polyphosphate extraction procedure was adapted from the yeast 
protocol previously described (Azevedo and Saiardi 2006) and as described by 
Pisani et al. (Pisani, Livermore et al. 2014). D. discoideum cells were collected 
during the vegetative growth phase (1-2x106cells/ml), washed twice with KK2 
and centrifuged at 2 k rpm on a Sorval RC-3C centrifuge for 2 min. The cell 
pellets were transferred to 1.5 ml tubes, resuspended in 1 M Perchloric acid, 
vortexed for 5 min at 4°C and centrifuged at 16 k g at 4°C for 10 min. The 
supernatants were transferred to a new tube and neutralised using 1 M 
Potassium Carbonate containing 3 mM EDTA. The samples were placed on ice 
for 2–3 hours and subsequently centrifuges for 10 min. The supernatants were 
transferred to new tubes and stored at 4°C.  
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• S. cerevisiae 
The inositol polyphosphate extraction procedure was as previously described 
(Azevedo and Saiardi 2006). Exponentially growing S. cerevisae cells were 
harvested by centrifugation at 2 k g for 2 min. Cells were washed twice in ice-
cold water and then resuspended in 1 M Perchloric acid, 1 volume of acid 
washed beads was added and cells were vortexed for 5 min at 4°C and 
centrifuged at 16 k g at 4°C for 10 min. Supernatants were transferred to a fresh 
tube and neutralised as above. 
2.6.2 Phenol chloroform extraction 
• D. discoideum 
PolyP was extracted by phenol-chloroform extraction. Cells were harvested at 
indicated time points or growth conditions. Pellets were resuspended in one 
volume of LETS buffer (100 mM LiCl, 10 mM EDTA, 10 mM TrisHCl pH 8.0, 
0.5% SDS), one volume of acidic phenol (pH 4.0) was added and samples were 
vortexed at 4°C for 5 min. Samples were centrifuged at 16 k g at 4°C and 
aqueous upper phase was recovered. 2 volumes of chloroform were added and 
samples were again vortexed at 4°C for 5 min before being centrifuged at 5k g 
for 5 min. Aqueous phase was collected and precipitated by adding 2.5 vol of 
ethanol and incubating at -80°C for 1-2 h. After centrifugation at 14 k g for 10 
min, pellets were washed once in 70% ethanol, then resuspended in 10 mM 
TrisHCl pH 7.4, 1 mM EDTA and 0.1 % SDS. RNA concentration was measured 
by nanodrop and used to normalise samples prior to loading on PAGE 
• S. cerevisiae 
Exponentially growing S. cerevisae cells were harvested by centrifugation at 2 k 
g for 2 min. Cells were resuspended in one vol of LETS (as above). One volume 
of acidic phenol (pH 4.0) was added alongside 1.5 volume of acid washed glass 
beads. Samples were then vortexed at 4°C for 5 min. Aqueous phase was 
collected and samples were treated as above. 
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2.6.3 Enzymatic treatments 
D. discoideum phenol-chloroform extracts were incubated in 45 µl enzymatic 
reactions and incubated with either DNaseI, RNase A and RNase T1, phytase 
(Sigma P1259) or Ddp1 and PPX recombinant protein purified as previously 
described (Losito, Szijgyarto et al. 2009). Reactions were conducted in either 
relevant commercially supplied buffer, RNase buffer (300 mM NaCl, 10mM Tris 
HCl (pH7.4), 5mM EDTA or 1x phosphatase buffer (100 mM KCl, 20 mM HEPES, 
6 mM MgSO4, 1 mM DTT) for 1.5 h at 37°C.  
2.6.4 Polyacrylamide Gel Electrophoresis (PAGE) 
20%-35.5% polyacrylamide gels, as indicated were, prepared using 24 x 16 x 
0.1 cm glass plates, 40 polyacrylamide (national diagnostics) in 1x TBE. 
Samples were mixed in with 6 x Dye (0.01 % Orange G or Bromophenol blue 
((BBF); 30 % glycerol; 10 mM TrisHCl pH 7.4; 1 mM EDTA). Gels were pre run 
for 30 min at 300 V and run overnight at 4 °C at 450 V and 3 mA for 20% gels 
and 700 V and 5 mA for 35 % gels in 1x TBE running buffer. Gels were stained 
with either DAPI or Toluidine Blue as previously described (Pisani, Livermore et 
al. 2014).  
• DAPI 
Gels were stained by gently agitating in DAPI staining solution (20 mM Tris 
Base; 20% Methanol; 2% glycerol; 20 mg/ml DAPI) under a daylight bulb for 45 
min at room temperature. Gels were then destained in the same buffer in the 
absence of DAPI. Inositol pyrophosphates or polyP species were visualised 
using a UV transilluminator at 360 nM, gels were exposed for 2-10 min to allow 
photobleaching to occur 
• Toluidine Blue 
Gels were gently agitated for 30 min at room temperature in a staining solution 
(20% methanol; 2% glycerol; 0.05% Toluidine Blue), then destained for 30 min – 
2 h in 20 % methanol with several changes. Gels were then scanned using a 
conventional Epsom scanner.  
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10x TBE 
Component Final concentration 
Tris Base 121.1 g/L 
Boric Acid 61.8 g/L 
EDTA 2 mM 
  
• Densitometry 
Inositol pyrophosphates were quantified by densitometry using ImageJ software 
as previously described (Pisani, Livermore et al. 2014). After scanning, the Tiff 
format file, band densitometry was performed using ImageJ software 
(http://rsbweb.nih.gov/ij/). Ratios between densitometry of bands were 
calculated as indicated. 
2.6.4 Strong anion exchange High Pressure Liquid Chromatography 
(SAX HPLC) 
SAX HPLC was conducted as previously described by Azevedo et al. (Azevedo 
and Saiardi 2006). Cells were labelled with [3H] inositol, either by: 
• S. cerevisiae, cells were grown overnight in URA- minimal media. This 
was diluted to an OD600 of 0.005-0.01 in inositol free, synthetic media, 
supplemented with 5 µCi /ml of [3H] inositol. Cells were grown at 30°C, 
shaking at 200 rpm overnight. 
• Vegetative cultures of D. discoideum, were diluted to a  density of 2 x 105 
cells/ml in inositol free synthetic media (SIH minus inositol, FormediumTM).  
Cells were grown at 22°C shaking at 120 rpm for 2-3 days. 
Inositol phosphates were extracted as described above. Neutralised extracts 
were resolved by SAX-HPLC using a 4.6x125 mm PartiPhere SAX column 
(Whatman). Elution was performed with a gradient of Buffer A (1 mM EDTA) and 
Buffer B (1. 3M (NH4)2HPO4) and 1 mM EDTA, pH to 3.8 with phosphoric acid). 
The gradient was as follows, 0-5 min, 0% Buffer B; 5-10 min 0-30% Buffer B; 
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10-60 min 30-100% Buffer B; 60-80 min 100% Buffer B. 1 ml fractions were 
collected and counted using 4 ml Ultima-Flo AP LCS-cocktail (Perkin Elmer). 
2.6.5 ATP quantification 
ATP was extracted from cell pellets by phenol-chloroform extraction as 
previously described, however after chloroform step samples were not ethanol 
precipitated. Instead aqueous phase was collected and immediately used in a 
luciferase assay using the Molecular Probes ATP Determination Kit according to 
manufacturers instructions. 
2.6.6 Gel filtration 
PolyP was fractionated according to size by FPLC with a gel filtration column 
(SuperdexTM peptide 10/300GL; GE Healthcare -17-5176-01). PolyP was 
extracted by phenol chloroform extraction (as described above) from either 
fruiting bodies or cells from vegetative cultures, as indicated. After ethanol 
precipitation samples were resuspended in 1 ml Buffer C (10 mM Tris-pH7.4, 1 
mM EDTA, 25 mM NaCl) at a concentration of ~2-8 mg/ml RNA. 200-700 µl of 
sample (500 µg – 6 mg of RNA) was injected into the FPLC and fractionated at a 
constant flow rate of 0.2 ml/min in. 52 fractions of 0.5 ml were collected. 
2.6.7 Acid degradation 
Acid degradation of both inositol pyrophosphates and polyP was conducted by 
incubating samples at 100°C for 30 min in the presence of 1 M perchloric acid. 
Acid-treated samples were neutralised using 1 M K2CO3 and 3 mM EDTA before 
loading. 
2.7 Statistical analysis 
Statistical analysis was performed using GraphPad Prism software. Comparison 
between strains was conducted by unpaired t-tests of experimental values 
obtained from 3 or more independent experiments. Analysis of spore 
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germination compared each time point separately by unpaired t-test. Difference 
in growth rate between WT and mutant strains was assessed by comparing cell 
density at indicated time points by multiple t test. Accumulation of inositol 
pyrophosphates was analysed by One-way ANOVA multiple comparisons, 
where each time point was compared to the level of inositol pyrophosphates in 
the vegetative state. Significant differences were indicated where (*p < 0.05), (**p 
< 0.01) and (***p < 0.0001). 
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2.8 Antibodies 
Table 2.2 Antibodies 
Name Company Cat. Number Application Dilution 
Primary 
 
    
Rabbit α-GST 
 
Sigma G7781 Western Blotting 1:7,000 
Secondary 
 
    
α-rabbit IgG 
peroxidase 
conjugate 
 
Sigma A1949 Western Blotting 1:100,000 
Mouse anti 
Xpress mouse 
 
Invitrogen 46-0528 Immunofluoresence 7.5 µg/µl 
α-mouse IgG 
alexa fluorR 488 
Invitrogen A11001 Immunofluoresence 1:5,000 
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2.9 Plasmid DNA constructs 
Table 2.3 Plasmid Vectors 
Vector Origin Application 
pGEMR T Easy 
 
Promega TA cloning 
pADH-GST (Draskovic, Saiardi et al. 
2008) 
Protein expression in yeast 
 
TMO1 
 
 
(Muramoto, Cannon et al. 
2012) 
D. discoideum deletion 
construct 
pDEX NLS Cre (Faix, Kreppel et al. 2004) Blasticidin Resistance 
excision 
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Table 2.4 Deletion constructs   
Vector 5’  
Insert 
5’ 3’ Insert 
origin 
3’  
Insert 
5’ 3’ Insert 
origin 
TMO1 IP6K 5A NotI EcoRI PCR 
gDNA 
 
IP6K 3A HindIII KpnI PCR from 
gDNA 
TMO1 PPIP5K 
5A 
NotI EcoRI PCR 
gDNA 
 
PPIP5K 
3A 
HindIII KpnI PCR from 
gDNA 
TMO1 IPMK 5A NotI EcoRI PCR 
gDNA 
 
IPMK 
3A 
HindIII KpnI PCR from 
gDNA 
TMO1 IPKA 5A NotI EcoRI PCR 
gDNA 
 
IPKA 3A HindIII KpnI PCR from 
gDNA 
TMO1 IPKA 
5A_2 
NotI EcoRI PCR 
gDNA 
 
IPKA 
3A_2 
NdeI KpnI PCR from 
gDNA 
TMO1 IPKB 5A NotI EcoRI PCR 
gDNA 
 
IPKB 3A HindIII KpnI PCR from 
gDNA 
TMO1 PPK 5A NotI EcoRI PCR 
gDNA 
PPKA 
3A 
HindIII KpnI PCR from 
gDNA 
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Table 2.5 Overexpression constructs 
Vector 5’ 
digest 
3’ 
digest 
Insert 5’ digest 3’ digest Insert 
origin 
pADH-GST BamHI EcoRI IPKA BglII EcoRI PCR from 
cDNA 
 
pADH-GST BamHI EcoRI IPKB BglII EcoRI PCR from 
cDNA 
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3. Inositol pyrophosphates: D. 
discoideum as a genetic model 
3.1 Introduction 
3.1.1 Background  
The inositol pyrophosphates were first described in two independent studies in 
1993, in mammalian cells (Menniti, Miller et al. 1993) and the social amoeba D. 
discoideum (Stephens, Radenberg et al. 1993). Since then these molecules have 
been observed in all eukaryotic organisms tested (Wilson, Livermore et al. 2013). 
In recent years the budding yeast S. cerevisiae has been the preferred model in 
which to study the structure and synthesis of the inositol pyrophosphates. 
Research in yeast has revealed the identity of a number of the key enzymes 
responsible for the synthesis of the inositol pyrophosphates, allowing their 
homologues to be identified in mammalian cells.  
 
However, due to their relatively low abundance, study of these molecules in 
yeast requires the use of radiolabelled [3H] inositol and HPLC. These techniques, 
although powerful, are laborious and inaccessible for a large number of cell 
biology laboratories. Recent improvements in the use of polyacrylamide gel 
electrophoresis (PAGE) techniques coupled with Toluidine staining has allowed 
the resolution and visualisation of these molecules. In fact this approach 
suggests that HPLC techniques may in fact underestimate the true abundance 
of the inositol pyrophosphates (Pisani, Livermore et al. 2014). Consequently the 
aim of this project is to make use of these techniques and return to the amoeba 
D. discoideum as a model to study the inositol pyrophosphates. In fact, this 
approach has already yielded the first detection of unlabelled inositol 
pyrophosphates extracted directly from cells (Pisani, Livermore et al. 2014). 
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The analysis of neutralised perchloric acid extract from 1 x 106 WT AX2 D. 
discoideum cells by 35.5% PAGE and Toluidine Blue staining reveals three 
distinct bands (Pisani, Livermore et al. 2014) (Fig 3.1 A). Toluidine Blue is a 
metachromatic dye that stains acidic phosphate-rich molecules. The strong 
staining of these bands indicates that they represent highly phosphorylated 
species. The fastest migrating of these bands co-migrates with IP6 standard. 
Together these results suggest that the likely identity of this fastest migrating 
band is IP6 and that the slower migrating bands are likely higher molecular 
weight inositol phosphates. Analysis of extract from the previously generated 
ip6k strain (Luo, Huang et al. 2003) revealed that only the putative IP6 band can 
be detected by Toluidine Blue staining (Figure 3.1). This genetic evidence 
supports the notion that this band is IP6 and the slower migrating bands are 
inositol pyrophosphates, most likely IP7 and IP8.  
 
In accordance with previous work (Stephens and Irvine 1990, Drayer, Van der 
Kaay et al. 1994) analysis of a plc strain reveals the same three major bands, as 
in WT, with no detectable decrease in the staining. This method corroborates 
previous suggestions that IP6 and inositol pyrophosphates are synthesised in a 
lipid-independent manner in D. discoideum.  
 
In addition, analysis of D. discoideum cell extract by PAGE and DAPI staining 
reveals the enhanced photo bleaching properties of the slower migrating bands 
(Figure 3.1 B), a property associated with the phosphoanhydride bond present 
in inositol pyrophosphates (Losito, Szijgyarto et al. 2009). The increased 
sensitivity of DAPI staining also reveals the presence of an additional band, 
migrating still slower than the putative IP8 band in both WT and plc null strains 
(Figure 3.1 B). The photo bleaching of this band suggests that it too is an 
inositol pyrophosphate species, probably possessing even more phosphates 
and most likely IP9, the first detection of such a species in vivo.  
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Figure 3.1 PAGE analysis of D. discoideum extract.  
Perchloric acid extracts from 10 ml culture growth of wild type (WT) D. 
discoideum (AX2 strain) and the IP6-Kinase (ip6k*) and phospholipase C mutant 
(plc) grown at a density of 2–4x106. Approximately 30–40 µl of neutralised cell 
extract (5% of total extract volume) was analysed by 35.5% PAGE. Inositol 
pyrophosphates were visualised with Toluidine blue (A) and DAPI staining (B), 
revealing three distinct bands. The figure shows a representative result of an 
experiment performed more than three times. Figure and figure legend adapted 
from (Pisani, Livermore et al. 2014), experiment performed by F. Pisani. 
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Treatment of this extract with phytase, which sequentially removes phosphate 
moieties from the inositol ring, degrades all three of these bands, confirming that 
they are indeed inositol phosphate species (Fig 3.2 A). Treatment of the extract 
with the pyrophosphatase Ddp1 (Lonetti, Szijgyarto et al. 2011) causes the 
putative IP7 and IP8 bands to collapse on to the fastest migrating IP6 band  (Fig 
3.2 B). Finally, treatment of this extract with acid also ablates the slower 
migrating, IP7 and IP8 bands. Following acid treatment there is stronger staining 
of the fastest migrating band indicating that acid degradation of the slower 
migrating bands yielded more of this material (Fig 3.2 C). However, three further 
bands that migrate faster than this band also appear after acid treatment. 
 
The sensitivity to phytase, but not Ddp1 nor acid, as well as co-migration with 
IP6 standard (Figure 3.2) confirms that the fastest migrating band of these three 
is in fact IP6 and the slower two migrating bands are IP7 and IP8. However, the 
appearance of three faster migrating bands, most likely isomers of IP5, after acid 
treatment indicates that there may also be IP5-derived inositol pyrophosphates 
present in this extract. Given that speed of migration is related to the number of 
phosphates, it is likely that these IP5-derived inositol pyrophosphates co-migrate 
with the “conventional” IP6-derived inositol pyrophosphates (e.g. (PP)2-IP3 and 
PP-IP5). This precludes the resolution of distinct IP5-derived inositol 
pyrophosphate such PP-IP4 bands in untreated extract. 
 
Analysis of gel-purified putative IP7 and IP8 bands (Figure 3.3 A) by mass 
spectrometry confirms the identity of these bands. The “IP7” band reveals two 
peaks in the 500-1000 m/z range, one at 738.822 m/z and another at 760.793 
m/z, representing the theoretical mass of deprotonated IP7 and the sodium 
adduct of deprotonated IP7 respectively (Figure 3.3 B). Similarly, analysis of the 
putative IP8 band reveals two peaks, one at 818.627 m/z and the other at   
840.590 m/z, representing deprotonated IP8 and its sodium adduct, respectively 
(Figure 3.3 C). These analyses confirm the identity of the three detectable bands   
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Figure 3.2 Enzymatic treatments of D. discoideum extract confirms identity 
of IP6, IP7 and IP8.  
Untreated WT D. discoideum cell extract (-) was incubated with phytase (Phy) 
(A), recombinant diphosphoinositol polyphosphate phosphohydrolase (DDP1) (B) 
or boiled in 1 M acid (C). Phytase degradation of extract (A) confirms these 
bands are inositol phosphates. DDP1 degradation of the two slower migrating 
bands confirms their identity as inositol pyrophosphates (B). Sensitivity to acid 
hydrolysis further confirms the pyrophosphate nature of these bands (C). The 
figure shows a representative result of an experiment performed more than three 
times. Figure and figure legend adapted from (Pisani, Livermore et al. 2014), 
experiment performed by F. Pisani.  
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Figure 3.3 Mass spectrometry analysis of inositol pyrophosphates purified 
from D. discoideum. 
Inositol pyrophosphates purified from gels (A) were analysed by mass 
spectrometry (B, C). The m/z spectrum of the IP7 band (B) and IP8 band (C) is 
shown. The peaks in the spectra describing inositol pyrophosphates are 
consistent with the theoretical values for molecular weight of 738.82 Da and 
818.78 Da respectively. Figure and figure legend adapted from (Pisani, 
Livermore et al. 2014), experiment performed by F. Pisani.  
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seen by PAGE analysis of WT extract as IP6, IP7 and IP8. Whilst the slowest 
migrating band detected by DAPI (Figure 3.1 B) has not been analysed by mass 
spectrometry, it seems highly likely that this band is IP9, thus representing the 
first detection of this molecule in cell extracts. 
 
Toluidine staining intensity reflects the number of phosphates present in a given 
molecule (Pisani, Livermore et al. 2014), allowing the concentration of IP6, IP7 
and IP8 to be estimated. Resolving acid treated IP8, along with the corresponding 
amount of untreated IP8 allows the comparison of the relative staining 
efficiencies of these two samples by densitometry, revealing that on average IP8 
is stained 1.27 +/- 0.08 more efficiently than the corresponding amount of IP6. 
This fits well with the theoretical value based on number of phosphates of 8/6 or 
1.33. Thus, the concentration of IP6, IP7 and IP8 during the vegetative state can 
be estimated at 520 µM, 60 µM and 180 µM respectively. The calculated value 
for IP6 concentration is consistent with previous estimates (Stephens and Irvine 
1990, Letcher, Schell et al. 2008). However, the levels of IP7 and IP8 were much 
higher than suggested by some earlier work, which measured the vegetative 
levels of IP8 to represent approximately 5% of the level of IP6 (Laussmann, 
Pikzack et al. 2000). This analysis clearly revealed that the levels of inositol 
pyrophosphates during the vegetative state are much higher than estimated by 
Laussmann et al.. It is also interesting to note that, unlike yeast and mammalian 
cells, the level of IP8 exceeds that of IP7, possibly indicating that the conversion 
of IP7 to IP8 occurs more rapidly than the conversion of IP6 to IP7. 
 
The ease of analysis of unlabelled inositol phosphates by PAGE and Toluidine 
staining or DAPI staining makes this model a technically attractive system in 
which to study the synthesis and metabolism of the inositol pyrophosphates. 
The ability to analyse the inositol pyrophosphates in this way has a number of 
benefits. This method allows the processing and analysis of numerous samples 
at once. A single poly acrylamide gel can be run overnight and can 
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accommodate more than ten samples. This is compared to HPLC, where each 
sample must be run and counted separately. The second benefit of this 
technique is that it does not require the use of radioactive material. This not only 
makes the technique more amenable, but more importantly, removes the need 
for labelling. Depending on the generation time and labelling efficiency, cells 
must be labelled for between overnight (yeast) and up to five days (mammalian 
cells) in order to reach equilibrium. The duration of labelling is a perennial 
problem for the study of inositol phosphates, removal of this step can not only 
drastically reduce the time required to generate samples, but also address any 
uncertainty associated with not reaching equilibrium labelling. In addition, this 
method allows the detection of metabolically inactive pools of inositol 
phosphates. 
 
3.1.2 Enzymology 
The technical advantages of working with this organism are clearly 
demonstrated in the work described above (Pisani, Livermore et al. 2014). In 
addition to the technical advantages of working with this organism, the D. 
discoideum genome encodes seven inositol phosphate kinases compared to 
just four in yeast (Table 3.1). This includes homologues to the two 
pyrophosphate synthesising enzymes, IP6K and PPIP5K. The IP6K gene, 
annotated I6Ka (ID: DDB_G0278739), encodes an 81 kDa protein, compared to 
the mammalian IP6K1 at ~52 kDa and the yeast Kcs1p at ~120 kDa (Figure 7.1). 
 
The PPIP5K (ID: DDB_G0284617) homologue in D. discoideum encodes a 56 
kDa protein, compared to the 130 kDa yeast protein and ~150 kDa in 
mammalian cells. As described previously this remarkable enzyme possesses 
both a kinase domain and a phosphatase domain in yeast and mammalian cells. 
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Table 3.1 Inositol phosphate kinases in D. discoideum  
  
Gene ID 
Annotated 
Gene 
name 
Chromo-
some 
Annotated gene 
product kDa 
Gene 
name 
Yeast 
Homo-
logue 
Mammalian 
Homo-
logue 
DDB_G0278739 I6KA 3 inositol phosphate 
kinase 
81 Ip6k Kcs1 IP6K 1-3 
DDB_G0284617 na 4 na 56 Ppip5k Vip1 PPIP5K 1-2 
DDB_G0281737 na 3 
inositol 
polyphosphate 
multikinase 
33 Ipmk Arg82 IPMK 
DDB_G0288351 ipkA1 2 
inositol 
polyphosphate 
multikinase 
36 Ipka na ? 
DDB_G0283863 na 4 
inositol 
hexakisphosphate 
kinase 
70 Ipkb na ? 
DDB_G0288351 na 5 
Inositol 
pentakisphosphate 
2 kinase 
59 Ipk1 Ipk1 IPPK 
DDB_G0269746 itpk1 1 
inositol-
tetrakisphosphate 
1-kinase 
38 Itpk1 na ITPK1 
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Interestingly the D. discoideum gene encodes a much smaller enzyme, which 
completely lacks the phosphatase domain (Figure 7.2). The absence of this 
phosphatase domain in the amoeba abolishes the futile cycle demonstrated by 
the yeast enzymes (Wang, Nair et al. 2015) simplifying the activity of this protein 
and possibly suggesting a more prominent role for the product of this enzyme, 
IP8. It might also provide some clues as to why the levels of IP8 exceed IP7 in this 
organism. 
 
Alongside IP6K and PPIP5K are five additional inositol phosphate kinases. An 
IPMK homologue (ID DDB_G0281737) (Arg82 in yeast) encodes a 32 kDa protein 
(Figure 7.3). This enzyme, which phosphorylates I(1,4,5)P3 to I(1,3,4,5,6)P5 in 
yeast has also been described to possess the ability to synthesise inositol 
pyrophosphates in vitro (Saiardi, Nagata et al. 2001). The catalytic flexibility of 
this enzyme is demonstrated still further by its ability to phosphorylate 
phosphoinositides, forming PIP3 in vitro (Resnick, Snowman et al. 2005). IPMK is 
a member of the inositol phosphate kinase family of proteins and is likely an 
evolutionary descendent of an ancient IP6K-like enzyme (Bennett, Onnebo et al. 
2006, Wang, DeRose et al. 2014).  
 
In addition the D. discoideum genome encodes two further members of the 
inositol phosphate kinase family, termed here IPKA (ID: DDB_G0288351) and 
IPKB (ID: DDB_G0283863). These genes have been annotated respectively as 
an IPMK and an IP6K, however both show some divergence from the 
anticipated sequence (Figures 7.4 and 7.5). The gene referred to here as Ipka 
encodes a 36 kDa protein and has previously been termed ipkA1 and annotated 
as and IPMK.  This gene has been cloned and overexpressed in D. discoideum 
cells lacking the phosphatase MIPP (King, Keim et al. 2010). Overexpression of 
IPKA was shown to confer resistance to Li+-mediated inhibition of chemotaxis. It 
was postulated that resistance was caused by the synthesis of IP5 by IPKA, 
however this was not confirmed by measurement of IP5 production.  
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The gene referred to here as Ipkb has been annotated as an additional Ip6k. 
This is based on homology and has not been experimentally tested. Sequence 
alignment (Figure 7.5) supports this annotation, however the observed 
phenotype of the ip6k* null mutant (Luo, Huang et al. 2003) suggests that the 
IPKB enzyme is not the major source of IP7 in D. discoideum in the vegetative 
state. 
 
Alongside these five kinases (four members of inositol phosphate kinase family 
and Ppip5k) the D. discoideum genome encodes two additional enzymes likely 
to be involved in the synthesis of inositol phosphates. Sequence alignment 
reveals a homologue to the yeast Ipk1 and mammalian Ippk in the amoeba 
genome (ID: DDB_G0288351), referred to here as Ippk. This gene has yet to be 
characterised, however homology suggest it is an inositol pentakisphosphates-
2-kinase (Figure 7.6). This enzyme represents a different fold to the inositol 
phosphate kinase family and is the only enzyme described to phosphorylate the 
axial position 2 of the inositol ring. 
 
The final inositol phosphate kinase identified in the D. discoideum genome is the 
inositol-tetrakisphosphate 1-kinase (Itpk1) (ID: DDB_G0269746). This gene 
product again has not been characterised, however it can be identified as an 
ITPK1 by sequence alignment (Figure 7.7). The mammalian homologue ITPK1 
has been described to phosphorylate the isomer I(1,3,4)P3 to I(1,3,4,5,6)P5 by 
placing a phosphate on positions 5 and 6 of the inositol ring (Zhang, Majerus et 
al. 2012). Yeast do not possess a homologue for this gene (nor, intriguingly, do 
Drosophila (Seeds, Sandquist et al. 2004)), thus its presence in the D. 
discoideum genome suggests a complexity of synthesis of inositol phosphates 
more akin to mammalian cells than that seen in yeast.  
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3.1.3 Expression 
The expression profiles of these genes as reported by DictyExpress database 
(https:// dictyexpress.research.bcm.edu/landing/) reveals that many of these 
genes are developmentally regulated (Figure 3.4). In the vegetative state (0 h 
post starvation) Ip6k, Ppi5k and Ipmk all show fairly low levels of expression, 
approximately 10 Reads per Kilobase per Million Mapped Reads (RPKM) (Figure 
3.4, top panel). Upon the onset of starvation the expression of all of these 
genes is increased. Both Ip6k and Ipmk mRNA levels show a rapid induction 
after just 4 hours, before either levelling off, in the case of Ipmk or dropping 
slightly, as in Ip6k. Expression of Ipmk reaches a peak of ~80 RPKM after 16 
hours of starvation. Meanwhile Ip6k, after dropping between 4 and 16 h, 
reaches its highest levels of expression after 24 h of starvation, at ~50 RPKM. 
The expression of Ppip5k does not increase as rapidly as either Ipmk or Ip6k, 
however expression does increase after a slight delay, ultimately rising to well 
over 100 RPKM at 12 h and 20 h post starvation. 
 
The expression profiles of both Ipka and Ipkb are also both developmentally 
regulated (Figure 3.4, middle panel). Ipka is expressed at very low levels during 
the vegetative state and undergoes a rapid increase in expression upon the 
onset of the starvation response. The expression of Ipka peaks at 16 h, with a 
read count of ~60 RPKM. Meanwhile Ipkb is more highly expressed during the 
vegetative state, before steadily increasing during the starvation response to 65 
RPKM after 24 h. 
 
Finally, neither Ippk, nor Itpk1 are developmentally regulated. In fact, neither 
gene is highly expressed at any stage of development, with read counts failing 
to exceed 5 RPKM for either gene (Figure 3.4, bottom panel). 
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3.1.4 Concluding remarks 
This short introduction to the technical advantages of the amoeba, D. 
discoideum, alongside the enzymology of inositol phosphate synthesis presents 
the amoeba as an ideal model to investigate inositol phosphate metabolism. The 
breadth of enzymes encoded in the D. discoideum genome suggests a more 
complex synthetic pathway than that described in yeast and possibly more 
analogous to mammalian cells. The presence of the Itpk1 in particular, invites 
speculation that the synthesis of inositol phosphates in this amoeba may offer 
insights into the mammalian system that the yeast model could not. The aim, 
therefore, of the work presented in the following results was to generate a panel 
of mutant strains in which the enzymes described above were deleted. 
Generation of a genetic model will provide insight into the synthesis of the 
inositol pyrophosphates and their precursors in D. discoideum, complementing 
the yeast model and potentially offering additional clues into the synthetic 
pathway of inositol pyrophosphates in mammalian cells. 
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Figure 3.4 Developmental expression profiles of inositol phosphate kinases.  
Expression profiles all seven inositol phosphate kinases during 24 hours of 
development. RNA copy number expressed as reads per kilobase per million 
mapped reads (RPKM). Expression of Ip6k (cyan line) Ppip5k (olive line) and 
Ipmk (green line) increase after the onset of starvation (A). Expression profiles of 
Ipka (blue line) Ipkb (red line) increase after the onset of starvation (B). 
Expression of Ippk (yellow line) and Itpk1 (orange line) are very low at all stages 
of development (C). All data from DictyExpress database 
(https://dictyexpress.research.bcm.edu/landing/).  
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3.2 Results 
3.2.1 Generation of knockouts 
A genetic approach was employed to investigate the synthetic pathway of the 
inositol pyrophosphates in D. discoideum. Deletion constructs were designed 
and cloned for each of the seven inositol phosphates kinases described above. 
Not all genes were successfully deleted by this approach, but a number of 
mutant strains were generated and these will be discussed below.  
 
A commonly used homologous recombination approach was used to generate 
knock out cell lines in D. discoideum (Gaudet, Pilcher et al. 2007). This approach 
involved cloning of two regions flanking (or slightly overlapping) the target gene 
and inserting them either side of a Blasticidin resistance marker gene in the 
TMO1 plasmid (materials and methods, 2.3.6)(Muramoto, Cannon et al. 2012). 
The strategy for deletion of the Ppip5k involved cloning 1.1 kb of genomic 
sequence overlapping slightly with the 5’ region of the gene and 0.8 kb 3’ of the 
gene (Figure 3.5 A). Homologous recombination using this construct deleted 44 
% of the coding sequence of the gene. Recombinant strains were initially 
screened by PCR (not shown) and confirmed by Southern blot (Figure 3.5 B) 
and Northern blot (Figure 3.5 C). This strain is hereafter referred to as ppip5k. 
 
Although the Ip6k gene has previously been deleted (Luo, Huang et al. 2003), 
this strain was generated again from the WT background used in this study. It 
was reasoned that any attempt to analyse the metabolic phenotype of the ip6k 
mutant should compare directly to a parental WT strain. Thus, deletion of the 
Ip6k gene followed a similar strategy, cloning a 5’ sequence of 1 kb and a 3’ 
sequence of 0.8 kb (Figure 3.6 A). Homologous recombinants had 56% of the 
coding sequence deleted and were screened by PCR (not shown). This strain is 
hereafter referred to as ip6k.  
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Figure 3.5 Deletion of PPIP5K by Homologous Recombination.  
Schematic of deletion strategy, deletion construct contained a 5’ targeting arm 
of 1069 bp and a 3’ targeting arm of 832 bp (A). Southern blot revealed that 
digestion with NdeI generated a fragment of 2.5 kb in WT genomic DNA and 2.2 
kb in ppip5k genomic DNA (B). Northern blot identified PPIP5K transcript in WT 
cells, but not ppip5k (B, upper panel), rRNA fragments revealed equal loading 
(C, lower panel). 
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Figure 3.6 Deletion of IP6K by Homologous Recombination.  
Schematic of deletion strategy, deletion construct contained a 5’ targeting arm 
of 1050 bp and a 3’ targeting arm of 835 bp . 
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Double mutants, in which both ppip5k and ip6k genes were disrupted, were 
generated using the same deletion constructs.  Using the ppip5k strain 
described above the Blasticidin resistance gene (BSR) was excised by 
overexpressing a recombinant Cre with a nuclear localisation signal (pDex Cre 
NLS) (materials and methods, 2.3.7). The loxP sites located either side of the 
BSR gene were cleaved and the resistance gene excised. The Ip6k gene was 
then disrupted as described above to generate the ip6k/ppip5k strain. These 
mutants were screened by PCR (not shown). 
 
Perchloric acid extracts of these mutants were analysed by PAGE to investigate 
the relative contributions of these genes to the pool of inositol pyrophosphates 
(Figure 3.7). For added sensitivity the gel was stained with DAPI. As described 
above an additional, slower migrating band, most likely IP9 is faintly visible in WT 
extracts stained with DAPI (Figure 3.7). 
 
Disruption of the ip6k gene completely ablated the level of IP8 and almost 
completely ablated the level of IP7. Some IP7 remained detectable by DAPI, 
however this is band was not visible by Toluidine staining (not shown). These 
results recapitulated those from the previously generated ip6k* mutant (Luo, 
Huang et al. 2003, Pisani, Livermore et al. 2014)(Figure 3.1), confirming that 
IP6K is the main, but not the only, source of IP7 in D. discoideum. 
 
Surprisingly, deletion of the ppip5k gene failed to ablate the IP8 band. Both IP7 
and IP8 were detectable in the ppip5k mutant. DAPI staining cannot be used to 
quantitatively assess the levels of inositol pyrophosphates, however, both IP8 
and IP7 seemed to be less abundant than in WT (Figure 3.7), IP6 was unaltered. 
 
Cells lacking both IP6K and PPIP5K enzymes also possessed residual levels of 
IP7, as detected in the ip6k mutant (Figure 3.7). This suggested that PPIP5K   
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Figure 3.7 PAGE analysis of panel of D. discoideum extract.  
Perchloric acid extracts of WT, ip6k, ppip5k, ip6k/ppip5k were analysed by 
35.5% PAGE and DAPI staining. Samples were normalised by protein. The 
figure shows a representative result of an experiment performed more than three 
times. 
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was not the enzyme responsible for synthesis of the IP7 detectable in ip6k and 
that an additional enzyme (or enzymes) were capable of synthesising inositol 
pyrophosphates in this amoeba. Nevertheless, these results confirmed that IP6K 
was the primary source of IP7 in the vegetative state in D. discoideum. Neither 
the presence of PPIP5K, nor the additional unidentified kinase(s), was able to 
compensate for the loss of IP6K. 
 
In order to better quantify the levels of inositol pyrophosphates in ppip5k mutant 
cells, perchloric acid extracts of two independent clones were analysed by 
PAGE and stained with Toluidine (Figure 3.8). Samples were normalised by cell 
number, with extract from 1.08 x 106 cells loaded in each lane. Toluidine staining 
confirmed that the levels of both IP8 and IP7 were reduced in absolute terms.  
 
Further analysis of the levels of inositol pyrophosphates in these figures, and all 
further figures, used IP6 as an internal control within each lane. Whilst this did 
not account for the differing staining intensity of IP8, IP7 and IP6 nor any changes 
in the level of IP6 in between strains, it allowed a more consistent measure of the 
ratio between IP8 or IP7 and IP6 in each experiment. It also allowed each lane of 
the gel to be internally normalised thereby allowing comparison of the ratio 
between samples run on different gels. Densitometry analysis of multiple gels 
stained with Toluidine was performed using Image J software (materials and 
methods, 2.6.4). The relative strength of each band was assessed and the 
average  ratio of IP7 :IP6 and IP8:IP6 calculated. Comparison of these ratios 
revealed that the level of IP7 (compared to IP6) was reduced by approximately 
40% in ppip5k extracts (Figure 3.8 B). Meanwhile, the level of IP8 (compared to 
IP6) was reduced by almost 70% in ppip5k extracts (Figure 3.8 C).  
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Figure 3.8 Quantification of inositol pyrophosphates in ppip5k.  
Perchloric acid extracts of WT and two independent clones of ppip5k were 
analysed by 35.5% PAGE and Toluidine staining (A). Densitometry analysis of 
the level of IP7 compared to IP6 (B) and the level of IP8 compared to IP6 (C). 
Average values +/-SD determined from three independent experiments. 
Significant differences were indicated where (*p < 0.05) and (***p < 0.0001). 
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Figure 3.9 HPLC analysis of D. discoideum extract. 
D. discoideum was labelled with [3H] inositol for 3-4 days. Perchloric acid 
extracts were analysed by HPLC and radioactivity contained in fractions 
counted. WT extract was compared to ip6k extract (A) and WT extract was 
compared to ppip5k extract (B). Traces shown on the same graph represent 
experiments conducted in parallel. 
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3.2.2 HPLC analysis of inositol phosphates in D. discoideum mutants 
To confirm the results obtained by PAGE analysis, WT, ip6k and ppip5k cells 
were labelled with [3H] inositol. Cells were grown in inositol-free media for 3-4 
days, supplemented with 50 µCi/ml [3H] inositol. Neutralised perchloric acid 
extracts were then analysed by HPLC (Azevedo and Saiardi 2006) (materials 
and methods, 2.3.1). HPLC traces of WT extract revealed three peaks 
corresponding to IP6, IP7 and IP8 (Figure 3.9). Both the IP7 and IP8 were 
completely absent from the ip6k extract (Figure 3.9 A).  In separate experiments 
the levels of inositol pyrophosphates were compared between WT and ppip5k 
(Figure 3.9 B). The peaks of both IP7 and IP8 were both reduced in ppip5k 
extract, corroborating the results obtained by PAGE and Toluidine staining.  
 
Labelling of D. discoideum was very poor, making these experiments 
challenging. In addition, the HPLC traces obtained in these experiments 
indicated that the use of DAPI and PAGE was more sensitive for detection of 
inositol pyrophosphates in D. discoideum. As noted previously (Pisani, 
Livermore et al. 2014), the level of inositol pyrophosphates is underestimated by 
detection with HPLC compared to PAGE. This was demonstrated by the failure 
to detect the residual IP7 in the ip6k strain by HPLC (Figure 3.9 A). Due to this 
combination of factors, all further analysis of inositol pyrophosphates in D. 
discoideum was performed by PAGE. 
3.2.3 PPIP5K synthesises bis-diphosphoinositol phosphate species 
PPIP5K has been described to possess activity towards both IP6 and IP7 in vitro 
(Wang, Falck et al. 2012). However, in vivo evidence from yeast (Onnebo and 
Saiardi 2009) and mammalian cells (personal communication M. Wilson) 
indicates that this enzyme contributes very little towards the steady state level of 
IP7 and is almost exclusively an IP7 kinase (hence PPIP5K). Conversely, the 
ppip5k strain generated in these experiments displayed decreased levels of both 
IP7 and IP8, as confirmed by both PAGE and HPLC. There are several 
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explanations for this, the first being that PPIP5K is both an IP6 and IP7 kinase in 
D. discoideum. The lack of the phosphatase domain in the amoeba PPIP5K 
could explain such a discrepancy in activity. Alternatively, it may be that the 
apparent IP7 band is comprised of other co-migrating species inositol 
pyrophosphate species derived from IP5, as suggested previously (Figure 3.2 
C)(Pisani, Livermore et al. 2014). A bis-diphosphoinositol species derived from 
IP5 ((PP)2-IP3) would be indistinguishable from IP7 (PP-IP5) by mass spectrometry. 
If these species are generated by PPIP5K, then the deletion of this gene may 
reduce their synthesis and be manifested by a reduction in the strength of the 
“IP7” band. 
  
To investigate this possibility, several isomers of IP5 were incubated with 
mammalian IP6K1. Mammalian IP6K1 is known to show activity towards IP5 
(Saiardi, Nagata et al. 2001) and was readily available in the lab hence it was 
used as a reliable means of assessing the migration of PP-IP4. As anticipated, 
mammalian IP6K was capable of utilising IP5 as a substrate as demonstrated by 
the appearance of two further, slower migrating bands when the I(2,3,4,5,6)P5 
was treated with IP6K (Figure 3.10 A). These two bands did not perfectly co-
migrate with those seen in the WT extract, however, the migration of different 
isomeric forms can vary (as seen by the differences in migration between the IP5 
isomers used as substrate). This data indicated that IP5-derived inositol 
pyrophosphates might co-migrate with IP6 and IP7 bands in WT extract. 
 
This hypothesis was explored by treatment of both WT and ppip5k extracts with 
acid at high temperature. Boiling of inositol pyrophosphates in acid hydrolyses 
the phosphoanhydride bond linking the beta-phosphate to the ring. 
Phosphoester bonds, which link alpha phosphates to the ring, are not degraded, 
although this treatment can induce their rearrangement around the inositol ring 
(Pisani, Livermore et al. 2014). Thus inositol pyrophosphates are degraded to 
their precursor form by acid hydrolysis. Acid hydrolysis of WT extract almost  
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Figure 3.10 Inositol pyrophosphates derived from IP5 can co-migrate with 
those derived from IP6.  
Four isomers of IP5 were treated with myc tagged mouse IP6K (Mm.IP6K1). 
Migration of products was compared to D. discoideum extract and IP6 treated 
with MmIP6K1 (A). Migration of untreated and acid treated extracts from WT and 
ppip5k D. discoideum extract revealed the formation of species that migrated 
faster than IP6 (B). All samples analysed by 35.5% PAGE and stained with 
Toluidine Blue.  
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completely ablated the presence of the IP7 and IP8 bands (Figure 3.10 B, right 
panel). Furthermore, there was a clear increase in the intensity of the IP6 band, 
indicating that most of this material was degraded to IP6. However, there was 
also a clear increase in the staining of three bands that migrated faster than IP6. 
Whilst IP5 migrates with these characteristics, nucleotides including ATP and 
GTP also migrate in this region (Losito, Szijgyarto et al. 2009)(Figure 3.10 A). 
The phosphoanhydride bonds in both ATP and GTP are also degraded by acid 
hydrolysis. Thus it seems most likely that the increase in strength of these bands 
was due to a release of IP5 by acid hydrolysis.  
 
Two of these bands clearly increased after acid hydrolysis of ppip5k extract, 
although the slowest migrating of the three did not. Nevertheless, acid 
hydrolysis of both WT and ppip5k extract revealed an increase in both IP6 and 
IP5, indicating that IP5-derived inositol pyrophosphates were present in D. 
discoideum extract. Thus it seems most likely that the observed decrease in the 
IP7 band in ppip5k (Figure 3.8-3.10) was due to a decrease in the 
bisdiphosphoinositol species derived from IP5 ((PP)2-IP3) and not PPIP5K acting 
as an in vivo IP6 kinase. 
3.2.4 Growth of mutant strains reveals no major fitness defect 
To investigate the effect of the altered inositol pyrophosphate metabolism on 
general fitness, the growth of the WT strain was compared to ip6k, ppip5k and 
the ip6k/ppip5k mutants. Cells were grown over 48 hours in rich (HL5) media 
(materials and methods, 2.3.1)(Figure 3.11). All three mutants displayed very 
slight growth defects. Only ppip5k appeared to grow significantly more slowly 
from WT. The mean generation time increased from 11 h in WT to ~ 12 h in ip6k, 
and ip6k/ppip5k, rising to >12 h in ppip5k. Thus the effect on growth did not 
completely correlate with the presence of inositol pyrophosphates, as the 
ppip5k mutant, which grew slowest possessed substantial levels of inositol 
pyrophosphates, in contrast to both ip6k and the double mutant (Figure 3.7).  
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Figure 3.11 Comparison of growth curves of panel of D. discoideum 
mutants.  
WT, ip6k, ppip5k and ip6k/ppip5k were grown for 48 h in HL5 media starting at a 
density of 1 x 105 cells per ml. After 48 h, the cell density of ip6k, ppip5k and 
ip6k/ppip5k were lower than WT. The figure shows averages +/- SD from three 
independent experiments. Differences in growth rate between WT and mutants 
were evaluated by multiple t tests (materials and methods, 2.7), significant 
differences were indicated where (*p < 0.05). 
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3.2.5 Inositol pyrophosphate accumulation during development 
Upon deprivation of nutrients, D. discoideum undergoes a developmental 
process in which the unicellular amoeboid cells aggregate, form motile “slugs” 
and culminate in the formation fruiting bodies, comprised of spore cells and 
stalk cells (Figure 1.8). This process is one of the few physiological examples of 
fluctuations in the levels of inositol pyrophosphates (Laussmann, Pikzack et al. 
2000). It has also been previously noted that the ip6k strain undergoes the early 
stages of this process more rapidly than WT cells (Luo, Huang et al. 2003).   
 
Consequently the level of inositol pyrophosphates during this process were 
investigated by PAGE both in WT and mutants to determine the relative 
contribution of each enzyme (Figure 3.12). Densitometry analysis of WT extracts 
taken at five time points during development revealed a 2.5-fold increase in IP8 
in comparison to IP6 (Figure 3.12 A). This value was dramatically less than the 
previously reported value of a 25 fold increase in inositol pyrophosphates 
(Laussmann, Pikzack et al. 2000). This discrepancy is most likely due to the 
underestimate of the level of IP8 in the vegetative state by previous work 
(Laussmann, Pikzack et al. 2000). It should be recognised, that this analysis 
does not account for fluctuations in the level of IP6, which was deemed to be 
relatively constant (Figure 3.12). 
 
During the development of ip6k no accumulation of inositol pyrophosphates was 
observed (Figure 3.12 B). Interestingly ppip5k (Figure 3.12 C) did show a 
developmental increase in the level of inositol pyrophosphates, although it did 
not reach siginificance. As previously discussed the level of IP8 (expressed as a 
ratio of IP6) was around 40% of that of WT, however an increase in the level of 
IP8 could be observed after 8 hours of starvation. Quantification of this increase 
indicated that IP8 did not increase to quite the same level as observed in WT, 
although it there was a substantial increase during development. Calculating   
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Figure 3.12 Accumulation of inositol pyrophosphates during development.  
Cells were starved as described in (materials and methods, 2.3.10). The 
inositol phosphates extracted at the indicated time points were resolved on 
35.5% PAGE and visualised with Toluidine. The analysis of WT developmental 
program revealed a 2-fold increase in the IP8/IP6 ratio in fruiting bodies as 
quantified by densitometry quantified (Bottom), average +/- SD of four 
independent experiments Panel adapted from (Pisani, Livermore et al. 2014),  
(A). Analysis of ip6k extract failed to detect any accumulation of inositol 
pyrophosphates during development. The figure shows the result of a 
representative experiment that was repeated at least twice for ip6k (B). Analysis 
of ppip5k extract revealed a developmental increase in the level of IP8, 
quantification by densitometry (bottom) average +/- SD of two independent 
experiments (C). Increases in inositol pyrophosphates during development were 
evaluated according One-way ANOVA, multiple comparisons (materials and 
methods, 2.7). Significant differences were indicated where (**p < 0.01).  
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the increase during development reveals a slightly higher fold change during 
development of ~ 3.5 times. However, the lower levels of IP8 in the vegetative 
state can explain this observation. These results indicated that the accumulation 
of inositol pyrophosphates during development occurred despite the disruption 
of PPIP5K and an alternative enzyme able to synthesis IP8 was likely to be 
developmentally regulated. 
 
The speed of D. discoideum development showed slight variation between 
experiments (data not shown). WT cells began to aggregate after between 7 and 
12 h of starvation. The speed of aggregation of ip6k cells appeared slightly 
faster, ranging between 6 and 8 hours, confirming previous observations (Luo, 
Huang et al. 2003), although this was not the focus of detailed investigation. No 
substantial alteration in speed of aggregation was observed in ppip5k. All strains 
tested formed fruiting bodies as normal.  
3.2.6 Inositol pyrophosphates and primary metabolism 
Previous experiments in the Saiardi lab have identified the inositol 
pyrophosphates to be key regulators of the cell’s energetic metabolism 
(Szijgyarto, Garedew et al. 2011). Yeast and mammalian cells lacking inositol 
pyrophosphates display dramatic increases in the level of ATP. In order to 
investigate the conservation of this link, the level of ATP in ip6k cells was 
compared to WT. This analysis revealed that the level of ATP was not 
dramatically affected by disruption of the Ip6k gene (Figure 3.13).  
 
This result suggested that the link between inositol pyrophosphates and 
energetic metabolism might not be conserved in D. discoideum. However, it is 
possible to speculate that the residual level of IP7 detectable in the ip6k mutant 
was sufficient to fulfil the regulatory role over energetic metabolism. 
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Figure 3.13 No significant difference between primary metabolism of WT 
and ip6k.  
ATP was quantified as described in (materials and methods, 2.6.5) from 
phenol-chloroform extracts of both WT and ip6k.  Samples were normalised by 
RNA and results shown are average +/- SD of three independent experiments, 
where the relative level of ATP was calculated by comparing to WT in each 
experiment. 
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3.2.7 Generation of an ipmk knock out strain 
The results described above illustrate a number of divergences in the synthetic 
pathway of inositol pyrophosphates between yeast and D. discoideum. Whilst 
IP6K was evidently the primary source of inositol pyrophosphates in these cells, 
both ip6k and ip6k/ppip5k retained low levels of IP7. However, IP6K and PPIP5K 
are not the only enzymes that have been described to possess activity capable 
of synthesising inositol pyrophosphates. As noted previously IPMK (Arg82 in 
yeast) has also been shown to be capable of producing inositol pyrophosphates 
in vitro (Saiardi, Nagata et al. 2001). In order to investigate the role of this 
enzyme and the possibility that it may be synthesising inositol pyrophosphates, 
the Ipmk gene was disrupted as detailed in (Figure 3.14 A). Homologous 
recombination was confirmed by Southern blot (Figure 3.14 B), whilst Northern 
Blot confirmed absence of expression (Figure 3.14 C). This strain is hereafter 
referred to as ipmk.  
 
Interestingly, Northern blot analysis with a probe for IPMK revealed two major 
bands and a third faint band in the WT strain (Figure 3.14 C). The fastest 
migrating of these bands was most consistent with the anticipated size of Ipmk 
mRNA. It is possible that the slower migrating bands were caused by non-
specific binding, perhaps to ribosomal RNA. However, these bands were not 
present in the ipmk knockout sample, suggesting that these bands may due to 
transcript variants of Ipmk. It is worthy of note that the mammalian Ipmk 
transcript possesses a particularly long 3’ UTR sequence of 4127 nt (Saiardi, 
Nagata et al. 2001). This observation was not explored in further detail due to 
time constraints. 
 
The level of inositol pyrophosphates found in the vegetative state of ipmk was 
analysed by 35.5% PAGE and densitometry. These experiments demonstrated 
that the levels of inositol pyrophosphates in ipmk were unchanged compared to   
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Figure 3.14 Deletion of IPMK by Homologous Recombination.  
Schematic of deletion strategy, deletion construct contained a 5’ targeting arm 
of 901 bp and a 3’ targeting arm of 749 bp (A). Southern blot revealed that 
digestion with HindIII generated a fragment of 14.9 kb in WT genomic DNA and 
4.3 kb in ipmk genomic DNA (B). Northern blot identified three IPMK transcript in 
WT cells, but none ipmk (B, upper panel), rRNA fragments revealed equal 
loading (C, lower panel). 
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Figure 3.15 Quantification of inositol pyrophosphates in ipmk.  
Perchloric acid extracts of WT and ipmk were analysed by 35.5% PAGE and 
Toluidine staining (A). Densitometry analysis of the level of IP8 compared to IP6 
(B) revealed no significant difference between WT and ipmk. Average values +/-
SD determined from three independent extractions analysed on a single gel. 
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WT (Figure 3.15). This result is again divergent from that obtained in the yeast 
arg82Δ mutant, which lacks higher inositol phosphates (Saiardi, Sciambi et al. 
2002). 
 
Whilst IPMK did not play a major role in the synthesis of inositol pyrophosphates 
in the vegetative state it may play a more prominent role at different stages of 
the life cycle. In order to test this hypothesis the accumulation of inositol 
pyrophosphates was examined in the ipmk strain (Figure 3.16). As in the 
vegetative state, ipmk showed no dramatic difference compared to WT. The 
level of IP8 increased to a level comparable to WT, suggesting that IPMK is not 
the enzyme responsible for the production of inositol pyrophosphates during 
development, nor the primary source of higher inositol phosphates at any point 
in the D. discoideum lifecycle. 
3.2.8 IP5 kinase activity in cell extract 
The results described above failed to identify the role of IPMK and were 
dramatically different from other model systems. In order to better characterise 
the ipmk mutant a series of cell-free experiments were conducted to assay 
whether this cell line lacked any activity that could be detected in WT. If the lack 
of phenotype in ipmk was due to redundancy in the pathway then it was 
possible that, whilst the overall synthesis of IP6 and beyond was unaffected, 
specific enzymatic activities may be absent from this strain. As described above, 
IPMK is best known as a 3-, 6- kinase using I(1,4,5)P3 as substrate, however 
conversion of IP3 to IP4 or IP5 is hard to assess by PAGE due to poor staining of 
lower inositol phosphates by Toluidine. Therefore the cell extracts of both WT 
and ipmk were assayed for their ability to metabolise IP5 isomers to IP6 (or PP-
IP4) (Figure 3.17). For reference the endogenous inositol phosphates present in 
the same volume of cell extract used to treat IP5 could be detected in lanes 10 
and 11.   
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Figure 3.16 Accumulation of inositol pyrophosphates during development in 
ipmk. 
Cells were starved as described in (materials and methods, 2.3.10). The 
inositol phosphates extracted at the indicated time points were resolved on 
35.5% PAGE and visualised with Toluidine. As shown in Figure 3.12, the 
analysis of WT revealed a 2-fold increase in the IP8/IP6 ratio during development 
as quantified by densitometry quantified (Bottom), average +/- SD of four 
independent experiments (A), panel adapted from (Pisani, Livermore et al. 2014),  
and Figure 3.12. Analysis of ipmk revealed a developmental increase in inositol 
pyrophosphates, quantified by densitometry (below) (B). Results for ipmk were 
not repeated and quantification was from the gel shown. Statistical differences 
were evaluated according One-way ANOVA, multiple comparisons. Significant 
differences were indicated where (**p < 0.01).  
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Figure 3.17 IP5 kinase activity in cell extract.  
Cell extracts were prepared as described in (materials and methods, 2.3.11) 
from vegetative cultures of WT and ipmk cells. Three isomers of IP5 were treated 
with extract and formation of IP6 was detected by PAGE analysis and Toluidine 
blue staining. This result is representative of an experiment was performed 
twice. 
  
WT ipm
k
-
I(1
,3,
4,5
,6)
P 5
No
 su
bs
tra
te
IP5
IP6
IP7
IP8
ATP
Extract
Substrate
WT -WT - WT -ipm
k
ipm
k
ipm
k
Toluidine
po
ly
P 
T2
5 I(1
,2,
4,5
,6)
P 5
I(1
,2,
3,4
,6)
P 5
1 2 3 4 5 6 7 8 9 10 11 12
	   143 
Phosphorylation of IP5 to either IP6 or PP-IP4 was observed by both the 
diminished strength of the IP5 band compared to untreated substrate (lanes 3, 6 
and 9) and the accumulation of IP6 or PP-IP4   in lanes 1,2,4,5,7 and 8. This 
experiment revealed strong activities towards the three tested isomers of IP5, 
the presence of which had all been previously described in D. discoideum 
(Stephens and Irvine 1990). All observed activities were present in both WT and 
ipmk extracts.  
 
Whilst a full panel IPMK substrates was not tested, this experiment once more 
failed to identify any difference between WT and ipmk. Nevertheless it should be 
noted that it is not possible to attribute this activity to any particular enzyme, nor 
is it possible to distinguish between synthesis of IP6 and PP-IP4  by the 
experiments described. Further experiments would be required to ascertain the 
precise identity of this band however these were not performed in this work. 
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3.3 Discussion 
3.3.1 Synthesis of inositol pyrophosphates 
The work described in this chapter demonstrates that the synthesis of the 
inositol pyrophosphates is more complex than anticipated in the myxamoeba D. 
discoideum. It also highlights further differences between the synthetic pathway 
of IP7 and IP8 between D. discoideum and S. cerevisiae. This should perhaps not 
come as a surprise given the previously noted discrepancies between the 
synthesis of inositol phosphates in yeast and D. discoideum. Inositol 
phosphates are synthesised independently of the lipid route in D. discoideum 
(Stephens and Irvine 1990), as confirmed by PAGE (Figure 3.1, (Pisani, 
Livermore et al. 2014)) unlike in S. cerevisiae  in which the plc1Δ lacks the higher 
soluble inositol phosphates (York, Odom et al. 1999). 
 
As previously noted the deletion of Ip6k results in a strain lacking almost all IP7 
and IP8. However, residual levels of IP7 could still be detected in this strain 
(Pisani, Livermore et al. 2014)(Figure 3.7). This finding was in contrast to the 
kcs1Δ yeast strain, in which IP7 is undetectable (Saiardi, Sciambi et al. 2002). In 
addition the generation of the ppip5k mutant reveals further, striking differences 
to the synthesis of IP8 compared to yeast. Whilst the levels of IP8 are 
dramatically reduced (Figure 3.8 and 3.9), readily detectable levels of IP8 
remain. This suggests that the PPIP5K enzyme is not the only IP7 kinase in the 
D. discoideum genome. These results are in stark contrast to those from the 
vip1Δ yeast strain, in which there is no detectable IP8 and an increase in the level 
of IP7 compared to WT yeast (Onnebo and Saiardi 2009).  
 
In fact, the ppip5k strain differs from vip1Δ, not only in the presence of IP8, but 
that rather than increasing, the band identified as IP7 actually decreases. Given 
that IP7 is predicted to be the substrate of the PPIP5K enzyme, it was 
counterintuitive that its deletion should result in a decrease in the substrate. In 
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fact, further investigation revealed that this was most likely due to the fact that 
the band identified as IP7 is comprised of two co-migrating species; the classical 
IP7 (PP-IP5) consisting of a fully phosphorylated inositol ring and a single 
pyrophosphate moiety, as well as an IP5-derived inositol pyrophosphate ((PP)2-
IP3) species hosting two pyrophosphate moieties. This is consistent with 
previous findings that the amoeba, D. discoideum, possesses significant levels 
of IP5-derived inositol pyrophosphates (Pisani, Livermore et al. 2014). 
Considering the loss of “IP7” staining in the ppip5k strain, as seen in Figure 3.8 
A, and quantified in Figure 3.8 B, it seems probable that PPIP5K products 
include IP5-derived inositol pyrophosphates ((PP)2-IP3). 
 
Furthermore, the generation of a double knockout strain in which both IP6K and 
PPIP5K were deleted, ip6k/ppip5k, revealed additional complexity. This strain, 
which lacks the two conventional inositol pyrophosphate-synthesising enzymes, 
retains low, but detectable levels of inositol pyrophosphates (Figure 3.7). The 
presence of IP8 in the ppip5k strain is suggestive of another inositol 
pyrophosphate-synthesising enzyme. While it cannot be excluded that the D. 
discoideum IP6K is a hybrid kinase, capable of phosphorylating both IP6 and IP7, 
the presence of IP7 in the ip6k/ppip5k strain confirms the presence of additional 
enzyme(s) capable of synthesising inositol pyrophosphates in the amoeba. 
 
These data demonstrate that IP6K is the primary source of IP7 in the amoeba D. 
discoideum. Whilst other enzymes are clearly capable of synthesising IP7 they 
are not able to compensate for the loss of IP6K. The presence of residual IP7 in 
the ip6k/ppip5k double mutant indicated that there is an additional enzyme 
capable of synthesising inositol pyrophosphates, however the low abundance of 
IP7 in this strain suggests that it’s activity towards IP6 is low. The presence of IP8 
in the ppip5k strain also indicates that PPIP5K is not the only enzyme capable of 
synthesising IP8 in this amoeba. It is possible that the same enzyme catalyses 
both of these activities. 
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It should perhaps not be surprising that the synthesis of IP8 in D. discoideum is 
more complex than in yeast. The amoeba is peculiar amongst all organisms 
examined for its increased abundance of IP8 over IP7. The accumulation of IP8 to 
high levels is an unusual feature, normally associated with particular treatments, 
such as NaF in mammalian cells (Menniti, Miller et al. 1993). However, IP8 is the 
most abundant form of inositol pyrophosphate in the amoeba, approximately 
three-times the abundance of IP7 (Pisani, Livermore et al. 2014). 
 
As noted previously, the amoeba’s PPIP5K enzyme lacks the phosphatase 
domain found in Vip1 and HsPPIP5K (Figure 7.2). Given the specific activity of 
this phosphatase domain towards the product of the attached kinase domain 
(Wang, Nair et al. 2015), one possible hypothesis for the accumulation of IP8 
could be the unmasking of PPIP5K activity by the removal of its own remarkable 
futile cycle. However, the genetic evidence described above indicates that this 
alone cannot explain the extraordinary abundance of IP8.  
3.3.2 Effect on general fitness 
Analysis of the general fitness of the ip6k, ppip5k and ip6k/ppip5k mutant strains 
failed to detect any major phenotypes associated with reduced levels of inositol 
pyrophosphates. Growth rate was mildly affected in three strains showing 
defective synthesis of inositol pyrophosphates. This was once again markedly 
different from yeast in which kcs1Δ displays a major growth defect (Saiardi, 
Erdjument-Bromage et al. 1999). However, it should be noted that these 
experiments were performed in rich (HL5) media. Analysis of the growth of 
kcs1Δ yeast on a range of carbon sources reveals that this growth phenotype is 
exacerbated by growth on different media (Szijgyarto, Garedew et al. 2011). The 
growth of the ip6k mutant was assayed in rich media and on bacterial lawns (not 
shown), revealing no major growth defects. Both HL5 and bacteria represent 
rich sources of nutrient and it is possible that faced with the additional challenge 
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of minimal or sub-optimal media, a more substantial fitness defect may have 
emerged. It would be interesting to test this possibility more rigorously in further 
work.   
3.3.3 Developmental accumulation of inositol pyrophosphates 
It was previously noted that IP8 increases 25 fold during the developmental 
response (Laussmann, Pikzack et al. 2000). However, this analysis reveals that, 
whilst there was a dramatic increase in the level of IP8 during development, it 
was not of the scale described (Figure 3.12). A more modest 2.5 fold increase in 
the level of IP8 was detected in these experiments. This figure was calculated 
relative to the level of IP6, which was considered to be broadly consistent 
throughout the developmental time course. This discrepancy with previously 
published data is due to the much higher levels of inositol pyrophosphates 
detected in the vegetative state (Figure 3.1). Meanwhile this analysis, which 
reveals the level to which IP8 accumulates in the fruiting bodies (Figure 3.12 A) 
is consistent with previous calculations (Laussmann, Pikzack et al. 2000). It is 
seems likely that the discrepancy between the levels of inositol pyrophosphates 
detected during the vegetative state were due to methodological differences, 
not genuine physiological differences. 
 
Analysis of the developmental accumulation of inositol pyrophosphates of the 
mutants generated reveals once more, that IP6K is the primary source of IP7 in 
this amoeba at all stages of development. The ip6k mutant completely fails to 
accumulate any inositol pyrophosphates during fruiting body formation. 
Meanwhile, the ppip5k mutant undergoes a developmental increase in the level 
of inositol pyrophosphates. This accumulation is evident from 8 h after onset of 
starvation. Averaging of two experiments reveals that the level of IP8 does not 
quite reach the level obtained in WT cells, with levels of IP8 rising to 
approximately 70% of IP6. This result indicates that, despite its dramatic 
developmental increase in expression (Figure 3.4), PPIP5K is not solely 
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responsible for the increase in inositol pyrophosphates during the starvation 
response. It seems likely, therefore, that the enzyme responsible for the increase 
in IP8 is developmentally regulated. It appears that this enzyme(s) has a strong 
preference in substrate for IP7 over IP6 as it is not able to induce a 
developmental increase of IP7 in the ip6k mutant. 
 
Despite the alterations in the accumulation of inositol pyrophosphates during 
development, neither mutant strain analysed in this way exhibits significant 
defects in developmental progression or timing. The ip6k strain showed a slight 
increase in aggregation speed, but both ip6k and ppip5k formed fruiting bodies 
as normal. The spores of both strains also appeared to germinate as normal 
(data not shown). These observations were somewhat surprising given the 
substantial amounts of energy invested in to the accumulation of these 
molecules during a period of starvation. It might, therefore, be reasonable to 
expect that the complete failure to accumulate these molecules would result in a 
more dramatic phenotype. 
3.3.4 Link between inositol pyrophosphates and primary metabolism? 
Given the conserved link between inositol pyrophosphates and energetic 
metabolism in yeast and mammalian cells, it is also surprising that no such link 
was detected in the amoeba in these experiments (Figure 3.13). There was no 
significant difference between the levels of ATP measured from WT or ip6k cells.  
3.3.5 A role for inositol pyrophosphates in D. discoideum? 
Given the apparent absence of dramatic metabolic defect and the absence of 
any major phenotype during development when the inositol pyrophosphates 
accumulate, it is not clear what exactly these molecules are doing either in the 
vegetative state or during development. The extraordinarily high levels of the 
inositol pyrophosphates in D. discoideum are almost unmatched in any other 
model tested to date. So it is natural to expect that loss of the vast majority of 
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this pool would precipitate major changes in the physiology of these cells. 
However, these analyses failed to detect such changes.  
 
In considering possible explanations for this lack of phenotypes it should be 
noted that it is far more common for the level of IP7 to exist at a fraction of that 
of IP6 and in the low µM range of concentrations, rather than the low mM range 
seen in D. discoideum. In yeast, where loss of IP7 in the kcs1Δ strain, induces a 
wide range of phenotypes and has substantial effects on general fitness, the 
steady state level of IP7 is barely 5% of the level of IP6, itself a fraction of the 
level of IP6 in the amoeba. Thus in other organisms very low steady state levels 
of inositol pyrophosphates are able to exert their influence on the physiology of 
a cell.  
 
Whilst no attempt was made to quantify the abundance of residual IP7 in either 
the ip6k or ip6k/ppip5k strains, IP7 was detectable in the extracts made from ~2 
x106 cells. Meanwhile, recent technological developments, including the use of 
Titanium dioxide (TiO2) beads to enrich inositol pyrophosphates have allowed 
the use of PAGE to analysis mammalian inositol pyrophosphates (Wilson, Bulley 
et al. 2015). In this study, IP7 could be detected by Toluidine in extracts made 
from 8 x107 cells, approximately 50 times more than required to detect IP7 (by 
DAPI) in the ip6k/ppip5k strain. Clearly the added sensitivity of DAPI over 
Toluidine plays a role in this discrepancy. At the same time it should be noted 
that detection of IP7 from barely 2 million cells still represents an abundance of 
IP7 which may be comparable to yeast and mammalian cells. Thus, whilst 
inositol pyrophosphates are hugely diminished compared to WT amoeba, it is 
possible that the failure to detect any notable phenotype in ip6k, ppip5k or 
ip6k/ppip5k mutant strains, might be due to the residual levels of IP7. It is 
possible that this residual pool might be sufficient to perform the many 
fundamental physiological roles of the inositol pyrophosphates. 
 
	   150 
This hypothesis has not been tested in this work since it would require the 
identification and deletion of the enzyme responsible for the synthesis of IP7 in 
the ip6k/ppip5k strain. Whilst this hypothesis could explain the lack of 
phenotype observed in these mutants, it poses an additional question of why 
exactly the amoeba would accumulate such high levels of inositol 
pyrophosphates in the first place. Especially if the residual levels observed in the 
ip6k/ppip5k are sufficient for almost normal cell function. 
 
At this point it is interesting to note a recent study postulating a possible 
explanation for the high abundance of IP6 in these amoeba (Weber, Stirnimann 
et al. 2014). This work identified a cysteine phytase, termed Lppa, in the genome 
of the intracellular pathogen Legionella pneumophila. This bacteria, the 
causative agent of Legionnaire’s disease, replicates in the “Legionella–
containing vacuole” of free-living amoeba and mammalian phagocytes. During 
infection the bacteria secretes >300 proteins into the host cell. One such protein 
is Lppa. Lppa is able to degrade phytate in vitro and was shown to offer a 
growth advantage for bacteria when they infected D. discoideum amoeba pre-
loaded with IP6 (Weber, Stirnimann et al. 2014).  
 
This study postulated that the degradation of intracellular IP6 was beneficial for 
the infecting bacteria, possibly due to the release of ions chelated by IP6. Thus 
the local degradation of IP6 by bacterial proteins might release important 
micronutrients that are beneficial for the pathogen. This interesting hypothesis 
could be further extrapolated to suggest that exceptionally high levels of inositol 
phosphates in the amoeba might represent a protective measure to defend 
against pathogenic bacteria. The chelation of micronutrients by high 
concentrations of IP6 might have been protective against pathogens, which have 
subsequently evolved phytase secretion as a means to counteract this measure. 
Whilst this work does not address the role of inositol pyrophosphates it does 
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offer interesting insight into the remarkably high concentrations of inositol 
phosphates in D. discoideum. 
3.3.5 IPMK 
The role of the IPMK was investigated by generating an ipmk null strain. In vivo 
evidence places this enzyme as primarily responsible for directly 
phosphorylating IP3 to IP5 (Saiardi, Sciambi et al. 2002), however, this enzyme 
has been shown to also synthesise inositol pyrophosphates (Saiardi, Nagata et 
al. 2001) and phosphoinositides (Resnick, Snowman et al. 2005) in vitro. 
Deletion of this gene was confirmed by Southern and Northern blot. Surprisingly, 
Northern blot analysis detected three bands hybridising to the IPMK probe in 
WT cells. All three were absent from the ipmk strain, suggesting that the two 
slower migrating bands may not be simply non-specific binding, but genuine 
IPMK transcripts. As discussed previously, the remarkably long 3’ UTR of 
mammalian IPMK (Saiardi, Nagata et al. 2001) adds credence to this possibility. 
  
Meanwhile, deletion of the Ipmk gene had no detectable effect on the synthesis 
of inositol pyrophosphates either in the vegetative state or during development. 
These results suggest that, as with the synthesis of inositol pyrophosphates, the 
synthetic pathway of inositol phosphates in D. discoideum is more complex than 
in yeast. Deletion of Arg82 ablates the presence of highly phosphorylated 
species of inositol phosphates above IP3 (Saiardi, Sciambi et al. 2002). The 
arg82Δ also displays a range of phenotypes, including slow growth rate and 
inability to grow on non-fermentable carbon sources (Saiardi lab observation). 
Thus the lack of phenotype in D. discoideum is surprising.  
 
The expansion in the number of inositol phosphate kinases encoded in the D. 
discoideum offers the most likely explanation for this difference from yeast.  The 
presence of the ITPK1, which is also able to phosphorylate IP3, may be of 
particular relevance. The expression levels of this gene are low (Fig 3.4), 
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however it is possible that its expression may be increased in response to 
deletion of Ipmk. This hypothesis was not tested.  
Furthermore, the presence of two additional inositol phosphate kinase family 
members, named here IPKA and IPKB may be able to compensate for the 
deletion of IPMK. In fact IPKA was annotated as an IPMK and has been used to 
recue to overexpression of the phosphatase MIPPS (King, Keim et al. 2010). It is 
also possible that IPMK performs a slightly different function in D. discoideum, 
perhaps even acting as a phosphoinositide kinase rather than a soluble inositol 
phosphate kinase. 
3.3.6 Concluding remarks 
It is documented the deletion of phospholipase C has no effect on the levels of 
inositol phosphates in the amoeba (Drayer, Van der Kaay et al. 1994, Pisani, 
Livermore et al. 2014) and that inositol can be phosphorylated in a stepwise 
manner to form IP6 (Stephens and Irvine 1990). When combined with the data 
described above it is evident that a large number of differences exist between 
the synthetic pathways of the inositol phosphates between S. cerevisiae and D. 
discoideum.  
 
Moreover, there are divergences between the roles played by these molecules in 
the amoeba. Despite being far lower abundance in yeast, the loss of inositol 
pyrophosphates has a range of dramatic phenotypes. Whilst only a small 
number of these were investigated in this work, no dramatic alterations to 
growth rate or primary metabolism were observed in the ip6k or ip6k/ppip5k 
strains. It is possible that these molecules play an altogether different role in the 
D. discoideum.  
 
The conservation in the function of inositol pyrophosphates between yeast and 
mammalian cells makes this conclusion a surprising one. An alternative 
explanation, as described above, could be the presence of residual levels of IP7 
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in both the single ip6k and the double ip6k/ppip5k mutants. When compared to 
virtually all other cells this abundance of IP7 reflects a substantial level of inositol 
pyrophosphates. Thus it is plausible that this apparently small residual pool is, 
nevertheless, functional and sufficient to protect the ip6k and ip6k/ppip5k 
strains from the phenotypes observed in other models. 
 
In order to investigate this hypothesis and to develop the amoeba as a clean 
genetic model, it is necessary to identify the enzyme or enzymes capable of 
synthesising inositol pyrophosphates in the ip6k/ppip5k strain. The final 
experiment in this chapter offers a tempting methodology to investigate this. The 
ability to detect the activity of inositol phosphate kinases in cell extracts allowed 
the activity towards a range of IP5 substrates to be tested (Figure 3.17). The 
availability of highly pure IP7 isomers (courtesy of Prof Henning 
Jessen)(Capolicchio, Thakor et al. 2013) could be used to test for the presence 
of the additional IP7 kinase activity identified in the ppip5k strain. If such an 
activity could be detected in the cell extract of D. discoideum it may allow the 
biochemical purification and identification of the enzyme responsible. Identifying 
this enzyme could ultimately help to develop a “clean” genetic model lacking all 
inositol pyrophosphates. 
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4. Identifying additional sources of 
inositol pyrophosphates 
4.1 Introduction 
The results discussed in Chapter 3 demonstrate the presence of at least one 
additional enzyme capable of synthesising inositol pyrophosphates. The 
detection of residual IP7 in the ip6k/ppip5k strain indicated that a further enzyme 
displays IP6 kinase activity. Furthermore, there is a pool of IP8 synthesised 
independently of PPIP5K, in a developmentally regulated way. It is possible that 
a single enzyme that is capable of phosphorylating both IP6 and IP7 catalyses 
both of these activities. If so, it would appear that the preferred substrate of this 
enzyme is IP7 rather than IP6 Alternatively, different enzymes may catalyse each 
reaction.  
 
It has previously been described that WT D. discoideum cell extract possesses a 
kinase activity towards a particular isomer of IP7 in which the pyrophosphate 
moiety is positioned on carbon 6 of the inositol ring (Laussmann, Reddy et al. 
1997). The identification of this activity is consistent with the NMR 
characterisation of IP8 in D. discoideum as either the (4,5)PP2-IP4 or (5,6)PP2-IP4 
(Laussmann, Eujen et al. 1996, Laussmann, Reddy et al. 1997) with positions 4 
and 6 being enantiomeric (Figure 1.1) and indistinguishable by NMR. In fact the 
identification of this activity allowed the distinction between the two possible 
isomeric forms, indicating that the IP8 found in D. discoideum is (5,6)PP2-IP4 , in 
contrast to the (1,5)PP2-IP4 thought to be present in both yeast and mammalian 
cells. In truth, the only inositol pyrophosphates extracted from cells to have 
been examined by NMR are those extracted from the amoeba D. discoideum.  
The enzyme responsible for the unusual IP7 kinase activity was partially purified, 
identifying an enzyme of ~40 kDa (Laussmann, Reddy et al. 1997). The precise 
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enzyme responsible for this activity was not cloned, however, the approximate 
size suggests that it is unlikely to be either IP6K or PPIP5K (Table 3.1). 
The objective of the work described in this chapter, was therefore to identify the 
additional enzyme, or enzymes, capable of synthesising inositol pyrophosphates 
in D. discoideum. The previous description of an IP7 kinase activity in WT 
extract, as well as the cell extract kinase assays performed in Figure 3.17 
offered an experimental design that could be followed. Testing for this activity in 
a panel of mutants could confirm that this activity is not attributable to either 
IP6K or PPIP5K. 
4.2 Results 
4.2.1 IP6 and IP7 kinase activity in cell extract 
Isomeric forms of IP7 were made available to the Saiardi lab courtesy of Dr 
Henning Jessen (Capolicchio, Thakor et al. 2013). These isomers facilitated cell-
free assays to test for IP7 kinase activity in WT and mutant D. discoideum 
extract as well as mouse (Mus musculus) brain extract. These assays were 
analogous to those described in Chapter 3 (Figure 3.17). IP6 was also provided 
as a substrate in order to test the presence of an IP6K activity in extract. The 
products of these cell-extract assays were analysed by 35.5% PAGE and 
stained with Toluidine (Figure 4.1-4.2).  
 
Initial experiments compared the IP7 kinase activities detected in WT D. 
discoideum extract (Dd) and M. musculus brain extract (Mm) (Figure 4.1) Extract 
alone was loaded in lanes 10 and 11 on both gel panels (A and B) for reference. 
Dd extract contained detectable endogenous levels of IP6, IP7 and IP8 as seen in 
lane 10. Meanwhile, endogenous inositol phosphates could not be detected in 
Mus musculus extract. Furthermore, the IP7 substrates provided in each reaction 
were not completely pure and contained some residual levels of IP6 and IP8. The   
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Figure 4.1 IP6 and IP7 kinase activity in D. discoideum (Dd) and Mus 
musculus (Mm) cell extract.  
Cell extracts were prepared as described (materials and methods, 2.3.11) from 
WT vegetative D. discoideum culture (Dd) and mouse brain (Mm). Five isomers 
of IP7 as well as IP6 were treated with extract. Formation of IP8 and IP7 was 
detected by 35.5% PAGE analysis and Toluidine staining and indicated with (*).  
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Figure 4.2 IP7 kinase activity in ip6k and ppip5k D. discoideum (Dd) cell 
extract.  
Cell extracts were prepared as described (materials and methods, 2.3.11) from 
vegetative D. discoideum culture as indicated. Three isomers of IP7 were treated 
with extract prepared from WT, ip6k and ppip5k. Formation of IP8 was detected 
by 35.5% PAGE analysis and Toluidine staining and indicated with (*)  
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substrates utilised in these assays were IP6 and five isomers of IP7, 2PP-IP5 was 
not available and therefore not included.   
 
Robust conversion of IP7 to IP8 by Dd extract could only be detected when the 
6PP-IP5 isomer was provided as a substrate (Figure 4.1 A, lane 4) marked with 
an asterix (*). Notably, IP6 kinase activity could not be detected in Dd extract 
(Figure 4.1 B, lane 7). Conversely, in mouse brain extract, no IP7 kinase activity 
could be detected, although IP6 kinase activity was present (Figure 4.1 B, lane 
8). 
 
The kinase activity identified towards 6PP-IP5 was consistent with the activity 
previously reported in D. discoideum extract (Laussmann, Reddy et al. 1997). 
The partial purification of this enzyme identified a protein of a ~40 kDa. 
However, its identity was not confirmed. To-date no inositol phosphate kinases 
have been found to be specific to 6PP-IP5. However, to confirm that neither 
IP6K, nor PPIP5K were responsible for the phosphorylation of 6PP-IP5, cell 
extracts from both ip6k and ppip5k were used in this assay (Figure 4.2). As in 
(Figure 4.1), extract alone was loaded in lanes 10 and 11 (Figure 4.2 A and B). 
It should be noted that whist IP6, IP7 and IP8 were detectable in WT extract; only 
IP6 was detected in ip6k (Figure 4.2 A, lane 11). However, despite the absence 
of IP6K, the conversion of 6PP-IP5 to IP8 was equally robust when treated with 
ip6k cell extract (Figure 4.2 A, lane 8). No other activity could be detected in 
either WT of ip6k extract.  Similarly, ppip5k cell extract also retained the ability 
to phosphorylate 6PP-IP5 to IP8 (Figure 4.2 B, lane 8). The conversion of IP7 to 
IP8 appeared slightly reduced in the ppip5k strain, however this may be due to a 
reduced concentration of extract as shown by the weaker endogenous IP6 band 
seen in extract alone (lanes 10 and 11). 
 
These results suggested that neither IP6K, nor PPIP5K were the enzymes 
responsible for the conversion of 6PP-IP5 to IP8. To unambiguously confirm this 
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the extract of the ip6k/ppip5k double mutant was tested (Figure 4.3). All 
extracts tested, including the previously generated ip6k* mutant (Luo, Huang et 
al. 2003)(Figure 4.3, lane 9) and the double mutant ip6k/ppip5k (lane 7), 
demonstrated very robust conversion of 6PP-IP5 to IP8. 
 
The identification of an IP7 kinase activity in the ip6k/ppip5k mutant extract 
clearly demonstrated the presence of an alternative source of inositol 
pyrophosphates in D. discoideum. The next step was to identify the enzyme 
responsible for this activity. Two separate approaches were employed; the first 
was the biochemical purification of this activity following diverse enrichment 
procedures. In order for this approach to be successful the activity must be very 
robustly detectable after numerous processing steps, explored in Figures 4.4 
and 4.5. The second approach was a candidate approach, described in Figure 
4.6 onwards. 
4.2.2 Biochemical purification of 6PP-IP5 kinase activity 
Initially, the ability of ip6k/ppip5k extract to phosphorylate 6PP-IP5 in a range of 
different conditions was tested (Figure 4.4) to study the stability of this activity 
and its suitability to purification. 
  
1) Testing the effect of freezing. Extract was prepared from fresh ip6k/ppip5k 
cell pellets as well as those that had been frozen at -80°C. These extracts were 
then incubated with substrate for between 30 min and 3 h. Faint IP6 bands were 
detectable in both fresh extract alone (Figure 4.4 A, lanes 1 and 4), as well a 
frozen extract alone (lanes 6 and 12), with a stronger IP6 band in the frozen 
extract. This may be due to more complete lysis during preparation of extract 
due to freezing. Substrate alone contained some IP6 contaminant, but no 
detectable IP8 (lanes 14 and 15). IP7 kinase activity could be observed in extract 
made from both fresh and frozen cell extract in reaction volumes of both 25 µl 
(lane 2, 7-10) and 40 µl lanes 3 and 11). Activity could be detected after  
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Figure 4.3 6PP-IP5 kinase activity in mutant panel of D. discoideum (Dd) cell 
extracts.  
Cell extracts were prepared as described in (materials and methods, 2.3.11) 
from vegetative D. discoideum culture as indicated. Three isomers of IP7 were 
treated with extract WT, ip6k, ppip5k, ip6k/ppip5k and ip6k*. Formation of IP8 
was detected by 35.5% PAGE analysis and Toluidine staining. 
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Figure 4.4 6PP-IP5 kinase activity could be robust detected in a range of 
conditions.  
Cell extracts were prepared as described (materials and methods, 2.3.11) from 
vegetative ip6k/ppip5k culture or from frozen pellets (as indicated) (A). The 
activity of these extracts in either 25 µl or 40 µl was assayed as were reaction 
incubations between 30 min and 3 h as indicated (A). Cell extracts were 
supplemented with between 18 and 1000 mM KCL. IP7-kinase activity of extract 
was determined by conversion of substrate to IP8 through 35.5% PAGE analysis 
and Toluidine staining (B).  
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incubation of only 30 min (lanes 2 and 7), although this was weak when using 
fresh extract (lane 2). 
 
2) Testing the effect of salt. The effect of salt concentration on IP7 kinase activity 
was then investigated by supplementing the reaction mix with concentrations 
between 18 mM KCl to 1 M KCl (Figure 4.4 B). IP7 kinase activity could be 
detected in all fractions up to 750 mM KCl. The strongest activity appeared at 
relatively high concentrations of salt, between 400 mM and 750 mM (lanes 7-9). 
No IP7 kinase activity could be detected in reactions containing 1 M KCl (lane 
10). Another activity could also be detected in these samples, degrading IP7 to 
IP6. This activity also showed a similar increasing activity up to 750 mM KCl. 
Degradation of substrate to IP6 could also be detected in conditions of 1 M KCl. 
These results indicated that the IP7 kinase activity present in this extract was 
very robust and possibly amenable to purification by fractionation. 
 
3) Identification of the appropriate chromatography substrate. Following these 
observations it was necessary to identify the appropriate chromatography to use 
in order to purify this activity. Three purification steps would be desirable to 
generate a fraction pure enough to be analysed by mass spectrometry. 
Biochemical purification can be achieved by several means, including selective 
precipitation, differential binding to chromatography substrates as well as size 
exclusion chromatography (also referred to as gel filtration). Preliminary 
experiments were performed by ion exchange chromatography using a DEAE 
column (GE Healthcare) (Figure 4.5 A) and a HiTrap Heparin column (GE 
Healthcare) (Figure 4.5 B). In both cases the activity could only be detected in 
the flow through (Figure 4.5 A, lanes 1-4 and Figure 4.5 B, lanes 4 and 5), 
indicating that the protein responsible for this activity did not bind to either 
column. 
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Figure 4.5 Biochemical purification of cell extract failed to identify a IP7 
kinase purification strategy  
Cell extracts were prepared as described (materials and methods, 2.3.11) from 
vegetative ip6k/ppip5k culture and subjected to biochemical purification using 
either Heparin (A) or DEAE (B) columns. The activity eluted in flow through of 
both fractionation approaches indicating the enzyme did not bind to either 
column. Reactions were analysed by 35.5% PAGE and stained with Toluidine. 
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Interestingly an increase in the level of IP6 could be detected in some fractions 
eluting from the Heparin column (Figure 4.5 B, lanes 7-9). There were two 
possible sources for this increase in IP6; the first was the elution of the IP7 
phosphatase activity noted in Figure 4.4 B, the second was the elution of 
endogenous IP6 that had bound to the column. Given that the level of IP7 did not 
seem to decrease in these reactions (which would be indicative of a 
phosphatase) it seemed most likely that endogenous IP6 bound to the Heparin 
column and eluted in these fractions. This was surprising due to strong negative 
charge of both heparin and IP6, however, the early elution suggests that this 
interaction was relatively weak. 
 
These preliminary purification procedures confirmed that it was possible to 
follow the kinase activity of this extract. However, the enzyme responsible for 
this activity did not bind to either column tested. Neither of these steps would 
therefore be appropriate for purificaion and identification of the enzyme by this 
approach. Whilst many other purification approaches and chromatography 
columns were available, a parallel, candidate approach was taken. 
 
4.2.3 Identifying the 6PP-IP5 kinase by a candidate approach 
As noted previously (Table 3.1) two genes for uncharacterised inositol 
phosphate kinases have been identified in the D. discoideum genome. One of 
these enzymes has been described as an IPMK (King, Keim et al. 2010), whilst 
the other has been annotated to encode an IP6K. These genes will be hereafter 
referred to as Ipka and Ipkb respectively. The gene products (referred to here as 
IPKA and IPKB) have predicted sizes of 37 kDa and 70 kDa (Table 3.1).  
 
Previous attempts to purify the 6PP-IP5 activity were able to identify the enzyme 
responsible to have a size of ~40 kDa (Laussmann, Reddy et al. 1997). 
Therefore, despite previous characterisation as an IPMK, IPKA appeared a 
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strong candidate for this activity. Consequently, several attempts were made to 
delete the gene by homologous recombination. Two deletion constructs were 
designed (Figure 4.6) and each used several times to try and delete this gene. 
However, neither approach was successful. Unfortunately, one disadvantage of 
using the haploid D. discoideum amoeba as a model system is the difficulty in 
confirming whether a gene is essential. Deletion of an essential gene, as in any 
system will result in a lethal phenotype. However, unlike in yeast crossing of 
heterozygous mutants is not possible. Therefore, after several failed attempts at 
deletion, it was assumed that this gene is either essential, or the local genomic 
environment of the gene prohibited the homologous recombination required for 
deletion. Whilst it is possible to use RNA-mediated knock down approaches in 
the D. discoideum (Friedrich, Meier et al. 2015), these were not investigated in 
this work. 
4.2.4 IPKA: cloning and expression in S. cerevisiae 
Due to the inability to delete this gene, an alternative approach was employed 
and this enzyme was cloned from a cDNA library, (generated as described in 
materials and methods, 2.2.9). Given its relatively small size (~900 bp) and high 
GC content it seemed possible that this gene could be expressed in the yeast, 
S. cerevisiae. The availability of a comprehensive panel of mutants in yeast 
allowed the enzymatic activity of this gene product to be probed according to its 
ability to rescue certain yeast strains. The disadvantage of this approach, aside 
from using a heterologous system, would be that the putative substrate for this 
enzyme, 6PP-IP5 is not present in yeast. Yeast has just two enzymes capable of 
synthesising inositol pyrophosphates, Kcs1p and Vip1p, which phosphorylate 
positions 5 and 1 of the inositol ring, respectively. 
 
In order to assess the activity of this enzyme and distinguish between action as 
an IPMK, as annotated, or an inositol-pyrophosphate synthesising enzyme, the  
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Figure 4.6 Deletion strategies for IPKA by Homologous Recombination. 
Schematic of deletion strategies, deletion construct contained a 5’ targeting arm 
of ~800 bp and a 3’ targeting arm of ~700 bp (top) or a 5’ targeting arm of 
~1200 bp and a 3’ targeting arm of ~1100 bp (bottom). 
Figure 4.7 Overexpression of GST-IPKA rescues growth defect of kcs1Δ 
and arg82Δ.  
WT, kcs1Δ and arg82Δ yeast overexpressing either GST or GST tagged IPKA 
were grown to an OD600 of 0.8, then serial dilutions were prepared and 10 µl 
dropped onto URA- minimal media plates. Growth rescue could be observed in 
both kcs1Δ and arg82Δ after 3 days at 30°C.  
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gene was overexpressed in both kcs1Δ and arg82Δ yeast strains. Neither kcs1Δ 
nor arg82Δ possess detectable inositol pyrophosphates. However these strains 
are defective at different stages of the synthetic pathway (Figure 1.4), with 
arg82Δ deficient in the synthesis of IP6 and kcs1Δ able to synthesise IP6 as 
normal but lacking the inositol pyrophosphates (Saiardi, Sciambi et al. 2002). 
Both kcs1Δ and arg82Δ display a growth defect on glucose minimal media 
(Figure 4.7). The ability of IPKA to rescue the growth defect of these mutants 
was assayed as an indicator of its kinase activity.   
 
Overexpression of a GST tagged IPKA was able to rescue the growth defect of 
both kcs1Δ and arg82Δ mutants (Figure 4.7 A and B).  The defect observed in 
kcs1Δ could be almost completely rescued by overexpression of IPKA, returning 
these cells to almost WT growth (Figure 4.7 A). The ability of IPKA to 
complement the growth defect of in arg82Δ was not quite so complete (Figure 
4.7 B). 
 
These results indicated that IPKA may be able to act as both an IPMK and an 
IP6K. Such a hybrid kinase activity was reminiscent of the recently described E. 
histolytica IP6K crystalized in the Shears laboratory (Wang, DeRose et al. 2014). 
However, an alternative explanation could be that IPKA was able to use IP3 as a 
substrate for IP3-derived inositol pyrophosphates. Given the presence of IP5-
derived inositol pyrophosphates in D. discoideum (Pisani, Livermore et al. 2014), 
it is plausible that a promiscuous kinase may also be able to pyrophosphorylate 
IP3. The observed rescue of arg82Δ could be due to either activity. In fact, the 
overexpression of Kcs1p in the arg82Δ strain is able to rescue a number of 
phenotypes including vacuole morphogenesis and growth defects (Dubois, 
Scherens et al. 2002). HPLC analysis of this strain reveals the formation higher 
inositol phosphates, including a range of “unconventional” inositol 
pyrophosphates, derived from IP5 and possibly other species (Dubois, Scherens 
et al. 2002).   
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In order to confirm that this enzyme was that responsible for the observed 6PP-
IP5 kinase activity in cell extract, the enzyme was purified from yeast extract by 
GST pull down. Glutathione sepharose beads were used to purify tagged IPKA 
(materials and methods, 2.5.3), as confirmed by the presence of a ~65 kDa 
band by silver staining (Figure 4.8). 
4.2.5 IPKA: in vitro activity 
The activity of this purified protein was tested against a range of substrates, 
including I(1,4,5)P3, I(1,3,4,5,6)P5, IP6 and 6PP-IP5. This range of substrates was 
chosen given the previous annotation of IPKA as an IPMK, with predicted 
activity towards IP3 (King, Keim et al. 2010). Furthermore, the ability of IPKA to 
rescue the growth defect in arg82Δ and kcs1Δ (Figure 4.7), suggested it might 
be able to utilise both IP3 and IP6 as substrates. These reactions, performed 
under the same conditions as the prior cell extract assays (materials and 
methods,, 2.5.5), revealed that GST-IPKA had very strong kinase activity 
towards 6PP-IP5, resulting in the formation of IP8 (Figure 4.9, lane 12). No 
activity towards any other substrate could be detected. However, it should be 
noted that PAGE technology and Toluidine staining, whilst excellent for 
detecting highly phosphorylated inositol species, is less effective for analysing 
less phosphorylated species such as IP3 and IP4. 
 
Subsequently the activity of this enzyme against all isomeric forms of IP7 was 
tested (Figure 4.10). Whilst each isomer contained different levels of 
contaminating IP6 and IP8 (particularly evident in lanes 7-10), clear activity 
towards 6PP-IP5 could be detected in lane 14. This activity was not as strong as 
seen in previous enzyme preparations, but activity could not be detected in any 
other lanes. 
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Figure 4.8 Silver stain of IPKA pull down.  
GST-IPKA was pulled down with Glutathione sepharose beads. 15 µl of GST 
beads were analysed by a 4-12% PAGE and protein was visualised by silver 
staining (materials and methods, 2.5.4). A band corresponding to GST –IPKA 
was detected at approximately 65 kDa, marked with an (*). A dilution of BSA 
from 5 – 500 ng was added for reference. 
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Figure 4.9 IPKA is an IP7 kinase.  
Purified GST-IPKA was incubated with indicated isomers of IP3 IP5, IP6 and IP7 for 
3 h at 37°C (materials and methods, 2.5.5). IP7 was robustly converted to IP8 by 
GST-IPKA, whilst no other activity could be detected. Reaction products were 
analysed by 35.5% PAGE and stained with Toluidine. Representative result of 
an experiment performed more than three times. 
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Figure 4.10 IPKA is specific to 6PP-IP5  
Purified GST-IPKA was incubated with indicated isomers of IP7 for 3 h at 37°C 
(materials and methods, 2.5.5). Only 6PP-IP5 was converted to IP8 by GST-
IPKA, whilst no other activity could be detected. Reaction products were 
analysed by 35.5% PAGE and stained with Toluidine. Representative result of 
experiment performed twice. 
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These results provided very strong evidence that IPKA is, in fact, the enzyme 
responsible for the 6PP-IP5 kinase activity detected in cell extract (Figures 4.1-
4.3). In vitro evidence pointed towards IPKA being a very robust IP7 kinase, 
possessing a very specific activity towards a single isomer of IP7. This activity is 
consistent with both the previously identified isomeric arrangement of IP8 
(Laussmann, Eujen et al. 1996) and genetic evidence to suggest that an 
additional enzyme, alongside PPIP5K, is able to phosphorylate IP7 to form IP8 in 
D. discoideum. Furthermore, examination of the expression level (Figure 3.4) of 
this gene revealed a developmental increase, suggesting that this enzyme could 
be responsible for the developmental increase observed in ppip5k amoeba. 
However, these results did not offer insight into the rescue of either arg82Δ or 
kcs1Δ. In fact, they showed some inconsistencies with in vivo rescue data. In 
vitro, IPKA appears to be a very specific enzyme, with activity only detectable 
towards 6PP-IP5, whilst the in vivo rescue of the growth defect of both arg82Δ 
and kcs1Δ indicated a far more promiscuous activity as neither strain should 
possess 6PP-IP5. 
 
It was reasoned that the inability to detect activity in vitro could be due to 
limitations in detection of less phosphorylated inositol species. Consequently, 
an alternative approach was employed to investigate the in vivo activity of IPKA. 
The catalytic flexibility of IPKA suggested by in vivo experiments offered the 
attractive hypothesis that this kinase may display other inositol phosphate 
kinase activities, including, perhaps the direct phosphorylation of myo-inositol 
described by Stephens, et al. (Stephens and Irvine 1990). Thus further 
experiments investigated this hypothesis by overexpressing IPKA in plc1Δ yeast 
strain. 
 
Plc1Δ yeast lack any soluble inositol phosphates above IP3 as well as lacking the 
second messenger DAG. Consequently, this strain displays diverse and very 
strong phenotypes, including a very severe growth defect (Yoko-o, Matsui et al. 
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1993), likely due to defects in the combined effect of lacking both soluble 
inositol phosphates and DAG signalling. Therefore, even complete rescue of 
levels of inositol pyrophosphates may not rescue the growth defect. 
Consequently, growth rescue was not assessed and an alternative approach 
was taken.  
4.2.6 IPKA: polyP rescue in S. cerevisiae 
Wild type S. cerevisae yeast possess high levels of inorganic polyphosphate 
(polyP). As outlined in Chapter One, the levels of polyP correlate with the levels 
of inositol pyrophosphates in yeast (Auesukaree, Tochio et al. 2005, Lonetti, 
Szijgyarto et al. 2011). Consequently, strains lacking inositol pyrophosphates, 
e.g. kcs1Δ, contain dramatically reduced levels of polyP (Figure 4.11). Thus the 
level of polyP can be used as an indirect measure of the level of inositol 
pyrophosphates in yeast cells. This method, whilst indirect, allowed the quick 
and easy assessment of a range of yeast to estimate the ability of IPKA 
overexpression to rescue levels of inositol pyrophosphates (Figure 4.11). PolyP 
was extracted from logarithmically growing WT, kcs1Δ arg82Δ and plc1Δ by 
phenol chloroform extraction (materials and methods, 2.6.2). As well as polyP, 
this method also extracted RNA, allowing RNA to be used as a loading control 
between samples. These extracts were analysed by 30% PAGE and stained 
with DAPI.  
 
Expression of GST and GST-IPKA in these strains was confirmed by Western 
blot (Figure 4.11, lower panel). Blotting with an α-GST antibody revealed a 
band of around 65 kDa in strains overexpressing the GST tagged IPKA. A 
second non-specific band could be seen migrating slightly faster than the GST-
IPKA. Expression levels of GST-IPKA were not uniform between strains, with the 
arg82Δ strain showing highest level of expression. 
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Figure 4.11 Overexpression of GST-IPKA rescues level of polyP in kcs1Δ, 
arg82Δ and plc1Δ.  
Phenol chloroform extracts from logarithmic WT, kcs1Δ, arg82Δ and plc1Δ 
cultures expressing either GST or GST-IPKA were analysed by 30% PAGE and 
stained with DAPI. Samples were normalised by RNA with 5 µg of RNA loaded in 
all lanes except 9 & 10 in which 10 µg was loaded. Overexpression of GST IPKA 
increased the level of polyP in all strains except WT (Upper panel). Protein 
extracts were analysed by Western and probed with an α-GST antibody at a 
dilution 1:5000. GST-IPKA expression was not uniform in all strains and was 
highest in arg82Δ (Lower panel). Representative result of experiment performed 
twice.  
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As expected due to the ability of IPKA to rescue the growth defect of both kcs1Δ 
and arg82Δ, overexpression of GST-IPKA was able to restore the levels of polyP 
to levels comparable to WT (Figure 4.11, lanes 4 and 6). This further suggested 
that the ability of IPKA to rescue the growth defect (Figure 4.7) was due to the 
synthesis of inositol pyrophosphates in these strains. However, as before these 
experiments failed to distinguish between synthesis of IP6-derived inositol 
pyrophosphates or those derived from less phosphorylated species.  
 
The plc1Δ strain possessed the lowest level of polyP of all strains examined in 
this work (Figure 4.11, lane 7). Surprisingly, overexpression of IPKA in the plc1Δ 
strain was also able to partially restore the level of polyP in these cells. Whilst 
DAPI staining of polyP precludes quantitation of the absolute level of polyP in 
extract, these observations indicated that the rescue of polyP in the plc1Δ GST-
IPKA strain was not complete. Even loading double the amount of material (10 
µg RNA) failed to recapitulate the level of polyP detected in 5 µg of WT extract. 
It was also evident that the average length of polyP present in lane 8 and 10 was 
shorter than in WT. The speed of migration of polyP through a 30% 
polyacrylamide gel is proportional to polymer length. Thus a stronger staining 
towards the bottom of the gel, as seen in lanes 8 and 10 indicated a shorter 
average chain length than seen in lanes 1, 2, 4 and 6, where the staining was 
stronger towards the top of the gel. 
 
The observed increase in polyP in the plc1Δ GST-IPKA strain was likely due to 
an increase in the level of inositol pyrophosphates in this strain. However, as 
with arg82Δ it was not possible to distinguish between IPKA restoring the levels 
of IP6 or generating IP2/IP3-derived inositol pyrophosphates. Nevertheless, these 
results offered further evidence that IPKA was more flexible with its substrate in 
vivo than in vitro. Furthermore, the partial rescue of plc1Δ polyP suggested that 
this enzyme could indeed play role in the direct synthesis of inositol phosphates 
and pyrophosphates from myo-inositol. 
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4.2.7 IPKA: HPLC analysis of S. cerevisiae overexpressing IPKA 
Further investigation of the inositol phosphate profile of these strains required 
their labelling with 3H myo-inositol. This analysis was conducted as described 
previously (Azevedo and Saiardi 2006), with cells labelled overnight before 
preparation of a perchloric acid extract and analysis by HPLC. Analysis of kcs1Δ 
by HPLC was performed twice and a representative trace is shown in Figure 
4.12 A. HPLC analysis was only performed once for arg82Δ and plc1Δ and 
samples were poorly labelled. Consequently the results for plc1Δ could not be 
interpreted and are not shown. Meanwhile the results of IPKA overexpression 
arg82Δ, whilst also afflicted by poor labelling, did offer insight into IPKA function 
(Figure 4.12). Nevertheless, repeats will be required to confirm these 
observations.  
 
Despite the limitations described above, it was clear that overexpression of 
GST-IPKA altered the inositol phosphate profile of both arg82Δ and kcs1Δ. 
HPLC traces are shown on different scales due to the differing labelling 
efficiency between experiments. 
  
Overexpression of IPKA in the kcs1Δ strain (Figure 4.12 A, blue line) resulted in 
the formation of a clear IP7 peak after ~71 min. This peak was identified as IP7 
due to its elution approximately 10 min after IP6 (~61 min), as identified by 
comparison to IP6 standard (data not shown). 
 
Meanwhile, overexpression of IPKA in the arg82Δ strain resulted in numerous 
alterations to the HPLC trace (Figure 4.12 B blue line). Peaks eluting before 30 
min, representing the less phosphorylated inositol phosphates were altered, 
however interpretation of these peaks was not possible due to poor labelling. It 
can be noted, however that overexpression of IPKA induced the formation of a 
peak that at 61 minutes. As indicated above, this elution profile is consistent 
with formation of IP6.  
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Figure 4.12 Overexpression of GST-IPKA alters the inositol phosphate 
profile in kcs1Δ and arg82Δ  
HPLC analysis of perchloric acid extract prepared (materials and methods, 
2.6.4). Overexpression of GST-IPKA (blue line) altered the inositol phosphate 
profile compared to strains overexpressing GST (black line). 
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These results suggested that whilst IPKA was an excellent IP7 kinase, it did also 
appear to display some ability to synthesise inositol pyrophosphates from other 
substrates, particularly IP6. Importantly it also appeared able to contribute to the 
synthesis of IP6 in arg82Δ. Thus, IPKA appeared to be a hybrid-kinase, 
displaying ability to synthesis a range of inositol phosphate products from a 
range of substrates. Further experiments are required to fully untangle substrate 
specificity and product formation of this enzyme, particularly of the lower inositol 
phosphates. 
4.2.8 IPKB: cloning 
As noted above, a further inositol phosphate kinase is encoded in the D. 
discoideum genome, referred to here as Ipkb. Similarly, attempts to delete this 
gene (Figure 4.13) proved unsuccessful. Therefore an analogous approach to 
that described above was employed to explore the activity of this gene. Ipkb 
was slightly less amenable to expression in yeast due to its larger size (70 kDa), 
highly AT-rich coding sequence (>75%) and repetitive amino acid sequence, 
including a 56 amino acid stretch containing 52 arginines.  
 
Overexpression of this GST-tagged fusion protein in WT yeast negatively 
affected growth rate, suggesting some toxicity was associated with expression 
of this enzyme (data not shown). Therefore, growth rescue experiments as 
performed in Figure 4.7 were not conducted using IPKB. 
4.2.9 IPKB: in vitro activity 
GST-tagged IPKB was purified from WT yeast by GST pull down. Although GST-
IPKB could not be detected by Western blot (data not shown), the activity of 
GST-IPKB was examined as described above, using the substrates I(1,4,5)P3, 
I(1,3,4,5,6)P5, IP6, 5PP-IP5 and 6PP-IP5 (Figure 4.14). Despite annotation of IPKB 
as an IP6K, no activity towards IP6 could be detected. In fact, the only activity 
that could be detected was the formation of IP8 from IP7. As with GST-IPKA, this 
activity also appeared to be specific to a particular isomer of IP7, although in   
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Figure 4.13 Deletion strategy for IPKB by Homologous Recombination. 
Schematic of deletion strategy, deletion construct contained a 5’ targeting arm 
of ~800 bp and a 3’ targeting arm of ~1200 bp. 
Figure 4.14 IPKB is an IP7 kinase.  
Purified GST-IPKB was incubated with indicated isomers of IP3 IP5, IP6 and IP7 for 
3 h at 37°C as described in (materials and methods, 2.5.5). Only 5PP-IP5 was 
robustly converted to IP8 by GST-IPKB, whilst no other activity could be 
detected. Reaction products analysed by 35.5% PAGE and stained with 
Toluidine. Representative result of an experiment performed twice.  
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this case it was 5PP-IP5 (Figure 4.14, lane 8). This activity was surprising as 
5PP-IP5 is the predicted product of this enzyme, rather than its substrate. 
 
Analysis of the gene expression pattern of IPKB during development also 
revealed a strong induction during the developmental response (Figure 3.4). 
Thus, in vitro activity suggested that IPKB might also be contributing to the 
increase in inositol pyrophosphates seen during development. 
4.2.10 IPKA: polyP rescue in S. cerevisiae 
The in vitro activity of IPKB appeared to be limited to phosphorylation of IP7, 
however given the discrepancies observed between in vitro and in vivo activities 
displayed by IPKA, the in vivo activity of IPKB was also investigated. First, the 
ability of this enzyme to rescue the accumulation of polyP in a range of yeast 
strains was tested. As described above, polyP provided a rapid method to 
estimate the levels of inositol pyrophosphates in unlabelled yeast. Once again 
GST-IPKB could not be detected by Western blot, nevertheless, phenol 
chloroform extracts from logarithmically growing yeast were analysed by 30% 
PAGE and DAPI staining (Figure 4.15). 
 
As noted with IPKA, overexpression of IPKB in kcs1Δ yeast was able to partially 
rescue the level of polyP (Figure 4.15, lane 3 and 4). Overexpression of IPKB in 
arg82Δ induced a very slight increase in the level of polyP (Figure 4.15, lane 5 
and 6) in contrast to IPKA, which displayed a very strong rescue in this strain. 
Finally, GST-IPKB was also able to induce an increase in the level of polyP in the 
plc1Δ strain to a similar degree to IPKA (Figure 4.15, lane 7-10). As with IPKA, 
the chain length of polyP molecules extracted from plc1Δ overexpressing IPKB 
were shorter on average than those extracted from WT (Figure 4.15, lane 1). 
 
These surprising results were, once again, in conflict with in vitro evidence, 
which suggested IPKB was a specific IP7 kinase. The ability of IPKB to rescue,  
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Figure 4.15 Overexpression of GST-IPKB rescues level of polyP in kcs1Δ, 
arg82Δ and plc1Δ.  
Phenol chloroform extracts from vegetative cultures of WT, kcs1Δ, arg82Δ and 
plc1Δ expressing either GST or GST-IPKA were analysed by 20% PAGE and 
stained with DAPI. Samples were normalised by RNA with 5 µg of RNA loaded in 
all lanes, except 9 & 10 in which 10 µg was loaded. Overexpression of GST IPKA 
increased the level of polyP in all strains except WT. Representative result of an 
experiment performed twice. 
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to varying levels, the amount of polyP found in kcs1Δ, arg82Δ and plc1Δ, 
suggested it too could restore the level of inositol pyrophosphates in these 
strains. However, as discussed previously these experiments failed to 
distinguish between direct synthesis of inositol pyrophosphates from IP6 
precursors and contribution to synthesis of IP6. 
4.2.11 IPKB: HPLC analysis of S. cerevisiae overexpressing IPKB 
The yeast strains: kcs1Δ, arg82Δ and plc1 overexpressing IPKB were labelled 
with [3H] myo-inositol as described above. Labelling of these cells was poor and 
HPLC analysis could not be interpreted. Consequently, the results of these 
experiments were excluded from this work and will require repetition to better 
characterise the effect of overexpression of IPKB 
 
Although the HPLC data could not be interpreted, it was clear from polyP rescue 
and in vitro kinase assays that there were discrepancies between IPKB activity 
in vitro and in vivo. It should be noted that GST-IPKB could not be detected 
using standard Western blotting, suggesting that this enzyme was poorly 
expressed in these cells, possibly due to the larger size and repetitive sequence. 
As with IPKA, further experiments are required to fully appreciate the 
physiologic catalytic activities of IPKB.  Nevertheless, in vitro data indicates that 
the annotation of this enzyme as an IP6K does not appear to be correct.  
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4.3 Discussion 
The experiments described above confirm the presence of an additional IP7 
kinase activity in the extract of WT D. discoideum, as well as all mutants tested. 
As previously described (Laussmann, Reddy et al. 1997) and in accord with 
NMR data (Albert, Safrany et al. 1997), this robust activity is highly specific for 
the 6PP-IP5 isomer. 
4.3.1 IPKA activity 
Initial attempts to purify this activity proved unsuccessful and thus an alternative 
candidate approach was employed. The cloning and expression of IPKA reveals 
an enzyme capable of rescuing the growth defects of both kcs1Δ and arg82Δ. 
These results suggest that this enzyme, whilst previously annotated as an IPMK, 
might in fact display the ability to synthesise inositol pyrophosphates. 
Meanwhile, purified IPKA shows very robust activity towards 6PP-IP5, 
suggesting that it is the enzyme responsible for the activity detected in cell free 
assays (Figures 4.1- 4.5). The predicted molecular weight of IPKA at 37 kDa 
(Table) is also consistent with previous work which partially purified this activity 
to a protein with a molecular weight of ~40 kDa (Laussmann, Reddy et al. 1997). 
 
These somewhat conflicting results suggest that at once this enzyme is highly 
selective for its substrate and yet also catalytically flexible. In addition, the 
strong activity towards 6PP-IP5 in vitro begs the question, what enzyme 
synthesises this isomer in vivo?  
 
Furthermore, the inability to delete IPKA, after numerous attempts with two 
constructs is notable. Local environments of the gene on a chromosome can 
influence the ability to knock a gene out, which may explain the problems 
encountered. However, an alternative explanation could be that this gene is in 
fact essential and deletion is lethal. If IPKA is simply an IP7 kinase, as suggested 
by in vitro data, it seems unlikely that it is an essential gene, particularly given 
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the relative lack of phenotype observed for ip6k. However, if IPKA is essential, 
this might be due to an additional role, perhaps in synthesising the lower inositol 
phosphates. This hypothesis is supported by the ability of IPKA to rescue 
growth defects of both kcs1Δ and arg82Δ, indicating that at the very least it can 
act as more than simply an IP7 kinase in vivo. 
 
Further investigation of the effect of overexpression of IPKA in a range of yeast 
mutants focused on the possibility that this enzyme may be catalytically flexible. 
This included investigating a potential role for IPKA direct phosphorylation of 
inositol. Therefore, the ability of IPKA to rescue the plc1Δ yeast was 
investigated.  In fact, IPKA is able to rescue the level of polyP (to a greater or 
lesser extent) in all mutants tested (kcs1Δ, arg82Δ and plc1Δ). This suggests that 
this enzyme is also restoring the level of inositol pyrophosphates in these 
strains. 
 
As discussed above, this data can be explained by two potential hypotheses. 
The first is that IPKA catalyses the synthesis of inositol pyrophosphates derived 
from lower forms of inositol phosphate, such as IP3 in the case of arg82Δ and 
even IP2 in the case of plc1Δ. The second is that IPKA directly phosphorylates 
the inositol ring, catalysing the formation of IP6. This IP6 is then a substrate for 
the endogenous Kcs1p found in both arg82Δ and plc1Δ. The experiments using 
polyP as an indirect measure for inositol pyrophosphate synthesis fail to 
distinguish between these hypotheses. Therefore, HPLC was employed to 
further investigate the activity of IPKA. 
 
As noted previously, the HPLC experiments conducted in this work showed very 
low labelling efficiency and so allow limited conclusions to be drawn. However, 
it is clear from the overexpression of IPKA in arg82Δ that a species resembling 
IP6 is formed. However, it is also evident that IP7 is formed by overexpression of 
the IPKA in the kcs1Δ strain. Whilst these data do not allow definitive 
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conclusions to be drawn about the activity of IPKA, they are consistent with 
both activity of IPKA as a hybrid kinase possessing the ability to synthesise, at 
the least, IP6 and IP7 when overexpressed in yeast. The ability of IPKA to directly 
phosphorylate myo-inositol will require further investigation. 
 
Despite, the highly flexible catalytic activity of IPKA overexpressed in yeast, in 
vitro evidence and the very robust extract detected in cell extract assays favour 
IPKA being an IP7 kinase. None of the yeast mutants tested possess the specific 
isomer of IP7 towards which IPKA is active, 6PP-IP5. Therefore, when 
overexpressed in yeast, IPKA is deprived of what seems to be its preferred 
substrate. Thus the catalytic flexibility seen here may be a reflection of a highly 
active enzyme exposed to a range of sub-optimal substrates. 
 
In fact, catalytic flexibility of inositol phosphate kinases is not unprecedented, as 
demonstrated by the recent structural analysis of the E. histolytica IP6K. This 
study, discussed in Chapter One, offers support for the existence of inositol 
phosphate kinases displaying hybrid activities. The results described above 
suggest that IPKA may also be an exceptionally versatile kinase, with IP7K 
activity, IPMK activity and perhaps even the ability to phosphorylate inositol to 
IP6. The latter activity is difficult to test using the methodologies described here 
and will require the use of radio-labelled inositol species for in vitro kinase 
assays to determine if IPKA can indeed catalyse the stepwise formation of IP6. 
4.3.2 IPKB activity 
The final experiments described in this chapter focused on the remaining 
member of the inositol phosphate kinase family of genes in the D. discoideum 
genome, referred to here as Ipkb. The IPKB enzyme is larger than IPKA and 
shows greater sequence homology to IP6K, as seen by sequence alignment to 
HsIP6K (Figure 7.5). Similarly, attempts to knock out this enzyme were 
unsuccessful. Overexpression of the GST-tagged IPKB protein also revealed an 
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enzyme, which displays robust IP7 kinase activity, but this time towards the 
5PP-IP5 isomer (Figure 4.14). 
 
However, as with IPKA the results of overexpression of GST-IPKB in yeast 
mutants did not match those from in vitro experiments (Figure 4.15). Expression 
of IPKB was poor in yeast and recombinant protein could not be detected by 
Western blot. Nevertheless IPKB was able to rescue the level of polyP in kcs1Δ 
and to a lesser extent in arg82Δ. Surprisingly it was able to rescue the level of 
polyP in plc1Δ at least as well as IPKA (Figure 4.11). Experiments with 
radiolabelled inositol analysed by HPLC also failed to give a clear answer 
regarding the activity of IPKB, although it can be noted that it was not possible 
to detect the formation of IP6 in these experiments (data not shown). 
 
These results again suggest that IPKB is not simply an IP7 kinase. Rather, IPKB 
might also be a catalytically flexible enzyme. Discrepancies in the ability of IPKB 
to rescue yeast levels of polyP in arg82Δ could indicate that this enzyme is not 
as flexible as IPKA. Alternatively, the lower expression of IPKB, perhaps due to 
the larger size of IPKB and its repetitive sequence (Figure 7.5), may explain the 
reduced activity detected. 
4.3.3 Why so many inositol phosphate kinases? 
Taken together these results are somewhat counterintuitive, revealing two 
specific IP7 kinases in vitro, but catalytically flexible kinases in vivo. 
Nevertheless, they do offer clues for the synthesis of inositol pyrophosphates in 
this amoeba. As discussed previously, the amoeba is highly unusual for its 
elevated levels of IP8. The apparent presence of three IP7 kinases, PPIP5K, IPKA 
and IPKB in these cells, goes some way towards explaining how this might be 
achieved. Cell extract experiments reveal that IP7 kinase activity can be readily 
detected, whilst IP6 kinase activity cannot. This is consistent with the higher 
abundance of IP8 compared to IP7 owing to rapid conversion of IP7 directly to 
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IP8. The enzyme responsible for the IP7 kinase activity detected in cell extract 
was identified as IPKA 
 
The activity of IPKB could not be detected in cell extract from vegetative 
cultures, however this developmentally regulated gene may play a more 
significant role during the onset of the starvation response, perhaps contributing 
the developmental accumulation of IP8. 
4.3.4 What is the source of 6PP-IP5? 
One interesting question to consider is the source of the substrate for IPKA. No 
enzymes have been described to phosphorylate IP6 at position 6. It is possible 
that this activity is artefactual and simply represents an activity of the enzyme 
that is not physiologically relevant. This appears unlikely due to the presence of 
high levels of IP8 in the ppip5k strain and previous NMR work identifying the 
isomer of IP8 as either 4,5 or 5,6 (Albert, Safrany et al. 1997). 
 
This work has identified 4 inositol phosphate kinases, which could be potential 
candidates, IP6K, PPIP5K, IPKA and IPKB. However, three of them appear to 
primarily be IP7 kinases rather than IP6 kinases (based on either genetic (PPIP5K) 
or biochemical (IPKA and IPKB) evidence). The genetic evidence suggests that 
in fact IP6K is the primary source of IP7 in D. discoideum, raising the possibility 
that this enzyme is the one responsible for the synthesis of 6PP-IP5. This would 
be unexpected, as in vitro both yeast and mammalian IP6K place a  
pyrophosphate moiety on position 5 (Draskovic, Saiardi et al. 2008). The 
divergence in sequence between D. discoideum IP6K and mammalian IP6K 
makes it difficult to predict whether the enzyme might have an altered catalytic 
specificity. 
 
This difference could be indicative of further discrepancies between the 
synthesis of inositol pyrophosphates in D. discoideum and other models. 
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However, it is worth noting again that it is only the amoeba, where inositol 
pyrophosphates are sufficiently abundant, that NMR has been performed on 
molecules extracted from cells (Laussmann, Eujen et al. 1996). Whilst the weight 
of evidence suggests that mammalian IP6K phosphorylates position 5, this data 
is based on in vitro experiments using purified enzyme (Draskovic, Saiardi et al. 
2008). The evidence presented here indicates that discrepancies can exist 
between the in vivo and in vitro specificities of certain inositol phosphate 
kinases.  
 
In fact, it should also be noted that the in vitro specificity of purified IP6K2 
towards IP5 is dependent upon the choice of buffer; reactions performed in 
cacodylate buffer produce 5(PP)-IP4, whilst those buffered with Tris generate 
1(PP)-IP4 (Draskovic, Saiardi et al. 2008). In light of these results it will be 
interesting to re-evaluate the isomeric nature of inositol pyrophosphates purified 
from D. discoideum using present day NMR techniques to confirm their isomeric 
arrangements. Moreover, it will be interesting to investigate whether the recently 
developed TiO2 enrichment method (Wilson, Bulley et al. 2015) will allow 
sufficient quantities of mammalian inositol pyrophosphates to be subjected to 
NMR analysis. 
4.3.5 Other functions of IPKA and IPKB? 
Whilst many questions remain unanswered, it is clear that the synthetic pathway 
of inositol pyrophosphates in this amoeba is not as straightforward as may have 
been anticipated. Analysis of WT extract by PAGE and Toluidine reveals just 
three major bands, however it is evident that more species are present. DAPI 
staining reveals an additional IP9 band, whilst the IP7 band clearly consists of 
multiple species, including PPIP5K products (as discussed in Chapter 3). The 
enzymatic complexity suggests still more isomeric arrangements may exist in 
the amoeba. 
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In fact further characterisation of IPKA and IPKB may provide insight into the 
formation of the low-abundance IP9 identified by Pisani et al. (Pisani, Livermore 
et al. 2014). It is possible that one, or both of these enzymes are responsible for 
the synthesis of this species. Unfortunately, isomers of IP8 were not available for 
in vitro assays. 
 
In addition to the possible role for IPKA and IPKB in the synthesis of inositol 
pyrophosphates, these enzymes both appear to display catalytic flexibility when 
overexpressed in yeast. Whether this catalytic flexibility represents a genuine 
activity in D. discoideum is not yet clear. Nevertheless, the inability to delete 
IPKA and IPKB, offers a hint that they may function as more than simply IP7 
kinases, particularly given the lack of phenotype of the ip6k strain. It is tempting 
to consider that these enzymes may act in concert to perform the stepwise 
phosphorylation of inositol described in these cells (Stephens and Irvine 1990). 
Whilst some work presented here supports this concept, additional work is 
required to explore this hypothesis. 
 
It is evident that neither enzyme in isolation is able to offer full rescue of the 
inositol phosphate profile in yeast mutants, however it may be that these 
enzymes work in tandem to synthesise the lower inositol phosphates. 
Overexpression of both IPKA and IPKB in the same yeast strain would allow this 
hypothesis to be tested.  
 
In addition, potential roles for these enzymes in D. discoideum should be 
explored as both in vitro and in vivo experiments using yeast have their 
limitations. Unfortunately, neither enzyme could be deleted, however methods to 
knock down mRNA in D. discoideum do exist (Friedrich, Meier et al. 2015). 
These methods were not tested in this work; however, transient knock down of 
IPKA and IPKB could provide insight into the true role of these enzymes in D. 
discoideum. 
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4.3.6 Concluding remarks 
The evidence presented in this chapter point to both IPKA and IPKB displaying 
novel properties for inositol phosphate kinase family members. Despite their 
sequence similarities to IPMK and IP6K respectively (Figure 7.4 and 7.5), it 
seems that both display unique properties, not previously identified in this family 
of kinases. These unusual characteristics and catalytic flexibility are reminiscent 
of the IP6K/IPMK hybrid crystalised from E. histolytica (Wang, DeRose et al. 
2014). It is possible that both IPKA and IPKB evolved divergently from an IP6K 
ancestor to generate this large family of inositol phosphate kinase activities in D. 
discoideum.  
 
The characterisation of members of inositol phosphate kinase family in yeast 
and mammalian cells may suggest that these activities are unique to this 
amoeba, perhaps explaining why these cells accumulate such high levels of 
inositol pyrophosphates. The evolutionary pressure behind such a wide array of 
inositol phosphate kinases and high level of inositol pyrophosphates remains 
unclear. RNA-mediated knockdown of IPKA and IPKB in the ip6k/ppip5k strain 
may offer a potential route to generate a strain lacking any inositol 
pyrophosphates and thereby explore the true function enzymes and their 
products in D. discoideum. 
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5. PolyP in D. discoideum 
5.1 Introduction 
The social amoeba D. discoideum is one of the few eukaryotic organisms in 
which the polyphosphate kinase (PPK) has been identified. As previously noted 
the amoeba possesses a bacterial-like PPK1, as well as a heterotrimeric 
complex known as DdPPK2. PPK1 was likely acquired through a horizontal 
gene transfer event from the bacteria on which this amoeba feeds. This gene 
was identified due to homology to the E. coli PPK1 gene, with which it shares 
30% identity and 51% similarity (Zhang, Gómez-García et al. 2007), although 
this is limited to the C terminal portion of the protein (Figure 5.1). Disruption of 
the PPK1 gene reveals a range of phenotypes, including aberrant fruiting body 
formation, impaired phagocytosis (Zhang, Gómez-García et al. 2005) and a 
defect in cytokinesis (Zhang, Gómez-García et al. 2007).  This strain does, 
however, retain approximately 20-50 % of the level of polyP detected in WT 
(Zhang, Gómez-García et al. 2005). The residual polyP can be attributed to the 
activity of a second, and to-date unique, polyP kinase, the DdPPK2 complex of 
actin related proteins (Gómez-García and Kornberg 2004). It should be noted, 
however, that the deletion strategy employed to delete PPK1 (Zhang, Gómez-
García et al. 2005) resulted in the removal of just 3% of the open reading frame 
of the gene. Consequently the residual polyP described in this strain could stem 
from the activity of a truncated PPK1. Nevertheless, the homology between 
components of DdPPK2 and a range of mammalian proteins has led to 
proposals that this enzyme complex might be a candidate for the mammalian 
polyphosphate kinase (Hooley, Whitehead et al. 2008). 
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Figure 5.1 Sequence alignment of DdPPK1 and EcPPK1. 
Protein sequence alignment of D. discoideum and E. coli PPK1 performed by 
CLUSTAL. Sequence similarity shown in red.  
  
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
MITNSKMENKILDEFDEEELNKLKINSNNKESTTTTTSTTTTTTTTTSTSGEESDDEHTGSSSSTAAMELHRYKISQECPVDFEDDYDEESSSFDEEDEDSAAESNGGNGKLIPNPNDKK
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
KKRSSKSSSKSSKSKSKSKNKETTANPVQNCQLMESGTLFSPTEFVKSSTVNPSKSPVQPIKLSSMLGLSELGTSNVLTVQNPQPISEPLKNDISSGSSSSSSSNNNNSNSNSNGNCNSD
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
STKSKFTSLNSWDAPPLANVLPDPSYCQDIVDSENNFIVPSVKHTILDVDNLFNNLIQNTNNNNNNDFKSSTMIGKPFSSGGDGSTSPLISGLSSSSIIPNGNGSLAEQQQQQQQSIPES
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
EIPIDIKVLQLSGSRMFFNRELSELIYFYRILYEAYNPTYPILERVRFIAITSQNLDMYFCKRALKLRLGYISTRKTL--KPEEHYINMVLNTTRNLINEIYNIYMNILAPELSNNNVFI
----------MGQEKLYIEKELSWLSFNERVLQEAADKSNPLIERMRFLGIYSNNLDEFYKVRFAELKRRIIISEEQGSNSHSRHLLGKIQSRVLKA-DQEFDGLYNELLLEMARNQIFL
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       500         *       520         *       540         *       560         *       580         *       600
IKYSDLTEPEKIQLRGFFLQHVFPLMTPLVVDAGHPFPNLSNLSLNIAVLLKHDEDTTRFVRIKVP-QRIPRFVHIKQRSNYS---IIPMEEIILANLDTLFPNT---KILTKSLFRVSR
INERQLSVNQQNWLRHYFKQYLRQHITPILINPDTDLVQFLKDDYTYLAVEIIRGDTIRYALLEIPSDKVPRFVNLPPEAPRRRKPMILLDNILRYCLDDIFKGFFDYDALNAYSMKMTR
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       620         *       640         *       660         *       680         *       700         *       720
HNDLKLSGEDQANDLLELIKTELHKRKFAPMVRLEVSHNMPAEILDMLKTQLALDAYDVYVINGPLGLQ-DLFELCKLNLPHLKFQPWVPHIPSRLVNLAKYPSEDVFSVIRKGELLVNL
DAEYDLVH-EMEASLMELMSSSLKQRLTAEPVRFVYQRDMPNALVEVLREKLTISRYDSIVPGGRYHNFKDFINFPNVGKANLVNKP-LPR--LRHIWFDKAQFRNGFDAIRERDVLLYY
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       740         *       760         *       780         *       800         *       820         *       840
PYLSFNSSVQFFIESAVKDPKVLAIKIAIYRTNSNSQLIRALCEAA-SHKEVMVLVDLKASGDEEQNTKFARLLEQAGCHVSYGLVGLKTHAKIAMVVREEENGLREYLNISTGNYNAST
PYHTFEHVLEL-LRQASFDPSVLAIKINIYRVAKDSRIIDSMIHAAHNGKKVTVVVELQARFDEEANIHWAKRLTEAGVHVIFSAPGLKIHAKLFLISRKENGEVVRYAHIGTGNFNEKT
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                                        
         *       860         *       880         *       900         *       920         *       940         *       960
SDVYADICLFSCDPDLGEDMCNLFNYLTGYSRVSSFKKLLIAPMNMRSTLIQLIDNEAKNAREGKDATINAVMNGLDDKRLVNALYQASIAGVKITLVVRGRCRILPGIKGISENIKVIS
ARLYTDYSLLTADARITNEVRRVFNFIENPYRPVTFDYLMVSPQNSRRLLYEMVDREIANAQQGLPSGITLKLNNLVDKGLVDRLYAASSSGVPVNLLVRGMCSLIPNLEGISDNIRAIS
                                                                                                                        
         
         
DdPPK1 : 
EcPPK1 : 
         
                                                                                                               
         *       980         *      1000         *      1020         *      1040         *      1060         * 
ILGRFLEHSRIYCFHNNGKPKAYIASADWLHRNLKRRVEVMVPVDDANNIKQLYEIINVYCNDSNAWEMLSD---GRYKKRSSPIDEDSQT---QFMNQTNQKHPVIWSK*
IVDRYLEHDRVYIFENGGDKKVYLSSADWMTRNIDYRIEVATPLLDPRLKQRVLDIIDILFSDTVKARYIDKELSNRYVPRGNRRKVRAQLAIYDYIKSLEQ--PE-----
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The work outlined above and in Chapter One laid the foundations for the study 
of polyP in this organism. The identification of polyP kinases in this organism 
provides the almost unique opportunity to develop a eukaryotic genetic model 
to study polyP function.  
 
As noted in Chapter One, polyP has been localised to the acidocalcisome of D. 
discoideum (Marchesini, Ruiz et al. 2002). These experiments relied upon the 
use of DAPI to localise polyP. The fluorophore DAPI, when bound to DNA, can 
be excited at 360 nm, and emits at 460 nm. However, DAPI also binds to the 
negatively charged polyP and induces a shift in fluorescence, such that DAPI-
polyP complexes can be excited with a wavelength of 410-420 nm and display 
an emission peak at 550 nm (Aschar-Sobbi, Abramov et al. 2008). Many groups 
have taken advantage of this fluorescence shift to localise polyP in cells from 
amoeba (Marchesini, Ruiz et al. 2002) to astrocytes (Holmström, Marina et al. 
2013). However, the specificity of this method has recently been called into 
question by the observation that highly phosphorylated inositol species 
including IP5, IP6, IP7 and IP8 are also able to bind to DAPI and induce the same 
fluorescence shift described for polyP (Kolozsvari, Parisi et al. 2014). The 
fluorescence efficiency of DAPI when bound to inositol phosphates is 
comparable to when bound to polyP. Nevertheless, the scarcity of genetic 
models has precluded the in vivo control experiments required to validate this 
technique. The potential contaminating effect of inositol phosphates is of 
particular concern in D. discoideum due the exceptionally high levels of IP6, IP7 
and IP8 which seem likely to induce significant background fluorescence when 
using this method.  
 
Whilst alternative methods to detect polyP do exist, including 32 P labelling and 
enzymatic assays utilising the PPK reverse reaction to drive ATP synthesis 
(Kornberg, Rao et al. 1999), these methods are not widely used. Instead, recent 
improvements in PAGE technology have allowed the reliable detection of polyP 
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from yeast extracts (Lonetti, Szijgyarto et al. 2011) (Chapter 4). This method, 
which can be coupled with either Toluidine Blue staining or DAPI, for added 
sensitivity, allows polyP to be resolved from co-purifying molecules such as 
RNA, inositol phosphates and nucleotides. In this way unlabelled polyP can be 
unambiguously detected. Therefore, the aim of the work described below was to 
utilise improvements in PAGE technology and develop the amoeba as a genetic 
model in which to study the synthesis, metabolism and function of polyP. In 
addition, the high levels of inositol pyrophosphates and strains generated in 
Chapter One place this amoeba as an ideal model in which to further investigate 
the metabolic relationship identified between inositol pyrophosphates and polyP 
(Auesukaree, Tochio et al. 2005, Lonetti, Szijgyarto et al. 2011, Ghosh, Shukla et 
al. 2013) 
5.2 Results 
Much of the work described in this chapter has been published in (Livermore, 
Chubb et al. 2016). Figures adapted from this publication are indicated 
accordingly. 
5.2.1 Detecting D. discoideum polyP by PAGE 
As described above, the presence of polyP in WT cells has been demonstrated 
by various methods, including [32P] labelling, biochemical assays and 
microscopy (Marchesini, Ruiz et al. 2002, Zhang, Gómez-García et al. 2005). To 
further validate the presence of polyP in D. discoideum phenol chloroform 
extracts were prepared from WT cells. Numerous extraction procedures have 
been used to extract polyP, however experiments in the Saiardi lab have found 
the phenol chloroform extracts to be the most consistent. This method, which 
also co-purifies RNA and inositol pyrophosphates, was used in concert with 
20% PAGE and DAPI staining to identify polyP in these amoeba (Figure 5.2) 
(materials and methods, 2.6.4). 
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Figure 5.2 D. discoideum polyP detected by PAGE analysis.  
Synthetic polyP standards with an average chain length of 25 (T25) and 65 (T65) 
were loaded, either untreated or after incubation with the exo- and endo-
polyphosphatase (Ppx1, Ddp1). Equal amounts of vegetative AX2 D. discoideum 
phenol chloroform extract, as normalized by RNA (70 µg ) were treated with 
DNase, RNase, exo- and endo-polyphosphatase (Ppx1, Ddp1) or treated in acid 
at high temperature (acid boiled). Samples were analysed by 20% PAGE and 
stained with DAPI. Phenol extract from wild isolate NC4 cells (right lane) was 
also analysed by PAGE. The figure shows the result of a representative 
experiment that was repeated more than three times. Figure and figure legend 
adapted from (Livermore, Chubb et al. 2016). .  
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This analysis revealed a negatively stained smear reminiscent of polyP. 
However, rather than displaying the characteristic laddering associated with 
polyP purified from yeast (Figure 4.11), this smear was comprised of species 
much more uniform in length, as shown by comparison to migration of 
standards (Figure 5.2). Furthermore visualisation of this smear required far more 
material to be loaded on the gel, 70 µg of RNA was loaded, compared to just 5 
µg of yeast extract (Figure 4.11).  
 
As noted, phenol chloroform extraction also purified a range of other molecules, 
including RNA, DNA, inositol phosphates and nucleotides. In order to confirm 
that the dark smear observed in WT extract was due to polyP and not due to 
these co-purifying molecules, the extract was subjected to a range of enzymatic 
and hydrolytic treatments. Treatment with either DNase or RNase had no effect 
on the smear, however, RNase treatment did ablate the slower migrating, 
positively staining RNA species visible at the top of the gel. Chemically 
synthesised polyP of average chain length or 25 and 65 phosphates (T25 and 
T65), as well as WT extract, were treated with a combination of 
polyphosphatases, Ddp1, the yeast endopolyphosphatase, and Ppx1 a yeast 
exopolyphosphatase. This treatment (Ddp1, Ppx1) was able to degrade both 
species of chemically synthesised polyP and the negatively staining smear in 
WT extract. Finally, the acidic extract was treated with acid at high temperature 
(acid boiled) causing the degradation of both the positively and negatively 
staining species. These treatments indicated that dark smear was indeed 
caused by photobleaching by DAPI-polyP complexes. Furthermore, the average 
chain length of this polyP could be estimated at approximately 50 residues due 
to its migration compared to synthetic standards of average length T25 and T65. 
 
Finally, the presence of the polyP smear was also confirmed in the wild isolate 
NC4 strain. This polymeric species displayed similar characteristics to the polyP 
extracted from WT AX2. 
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These results demonstrated, for the first time, that unlabelled polyP could be 
detected in D. discoideum extract by PAGE and DAPI staining. It was notable 
that the abundance polyP in this amoeba was dramatically less than could be 
detected in yeast. This analysis also provided the first estimate of the average 
chain length of polyP found in D. discoideum. In fact, the polyP detected in both 
AX2 and NC4 extract was of a much more homogeneous length than detected 
in yeast extract (Figure 4.11), where the smear is comprised of a very mixed 
range of polymer lengths from few units to many hundreds units of phosphate 
groups. 
5.2.2 Link between polyP and inositol pyrophosphates 
Given that unlabelled polyP could be easily detected in WT phenol chloroform 
extract, the level of polyP present in the ip6k mutant described in Chapter 3 
was assessed. Ip6k mutants possess barely detectable levels of inositol 
pyrophosphates (Figure 3.5), providing an ideal model in which to assess the 
conservation of the correlation between levels of polyP and levels of inositol 
pyrophosphates. Therefore, 70 µg of RNA extracted from vegetative cultures of 
both WT and ip6k cultures were analysed by 20% PAGE (Figure 5.3). No 
difference could be detected between the levels of polyP in these strains, 
despite the clear difference in the level of inositol pyrophosphates (seen at 
bottom of the gel). PolyP extracted from both strains was of the same length 
and, crucially, of approximately the same abundance, suggesting that the 
correlation between the levels of inositol pyrophosphate and polyP was not 
conserved in the vegetative state of D. discoideum. 
5.2.3 PolyP accumulation during development 
As described in Chapter 3, the level of inositol pyrophosphates increases during 
development of D. discoideum (Figure 3.10), in addition earlier work suggested 
that polyP is highest in the spore (Gezelius 1974, Klein, Cotter et al. 1988, 
Zhang, Gómez-García et al. 2005). Since the expression of PPK1 is   
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Figure 5.3 Vegetative levels of polyP do not correlate with inositol 
pyrophosphates.  
Phenol chloroform extracts from vegetative cultures of WT and ip6k cells, 
normalized by 70 mg of co-purified RNA, were analysed by 20% PAGE and 
stained with DAPI. The figure shows the result of representative experiments 
that were repeated more than 3 times. 
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developmentally regulated, undergoing a dramatic increase in expression upon 
the onset of starvation (Figure 5.4) 
(https://dictyexpress.research.bcm.edu/landing/), it was investigated if there 
was any modulation in the level of polyP during D. discoideum development. WT 
cells were starved on 20 mM potassium phosphate (KK2) agar for up to 24 
hours (as described in materials and methods,, 2.3.10). PolyP was extracted at 
five time points between the vegetative state and fruiting bodies. Extracts were 
analysed by 20% PAGE, with 70 µg of RNA loaded at each time point. Gels 
were stained with DAPI (Figure 5.5 A) and Toluidine (Figure 5.5 B).  
 
Following the onset of the starvation response, the level of polyP underwent a 
dramatic accumulation, beginning very shortly after nutrient deprivation. The 
accumulation of polyP, observed by both staining methods, is at least two 
orders of magnitude, as calculated by densitometry of Toluidine stained gels 
(data not shown). Unfortunately this method is not sufficiently accurate to place 
a specific value on this accumulation as the signal becomes saturated in the 
fruiting bodies. Toluidine staining also confirmed that whilst the absolute level of 
polyP is dramatically increased, the average chain length appears unchanged. 
The broader smears observed by DAPI staining are most likely related to the 
increased abundance of polymers of all chain lengths, including those at the 
extremes. 
 
This accumulation is consistent with previous observations that polyP is most 
abundant in the spores (Gezelius 1974, Klein, Cotter et al. 1988, Zhang, Gómez-
García et al. 2005). However, the scale of this increase was not fully appreciated 
in previous work. In fact, the dramatic accumulation of polyP observed in these 
experiments was of a scale not previously seen in eukaryotic cells. It is 
interesting to note that the accumulation of polyP occurred in parallel with an 
increase in the level of inositol pyrophosphates, as seen in Chapter 3. 
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Figure 5.4 Developmental expression of PPK1.  
Expression of PPK1 during development, source 
https://dictyexpress.research.bcm.edu/landing/ 
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Figure 5.5 Developmental accumulation of polyP.  
70 µg of RNA WT cell extracts from 5 developmental time points were analysed 
by 20% PAGE stained with Toluidine (A) and DAPI (B). Toluidine stained gels 
were analysed by densitometry using ImageJ. Figure and figure legend adapted 
from (Livermore, Chubb et al. 2016). 
  
po
ly
P 
T2
5
0 1 8 17 25
ve
ge
tat
ive
sta
rva
tio
n
ag
gr
eg
ati
ng
slu
g
IP8
IP6
polyP
RNA
DAPIToluidine
70 ug RNA
fru
it. 
bo
dy
po
ly
P 
T2
5
0 1 8 17 25
ve
ge
tat
ive
sta
rva
tio
n
ag
gr
eg
ati
ng
slu
g
70 ug RNA
fru
it. 
bo
dy
DAPI
A B
	   202 
 
 
 
Figure 5.6 Developmental accumulation of polyP in NC4.  
PolyP was extracted from NC4 cells at 3 time points during development, 
analysed by 20% PAGE and stained with DAPI. Figure and figure legend 
adapted from (Livermore, Chubb et al. 2016). 
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The accumulation of polyP during starvation was counterintuitive due to the 
substantial energetic investment required to synthesise polyP. Polyphosphate 
kinases utilise ATP to synthesise polyP, suggesting that this accumulation 
places a significant demand for ATP on starving cells. Therefore, to ensure that 
this was a physiological process, not an abnormality associated with AX2 lab 
strains, the level of polyP in developing NC4 cells was analysed. NC4 cells were 
starved as described above and polyP extracted at three time points, 20 µg of 
RNA was resolved by 20% PAGE and stained with DAPI (Figure 5.6). As in AX2 
cells, the accumulation of polyP during this developmental response was 
dramatic.  
 
In order to confirm that the results described above reflected a genuine increase 
in polyP, extract obtained from WT (AX2) fruiting bodies was subjected to 
enzymatic treatment (Figure 5.7). As observed previously (Figure 5.2), neither 
DNase, nor RNase affected the smear, whilst Ddp1, Ppx1 treatment and acid 
hydrolysis completely degraded the smear, confirming the identity of this smear 
as polyP. The increased abundance of polyP in the fruiting bodies made polyP 
detectable when just 1 µg of RNA was loaded per well. Thus no positive staining 
could be observed at the top of the gel. 
 
The level of polyP during the vegetative state was unaffected by the level of 
inositol pyrophosphates (Figure 5.3), however as the inositol pyrophosphates 
increased during development in WT, so did polyP (Figure 5.5). Therefore, the 
correlation between these two phosphate rich species was examined during the 
development of a mutant strain displaying altered levels of inositol 
pyrophosphates, ip6k (Figure 5.8). The ip6k* strain used in this experiment had 
been previously generated (Luo, Huang et al. 2003) and was the same as used 
in Figure 4.3. Experiments not shown here demonstrated that this strain also 
contained no detectable inositol pyrophosphates during development (Pisani, 
Livermore et al. 2014), as observed in the lower portion of  
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Figure 5.7 Enzymatic treatment of polyP from fruiting bodies.  
Synthetic polyP standards with an average chain length of 25 (T25) was loaded, 
either untreated or after incubation with the exo- and endo-polyphosphatase 
(Ppx1, Ddp1). 1 µg samples of RNA phenol chloroform extract from fruiting 
bodies were treated with DNase, RNase, exo- and endo-polyphosphatase (Ppx1 
and Ddp1) or treated in acid at high temperature (acid boiled). Samples were 
analysed by 20% PAGE and stained with DAPI. 
  
dd
p1
 p
px
1
ac
id
 b
oi
le
d 
un
tr
ea
te
d
dd
p1
 p
px
1
D
N
as
e 
I
RN
as
e
un
tr
ea
te
d
polyP
T25
Fruiting body 
polyP
1 ug RNA
DAPI
	   205 
 
 
 
Figure 5.8 Developmental accumulation of polyP in ip6k. 
PolyP was extracted from ip6k* cells at 5 time points during development, 
analysed by 20% PAGE and stained with DAPI. Samples from were normalised 
by RNA with 70 µg RNA loaded. 
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Figure 5.8. Despite the failure to accumulate inositol pyrophosphates, this strain 
also underwent a dramatic accumulation of polyP during development. 
 
These results indicated that although there was a correlation between the 
increases in inositol pyrophosphates and polyP during the development of WT 
cells, the increase in polyP was not dependent on an increase in inositol 
pyrophosphates. The observed increase in polyP in ip6k was comparable to that 
observed in WT, despite altered metabolism of inositol pyrophosphates. These 
results indicated once again that the correlation between inositol 
pyrophosphates and polyP present in yeast was not conserved in D. 
discoideum. 
5.2.4 Deletion of PPK1 
The scale of accumulation of polyP observed in Figures 5.5 and 5.8 had never 
before been observed in eukaryotic cells. However the identity of the enzyme 
responsible for this accumulation was not clear. Two polyphosphate kinases 
have been described in D. discoideum, PPK1 and the DdPPK2 complex. The 
previously generated ppk1 mutant generated by Zhang et al. (Zhang, Gómez-
García et al. 2005) was not available and therefore could not be tested. 
Furthermore, the genes encoding DdPPK2 were not cloned. The D. discoideum 
genome encodes 41 actin or actin related genes, some with identical gene 
products (Joseph, Fey et al. 2008).  The exact genes that encode the DdPPK2 
gene were not unambiguously identified (Zhang, Gómez-García et al. 2007).  
 
Consequently, the bacterial-like PPK1 gene was deleted. This strain will 
hereafter be referred to as ppk1. Unlike the previous ppk1 strain, which deleted 
just 114 nucleotides, or ~3% of the coding sequence, the approach detailed in 
Figure 5.9 A deleted 69% of the Ppk1 ORF and >95% of the putative catalytic 
domain. This domain, identified by homology with the 688 amino acid E. coli 
Ppk1 (Figure 5.1), is found in the C-terminal portion of the larger (1050 amino   
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Figure 5.9 Deletion of PPK1.  
Diagram showing the homologous recombination knockout strategy to generate 
ppk1 amoeba (A). Southern blot of WT and ppk1 genomic DNA (B). Genomic 
DNA was digested with BsrGI and probed for the 5’ region, as indicated in (A). 
Figure and figure legend adapted from (Livermore, Chubb et al. 2016), . 
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acid) D. discoideum Ppk1. Deletion of this region was confirmed by Southern 
blot (Figure 5.9 B).   
5.2.5 ppk1 contains no detectable polyP  
To investigate the presence of polyP in this strain, phenol chloroform extracts of 
vegetative WT and ppk1 cells were analysed by 20% PAGE and DAPI staining 
(Figure 5.10). In this case 90 µg of RNA was loaded on the gel, the maximum 
possible without negatively affecting the migration of polyP in the gel, to ensure 
that any residual polyP could be detected. In fact, whilst the polyP in WT was 
clearly visible, no polyP smear could be detected in ppk1 cells in the vegetative 
state. Equal loading of sample could be confirmed by the detection of RNA 
(above) and inositol phosphate species (below). This result provided further 
genetic evidence that the dark smear stained by DAPI was genuine polyP and 
that the ppk1 strain contained no polyP. 
 
Having confirmed the absence of polyP in the ppk1 strain, the physiological 
effect on this strain was investigated. The growth rate of the ppk1 strain in rich 
media was significantly reduced compared to WT (Figure 5.11 A), with a mean 
generation time of 11 h for WT and 15 h for the ppk1 strain. The observed 
growth defect was also in contrast to previous findings, where no growth defect 
was reported in rich media (Zhang, Gómez-García et al. 2005). 
5.2.6 PolyP and primary metabolism 
It was reasoned that the poor growth of the ppk1 strain might indicate an overall 
reduction in cellular fitness, perhaps due to altered phosphate metabolism and 
thus ATP synthesis. Therefore the cellular concentration of ATP was measured 
(Figure 5.11 B). Phenol chloroform extracts were analysed by ATP quantification 
luciferase assay (materials and methods, 2.6.5). This analysis revealed a 
striking and significant (p<0.01) decrease in the cellular concentration of ATP in 
ppk1 cells (normalised by RNA). The concentration of ATP in vegetative WT cells 
was measured at approximately 2.5 nmoles/mg RNA. In contrast the  
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Figure 5.10 Ppk1 is the only polyphosphate kinase in D. Discoideum. 
Phenol chloroform extracts, normalized by loading 90 µg of co-purified RNA, 
from vegetative growing WT and ppk1 cells were analysed by 20% PAGE and 
stained with DAPI. The figure shows the result of representative experiments 
that were repeated more than 3 times. Figure and figure legend adapted from 
(Livermore, Chubb et al. 2016).  
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Figure 5.11 Ppk1 deletion affects growth and basic metabolism.  
Cell growth curves in HL5 media. WT black line; ppk1 dashed line. Average +/- 
SD of 3 experiments run in duplicate (*p < 0.05)(A). Quantification of ATP levels 
in vegetative growing WT and ppk1 cells. Average +/- SD of 3 experiments run 
in duplicate (**p < 0.01)(B). Figure and figure legend adapted from (Livermore, 
Chubb et al. 2016). 
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concentration of ATP in vegetative ppk1 cells was measured at just 1.0 
nmoles/mg RNA. This dramatic decrease in cellular availability of ATP offered 
some explanation for the observed growth defect of ppk1 and suggested a 
potential role for polyP in the control of primary metabolism. 
 
This genetic evidence suggested a link between polyP and primary metabolism. 
Consequently, the effect of pharmacological inhibition of ATP production on 
polyP metabolism was investigated. Both WT and ppk1 cells were treated with 
sublethal doses of KCN and benzohydroxamate (BHAM), to inhibit cytochrome 
oxidase and alternative oxidation respectively (Jarmuszkiewicz, Behrendt et al. 
2002) (Figure 5.12). After two hours cells were visibly rounding (data not shown), 
but remained adherent. Treatment of WT cells for two hours induced an 
unexpected increase in polyP (Figure 5.12 A) despite significantly reducing the 
level of ATP by ~40% (Figure 5.12 C).   
 
Unsurprisingly, the same treatment of ppk1 cells (Figure 5.12 B) did not induce 
any accumulation of polyP. Nor did it result in a significant change in the level of 
ATP (Figure 5.12 D). The level of inositol pyrophosphates remained largely 
unchanged throughout this time course in both WT and ppk1 cells (Figure 5.12 
A and B). These unexpected results underscored the existence of a link 
between primary metabolism and polyP in these cells. 
5.2.7 PPK1 responsible for developmental accumulation of polyP 
Whilst the ppk1 strain was demonstrated to possess no polyP in the vegetative 
state (Figure 5.10) or after inhibition of ATP synthesis (Figure 5.12), it was 
possible that the dramatic accumulation of polyP during the development of this 
amoeba (Figure 5.5) was due to the combined activity of PPK1 and DdPPK2. 
This possibility was assessed by starvation of the amoeba as previously 
described and analysis of extracts by 20% PAGE and DAPI staining (Figure 
5.13).  
	   212 
Figure 5.12 Inhibition of ATP synthesis induces an increase in polyP in WT 
cells.  
Phenol chloroform extracts, normalized by loading 65 µg of co-purified RNA, 
from WT (A) and ppk1 (B) cells treated with KCN and BHAM (see materials and 
methods, 2.3.12) for the indicated times were analysed by 20% PAGE and 
stained with DAPI. The figure shows the result of representative experiments 
that were repeated more than 3 times.  Quantification of ATP levels in KCN and 
BHAM treated WT (C) and ppk1 (D). Average +/- SD of 3 experiments run in 
duplicate (*p < 0.05, **p < 0.01). Figure and figure legend adapted from 
(Livermore, Chubb et al. 2016).  
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Figure 5.13 Ppk1 is the enzyme responsible for developmental 
accumulation of polyP in D. Discoideum.  
WT and ppk1 cells were developed on nutrient free agar and harvested at 5 time 
points. PolyP was extracted and 15 µg of RNA was analysed by 20% PAGE and 
stained with DAPI. Figure and figure legend adapted from (Livermore, Chubb et 
al. 2016). 
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As described above polyP dramatically accumulated during development in WT. 
However, no polyP could be detected at any stage of development in ppk1 cells. 
This failure to accumulate any polyP in ppk1 suggested that the synthesis of 
polyP during development was dependent upon the presence of the Ppk1 gene 
and the catalytic activity of the PPK1 enzyme. This offered further evidence that 
PPK1 was the only source of polyP in D. discoideum.  
 
Interestingly, the co-purification of the inositol pyrophosphates during phenol 
chloroform extraction revealed the accumulation of inositol pyrophosphates in 
the latter stages of development. The increase in IP8 in WT extract could be 
observed in the lower portion of the gel (Figure 5.13). Strikingly, the increase 
observed in the ppk1 strain appeared to be greater. A very strong IP8 band could 
be detected in this ppk1 extract during the later stages of development (after 8 h 
or more). This band appeared to stain more strongly with DAPI than the 
corresponding band in WT extracts. Furthermore, an IP7 band could also be 
detected in ppk1 extracts beyond 8 h. The resolution of these bands was not as 
clear as when extracted with perchloric acid and analysed by 35.5% PAGE, 
however the difference was noticeable and reproducible and will be explored in 
more detail below. 
5.2.8 ppk1 defect in fruiting bodies formation 
Despite the inability to identify morphological differences between WT and ppk1 
cells during the early stages of development by bright field microscopy (data not 
shown), a difference could be observed between the fruiting body structure 
(Figure 5.14), in accord with previously published results (Zhang, Gómez-García 
et al. 2005). In contrast to these previous reports, however, the speed of fruiting 
body formation was not dramatically altered (Figure 5.13). Fruiting bodies 
formed by ppk1 cells did possess the basal disc, stalk and spore head, as found 
in WT fruiting bodies, however the size of the spore head was reduced (Figure  
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Figure 5.14 ppk1 cells show impaired fruiting body formation. 
Representative images of fruiting bodies from WT and ppk1 cells. Images were 
taken after 48 h starvation at the same magnification. Figure and figure legend 
adapted from (Livermore, Chubb et al. 2016).  
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5.14). This striking phenotype in fruiting body formation correlated well with the 
developmental increase in polyP. 
5.2.9 PolyP accumulates predominantly in spore cells 
Fruiting body formation involves the differentiation of amoeboid cells first into 
prespore and prestalk cells and ultimately into the stalk and spore cells as seen 
in Figure 5.14. These cell types display different gene expression profiles 
(Williams 2006) and play dramatically different roles in the lifecycle of the 
amoeba. Stalk cells, which comprise approximately 20% of the cells in the 
structure, die during the formation of the fruiting body (Williams 2010). 
Meanwhile the spore cells enter into a dormant metabolic state until germination 
into unicellular amoeboid cells upon the restoration of a nutrient source. Given 
the differing expression profiles and roles of these cell types it was reasoned 
that identifying in which cell type polyP accumulated might provide clues to the 
physiological role of this accumulation of polyP. Interestingly the PPK1 gene 
expression profile displays no significant enrichment in either prespore or 
prestalk cells (https://dictyexpress.research.bcm.edu/landing/). 
 
Therefore, spore cells were isolated from the fruiting bodies by vortexing and 
passing through Whatman No 114 filter paper via a method adapted from 
(Chiew, Reimers et al. 1985, Dynes, Clark et al. 1994)(materials and methods, 
2.3.14). It was not possible to isolate pure preparations of stalk cells that were 
free of contaminant with spore cells. Consequently, polyP was extracted from 
pure spore preparations and compared to polyP extracted from whole fruiting 
bodies. Due to the relatively inert metabolic state of spore cells, RNA was not 
deemed to be the most accurate method for normalising. Therefore in this case 
the number of spore cells was counted after isolation and polyP was extracted 
from 5x106 spores for both pure spores and fruiting bodies (comprised of both 
spore and stalk cells) of WT and ppk1 strains. Analysis by 20% PAGE and DAPI 
revealed that polyP could be detected in both the fruiting bodies and the pure 
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spore preparation of WT cells (Figure 5.15). The level of polyP extracted from 
spores alone was broadly comparable to that extracted from whole fruiting 
bodies. No polyP was detected in either spores or whole fruiting bodies of ppk1.  
 
These results indicated that polyP was present in WT spore cells. The inability to 
isolate pure stalk cells meant that it could not be concluded whether stalk cells 
contained any polyP, however, the similarity in the amount of polyP extracted 
from spores alone and from whole fruiting bodies suggested that the majority of 
polyP accumulated in spore cells. 
5.2.10 PolyP plays a role in spore germination 
The accumulation of polyP in the spores of D. discoideum was reminiscent of 
the accumulation of phytic acid (IP6) in plant seeds. Germination of seeds 
containing low levels of phytic acid can be negatively affected (Pilu, Panzeri et 
al. 2003, Raboy 2007, Doria, Galleschi et al. 2009). Therefore the potential effect 
of a lack of polyP on spore germination was investigated by scoring the 
germination of WT and ppk1.  
 
Spores were harvested from fruiting bodies 2-3 days after being plated on 
nutrient free agar. Fruiting bodies were washed in 0.5% NP40 to kill any 
remaining amoeboid cells. Spores were counted and then diluted to a density of 
1.5 x106 spores per ml. Germination was then scored at indicated time points, 
with cells scored as ungerminated spores, swollen spores or amoeba. The 
percentage of cells remaining as ungerminated spores was calculated and 
plotted (Figure 5.16, average of three experiments).  
 
WT spores germinated very rapidly in rich media (HL5) (Figure 5.16 A, solid line), 
with only ~15% remaining ungerminated after 4 h. Approximately 10% of spores 
remained ungerminated after 8 h and this was unchanged after 24 h. In contrast, 
ppk1 spores showed a delay in germination (dashed line), after 4 h   
	   218 
 
 
Figure 5.15 PolyP is predominantly present in the spores of fruiting bodies.  
Pure spore preparations were obtained (materials and methods, 2.3.14). 20% 
PAGE analysis of polyP extracted from whole fruiting bodies and pure spore 
preps, stained with DAPI. Figure and figure legend adapted from (Livermore, 
Chubb et al. 2016). 
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Figure 5.16 ppk1 cells show delayed spore germination.  
Spore germination in HL5 media (A), HL5 media supplemented with 0.2 M 
sorbitol (B) and SIH minus phosphate (C) over 24 hours. WT black line; ppk1 
dashed line. Average +/- SD of 3 experiments run in duplicate (*p < 0.05). Figure 
and figure legend adapted from (Livermore, Chubb et al. 2016).  
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approximately 40% of ppk1 spores had failed to germinate. After 8 h there 
remained a significant difference (p<0.05) in the percentage germinated between 
WT and ppk1 spores. However, only approximately 10% of spores remained 
ungerminated after 24 h, indicating that the defect in germination in rich media 
was a delay and not an absolute failure to germinate. 
 
It was reasoned that the accumulation of polyP might indicate that the polymer 
acts as a storage molecule designed to aid germination in suboptimal 
conditions. Consequently the ability of ppk1 spores to germinate in more 
challenging conditions was assayed. Both WT and ppk1 spores were diluted in 
rich media supplemented with 0.2 M sorbitol (Figure 5.16 B) to determine the 
effect of osmotic stress on germination. In this case the germination of WT 
spores (solid line) was delayed, compared to rich media that had not been 
supplemented (Figure 5.16 A).  Even after 24 h, approximately 20% of cells had 
not begun to germinate. The germination of ppk1 cells (dashed line) was also 
delayed and was significantly different from WT germination after both 4 and 8 
h. Whilst the difference was not significant after 24 h, almost 40% of spores had 
failed to germinate. This defect in germination under osmotic stress appeared to 
be slightly greater than in unsupplemented rich media.  
 
To investigate the possibility that the accumulation of polyP in spores might 
represent a phosphate store this experiment was conducted in synthetic media 
deprived of phosphate. It was reasoned that the absence of phosphate in this 
experiment might exacerbate the difference seen between these strains. In fact 
the germination of both WT and ppk1 was greatly impaired, with only ~60% of 
WT spores (solid line) germinating even after 24 h (Figure 5.16 C). Once again 
the germination of ppk1 cells (dashed line) was slowed and significantly fewer 
ppk1 spores had germinated after 24 h. Despite this significant reduction in 
germination compared to WT, >40% of ppk1 spores were able to germinate 
after 24 h, even when deprived of any external phosphate. Once again it was not 
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possible to conclude whether the effect was simply a delay or an absolute 
failure to germinate in ppk1 spores. However, very little change in germination 
was observed between 8 and 24 h in ppk1 spores, perhaps suggesting that 
these spores might have failed to germinate had the experiment continued. 
5.2.11 Electron microscopy to localise polyP in the spore 
Given the failure to localise polyP in the vegetative state or during the first five 
hours of starvation (data not show), it was reasoned that spore cells, which 
contain the highest levels of polyP (Gezelius 1974, Klein, Cotter et al. 1988, 
Zhang, Gómez-García et al. 2005) (Figure 5.5 and 5.15), might represent the 
best cell type to localise polyP. However, spore cells are surrounded by a 
proteinaceous and polysaccharide coat, making them inappropriate for light 
microscopy studies. Consequently, the localisation of polyP in the spores was 
assayed by electron microscopy (Figure 5.17).  
 
In the yeast S. cerevisiae, the majority of polyP is within the vacuole (Kornberg, 
Rao et al. 1999). It is possible to distinguish between yeast strains with different 
levels of polyP by electron microscopy. Yeast strains with high levels of polyP 
appear to have “dark-staining”, electron dense vacuoles by electron 
microscopy, whilst strains with low polyP have much “lighter-staining” less 
electron dense vacuoles (unpublished observation, Saiardi lab). Therefore, a 
similar approach was applied to WT and ppk1 spores. Spores were embedded 
in an agarose pellet, sectioned and stained with lead citrate (materials and 
methods, 2.3.17). The integrity of structures appeared to be well conserved in 
this process, representative electron micrographs of WT and ppk1 spores are 
shown in Figure 5.17. It was not possible to discern any electron dense 
organelle structures that were present in the WT spores but not the ppk1 
spores. This suggested that this method would not be appropriate to ascertain 
the subcellular localisation of polyP. In fact no gross morphological variations 
could be detected between the spores generated by WT and ppk1 strains.  
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Figure 5.17 WT and ppk1 spores indistinguishable by electron microscopy.  
Representative images taken by Transmission Electron Microscopy of pure 
spore preparations from WT (left) and ppk1 (right). Spores were sectioned and 
stained with lead citrate and imaged (materials and methods, 2.3.17). Images 
are shown at the same scale and are representative of >20 spores analysed in 
this way.  
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5.2.12 PolyP and inositol pyrophosphates during development 
As previously discussed the metabolism of inositol pyrophosphates and polyP 
are linked in yeast. However, the correlation between the levels of these two 
molecules in the vegetative state was not conserved in the D. discoideum 
(Figure 5.3). Nevertheless, it did appear that ppk1 accumulated more inositol 
pyrophosphates during development than WT (Figure 5.13). This observation 
was further investigated by analysing perchloric acid extract of both WT and 
ppk1 cells at different time points during development. Extracts were analysed 
by 35.5% PAGE and Toluidine staining (Figure 5.18 A). This analysis confirmed 
that the accumulation of inositol pyrophosphates during ppk1 development was 
greater than in WT. This effect was most notable in the level of IP7, which was 
dramatically increased in ppk1 particularly after 16 h. The increase of total 
inositol pyrophosphates (IP7 and IP8) was quantified in comparison to IP6 by 
densitometry as previously described. This quantification revealed that the total 
level of inositol pyrophosphates in ppk1 fruiting bodies was double the level 
attained in WT fruiting bodies (when normalised by IP6) (Figure 5.18 B). 
 
The analyses thus far suggested that whilst the link between inositol 
pyrophosphates and polyP was not as seen in yeast (Lonetti, Szijgyarto et al. 
2011), some metabolic link did exist in the amoeba. In the absence of polyP, it 
appeared that the level of high-energy phosphoanhydride bonds was partially 
compensated by an increase in the accumulation of another phosphate rich 
molecule, containing phosphoanhydride bonds, the inositol pyrophosphates. 
However, the nature of this link was not clear. Given that synthesis of polyP 
during the developmental process clearly requires large of energetic input in the 
form of ATP, it was reasoned that a strain lacking PPK1 might consume less 
ATP during development. Therefore the level of ATP in the ppk1 strain was 
investigated.  
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Figure 5.18 Developmental failure to accumulate polyP affects inositol 
pyrophosphate.  
35.5% PAGE analysis of perchloric acid extract from WT and ppk1 cells during 
development, stained with Toluidine (A). Quantification of the ratio between 
inositol pyrophosphates (IP7 and IP8) and their precursor, InsP6 in fruiting bodies. 
Quantification by densitometry using ImageJ software, results represent the 
average +/- SD of 3 independent experiments (***p < 0.0001) (B). Figure and 
figure legend adapted from (Livermore, Chubb et al. 2016). 
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Figure 5.19 Developmental failure to accumulate polyP affects ATP 
metabolism. 
Quantification of fold change in ATP between vegetative cells and “aggregating” 
cells starved for 10 hours.  Average +/- SD of 6 experiments run in duplicate (*p 
< 0.05). Figure and figure legend adapted from (Livermore, Chubb et al. 2016). 
  
5
Fo
ld
 c
ha
ng
e 
AT
P
 a
fte
r 1
0 
h 
de
ve
lo
pm
en
t
0
1
2
3
4
WT pp
k1
*
	   226 
Due to the technical difficulty in extracting ATP from multicellular stages of D. 
discoideum development, ATP was quantified at 0 h of starvation and at 10 h. 
The fold change of ATP was then calculated over this period (Figure 5.19). 
Whilst the level of ATP did not change dramatically during the first 10 h of 
development in WT cells, the level of ATP in ppk1 strains increased ~2.5 fold, 
rising to a level slightly exceeding WT. Thus, whilst ppk1 cells failed to 
accumulate polyP during the developmental process, they accumulated both 
inositol pyrophosphates and ATP to a greater extent than WT cells. A common 
feature to all these molecules is the presence of high-energy phosphoanhydride 
bonds. 
5.2.13 Investigating a molecular link between polyP and inositol 
pyrophosphates 
Whilst the link between polyP and inositol pyrophosphates was not as described 
in yeast, these phosphate rich molecules did show some metabolic link in D. 
discoideum. A number of possible explanations for this metabolic link could be 
conceived, including a direct effect of inositol pyrophosphates on the polyP 
synthesising enzyme. Other explanations could include a direct linkage between 
these molecules, perhaps with inositol pyrophosphates “decorating” polyP and 
capping the ends of the polymer, potentially protecting it from degradation by 
exopolyphosphatases as has been proposed previously (Saiardi 2012). 
Alternatively a more general metabolic link could exist, exerted through the 
energetic status of the cell and the effect that both polyP and inositol 
pyrophosphates exert on ATP levels. The observed differences between yeast 
and D. discoideum does not allow one model to be favoured as universal. 
 
It was reasoned that the different synthetic pathways of polyP in yeast and the 
amoeba made a direct effect on the synthetic enzyme (Vtc4 and PPK1 
respectively) unlikely. The effect observed upon ATP levels was also not 
conserved between yeast and amoeba (Figure 3.11 and Figure 5.11). 
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Therefore, the most attractive model was reasoned to be a direct linkage 
between these molecules. It has previously been hypothesised that inositol 
pyrophosphates may act as a “cap” on the ends of the polyP polymer, possibly 
offering protection from degradation by exopolyphosphatases (Saiardi 2012). To 
explore this possibility an experimental procedure was devised in which polyP 
extracted by phenol chloroform was separated from co-purifying inositol 
pyrophosphates by gel filtration and then degraded by acid boiling. Complete 
hydrolysis of phosphoanhydride bonds would release any other attached 
molecules, including inositol species such as IP6 (which is insensitive to acid 
hydrolysis).  The potential release of IP6 was then examined by PAGE and 
Toluidine staining. These experiments are detailed in Figures 5.20 to 5.23. 
 
In order to obtain the high levels of polyP required, polyP was extracted from 
fruiting bodies. 6 x108 cells were allowed to develop for 2 days on KK2 agar. 
These cells were then used to prepare a phenol-chloroform extract that was 
spiked with 20 µl of 10 mM IP6 and loaded on a Superdex peptide 10/300 gel 
filtration column (GE Healthcare Life Sciences). Eluted fractions were then 
pooled in pairs and 1/10 of fractions 11-30 were analysed by 30% PAGE and 
stained with DAPI (Figure 5.20). These experiments revealed that polyP 
extracted from fruiting bodies eluted in fractions 15-22. Spiked IP6 (as well as 
small amounts of endogenous IP7 and IP8) could be detected in fractions 25-28. 
Thus this method allowed good separation of these two species based on their 
differing sizes. For future experiments polyP in fractions 15-19 were pooled and 
used for further analysis. Whilst polyP could still be detected in fractions 20-22, 
these were deemed to elute too close to inositol pyrophosphates and therefore 
discarded to avoid any potential contamination. 
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Figure 5.20 Fruiting body inorganic polyP can be separated according to 
size.  
Phenol chloroform extracts from fruiting bodies were “spiked” with IP6 were 
resolved by gel filtration (materials and methods, 2.6.6). Fractions were pooled 
as indicated, resolved by 30% PAGE and stained with DAPI. 
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Figure 5.21 PAGE analysis of fruiting body polyP degraded by acid 
hydrolysis failed to detect inositol phosphates.  
PolyP was resolved by gel filtration as shown in Figure 5.20. PolyP fractions 
were pooled as indicated and split into three, untreated, acid boiled for 1.5 h at 
100°C and neutralised or acid boiled followed by phytase treatment. IP6 samples 
were treated identically. Samples were concentrated in a vacuum evaporator 
and resolved by 30% PAGE and stained with Toluidine. 
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After pooling fractions 15-19, this sample was split into 3 equal volumes. One 
volume was stored on ice, whilst the other two were boiled in 1 M perchloric 
acid for 1.5 h. After acid treatment, these samples were neutralised with 1 M 
K2CO3 (supplemented with 3 mM EDTA). After neutralisation, one of the acid 
treated samples was treated with phytase. This step was designed to determine 
if any species that was released during acid boiling contained inositol. These 
experiments were performed in parallel with IP6 (untreated; acid boiled; acid 
boiled then treated with phytase) to confirm that IP6 was not degraded by acid 
boiling, but could be degraded by subsequent phytase treatment, as shown in 
lanes 2, 7 and 8 (Figure 5.21). Importantly, this analysis demonstrated that the 
polyP prepared by pooling of samples 15-19 from Figure 5.20 was not 
contaminated with inositol pyrophosphates (lane 1). This smear was completely 
degraded by acid treatment (lane 5 and 6), however no band resembling IP6 was 
released (lane 5). 
 
This approach failed to demonstrate the release of any inositol phosphate 
containing species from fruiting body derived polyP. A similar approach was 
applied to polyP extracted from vegetative cells. Due to the lower abundance of 
polyP in the vegetative state, phenol chloroform extracts were prepared from 3 
x109 cells. Prior to loading on a gel filtration column, these samples were then 
treated with RNase to degrade co-purifying RNA. This extract was then 
separated by Superdex peptide 10/300 gel filtration column (Figure 5.22). These 
species showed slightly different separation, with polyP eluting between 
fractions 13-20. In addition, much higher levels of endogenous inositol 
phosphates could be detected in fractions 21-28 (no IP6 spike was included in 
these experiments). Fractions 16-20 were utilised in the following experiments.  
 
As described above, pooled fractions were split into three and treated 
accordingly (Figure 5.23). Once again, IP6 was unaffected by acid treatment 
(lane 7), but could be degraded by phytase (lane 8). Similarly, no inositol 
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phosphate contaminants could be detected in untreated, purified polyP (lane 3). 
Acid treatment once again degraded the polyP smear, however it also released 
three diffuse bands in the process (lane 4). These bands were not degraded by 
phytase treatment (lane 5), indicating that they were not inositol-containing 
species. This figure is representative of an experiment performed several times, 
where the three released bands could not be degraded by phytase. The identity 
of these bands was not thoroughly investigated. They could represent RNA 
degradation products, generated in the RNase step or be a non-inositol 
phosphate polyP-associated molecule. 
 
This approach did not reveal the release of inositol species from either 
vegetative polyP or fruiting body polyP. Several attempts were made to refine 
this approach, including the use of TiO2 beads to purify phosphate-rich species 
after acid hydrolysis (Wilson, Bulley et al. 2015), however the experiments 
described above gave the clearest results. Whilst this approach did not 
conclusively disprove the hypothesis that polyP and inositol phosphates are 
covalently linked or bound, however it failed to offer compelling evidence in 
support of this hypothesis. 
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Figure 5.22 Vegetative inorganic polyP can be separated according to size.  
Phenol chloroform extracts from vegetative cells were resolved by gel filtration 
(materials and methods, 2.6.6). Fractions were pooled as indicated, resolved 
by 30% PAGE and stained with DAPI.  
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Figure 5.23 PAGE analysis of vegetative polyP degraded by acid hydrolysis 
failed to detect inositol phosphates.  
PolyP samples were treated with RNase A and RNase T1 at 37°C for 1.5 h. 
PolyP was then resolved by gel filtration as shown in Figure 5.22. PolyP 
fractions were pooled as indicated and split into three, untreated, acid boiled for 
2 h at 100°C for 2 h and neutralised or acid boiled followed by phytase 
treatment. IP6 samples were treated identically (except RNase treatment). 
Samples were concentrated in a vacuum evaporator and resolved by 30% 
PAGE and stained with Toluidine.  
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5.3 Discussion 
The experiments described above confirm that D. discoideum offers excellent 
potential as a model in which to study the role of inorganic polyphosphate on 
cellular metabolism. The application of PAGE technology, coupled with either 
Toluidine or DAPI staining allows the direct visualisation of unlabelled polyP 
extracted from D. discoideum for the first time (Figure 5.2). This method 
provides the most robust and reliable detection of polyP, allowing the polymer 
to be discerned from co-purifying molecules.  
5.3.1 Detection of polyP in D. discoideum 
Phenol chloroform extractions commonly used to purify polyP also co-extract a 
range of molecules, including RNA (Figure 5.2), inositol pyrophosphates (Figure 
5.5), ATP (Figure 3.13) and perhaps even free phosphate. Traditional methods 
for polyP detection are indirect, requiring the degradation of polyP and 
quantification, by malachite green, or free phosphate released; use of polyP as a 
substrate to regenerate ATP using purified PPK; or the detection of a shift in 
DAPI fluorescence induced by polyP. All of these assays are influenced by co-
purifying molecules, in particular the inositol pyrophosphates, which are 
degraded by both acid treatment and certain endopolyphosphatases (Lonetti, 
Szijgyarto et al. 2011). Furthermore, inositol phosphates are able to induce a 
fluorescence shift when bound to DAPI (Kolozsvari, Parisi et al. 2014). The 
methods used in these experiments are able to discern polyP from any other co-
purifying molecules through both speed of migration and a range of biochemical 
treatments (Figure 5.3). An additional advantage of this technique is its ability 
the discern polyP chain length, something that other methods preclude. Thus, 
this work demonstrates the simple and reliable visualisation of unlabelled polyP 
extracted from a range of D. discoideum mutants at different stages of 
development. 
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In fact, these experiments surprisingly reveal that the nature of the link between 
polyP and inositol pyrophosphate metabolism seen in yeast is not conserved in 
D. discoideum (Figure 5.4). Nevertheless, the data described above does 
indicate a possible functional relationship, as shown by cells lacking polyP, 
which accumulate high levels of inositol pyrophosphates (Figure 5.18). 
 
These results demonstrate, for the first time the true scale of the accumulation 
of polyP during the developmental time course. Whilst this unusual 
accumulation of polyP had been described before by a number of laboratories 
(Gezelius 1974, Klein, Cotter et al. 1988, Zhang, Gómez-García et al. 2005), 
previous estimates greatly underestimated the scale of the accumulation, which 
is at least two orders of magnitude (Figure 5.5). In accord with observations in 
the vegetative state, altered metabolism of inositol pyrophosphates does not 
affect the accumulation of polyP (Figure 5.8). 
5.3.2 PPK1 is the only polyphosphate kinase in D. discoideum 
Strikingly, these results also demonstrate that polyP cannot be detected in cells 
lacking the bacterial-like PPK1. This enzyme was previously deleted by Zhang et 
al., generating a mutant strain possessing 20-50% of WT polyP. In stark 
contrast, the experiments presented here describe the generation of a ppk1 null 
strain in which >95% of the catalytic domain is deleted (Figure 5.9) and no 
polyP can be detected. Two possible explanations could account for this 
discrepancy, the first is the different methodologies used to detect polyP. It is 
possible that the signal obtained in the ppk1 mutant by Zhang et al. was in fact 
due to co-purifying molecules. Alternatively, it is possible that a partially active, 
truncated PPK1 remained in this strain, as only ~3% of the coding sequence of 
this gene was deleted. 
 
In fact, this discrepancy is significant as the presence of polyP in Zhang et al.’s 
mutant was presented as evidence for an additional polyP kinase activity in the 
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amoeba. This activity was attributed to the remarkable DdPPK2 complex 
(Gómez-García and Kornberg 2004). However, the experiments presented here 
failed to detect residual polyP in the ppk1 strain, calling into question the 
physiological relevance of the DdPPK2 complex as a source of polyP either in 
the vegetative state or during development. Thus proposals that DdPPK2-like 
complexes might be the source of mammalian polyP (Hooley, Whitehead et al. 
2008) must be reconsidered in light of this work. If, as seems to be the case, 
DdPPK2 is not a physiological polyP kinase, then the search for the true 
mammalian polyP kinase must continue. 
 
5.3.3 PolyP is linked to primary metabolism in D. discoideum 
Furthermore, the absence of detectable polyP in the ppk1 strain offers an 
explanation for additional discrepancies between the results described here and 
those obtained by Zhang et al. The ppk1 strain generated in this work has a 
defect in growth rate, causing an extension in doubling time from 11 h to 15 h 
compared to WT. No such defect was observed by Zhang et al., possibly due to 
the residual polyP present in their Ppk1 null strain.  
 
The observed defect in growth is underpinned by a more than two-fold decrease 
in the level of ATP in the ppk1 strain. This should perhaps not be surprising due 
to the ability of polyP to act as phosphate buffer and thus as a Pi donor for 
general metabolism. The consequences of which seem likely to affect the cell’s 
ability to synthesise ATP. In fact, polyP has previously been linked to metabolic 
control. A genome-wide screen in yeast revealed a strong inter-dependence 
between polyP and primary metabolism (Freimoser, Hürlimann et al. 2006). As 
described above, this study demonstrated that deletion of genes involved in 
polyP metabolism was most frequently coincident with altered metabolism. The 
authors of this study postulated that the interdependence of polyP and basic 
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energetic metabolism positioned polyP as an indirect link between phosphate 
homeostasis and primary metabolism.  
 
Furthermore, as described in Chapter One, polyP has been implicated in 
mitochondrial function in mammalian cells, including as a constituent of the 
mitochondrial permeability transition pore complex (Seidlmayer, Blatter et al. 
2012). In contrast to the work presented in this chapter however, inhibition of 
mitochondrial function using the uncoupling agent FCCP, induced a decrease in 
polyP, as detected by DAPI fluorescence. Conversely, stimulation of 
mitochondrial activity by providing the substrate of complex II, methyl-
succinate, prompted an increase in polyP. These results are in conflict to those 
described here and the exact role of polyP in mitochondrial functionality will 
require further investigation. 
 
The interdependence between polyP and cellular ATP was demonstrated by 
both genetic means, through the dramatic decrease in ATP levels in the ppk1 
mutant, and also by pharmacological treatment with KCN and BHAM. Sublethal 
doses of inhibitors for both the electron transport chain and alternative oxidation 
pathway resulted in decrease in the cellular level of ATP in WT cells (Figure 
5.12). Counterintuitively, this fall in ATP production was coupled with an 
increase in the level of polyP.  
 
The failure of KCN and BHAM to induce significant reductions in the cellular ATP 
of ppk1 cells raises the interesting question of how these cells generate ATP. 
The resistance of ppk1 ATP levels to KCN and BHAM treatment, as well as the 
lower overall level of ATP in vegetative cells could indicate that the 
mitochondrial activity of the ppk1 null cells is compromised. Whilst experimental 
evidence is lacking, these results could be consistent with a role for polyP in 
promoting efficient mitochondrial activity. Extending this hypothesis further, the 
observed increase in polyP in WT cells treated with mitochondrial inhibitors 
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might represent an adaptive measure to preserve mitochondrial function in the 
face of extreme stress. 
 
Whilst this is an attractive hypothesis, the data presented here could also offer 
an alternative hypothesis for the accumulation of polyP upon inhibition of ATP 
production. As discussed above and demonstrated in Figures 5.5-5.7 induction 
of the starvation response induces a rapid accumulation polyP. Inhibition of 
mitochondrial activity with KCN and BHAM could be considered as akin to the 
most acute starvation response, causing a dramatic reduction in the energetic 
currency of the cell. Thus the unexpected increase in polyP observed upon 
treatment with KCN and BHAM may represent a similar phenomenon to that 
observed upon starvation and during the developmental response. 
 
The developmental response of the amoeba D. discoideum is a complex 
process involving the altered expression of a large network of genes (Loomis 
2015). In fact, Ppk1 is one of the genes to be upregulated during development 
(Figure 5.4). The expression of Ppk1 during treatment with KCN or BHAM was 
not measured, but it seems unlikely that treatment with KCN and BHAM could 
mimic the effects of starvation and change expression of such a high number of 
genes. In fact, the role of cAMP as the key signalling molecule in this pathway, 
which is synthesised in a single catalytic step from ATP, suggests that any 
inhibition of ATP production might in fact preclude the starvation response. 
Thus, treatment with KCN and BHAM mimicking the starvation response seems 
unlikely. Instead, these results suggest a model in which the relationship 
between polyP and primary metabolism is a complex one. Further experiments 
are required to understand the precise nature of this link and the effect of polyP 
on mitochondrial function in these D. discoideum. 
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5.3.4 Why do spores accumulate polyP? 
Whilst the accumulation of polyP in response to ATP depletion may not be 
related to the starvation induced increase, the scale of the increase of polyP 
during development is stark. It had been previously reported that the ppk1 null 
strain show aberrant fruiting body formation (Zhang, Gómez-García et al. 2005). 
This observation is confirmed by this work (Figure 5.14). Therefore, the role of 
polyP in development was a focus of investigation. Separation of spore cells 
from stalks reveals that a large proportion of the polyP contained in fruiting 
bodies accumulates in the spores (Figure 5.15), leading to speculation that 
there may be a defect in sporulation.  
 
Analysis of plaque formation failed to adequately distinguish between the 
growth defect shown by ppk1 (Figure 5.11) and impaired sporulation (data not 
shown). Consequently an alternative method, adapted from van Dijken et al. 
(Van Dijken and Van Haastert 2001) was employed. This analysis identified a 
sporulation defect in ppk1 spores (Figure 5.16). The germination delay in 
germination of ppk1 could be caused by numerous factors, including the loss of 
polyP as an energy store. Considering polyP as an energy store to be utilised 
upon germination offers a potential explanation for the large investment of 
limited resources in polyP synthesis during the starvation response. 
 
However, this germination defect is exacerbated by osmotic stress conditions in 
media supplemented with 0.2 M sorbitol. Given that synthesis and degradation 
of polyP affects not only the cellular abundance of free phosphate, but also the 
availability of the divalent cations such as Ca2+ and Mg2+ it is unsurprising that 
the loss of polyP might exert an osmotic effect. PolyP chelation of divalent 
cations may also have additional properties, acting as a sponge for these ions. 
Thus degradation of polyP during germination would allow the rapid release of 
these cations. The ability of ppk1 to germinate in media depleted of divalent 
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cations was not tested, however, it would be interesting to explore this 
hypothesis further. 
 
It was perhaps surprising that ppk1 spores showed a less dramatic germination 
defect compared to WT in media lacking phosphate (Figure 5.16). It should be 
noted that both WT and ppk1 spores were slower to germinate in media lacking 
phosphate, however the ability of over 40% of ppk1 spores to germinate over 
the course of 24 hours was surprising. If the accumulation of polyP was simply 
considered a store of phosphate then it would be anticipated that failure to 
synthesise this store might have catastrophic effects on the ability of this strain 
to germinate in the absence of phosphate. This was not the case, suggesting 
that the role of polyP may be more complex, or that ppk1 cells are able to 
compensate for the loss of polyP in other ways. 
5.3.5 Inositol pyrophosphates compensating for loss of polyP? 
This work also demonstrated that the ppk1 strain accumulated significantly 
more inositol pyrophosphates than WT during development (Figure 5.17). Thus 
the accumulation of these phosphate rich and high-energy molecules may 
represent a partial compensation for the absence of polyP. In fact, the 
phosphate rich inositol pyrophosphates represent not only a store of phosphate, 
but also a store of phosphoanhydride bonds. It must be noted that the 
additional energy stored in the increase in IP7 and IP8 in ppk1 spores is far less 
than that stored in the polyP pool of WT. Nevertheless, inositol pyrophosphates 
may offer some partial compensation for the lack of polyP both in phosphate 
storage, energy storage and in chelation of divalent cations; an additional 
property shared by polyP and inositol phosphates (Kornberg, Rao et al. 1999, 
Shears 2001). 
 
These observations offer the attractive hypothesis, that whilst inositol 
pyrophosphates and polyP are not metabolically coupled as in yeast, there is a 
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more functional link between these molecules, particularly during the starvation 
and germination response. 
 
It should also be noted that during the first 10 hours of development there is 
very little change observed in the level of ATP in WT cells. In contrast, ppk1 cells 
increase their level of ATP by approximately 2.5 fold. This increase in ATP could 
be considered to be a consequence of the failure to accumulate polyP as ATP is 
not expended by PPK1 activity. In this context, the increase in inositol 
pyrophosphates in ppk1 could simply be due to elevated cellular ATP 
(compared to vegetative growth). However, this seems to be an 
oversimplification as it implies a direct correlation between the level of inositol 
pyrophosphates and ATP. Numerous experiments, including the relatively 
unchanged level of inositol pyrophosphates in the vegetative state of ppk1 
despite low levels of ATP, suggest that the relationship is more complex than 
this. It is also worthy of note that the increase in ATP observed during 
development of ppk1 cells brought the level of ATP to a value comparable to 
that of WT cells. Thus ATP was not raised to such aberrantly high levels to 
expect a total distortion of the synthesis of inositol pyrophosphates. 
5.3.6 Capping things off? 
Finally, one alternative hypothesis for the increase in inositol pyrophosphates 
during development of ppk1 is that it might not represent increased synthesis at 
all. Rather it could be a result of failure to utilise these molecules. Whilst it is 
known that the PPK enzymes use ATP as a substrate (not IP7 or IP8) it is 
possible that synthesis of polyP may provide an alternative “sink” for inositol 
pyrophosphates. It has been postulated previously (Saiardi 2012) that polymers 
of polyP may be “capped” at their ends by molecules related to the inositol 
pyrophosphates. If this were true then a failure to accumulate polyP might 
manifest itself in an increase in the unused “capping molecules”, i.e. inositol 
pyrophosphates.  
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Indeed such a hypothesis could also offer a widely applicable model for the 
linkage between these molecules in divergent organisms from yeast 
(Auesukaree, Tochio et al. 2005, Lonetti, Szijgyarto et al. 2011) to mammals 
(Ghosh, Shukla et al. 2013). So-called, “capping” of polyP could confer 
protection against degradation by the exopolyphosphatases, which would not 
be able to access and cleave the terminal phosphate. Thus a decrease in 
inositol pyrophosphates would offer less protection to polyP and vice versa.  
 
This attractive hypothesis is challenged by the normal levels of polyP observed 
in the ip6k strain of D. discoideum (Figure 5.4), but as discussed previously, this 
strain does contain residual levels of IP7. It is possible this residual IP7 might be 
sufficient to “protect” the low level of polyP present in the vegetative state. 
 
Efforts to find experimental evidence for inositol pyrophosphates capping polyP 
failed to offer any support for this hypothesis (Figures 5.20-5.23). No inositol 
containing molecules could be detected upon degradation of either vegetative 
or fruiting body polyP. The absence of proof does not dispel this hypothesis 
completely, however it does suggest that it is not the cause of the observed 
increase of inositol pyrophosphates in ppk1. With this in mind, it is reasonable to 
conclude that the increase in inositol pyrophosphates noted in Figure 5.17 is 
due to increased synthesis. 
5.3.7 Concluding remarks 
It is evident from the work described here that the amoeba D. discoideum can 
reveal much about the synthesis, regulation and function of the once overlooked 
polymer, polyP. This model represents only the second eukaryotic genetic 
model in which to study polyP. The yeast vtc4Δ represents the only other model 
in which the polyphosphate kinase has been identified and deleted. Remarkably, 
despite the very high levels of polyP found in yeast, this mutant displays a very 
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mild phenotype. In contrast the ppk1 strain generated in this work shows a 
range of phenotypes, including slow growth, altered primary metabolism and 
defective fruiting body formation. The evidence presented here demonstrates 
that in the amoeba, polyP, primary metabolism and inositol pyrophosphates are 
linked. To elucidate the precise nature of these relationships will require further 
work, in particular assessing the mitochondrial activity in the ppk1 strain and 
exploring the effect of mitochondrial inhibition on polyP synthesis in WT.  
 
Furthermore, this clean genetic system will provide the ideal test bed for the 
development of fluorescent probes to detect polyP inside cells. This is 
particularly important as currently available methods fail to detect any 
differences between WT and ppk1 cells (data not shown). Development and 
validation of improved polyP probes in D. discoideum would offer the invaluable 
opportunity to critically evaluate the available literature, as well as to facilitate 
future studies in the amoeba as well as in other models. 
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6. Conclusions and Perspectives 
The work presented in this thesis has focused on the synthesis, metabolism and 
cellular function of the inositol pyrophosphates and inorganic polyphosphate, 
two of the most phosphate rich molecules in the cell. Using the social amoeba 
D. discoideum, this work has sought to develop a genetic model in which to 
study these molecules. It was demonstrated that recent improvements to PAGE 
technology allow the detection of both inositol pyrophosphates and polyP by 
either Toluidine or DAPI staining. This approach delivers the significant 
advantage that it allows the visualisation of both unlabelled inositol 
pyrophosphates and polyP. The straightforward detection of both of these 
molecules in the amoeba makes it an ideal model in which to study not only the 
synthesis and metabolism of each molecule, but also how they are related. 
6.1 Inositol pyrophosphates 
A genetic approach reveals that the synthesis of the inositol pyrophosphates is 
more complex than initially expected. A mutant lacking the only characterised 
IP7 kinase (ppip5k) still possesses IP8, whilst the double mutant lacking 
ip6k/ppip5k still possesses IP7. In fact, this study, by either genetic or 
biochemical evidence, has identified at least four enzymes capable of 
synthesising inositol pyrophosphates. The novel inositol phosphate kinases 
IPKA and IPKB are both able to phosphorylate IP7 to IP8 in vitro, taking the 
number of IP7 kinases encoded in the D. discoideum genome to three. This 
surprising abundance of IP7 kinases, as well as the extremely robust activity of 
IPKA may offer insight into why D. discoideum possesses a higher level of IP8 
than IP7 a property almost unique in models studied to date. 
 
Whilst the presence of three IP7 kinases might suggest an explanation for the 
source of such high levels of IP8, it begs the question, why? The amoeba 
possesses by far the highest levels of inositol pyrophosphates identified in any 
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organism investigated. Deletion of both Ip6k and Ppip5k genes generates a 
strain lacking the majority of the inositol pyrophosphates. However, analysis of 
this strain failed to identify any major phenotype. Given the substantial energetic 
investment in synthesising and maintaining the inositol pyrophosphate pool this 
lack of phenotype is surprising. 
 
As explored in Chapter Three, these results could be explained by the presence 
of a residual and potentially functional pool of IP7 in the ip6k/ppip5k strain. Thus 
generation of a truly clean model system, in which no inositol pyrophosphates 
are present, will require the deletion, or depletion, of all four inositol phosphate 
kinases identified to date. As discussed above, numerous unsuccessful 
attempts were made to delete IPKA, suggesting lethality. Thus the generation of 
a “quadruple mutant” may not be practical. An alternative approach would be 
the depletion of both IPKA and IPKB by RNAi. Such an experimental approach 
may be required to shed further light on the role of these molecules in D. 
discoideum. This strategy is far more convoluted than originally anticipated and 
the value of pursuing this line of research should be critically evaluated. 
 
Despite these limitations, the value of D. discoideum as a model for inositol 
pyrophosphates should not be underestimated. In Chapter Four of this work, 
the remarkable activities of two novel enzymes, IPKA and IPKB were 
investigated. Both enzymes show robust IP7 kinase activities, however many 
questions remain unanswered regarding these two enzymes. The most 
prominent question of all is whether these catalytically flexible enzymes may 
operate in tandem to produce IP6 in a stepwise manner, as was first described in 
1990 (Stephens and Irvine 1990). Such a possibility is hinted at by the ability of 
both enzymes to partially rescue polyP in the plcΔ yeast as well as IPKA’s 
synthesis of IP6 in arg82Δ yeast.  Further experiments are required to explore the 
physiological roles of these kinases. 
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Finally, the experiments in Chapter Four suggest that, in D. discoideum at least, 
IP6K may phosphorylate position 6 of the inositol ring, not position 5 as 
expected. It will be interesting to further investigate this possibility and to apply 
modern NMR techniques to inositol pyrophosphates extracted from D. 
discoideum mutants. It is possible that lessons learned in the amoeba might 
inform other models, which have to date relied on in vitro evidence to identify 
the precise products of IP6K and PPIP5K. 
6.2 Inorganic polyphosphate 
The work described in Chapter Five firmly establishes the amoeba as a 
powerful model in which to study the role of polyP. Whilst this work calls into 
question the physiological significance of the DdPPK2 enzyme, it identifies the 
true scale of polyP accumulation during spore formation and a role for this 
polymer in germination. Further investigation of this process might focus on the 
possibility that inositol pyrophosphates are able to partially compensate for the 
lack of polyP in ppk1 spores. The generation of an ip6k/ppk1 double mutant 
would be illuminating to test this nascent hypothesis. 
 
The most striking observations in this work reveal a link between polyP and 
primary metabolism. The absence of polyP in the ppk1 strain results in cells with 
dramatically reduced ATP, whilst the inhibition of ATP production in WT cells 
induces the accumulation of polyP. This is not the first time that polyP has been 
linked to primary metabolism (Freimoser, Hürlimann et al. 2006) and it is perhaps 
not surprising given the ability of polyP to buffer free phosphate concentration. 
Further investigation is required to understand the nature of this link. It will be 
particularly interesting to explore the possible link between polyP and 
mitochondrial function in both WT and ppk1 cells. 
 
Finally, the development of D. discoideum as a clean genetic model to study 
polyP represents a significant boost to the development of specific probes for 
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the in vivo detection of polyP. The relatively large size of the amoeba and lack of 
cell wall offer significant advantages for microscopy over the yeast model. Thus 
D. discoideum may represent the ideal model in which to develop much-needed 
tools for the study of polyP. 
6.3 Concluding remarks 
The experiments described in this work have revealed many unexpected and 
intriguing results. Developing the amoeba as a genetic model for both the 
inositol pyrophosphates and polyP has identified notable differences from the 
only other genetic model the yeast, S. cerevisiae.  
 
In yeast the levels of inositol pyrophosphates are relatively low, however their 
absence causes a severe metabolic defect (Szijgyarto, Garedew et al. 2011). 
Meanwhile, polyP is highly abundant and yet complete loss of this polymer does 
not appear to induce major phenotypic effects. In the amoeba, almost the 
opposite appears to be true. The amoeba possesses very high levels of inositol 
pyrophosphates, however this work failed to identify a significant phenotype in 
cells lacking the vast majority of this pool. In contrast, the loss of the relatively 
low levels of polyP found in vegetative cells causes a substantial defect in the 
general fitness and primary metabolism of the amoeba. 
 
Whilst this summary may represent an over simplification, it is important to note 
that there are clear differences between the phenotypes observed in these two 
genetic models. Nevertheless, it is evident that a link between the metabolism of 
inositol pyrophosphates and polyP exists in both organisms. These observations 
strengthen the hypothesis that phosphate, inositol and polyphosphates are 
intimately linked (Livermore, Azevedo et al. 2016). It will be fascinating to explore 
the nature of these relationships and how they regulate primary metabolism. For 
this, the development of D. discoideum as a parallel model to yeast will be 
invaluable.  
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D. discoideum has been a highly influential model in the study of both the 
inositol pyrophosphates and polyP. It was in this organism that the inositol 
pyrophosphates were first described (Stephens, Radenberg et al. 1993) and that 
the first eukaryotic PPK was identified (Zhang, Gómez-García et al. 2005). 
Returning to this organism as a model to study these fascinating and 
functionally related molecules has revealed some surprising results and posed 
many more interesting questions. It is clear that D. discoideum still has much to 
offer and will continue to influence both fields for years to come. 
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7. Appendix 
Figure 7.1 Sequence alignment of D. discoideum IP6K with S. cerevisiae 
KCS1 and H. sapiens IP6K1-3. 
D. discoideum IP6K (top: DDB0233043), KCS1, H. sapiens IP6K1-3 
(sp|Q9UHH9|, sp|Q92551| and sp|Q96PC2|). Protein sequence alignment 
performed by CLUSTAL, primary sequence similarity (across all sequences) 
shown in red, secondary similarity (between four sequences) shown in orange, 
tertiary similarity (between three sequences) shown in yellow.  
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
------------------------------------------------------------------------------------------------------------------------
MDTSHEIHDKIPDTLREQQQHLRQKESEGCITTLKDLNVPETKKLSSVLHGRKASTYLRIFRDDECLADNNNGVDSNNGGSVTCADKITRSEATPKSVPEGLQVSEKKNNPDTLSSSLSS
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
-------------------------------------------------------------------------------------MHIFYLVNSKKSK-------VNN------------
FILSNHEEPAIKPNKHVAHRNNITETGQGSGEDIAKQQSHQPQVLHHQTSLKPIQNVDEGCISPKSTYQESLHGISEDLTLKPVSSATYYPHKSKADSGYEEKDKMENDIDTIQPATINC
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
-------SESFIKDD---RKY-NLEIDLNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNSNNMENENNSDNNSMKIDQFPHQVGGHSAMLSVN-GNICKP
ASGIATLPSSYNRHTFKVKTYSTLSQSLRQENVNNRSNEKKPQ--------QFVPHSESIKEKPNTFEQDKEGEQADEEEDEGDNEHREYPLAVELKPFTNRVGGHTAIFRFSKRAVCKA
-----------------------------------------------------------------------------MSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFNETTLCKP
----------------------------------------------------------------------MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKP
----------------------------------------------------------------------MVVQN--------SADAGDMRAGVQLEPFLHQVGGHMSVMKYDEHTVCKP
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
LINRELQFYEFSQLKNNIHSFFISPFLANFFGVVEVL---KSKNDIVTDLDQSQNQEAQQQQQQ----------------------------------------QQQ-------------
LVNRENRWYENIELCHKEL----LQFMPRYIGVLNVRQHFQSKDDFLSDLDQENNGKNDTSNENKDIEVNHNNNDDIALNTEPTGTPLTHIHSFPLEHSSRQVLEKEHPEIESVHPHVKR
LVPREHQFYETLPA---EM----RKFTPQYKGVVSVRFEEDEDR-NLC------------------------------------------LIAYPLKGDHGIVDIVD-------------
LISREQRFYESLPP---EM----KEFTPEYKGVVSVCFEGDSDG-YIN------------------------------------------LVAYPYVESETVEQDDT-------------
LVSREQRFYESLPL---AM----KRFTPQYKGTVTVHLWKDSTG-HLS------------------------------------------LVANPVKESQEPFKVST-------------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       500         *       520         *       540         *       560         *       580         *       600
------------------------Q------QQQ-------------------------------QQ----QQ----------------------------------QQQQQKPSLGSPK
SLSSSNQPSLLPEVVLNDNRHIIPESLWYKYSDSPNSAPNDSYFSSSSSHNSCSFGERGNTNKLKRRDSGSTMINTELKNLVIREVFAPKCFRRKRNSNTTTMGNHNARLGSSPSFLTQK
------------------NSDC--EPKSKLLRWT-----------------------------TNKK----HH----------------------------------V-LETEKT---PK
------------------TERE--QPRRKHSRRS-----------------------------LHRSGSGSDH----------------------------------KEEKASLS---LE
------------------ESAA--VAIWQTLQQT-------------------------------TGSNGSDC----------------------------------T----------LA
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       620         *       640         *       660         *       680         *       700         *       720
SS-----------------------------------------------------------Q-------------------------------------QSYMSNQQQINYSNIINNKN-
SRASSHDASNTSMKTLGDSSSQASLQMDDSKVNPNLQDPFLKKSLHEKISNALDGSHSVMDLKQFHKNEQIKHKNSFCNSLSPILTATNSRDDGEFATSPNYISNAQDGVFDMDEDTGNE
DWVRQHRKE---------------EKMK---------------------------SHKLEEEFEWLKK--------------------------------------SEVLYYTVEKKGNI
TSESSQEAKS--------------PK--------------------------------VE-L---HSH--------------------------------------SEVPFQMLDGNSGL
QWPHAQLARS--------------PKES---------------------------PAKAL-LRSEPHL--------------------------------------NTPAFSLVEDTNGN
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       740         *       760         *       780         *       800         *       820         *       840
---------------------------------------KKKVKECKHPSGTQQKYIVLSDLTSSYNSPCIVDIKIGTRQRGV------------ICSSTTSTSHGIRVCGMKIYCPQLG
TI-----NMDNHGCHLDSGKNMIIKSLAYNVSNDYSHHDIESITFEETSHTIVSKFILLEDLTRNMNKPCALDLKMGTRQYGVDAKRAKQLSQRAKCLKTTSRRLGVRICGLKVWN--KD
SSQLKHYNPWSMKCHQQ----------------------QLQRMKENAKHRNQYKFILLENLTSRYEVPCVLDLKMGTRQHGDDASEEKAANQIRKCQQSTSAVIGVRVCGMQVYQAGSG
SSEKISHNPWSLRCHKQ----------------------QLSRMRSESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQVYQLDTG
QVERKSFNPWGLQCHQA----------------------HLTRLCSEYPENKRHRFLLLENVVSQYTHPCVLDLKMGTRQHGDDASEEKKARHMRKCAQSTSACLGVRICGMQVYQTDKK
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       860         *       880         *       900         *       920         *       940         *       960
EMITFDRYFGRTLDGN-TLEESLFHFFTSNMFFNNNNNNINNSNDNFNNNKNFISCDFHLQRINLIESILEKLGQIECILSNKNDPFPFKIYSSSLLIIYEGKPNEILNQSLINNINNIN
YYITRDKYFGRRVKVGWQFARVLARFLYDGKTIE--------------------------SLIRQIPRLIKQL---DTLYSEIFNLKGYRLYGASLLLMYDGDANKSNSKRKKAA-----
QLMFMNKYHGRKLSVQ-GFKEALFQFFHNGRYLR--------------------------RE--LLGPVLKKL---TELKAVLERQESYRFYSSSLLVIYDGKERPEVVLDSDAE-----
HYLCRNKYYGRGLSIE-GFRNALYQYLHNGLDLR--------------------------RD--LFEPILSKL---RGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRS-----
YFLCKDKYYGRKLSVE-GFRQALYQFLHNGSHLR--------------------------RE--LLEPILHQL---RALLSVIRSQSSYRFYSSSLLVIYDGQEPPERAPGS--------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *       980         *      1000         *      1020         *      1040         *      1060         *      1080
NSSNNNNNNNNNNNNNNSNINSIISDCMNIGFSDIDSTSSSCTTTPSQSPITNILDSNIQSSTDSYTNSVENNSNNNNNNNDNIIISVSNSISIQRNINKSLESNSCISSNNSMIEDMED
------------------------------------------------------------------------------------------------------------------------
---------------------DLED---------------LSE--ESADESAG-------------------------------------------------------------------
---------------------EMRLKHLDMVLPEVAS---SCG--PSTSPSNT-------------------------------------------------------------------
-----------------------------------------PH--PHEA-PQA-------------------------------------------------------------------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                                                        
         *      1100         *      1120         *      1140         *      1160         *      1180         *      1200
GFHSFGSEEEIDDSCVSSDLDSDSDEMPSNRSTRSNSGNFSGSKPQPSKFIQNAVKMIDFAHAIPI-------------IEKEAQEDDGYLFGINNLQLLLFKIKSRLLLSLSVQKEQQN
---------------------------------------------------NVKVNLIDFARCVTKEDAMECMDKFRIPPKSPNIEDKGFLRGVKSLRFYLLLIWNYLTSDMPLIFDEVE
-----------------------------------------AYAYKPIGASSVDVRMIDFAHTTCR--------LYGEDTVVHEGQDAGYIFGLQSLIDIVTEI----------------
-----------------------------------------SPEAGPSSQPKVDVRMIDFAHSTFK--------GFRDDPTVHDGPDRGYVFGLENLISIMEQM----------------
-----------------------------------------AHGSSPGGLTKVDIRMIDFAHTTYK--------GYWNEHTTYDGPDPGYIFGLENLIRILQDI----------------
                                                                                                                        
             
             
DDB0233043 : 
KCS1       : 
sp|Q9UHH9| : 
sp|Q92551| : 
sp|Q96PC2| : 
             
                                                                                    
         *      1220         *      1240         *      1260         *      1280    
QQQQQQQQQQQQQNQQQNNSSELSSPSS---S----------FSSLNNSMINNRNDDCGNLEFSFNKMFNHHHQQNTVINTN*-
MNDMISE---------EADSNSFTSATGSKINFNSKWDWLDEFDKEDEEMYNDPNSKLRQKWRKYELIFDAEPRYNDDAQVSD*
-----SE---------ESGE----------------------------------------------------------------
-----RD---------ENQ-----------------------------------------------------------------
-----QE---------GE------------------------------------------------------------------
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Figure 7.2 Sequence alignment of D. discoideum PPIP5K with S. cerevisiae 
VIP and H. sapiens PPIP5K1-3. 
Protein sequence alignment performed by CLUSTAL, primary sequence 
similarity (across all sequences) shown in red, secondary similarity (between 
three sequences) shown in orange, tertiary similarity (between two sequences) 
shown in yellow. The C terminal portion of the S. cerevisiae and H. sapiens 
proteins is absent from D. discoideum PPIP5K. 
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
------------------------------------------------------------------------------------------------------------------------
MSGIKKEPIESDEVPQQETKNNLPSAPSEMSPLFLNKNTQKAMQSIAPILEGFSPKTSASENMSLKLPPPGIQDDHSEENLTVHDTLQRTISTALGNGNNTNTVTTSGLKKADSESKSEA
-------------------------------------------------------------------------------------------------------------------MWSLT
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
----------------------------------------------------------------MAKISLGICCMEEKLKCNVMKYFIKKLKEFKELEIIEFDSNTIFNLPIQEWPIVDS
DPEGLSNSNIVNDADNINSISKTGSPHLPQGTMDAEQTNMGTNSVPTSSASSRKSSTSHPKPRLPKVGKIGVCAMDAKVLSKPMRHILNRLIEHGEFETVIFGDKVILDERIENWPTCDF
ASEG-----------------ESTTAHFFLGAGDEGLGTRGIGMRPEESDSELLEDE-EDEVPPEPQIIVGICAMTKKSKSKPMTQILERLCRFDYLTVVILGEDVILNEPVENWPSCHC
---------------------MSEAPRFFVGPEDTEINPGNYRHF--FHHADEDDEE-EDDSPPERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDC
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
FLSFYSNGFPLEKAIRYWKLRRPYLVNDLELQLLLQDRQKVNKILEDNNIPCPKSLYVLRDPITN--N---------------LITPNFN-QSDDYIEVNGNRIYKPFIEKPFNSDDHNN
LISFFSSGFPLDKAIKYVKLRKPFIINDLIMQKILWDRRLCLQVLEAYNVPTPPRLEISRDGGPRANEELRAKLREHGVEVKPVEEPEWKMVDDDTLEVDGKTMTKPFVEKPVDGEDHNI
LISFHSKGFPLDKAVAYSKLRNPFLINDLAMQYYIQDRREVYRILQEEGIDLPRYAVLNRDPARPEEC--------------------NLIEGEDQVEVNGAVFPKPFVEKPVSAEDHNV
LISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKEC--------------------NLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNV
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
YIYYPKSQGGGCRKLFRKVGNNSSDYFNDINTIRDKGSYTYEEFLKIDDFKDVKIYST-KSFSYSELRKSPSVDGFVERTTMGKEKRSVTNLSDQEVNISFKINKAFKQFVCGFDILRVN
YIYYHSKNGGGGRRLFRKVGNKSSEFDPTLVHPRTEGSYIYEQFMDTDNFEDVKAYTIGENFCHAETRKSPVVDGIVRRNTHGKEVRYITELSDEEKTIAGKVSKAFSQMICGFDLLRVS
YIYYPSSAGGGSQRLFRKIGSRSSVYSPES-SVRKTGSYIYEEFMPTDG-TDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEIRYPVMLTAMEKLVARKVCVAFKQTVCGFDLLRAN
YIYYPTSAGGGSQRLFRKIGSRSSVYSPES-NVRKTGSYIYEEFMPTDG-TDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRAN
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       500         *       520         *       540         *       560         *       580         *       600
GISYVCDVNGWSFVKGDHFKTFYDSTSKSLFEKLFNHFKN-------RN------TIITNINTNT--IHNCSIGIAENAPQPSSTNTSPEQPTFDFSPSSSPTNLYPSSSSPLFNLNLN-
GKSYVIDVNGFSFVKDNK--AYYDSCANILRSTFIEAKKK-------MDMEKKNLPIIREEKEQKWVFKGLAIIIRHAD-------RT---PKQKFK---------HSFTSPIFISLLKG
GHSFVCDVNGFSFVKNSM--KYYDDCAKILGNTIMRELAPQFQIPWSIPTEAEDIPIVPTTSGTMMELRCVIAIIRHGDRT----------PKQKMKMEVKHP---------RFFALFEK
GQSYVCDVNGFSFVKNSM--KYYDDCAKILGNIVMRELAPQFHIPWSIPLEAEDIPIVPTTSGTMMELRCVIAVIRHGDRT----------PKQKMKMEVRHQ---------KFFDLFEK
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       620         *       640         *       660         *       680         *       700         *       720
------------NLNNLNNLNNNN-NSN--------NNSIGND-------------QNNSNST--VTT--PPH----------FD---------LISSSAYDKHHQDIF-SRHIRVYNHQ
HK----EEVVIRNVNDLKIVLQALRIAL--------DEKAGNPAKIKVLANALEKKLNFPGTK--IQL--KPV----------LNKENEVEKVQFILKWGGEPTHSAKYQATELGEQMRQ
HGGYKTGKLKLKRPEQLQEVLDITRLLLAELEKEPGGEIEEKTGKLEQLKSVLEMYGHFSGINRKVQLTYYPHGVKASNEGQDPQRETLAPSLLLVLKWGGELTPAGRVQAEELGRAFRC
CDGYKSGKLKLKKPKQLQEVLDIARQLLMELGQNNDSEIEENKPKLEQLKTVLEMYGHFSGINRKVQLTYLPHGCPKTSSEEED-SRREEPSLLLVLKWGGELTPAGRVQAEELGRAFRC
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       740         *       760         *       780         *       800         *       820         *       840
NLNLNNNNN--------NNNKNNNNNNNNIFSTISSSISVD-DSFTG-----------SAI------*----------------------------------------------------
DFDLLNKS---------------ILQNIKIFSSSERRVLHTAQYWTRALFGADEL-GSDEI------SIRKDLLDDSNAAKDLMDKVKKKLKPLLREGKEAPPQFAWPSKMPEPYLVIKR
MYPGGQGDYAGFPGCGLLRLHSTFRHDLKIYASDEGRVQMTAAAFAKGLLALEGELTPILVQMVKSANMNGLLDSDGDSLSSCQHRVKARLHHILQQDAPFGPE-DYDQLAPTRSTSLLN
MYPGGQGDYAGFPGCGLLRLHSTYRHDLKIYASDEGRVQMTAAAFAKGLLALEGELTPILVQMVKSANMNGLLDSDSDSLSSCQQRVKARLHEILQKDRDFTAE-DYEKLTPSGSISLIK
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       860         *       880         *       900         *       920         *       940         *       960
------------------------------------------------------------------------------------------------------------------------
VVELMNYHKKIMDNNF------------AKKDVNSMQTRWCTSEDPSLFKERWDKLFKEFNNA-EKVDPSKISELYDTMKYDALHNRQFLENIFDPGLPNEAIADELGSHSLVDRYPINV
SMTIIQNPVKVCDQVFALIENLTHQIRERMQDPRSVDLQLYHSETLELMLQRWSKLERDFRQKSGRYDISKIPDIYDCVKYDVQHNGSLG------------------------------
SMHLIKNPVKTCDKVYSLIQSLTSQIRHRMEDPKSSDIQLYHSETLELMLRRWSKLEKDFKTKNGRYDISKIPDIYDCIKYDVQHNGSLK------------------------------
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *       980         *      1000         *      1020         *      1040         *      1060         *      1080
------------------------------------------------------------------------------------------------------------------------
LAKNNFKIIDSHSMNNSGKNSSNSVGSLGWVLESGKTSTARNPKSSSQFDEPRFMQLRELYKLAKVLFDFICPKEYGISDAEKLDIGLLTSLPLAKQILNDIGDMKNR-----ETPAC--
-----------------------------------------------------LQGTAELLRLSKALADVVIPQEYGISREEKLEIAVGFCLPLLRKILLDLQRTHEDESVNKLHPLCYL
-----------------------------------------------------LENTMELYRLSKALADIVIPQEYGITKAEKLEIAKGYCTPLVRKIRSDLQRTQDDDTVNKLHPV---
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *      1100         *      1120         *      1140         *      1160         *      1180         *      1200
------------------------------------------------------------------------------------------------------------------------
---------------VAYFTKESHIYTLLNIIYESGIPMRI----------ARNALPELDYLSQITFELYESTDAS--GQKSHSIRLKMSPGCHTQDPLDVQLDDRHYISCIPKIS--LT
RYSRGVLSPGRHVRTRLYFTSESHVHSLLSVFRYGGLLDETQDAQWQRALDYLSAISELNYMTQIVIMLYEDNTQDPLSEERFHVELHFSPGVKGVEEEGSAPAGCGFRPASSENEEMKT
-YSRGVLSPERHVRTRLYFTSESHVHSLLSILRYGALCNESKDEQWKRAMDYLNVVNELNYMTQIVIMLYEDPNKDLSSEERFHVELHFSPGAKGCEEDKNLPSGYGYRPASRENEGRRP
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *      1220         *      1240         *      1260         *      1280         *      1300         *      1320
------------------------------------------------------------------------------------------------------------------------
KHLDMDY-VQQKLRNKFTRVIMPPKFTPVNITSPNLSFQKRKTR-RKSVSVE-----KLKRPASSGSSSSTSV---------------------NKTLD*--------------------
NQGSMENLCPGKASDEPDRAL-Q--TSPQPPEGPGLPRRSPLIRNRKAGSMEVLSETSSSRP-------------------------------------------GGYRLF--------S
FKIDNDDEPHTSKRDEVDRAVIL--FKPMVSEPIHIHRKSPLPRSRKTATNDEESPLSVSSPEGTGTWLHYTSGVGTGRRRRRSGEQITSSPVSPKSLAFTSSIFGSWQQVVSENANYLR
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *      1340         *      1360         *      1380         *      1400         *      1420         *      1440
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
SSR-PPTEMKQSGLGSQCTGLFSTTVLGGSSSAPNLQDYARSHGKKLPPASLKHRDELLFVPAVKRFSVSFAKHPTNGFEGCSMVPTIYPLETLHNALSLRQVSEFLSRVCQRHTDAQAQ
TPRTLVEQKQNPTVGSHCAGLFSTSVLGGSSSAPNLQDYARTHRKKLTSSGC--IDDATRGSAVKRFSISFARHPTNGFELYSMVPSICPLETLHNALSLKQVDEFLASIASPSSDVPRK
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *      1460         *      1480         *      1500         *      1520         *      1540         *      1560
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
ASAALF-----DSMHSSQASDNPFSPPRTLHSPPLQLQQRSEKPPWYSSGPSSTVSSAGPSSPTTVDGNSQFGFSDQPSLNSHVAEEHQGLGLLQETPGSGAQELSIEGEQELFEPNQSP
TAEISSTALRSSPIMRKKVSLNTYTPAKILPTPPATLKSTKASSKPATSGPSSAVVPNTSSRKKNITSKT----------ETHEHKK--NTGK---------KK----------------
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                                                                        
         *      1580         *      1600         *      1620         *      1640         *      1660         *      1680
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
QVPPMETSQPYEEVSQPCQEVPDISQPCQDISEALSQPCQKVPDISQQCQENHDNGNHTCQEVPHISQPCQKSSQLCQKVSEEVCQLCLENSEEVSQPCQGVSVEVGKLVHKFHVGVGSL
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
            
            
DdPPIP5k  : 
ScVIP1    : 
HsPPIP5K1 : 
HsPPIP5K2 : 
            
                                                                         
         *      1700         *      1720         *      1740         *   
-------------------------------------------------------------------------
-------------------------------------------------------------------------
VQETLVEVGSPAEEIPEEVIQPYQEFSVEVGRLAQETSAINLLSQGIPEIDKPSQEFPEEIDLQAQEVPEEIN
-------------------------------------------------------------------------
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Figure 7.3 Sequence alignment of D. discoideum IPMK with S. cerevisiae 
ARG82 and H. sapiens IPMK. 
Protein sequence alignment performed by CLUSTAL, primary sequence 
similarity (across all sequences) shown in red, secondary similarity (between two 
sequences) shown in orange. 
  
          
          
DdIPMK  : 
ScARG82 : 
HsIPMK  : 
          
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
----------------------------------------MSSSSLKPLEDQIAGHTEEDGGSENIPRFLKSDEGYV-FKPVPTTRGGKELEFYKSLDK---YDK--------TLVEFLP
---------------------------------------MDTVNNYRVLEHKAAGHDG----------TLTDGDGLLIFK----PAFPQELEFYKAIQVRDVSRRKSSADGDAPLCSWMP
MATEPPSPLRVEAPGPPEMRTSPAIESTPEGTPQPAGGRLRFLNGCVPLSHQVAGHMYGK---DKVG-ILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDG-----VLLELRKYLP
                                                                                                                        
          
          
DdIPMK  : 
ScARG82 : 
HsIPMK  : 
          
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
KYIRTE----------------------------------IVNNIPYMGIEDLTYGYLEDFANVADIKMGTRTYDNSATEEKIKAEEHKSSKTTTKSLGIRFCGAKLVHPNT--------
TYLGVLNEGAKIEQSGDAALLKIDERLSDSTDNLDSIPVKSEKSKQYLVLENLLYGFS--KPNILDIKLGKTLYDSKASLEKRERMKRVSETTTSGSLGFRICGMKIQKNPSVLNQLSLE
KYYGIWSPP-------------------------------TAPNDLYLKLEDVTHKFN--KPCIMDVKIGQKSYDPFASSEKIQQQVSKY--PLMEEIGFLVLGMRVYHVHS--------
                                                                                                                        
          
          
DdIPMK  : 
ScARG82 : 
HsIPMK  : 
          
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
-------GEKTKLSKVWGKQLKHDRIYEDGIKRFFWHPDRSVKENQLIVKSFLNKLERLLTFFENNQQFAFYSSSLLFVYGPTDSNKS-KLRDTITL-VSD-------------------
YYEEEADSDYIFINKLYGRSRTDQN-VSDAIELYFNNPHLSDARKHQLKKTFLKRLQLFYNT-MLEEEVRMISSSLLFIYEGDPERWE-LLNDVDKLMRDDFIDDDDDDDDNDDDD----
-------DSYETENQHYGRSLTKET-IKDGVSRFFHNGYC-LRK--DAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQPTTTKLNDR-TL-AEKFLSKGQLSDTEVLEYNNNF
                                                                                                                        
          
          
DdIPMK  : 
ScARG82 : 
HsIPMK  : 
          
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
------------------------------------------------------------------------------DSNIGISLKMIDFAHVDPLTPPTKDESYIFGLKNLISFFNQL
---DDDAEGSSEGPKDK------------------------------------------------------------KTTGSLSSMSLIDFAHSEITPGKGYDENVIEGVETLLDIFMKF
HVLSSTANGKIESSVGKSLSKMYARHRKIYTKKHHSQTSLKVENLEQDNGWKSMSQEHLNGNVLSQLEKVFYHLPTGCQEIAEVEVRMIDFAHVFP--SNTIDEGYVYGLKHLISVLRSI
                                                                                                                        
          
          
DdIPMK  : 
ScARG82 : 
HsIPMK  : 
          
     
     
LSEN*
*----
LDN--
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Figure 7.4 Sequence alignment of D. discoideum IPKA with H. sapiens 
IPMK and IP6K1. 
Protein sequence alignment performed by CLUSTAL, primary sequence 
similarity (across all sequences) shown in red, secondary similarity (between two 
sequences) shown in orange. 
  
          
          
DdIPKA  : 
HsIPMK1 : 
HsIP6K1 : 
          
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
------------------------------------------------------------------------------------------------------------------------
---------------------------------------MA------TEP--PSPLRVEAPGPPEMRT-------------------------SPAIEST--------PEGTPQPAGGRL
MCVCQTMEVGQYGKNASRAGDRGVLLEPFIHQVGGHSSMMRYDDHTVCKPLISREQRFYESLPPEMKEFTPEYKGVVSVCFEGDSDGYINLVAYPYVESETVEQDDTTEREQPRRKHSRR
                                                                                                                        
          
          
DdIPKA  : 
HsIPMK1 : 
HsIP6K1 : 
          
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
--MNEQ-NKFQVVAGTPFKKS-----K----------------EQEGKVFKEC-----TIKEKQFYESLS-------PDNELSKLIPKYYGTVIQ---DGKEWIVLEDLTYGYSKPNIMD
RFLNGCVPLSHQVAGHMYGKDKVGILQ----------------HPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMD
-------SLHRSGSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGNSGLSSEKISHNPWSLRCHKQQLSRMRS---------ESKDRKLYKFLLLENVVHHFKYPCVLD
                                                                                                                        
          
          
DdIPKA  : 
HsIPMK1 : 
HsIP6K1 : 
          
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
IKLGLSHHDVDLETIYSPPSSNDPNVNFETLKRQANMSLHKELYESWLLSKYITTPKLGFCVCGSQKYNCCTNQLEKIQKEQGRTFTAVTVKDKLYDFFHNGIKFRPEIIESMINRLSLF
VKIGQKSYDP--------FAS------SEKI--------------QQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKI
LKMGTRQHGDDASAE--------------KAAR------------QMRKCEQSTSATLGVRVCGMQVYQLDTGHYLCRNKYYGRGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKLRGL
                                                                                                                        
          
          
DdIPKA  : 
HsIPMK1 : 
HsIP6K1 : 
          
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
KDFFENNPDYRFRSTSILFLYEGDCEFSNRC-----------------DIRLIDFT---------------------HTKLYPSHMKPHSSKLSHYKSIDVNNIDSKTT-----------
LQWFENQKQLNFYASSLLFVYEGSSQPTTTKLNDRTLAEKFLSKGQLSDTEVLEYNNNFHVLSSTANGKIESSVGKSLSKMYARHRKIYTKKHHSQTSLKVENLEQDNGWKSMSQEHLNG
KAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMR------------LKHLDMVLP--------EVASSCGPSTS---------------------PSNT----------------
                                                                                                                        
          
          
DdIPKA  : 
HsIPMK1 : 
HsIP6K1 : 
          
                                                                              
         *       500         *       520         *       540         *        
-----------SITSG-----------FDHE------------TYFPIDGGYLFGITNLLKILNSLKNKQQPQQPQK*
NVLSQLEKVFYHLPTGCQEIAEVEVRMIDFAHVF---------PSNTIDEGYVYGLKHLISVLRSILDN---------
-----------SPEAGPSSQPKVDVRMIDFAHSTFKGFRDDPTVHDGPDRGYVFGLENLISIMEQMRDENQ-------
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Figure 7.5 Sequence alignment of D. discoideum IPKB with H. sapiens 
IP6K1 and IPMK. 
Protein sequence alignment performed by CLUSTAL, primary sequence 
similarity (across all sequences) shown in red, secondary similarity (between two 
sequences) shown in orange. 
  
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
MELDMIPYTLSSVCEYKTSGNNSLGNSNNRLNNSLFSNSEIRHSVSTPSTPMTHSVTFNLSTPPSLPLQPFINNNNESNLNNSSGNNINSFNNNNNNNNNNNNNNNNNNNNNNTNNNNNT
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
NNIASSPSVHSLNNSNNSINNNGSFLSVSPNSIPGLTLSKCYQHCNTIFKNNNNNSNNKDYNPLKHLYEPPLQQQQQHHQQTTTINSQSLSQSTQPSIQSQPTPQIIINGENIENNNNNN
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTNSSNNNNNSNNNNNNEQSSNSTNFDLDNPIQRKRSTSFSMK---NLNILSHQVAGQA------PLLKLPDGKILKPLVP-----Q
----------------------------------------------------MCVCQTMEVGQYGKNASRAGDRGV---LLEPFIHQVGGHS------SMMRYDDHTVCKPLIS-----R
--------------------------------MATEPP--SPLRVEAPGPPEMRTSPAIESTPEG-TPQPAGGRLRFLNGCVPLSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPR
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
EYYFYESIKYHQEFIGFTPKFHGLLDL------------KNYDFRYLEETFK--------------------------------------------------------------------
EQRFYESLPP--EMKEFTPEYKGVVSVCFEGDSDGYINLVAYPY--VESETVEQDDTTEREQPRRKHSRRSLHRSGSGSDHKEEKASLSLETSESSQEAKSPKVELHSHSEVPFQMLDGN
ELEFYN------------------------------------------------------------------------------------------------------------------
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       500         *       520         *       540         *       560         *       580         *       600
SQHSSHSIDYNHWRNKTINL------------------PKDWQNLYIKIEDLTYLCKYPCILDLKMGVRQHGVDAPIEKINKMQLKCKQTTSFSLGFRVCGLKVYDQKQATYSTYDKFYG
SGLSSEKISHNPWSLRCHKQQLSRMRS---------ESKDRKLYKFLLLENVVHHFKYPCVLDLKMGTRQHGDDASAEKAARQMRKCEQSTSATLGVRVCGMQVYQLDTGHYLCRNKYYG
----------MVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKY--PLMEEIGFLVLGMRVYHVHSDSYETENQHYG
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       620         *       640         *       660         *       680         *       700         *       720
RKLRDNDIPSVICKFVDNGLRHRTEILSGIAKRLYQLISLFESQQCFKFYGGSLLLIYDAQSTNVQD-----------------------------------------------------
RGLSIEGFRNALYQYLHNGLDLRRDLFEPILSKLRGLKAVLERQASYRFYSSSLLVIYDGKECRAESCLDRRSEMRL-------KHLD--------MVLP-----EVASSCGPSTSP---
RSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQPTTTKLNDRTLAEKFLSKGQLSDTEVLEYNNNFHVLSSTANGKIESSVGKSLSKMYA
                                                                                                                        
          
          
DdIPKB  : 
HsIP6K1 : 
HsIPMK  : 
          
                                                                                                                        
         *       740         *       760         *       780         *       800         *       820         *       840
---------------------------------------------------------AKINIKMVDFAHASPNHNHHENNNKIETDSDLDEGYLFGLKNLLKIINNLVQISNVNIGETI*
---------------------------------------------SNTSPEAGPSSQPKVDVRMIDFAHSTFKGF----RDDPTVHDGPDRGYVFGLENLISIMEQMRDENQ--------
RHRKIYTKKHHSQTSLKVENLEQDNGWKSMSQEHLNGNVLSQLEKVFYHLPTGCQEIAEVEVRMIDFAHVFPS-------------NTIDEGYVYGLKHLISVLRSILDN----------
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Figure 7.6 Sequence alignment of D. discoideum IPK1 with S. cerevisiae 
IPK1 and H. sapiens IPPK. 
Protein sequence alignment performed by CLUSTAL, primary sequence 
similarity (across all sequences) shown in red, secondary similarity (between two 
sequences) shown in orange. 
  
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
MTCNISKVDIGLPEYWVYKGEGAMNIVLSYNGPRNEKLDGLVLRVKKLSNG-----GSDLEKEIGLYNFVSNVMSPLLGDKYVFPGS---MINVTSDFLVKLDNLIFNYRPIKRSTIRLD
---------------MQVIGRGGANILIDYGDPTWLWRCCIRWPDLLSSNN-----SYTIKNISYIKDYVEPLLHGLLCPMYLIDVDIEAIRPILSDFILNLDDKVVKVI----------
-----MEEGKMDENEWGYHGEGNKSLVVAHAQ------RCVVLRFLKFPPNRKKTSEEIFQHLQNIVDFGKNVMKEFLGENYVHYGE---VVQLPLEFVKQLCLKIQSERPESRCDKDLD
                                                                                                                        
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
TNLTTAFLIMDLTRLDNNTPNQIEYLHHHNDNDNNNDNNDNNNNDNNDNNNNNNNEIGNNKFSKVICIEIKPKWAFLPKPHKYMNRELLDVKLNKCRYCMHQQLKLKEGSID---EISSY
-------K---IKNLTNNTSNLILN-------------------------NHFLKSY-CSQNLQTVILELKPKWLYYDT--------------DYCRNCTHNAFKGRGTKYCYNQLLMNP
TLSGYAMCLPNLTRLQT---------------------------------------YRFAEHRPILCVEIKPKCGFIPFSSDV----THEMKHKVCRYCMHQHLKVATGKWK---QISKY
                                                                                                                        
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
CPLDLFSSDCNRQKQSIINMIHHP----QNNLKVYCDGILSFTGSLGGGVERNKSTNSNLLSSLLINSN-----------------------IIKNNKKEEK---EEK-EEKGGKEEE--
AHLELIFGECNIFPVKFKDAMHEYLRNDNNIFKILYDLQKKLTK--NTTPISDIKSINDV------------NDEHLLLMTLRDVTCF-----IEWNSAENALHVNIIDVDLKPKEKWTH
CPLDLYSGNKQRMHFALKSLLQEA----QNNLKIFKNGELIYGCKDARSPVADWSELAHHLKPFFFPSNGLASGPHCTRAVIRELVHVITRVLLSGSDKGRA---GTLSPGLGPQGPRVC
                                                                                                                        
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
                                                                                                                        
         *       380         *       400         *       420         *       440         *       460         *       480
---EIERNIYL--LSTIISSILQRETILQNIKNVQLYDDMDIEGIYYLYNKLNGGQVNN--------------DINYEELNKLT------DSEAKEKIDRFMISCTAKDCSIMISFNVDN
WTKTY--------------SQLTS-----------------SQKIYHTSNK*--------------------------------------------------------------------
EASPFSRSLRCQGKNTPERSGLPKGCLLYKTLQVQMLDLLDIEGLYPLYNRVERYLEEFPEERKTLQIDGPYDEAFYQKLLDLSTEDDGTVAFALTKVQQYRVAMTAKDCSIMIALSPCL
                                                                                                                        
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
                                                                                                                        
         *       500         *       520         *       540         *       560         *       580         *       600
PINNNNNNNNNNNNNNNNNNNNNNNNNNNNNINDVDSYFNFINTIDIGDNDDTLINSSGNKGKTNIHYKIGVVDLDTKKMNAIPKYYKLDQDIVKLYKSNINTIKSCK*-----------
------------------------------------------------------------------------------------------------------------------------
QDAS--------------------------------------------SDQRPV----VPSSRSRFAFSVSVLDLDLKPYESIPHQYKLDGKIVNYYSKTVRAKDNAVMSTRFKESEDCT
                                                                                                                        
         
         
DdIPK1 : 
ScIPK1 : 
HsIPPK : 
         
      
      
------
------
LVLHKV
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Figure 7.7 Sequence alignment of D. discoideum ITPK1 with S. H. sapiens 
ITPK1. 
Protein sequence alignment performed by CLUSTAL, sequence similarity shown 
in red. 
  
          
          
DdITPK1 : 
HsITPK1 : 
          
                                                                                                                        
         *        20         *        40         *        60         *        80         *       100         *       120
MGRNNTLPNDFTVGYYLSDSKINKLKWNLFVDMCKEKYNINVVPIDMNKDINSINTRPYHVIIDKLTDELGDLDNP--SNKQKVDYIQSLIDKFPSIVEVDPLESQKPVLSRDTLTKLLD
---MQTFLKGKRVGYWLSEKKIKKLNFQAFAELCRKRG-MEVVQLNLSRPI--EEQGPLDVIIHKLTDVILEADQNDSQSLELVHRFQEYIDAHPETIVLDPLPAIRTLLDRSKSYELIR
                                                                                                                        
          
          
DdITPK1 : 
HsITPK1 : 
          
                                                                                                                        
         *       140         *       160         *       180         *       200         *       220         *       240
KLNDVSPELNIKNPKFVLVPEDYNNNDYNQLLKDANIKFPVVCKTIKACGSKESHYMGIVFNEKDIHQFKQPMLIQEFINHNAIIYKVFAIGDFIQVVHRKSIRNMNENEN--ELIKFDS
KIEAYMEDDRICSPPFMELTS-LCGDDTMRLLEKNGLTFPFICKTRVAHGT-NSHEMAIVFNQEGLNAIQPPCVVQNFINHNAVLYKVFVVGESYTVVQRPSLKNFSAGTSDRESIFFNS
                                                                                                                        
          
          
DdITPK1 : 
HsITPK1 : 
          
                                                                                                                        
         *       260         *       280         *       300         *       320         *       340         *       360
Q---KPFPTSL-LPTDGQELKIEMPSKSTLSVISKDIQKNLDISLFGFDVIVDCETKKLAVVDINYFPTFSGVDDFYTLLIEHVINVYKRKSSV*-------------------------
HNVSKPESSSVLTELDKIEGVFERPSDEVIRELSRALRQALGVSLFGIDIIINNQTGQHAVIDINAFPGYEGVSEFFTDLLNHIATVLQGQSTAMAATGDVALLRHSKLLAEPAGGLVGE
                                                                                                                        
          
          
DdITPK1 : 
HsITPK1 : 
          
                                                              
         *       380         *       400         *       420  
--------------------------------------------------------------
RTCSASPGCCGSMMGQDAPWKAEADAGGTAKLPHQRLGCNAGVSPSFQQHCVASLATKASSQ
                                                              
	   256 
8. References 
Abramov, A. Y., C. Fraley, C. T. Diao, R. Winkfein, M. A. Colicos, M. R. Duchen, 
R. J. French and E. Pavlov (2007). Targeted polyphosphatase expression alters 
mitochondrial metabolism and inhibits calcium-dependent cell death. Proc Natl 
Acad Sci USA. 104: 18091-18096. 
Ahn, K. and A. Kornberg (1990). Polyphosphate kinase from Escherichia coli. 
Purification and demonstration of a phosphoenzyme intermediate. J Biol Chem. 
265: 11734-11739. 
Albert, C., S. T. Safrany, M. E. Bembenek, K. M. Reddy, K. Reddy, J. Falck, M. 
Bröcker, S. B. Shears and G. W. Mayr (1997). Biological variability in the 
structures of diphosphoinositol polyphosphates in Dictyostelium discoideum 
and mammalian cells. Biochem J. 327 ( Pt 2): 553-560. 
Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. 
Reese and P. Cohen (1997). Characterization of a 3-phosphoinositide-
dependent protein kinase which phosphorylates and activates protein kinase 
Balpha. Curr Biol. 7: 261-269. 
Andreeva, N., L. Trilisenko, M. Eldarov and T. Kulakovskaya (2015). 
Polyphosphatase PPN1 of Saccharomyces cerevisiae: switching of 
exopolyphosphatase and endopolyphosphatase activities. PLoS ONE. 10: 
e0119594. 
Aschar-Sobbi, R., A. Y. Abramov, C. Diao, M. E. Kargacin, G. J. Kargacin, R. J. 
French and E. Pavlov (2008). High sensitivity, quantitative measurements of 
polyphosphate using a new DAPI-based approach. J Fluoresc. 18: 859-866. 
	   257 
Auesukaree, C., H. Tochio, M. Shirakawa, Y. Kaneko and S. Harashima (2005). 
Plc1p, Arg82p, and Kcs1p, enzymes involved in inositol pyrophosphate 
synthesis, are essential for phosphate regulation and polyphosphate 
accumulation in Saccharomyces cerevisiae. J Biol Chem. 280: 25127-25133. 
Ault-Riché, D., C. D. Fraley, C. M. Tzeng and A. Kornberg (1998). Novel assay 
reveals multiple pathways regulating stress-induced accumulations of inorganic 
polyphosphate in Escherichia coli. J Bacteriol. 180: 1841-1847. 
Azevedo, C., A. Burton, E. Ruiz-Mateos, M. Marsh and A. Saiardi (2009). Inositol 
pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag 
release. Proc Natl Acad Sci USA. 106: 21161-21166. 
Azevedo, C., T. Livermore and A. Saiardi (2015). Protein Polyphosphorylation of 
Lysine Residues by Inorganic Polyphosphate. Molecular cell. 
Azevedo, C., T. Livermore and A. Saiardi (2015). "Protein polyphosphorylation of 
lysine residues by inorganic polyphosphate." Molecular cell 58(1): 71-82. 
Azevedo, C. and A. Saiardi (2006). Extraction and analysis of soluble inositol 
polyphosphates from yeast. Nature Protocols. 1: 2416-2422. 
Azevedo, C. and A. Saiardi (2014). Functions of inorganic polyphosphates in 
eukaryotic cells: a coat of many colours. Biochem Soc Trans. 42: 98-102. 
Balla, T. (2013). Phosphoinositides: tiny lipids with giant impact on cell 
regulation. Physiol Rev. 93: 1019-1137. 
Banfic, H., A. Bedalov, J. D. York and D. Visnjic (2012). Inositol pyrophosphates 
modulate S phase progression after pheromone-induced arrest in 
Saccharomyces cerevisiae. J Biol Chem. 
	   258 
Barker, C. J., J. Wright, P. J. Hughes, C. J. Kirk and R. H. Michell (2004). 
Complex changes in cellular inositol phosphate complement accompany transit 
through the cell cycle. Biochem J. 380: 465-473. 
Bennett, M., S. M. N. Onnebo, C. Azevedo and A. Saiardi (2006). Inositol 
pyrophosphates: metabolism and signaling. Cell Mol Life Sci. 63: 552-564. 
Berridge, M. J. (1993). Inositol trisphosphate and calcium signalling. Nature. 
361: 315-325. 
Bhandari, R., K. R. Juluri, A. C. Resnick and S. H. Snyder (2008). Gene deletion 
of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation 
of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci USA. 105: 
2349-2353. 
Bhandari, R., A. Saiardi, Y. Ahmadibeni, A. M. Snowman, A. C. Resnick, T. Z. 
Kristiansen, H. Molina, A. Pandey, J. K. Werner, K. R. Juluri, Y. Xu, G. D. 
Prestwich, K. Parang and S. H. Snyder (2007). Protein pyrophosphorylation by 
inositol pyrophosphates is a posttranslational event. Proc Natl Acad Sci USA. 
104: 15305-15310. 
Blind, R. D., M. Suzawa and H. A. Ingraham (2012). Direct modification and 
activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMK. 
Sci Signal. 5: ra44. 
Boer, V. M., C. A. Crutchfield, P. H. Bradley, D. Botstein and J. D. Rabinowitz 
(2010). Growth-limiting intracellular metabolites in yeast growing under diverse 
nutrient limitations. Molecular biology of the cell. 21: 198-211. 
	   259 
Burton, A., C. Azevedo, C. Andreassi, A. Riccio and A. Saiardi (2013). Inositol 
pyrophosphates regulate JMJD2C-dependent histone demethylation. Proc Natl 
Acad Sci USA. 110: 18970-18975. 
Caffrey, J. J., S. T. Safrany, X. Yang and S. B. Shears (2000). Discovery of 
molecular and catalytic diversity among human diphosphoinositol-
polyphosphate phosphohydrolases. An expanding Nudt family. J Biol Chem. 
275: 12730-12736. 
Capolicchio, S., D. T. Thakor, A. Linden and H. J. Jessen (2013). Synthesis of 
unsymmetric diphospho-inositol polyphosphates. Angew Chem Int Ed Engl. 52: 
6912-6916. 
Chakraborty, A., M. A. Koldobskiy, N. T. Bello, M. Maxwell, J. J. Potter, K. R. 
Juluri, D. Maag, S. Kim, A. S. Huang, M. J. Dailey, M. Saleh, A. M. Snowman, T. 
H. Moran, E. Mezey and S. H. Snyder (2010). Inositol pyrophosphates inhibit Akt 
signaling, thereby regulating insulin sensitivity and weight gain. Cell. 143: 897-
910. 
Chiew, Y. Y., J. M. Reimers and B. E. Wright (1985). Steady state models of 
spore cell metabolism in Dictyostelium discoideum. J Biol Chem. 260: 15325-
15331. 
Coates, M. L. (1975). Hemoglobin function in the vertebrates: an evolutionary 
model. Journal of molecular evolution. 6: 285-307. 
Corrigan, A. M. and J. R. Chubb (2014). Regulation of transcriptional bursting by 
a naturally oscillating signal. Curr Biol. 24: 205-211. 
	   260 
de Boer, I. H., T. C. Rue and B. Kestenbaum (2009). Serum phosphorus 
concentrations in the third National Health and Nutrition Examination Survey 
(NHANES III). Am J Kidney Dis. 53: 399-407. 
Di Paolo, G. and P. De Camilli (2006). Phosphoinositides in cell regulation and 
membrane dynamics. Nature. 443: 651-657. 
Dick, C. F., A. L. A. Dos-Santos and J. R. Meyer-Fernandes (2014). Inorganic 
phosphate uptake in unicellular eukaryotes. Biochim Biophys Acta. 1840: 2123-
2127. 
Dijken, P. V., J.-R. d. Haas, A. Craxton, C. Erneux, S. B. Shears and P. J. M. V. 
Haastert (1995). A novel, phospholipase C-independent pathway of inositol 1, 4, 
5-trisphosphate formation in Dictyostelium and rat liver. Journal of Biological 
Chemistry. 270: 29724-29731. 
Docampo, R. and S. N. J. Moreno (2011). Acidocalcisomes. Cell Calcium. 50: 
113-119. 
Doria, E., L. Galleschi, L. Calucci, C. Pinzino, R. Pilu, E. Cassani and E. Nielsen 
(2009). Phytic acid prevents oxidative stress in seeds: evidence from a maize 
(Zea mays L.) low phytic acid mutant. J Exp Bot. 60: 967-978. 
Draskovic, P., A. Saiardi, R. Bhandari, A. Burton, G. Ilc, M. Kovacevic, S. H. 
Snyder and M. Podobnik (2008). Inositol hexakisphosphate kinase products 
contain diphosphate and triphosphate groups. Chemistry & biology. 15: 274-286. 
Drayer, A. L., J. Van der Kaay, G. W. Mayr and P. J. Van Haastert (1994). Role of 
phospholipase C in Dictyostelium: formation of inositol 1,4,5-trisphosphate and 
normal development in cells lacking phospholipase C activity. EMBO J. 13: 
1601-1609. 
	   261 
Dubois, E., B. Scherens, F. Vierendeels, M. M. W. Ho, F. Messenguy and S. B. 
Shears (2002). In Saccharomyces cerevisiae, the inositol polyphosphate kinase 
activity of Kcs1p is required for resistance to salt stress, cell wall integrity, and 
vacuolar morphogenesis. J Biol Chem. 277: 23755-23763. 
Dynes, J. L., A. M. Clark, G. Shaulsky, A. Kuspa, W. F. Loomis and R. A. Firtel 
(1994). LagC is required for cell-cell interactions that are essential for cell-type 
differentiation in Dictyostelium. Genes Dev. 8: 948-958. 
Efanov, A. M., S. V. Zaitsev and P. O. Berggren (1997). Inositol 
hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated 
exocytosis of insulin by activation of protein kinase C. Proc Natl Acad Sci USA. 
94: 4435-4439. 
Eichinger, L. and A. A. Noegel (2003). Crawling into a new era-the Dictyostelium 
genome project. The EMBO journal. 22: 1941-1946. 
Elias, M., A. Wellner, K. Goldin-Azulay, E. Chabriere, J. A. Vorholt, T. J. Erb and 
D. S. Tawfik (2012). The molecular basis of phosphate discrimination in 
arsenate-rich environments. Nature. 491: 134-137. 
Faix, J., L. Kreppel, G. Shaulsky, M. Schleicher and A. R. Kimmel (2004). A rapid 
and efficient method to generate multiple gene disruptions in Dictyostelium 
discoideum using a single selectable marker and the Cre-loxP system. Nucleic 
Acids Res. 32: e143. 
Fang, J., P. Rohloff, K. Miranda and R. Docampo (2007). Ablation of a small 
transmembrane protein of Trypanosoma brucei (TbVTC1) involved in the 
synthesis of polyphosphate alters acidocalcisome biogenesis and function, and 
leads to a cytokinesis defect. Biochem J. 407: 161-170. 
	   262 
Feoktistova, A., D. McCollum, R. Ohi and K. L. Gould (1999). Identification and 
characterization of Schizosaccharomyces pombe asp1(+), a gene that interacts 
with mutations in the Arp2/3 complex and actin. Genetics. 152: 895-908. 
Freimoser, F. M., H. C. Hürlimann, C. A. Jakob, T. P. Werner and N. Amrhein 
(2006). Systematic screening of polyphosphate (poly P) levels in yeast mutant 
cells reveals strong interdependence with primary metabolism. Genome Biol. 7: 
R109. 
Friedrich, M., D. Meier, I. Schuster and W. Nellen (2015). A Simple Retroelement 
Based Knock-Down System in Dictyostelium: Further Insights into RNA 
Interference Mechanisms. PLoS ONE. 10: e0131271. 
Fu, C., J. Xu, R.-J. Li, J. A. Crawford, A. B. Khan, T. M. Ma, J. Y. Cha, A. M. 
Snowman, M. V. Pletnikov and S. H. Snyder (2015). Inositol Hexakisphosphate 
Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar 
Purkinje Cells via Spectrin/Adducin. J Neurosci. 35: 11056-11067. 
Gao, Y. and H.-y. Wang (2007). Inositol pentakisphosphate mediates Wnt/beta-
catenin signaling. J Biol Chem. 282: 26490-26502. 
Gaudet, P., K. E. Pilcher, P. Fey and R. L. Chisholm (2007). Transformation of 
Dictyostelium discoideum with plasmid DNA. Nat Protoc. 2: 1317-1324. 
Gerasimaitė, R., S. Sharma, Y. Desfougères, A. Schmidt and A. Mayer (2014). 
Coupled synthesis and translocation restrains polyphosphate to 
acidocalcisome-like vacuoles and prevents its toxicity. J Cell Sci. 127: 5093-
5104. 
	   263 
Gezelius, K. (1974). Inorganic polyphosphates and enzymes of polyphosphate 
metabolism in the cellular slime mold Dictyostelium discoideum. Archives of 
microbiology. 98: 311-329. 
Ghosh, S., D. Shukla, K. Suman, B. J. Lakshmi, R. Manorama, S. Kumar and R. 
Bhandari (2013). Inositol hexakisphosphate kinase 1 maintains hemostasis in 
mice by regulating platelet polyphosphate levels. Blood. 122: 1478-1486. 
Glennon, M. C. and S. B. Shears (1993). Turnover of inositol 
pentakisphosphates, inositol hexakisphosphate and diphosphoinositol 
polyphosphates in primary cultured hepatocytes. Biochem J. 293 ( Pt 2): 583-
590. 
Godlee, C. and M. Kaksonen (2013). Review series: From uncertain beginnings: 
initiation mechanisms of clathrin-mediated endocytosis. The Journal of cell 
biology. 203: 717-725. 
Gómez-García, M. R. and A. Kornberg (2004). Formation of an actin-like filament 
concurrent with the enzymatic synthesis of inorganic polyphosphate. Proc Natl 
Acad Sci USA. 101: 15876-15880. 
Gray, M. J., W.-Y. Wholey, N. O. Wagner, C. M. Cremers, A. Mueller-Schickert, 
N. T. Hock, A. G. Krieger, E. M. Smith, R. A. Bender, J. C. A. Bardwell and U. 
Jakob (2014). Polyphosphate is a primordial chaperone. Mol Cell. 53: 689-699. 
Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. 
Journal of molecular biology. 166: 557-580. 
Hernández-Ruiz, L., A. Sáez-Benito, N. Pujol-Moix, J. Rodríguez-Martorell and F. 
A. Ruiz (2009). Platelet inorganic polyphosphate decreases in patients with delta 
storage pool disease. J Thromb Haemost. 7: 361-363. 
	   264 
Hilgemann, D. W., S. Feng and C. Nasuhoglu (2001). The complex and intriguing 
lives of PIP2 with ion channels and transporters. Sci STKE. 2001: re19. 
Hoeller, O., P. Bolourani, J. Clark, L. R. Stephens, P. T. Hawkins, O. D. Weiner, 
G. Weeks and R. R. Kay (2013). Two distinct functions for PI3-kinases in 
macropinocytosis. J Cell Sci. 126: 4296-4307. 
Hoeller, O. and R. R. Kay (2007). Chemotaxis in the absence of PIP3 gradients. 
Curr Biol. 17: 813-817. 
Holmström, K. M., N. Marina, A. Y. Baev, N. W. Wood, A. V. Gourine and A. Y. 
Abramov (2013). Signalling properties of inorganic polyphosphate in the 
mammalian brain. Nat Commun. 4: 1362. 
Hooley, P., M. P. Whitehead and M. R. W. Brown (2008). Eukaryote 
polyphosphate kinases: is the 'Kornberg' complex ubiquitous? Trends Biochem 
Sci. 33: 577-582. 
Hothorn, M., H. Neumann, E. D. Lenherr, M. Wehner, V. Rybin, P. O. Hassa, A. 
Uttenweiler, M. Reinhardt, A. Schmidt, J. Seiler, A. G. Ladurner, C. Herrmann, K. 
Scheffzek and A. Mayer (2009). Catalytic core of a membrane-associated 
eukaryotic polyphosphate polymerase. Science. 324: 513-516. 
Hsieh, P. C., B. C. Shenoy, J. E. Jentoft and N. F. Phillips (1993). Purification of 
polyphosphate and ATP glucose phosphotransferase from Mycobacterium 
tuberculosis H37Ra: evidence that poly(P) and ATP glucokinase activities are 
catalyzed by the same enzyme. Protein Expr Purif. 4: 76-84. 
Hyvönen, M., M. J. Macias, M. Nilges, H. Oschkinat, M. Saraste and M. 
Wilmanns (1995). Structure of the binding site for inositol phosphates in a PH 
domain. EMBO J. 14: 4676-4685. 
	   265 
Iijima, M., Y. E. Huang and P. Devreotes (2002). Temporal and spatial regulation 
of chemotaxis. Developmental cell. 3: 469-478. 
Illies, C., J. Gromada, R. Fiume, B. Leibiger, J. Yu, K. Juhl, S.-N. Yang, D. K. 
Barma, J. R. Falck, A. Saiardi, C. J. Barker and P.-O. Berggren (2007). 
Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic 
beta cells. Science. 318: 1299-1302. 
Irvine, R. F. and M. J. Schell (2001). Back in the water: the return of the inositol 
phosphates. Nat Rev Mol Cell Biol. 2: 327-338. 
Ishige, K., H. Zhang and A. Kornberg (2002). Polyphosphate kinase (PPK2), a 
potent, polyphosphate-driven generator of GTP. Proc Natl Acad Sci USA. 99: 
16684-16688. 
Jarmuszkiewicz, W., M. Behrendt, R. Navet and F. E. Sluse (2002). Uncoupling 
protein and alternative oxidase of Dictyostelium discoideum: occurrence, 
properties and protein expression during vegetative life and starvation-induced 
early development. FEBS letters. 532: 459-464. 
Johnson, L. F. and M. E. Tate (1969). The structure of myo-inositol 
pentaphosphates. Annals of the New York Academy of Sciences. 165: 526-532. 
Joseph, J. M., P. Fey, N. Ramalingam, X. I. Liu, M. Rohlfs, A. A. Noegel, A. 
Müller-Taubenberger, G. Glöckner and M. Schleicher (2008). The actinome of 
Dictyostelium discoideum in comparison to actins and actin-related proteins 
from other organisms. PLoS ONE. 3: e2654. 
Kaffman, A., I. Herskowitz, R. Tjian and E. K. O'Shea (1994). Phosphorylation of 
the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85. 
Science. 263: 1153-1156. 
	   266 
Kay, R. R., P. Flatman and C. R. Thompson (1999). DIF signalling and cell fate. 
Semin Cell Dev Biol. 10: 577-585. 
Kay, R. R., P. Langridge, D. Traynor and O. Hoeller (2008). Changing directions 
in the study of chemotaxis. Nat Rev Mol Cell Biol. 9: 455-463. 
King, J., M. Keim, R. Teo, K. E. Weening, M. Kapur, K. McQuillan, J. Ryves, B. 
Rogers, E. Dalton, R. S. B. Williams and A. J. Harwood (2010). Genetic control of 
lithium sensitivity and regulation of inositol biosynthetic genes. PLoS ONE. 5: 
e11151. 
Klein, G., D. Cotter, J. Martin, M. Bof and M. Satre (1988). Germination of 
Dictyostelium discoideum spores. A phosphorus-31 NMR analysis. 
Biochemistry: 8199-8203. 
Kolozsvari, B., F. Parisi and A. Saiardi (2014). Inositol phosphates induce DAPI 
fluorescence shift. Biochem J. 460: 377-385. 
Komander, D., A. Fairservice, M. Deak, G. S. Kular, A. R. Prescott, C. Peter 
Downes, S. T. Safrany, D. R. Alessi and D. M. F. van Aalten (2004). Structural 
insights into the regulation of PDK1 by phosphoinositides and inositol 
phosphates. EMBO J. 23: 3918-3928. 
Kornberg, A. (1995). Inorganic polyphosphate: toward making a forgotten 
polymer unforgettable. J Bacteriol. 177: 491-496. 
Kornberg, A., N. N. Rao and D. Ault-Riché (1999). Inorganic polyphosphate: a 
molecule of many functions. Annu Rev Biochem. 68: 89-125. 
Kulaev, I. S. (1975). Biochemistry of inorganic polyphosphates. Rev Physiol 
Biochem Pharmacol. 73: 131-158. 
	   267 
Kumble, K. D., K. Ahn and A. Kornberg (1996). Phosphohistidyl active sites in 
polyphosphate kinase of Escherichia coli. Proc Natl Acad Sci USA. 93: 14391-
14395. 
Kumble, K. D. and A. Kornberg (1995). Inorganic polyphosphate in mammalian 
cells and tissues. J Biol Chem. 270: 5818-5822. 
Laha, D., P. Johnen, C. Azevedo, M. Dynowski, M. Weiß, S. Capolicchio, H. Mao, 
T. Iven, M. Steenbergen, M. Freyer, P. Gaugler, M. K. F. de Campos, N. Zheng, I. 
Feussner, H. J. Jessen, S. C. M. Van Wees, A. Saiardi and G. Schaaf (2015). 
VIH2 Regulates the Synthesis of Inositol Pyrophosphate InsP8 and Jasmonate-
Dependent Defenses in Arabidopsis. Plant Cell. 27: 1082-1097. 
Laussmann, T., R. Eujen, C. M. Weisshuhn, U. Thiel and G. Vogel (1996). 
Structures of diphospho-myo-inositol pentakisphosphate and bisdiphospho-
myo-inositol tetrakisphosphate from Dictyostelium resolved by NMR analysis. 
Biochem J. 315 ( Pt 3): 715-720. 
Laussmann, T., C. Pikzack, U. Thiel, G. W. Mayr and G. Vogel (2000). 
Diphospho-myo-inositol phosphates during the life cycle of Dictyostelium and 
Polysphondylium. Eur J Biochem. 267: 2447-2451. 
Laussmann, T., K. M. Reddy, K. K. Reddy, J. R. Falck and G. Vogel (1997). 
Diphospho-myo-inositol phosphates from Dictyostelium identified as D-6-
diphospho-myo-inositol pentakisphosphate and D-5,6-bisdiphospho-myo-
inositol tetrakisphosphate. Biochem J. 322 ( Pt 1): 31-33. 
Lee, Y.-S., S. Mulugu, J. D. York and E. K. O'Shea (2007). Regulation of a cyclin-
CDK-CDK inhibitor complex by inositol pyrophosphates. Science. 316: 109-112. 
	   268 
Letcher, A. J., M. J. Schell and R. F. Irvine (2008). Do mammals make all their 
own inositol hexakisphosphate? Biochem J. 416: 263-270. 
Lev, S., C. Li, D. Desmarini, A. Saiardi, N. L. Fewings, S. D. Schibeci, R. Sharma, 
T. C. Sorrell and J. T. Djordjevic (2015). Fungal Inositol Pyrophosphate IP7 Is 
Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity. 
MBio. 6: e00531-00515. 
Livermore, T. M., C. Azevedo, B. Kolozsvari, M. S. C. Wilson and A. Saiardi 
(2016). Phosphate, inositol and polyphosphates. Biochem Soc Trans. 44: 253-
259. 
Livermore, T. M., J. R. Chubb and A. Saiardi (2016). Developmental 
accumulation of inorganic polyphosphate affects germination and energetic 
metabolism in Dictyostelium discoideum. Proc Natl Acad Sci USA. 113: 996-
1001. 
Lonetti, A., Z. Szijgyarto, D. Bosch, O. Loss, C. Azevedo and A. Saiardi (2011). 
Identification of an evolutionarily conserved family of inorganic polyphosphate 
endopolyphosphatases. J Biol Chem. 286: 31966-31974. 
Loomis, W. F. (2015). Genetic control of morphogenesis in Dictyostelium. Dev 
Biol. 402: 146-161. 
Losito, O., Z. Szijgyarto, A. C. Resnick and A. Saiardi (2009). Inositol 
Pyrophosphates and Their Unique Metabolic Complexity: Analysis by Gel 
Electrophoresis. PLoS ONE. 4: e5580. 
Loss, O., C. T. Wu, A. Riccio and A. Saiardi (2013). Modulation of inositol 
polyphosphate levels regulates neuronal differentiation. Molecular biology of the 
cell. 24: 2981-2989. 
	   269 
Luo, H. R., Y. E. Huang, J. C. Chen, A. Saiardi, M. Iijima, K. Ye, Y. Huang, E. 
Nagata, P. Devreotes and S. H. Snyder (2003). Inositol pyrophosphates mediate 
chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 
interactions. Cell. 114: 559-572. 
Macbeth, M. R., H. L. Schubert, A. P. Vandemark, A. T. Lingam, C. P. Hill and B. 
L. Bass (2005). Inositol hexakisphosphate is bound in the ADAR2 core and 
required for RNA editing. Science. 309: 1534-1539. 
Manning, G., D. B. Whyte, R. Martinez, T. Hunter and S. Sudarsanam (2002). 
The protein kinase complement of the human genome. Science. 298: 1912-1934. 
Marchesini, N., F. A. Ruiz, M. Vieira and R. Docampo (2002). Acidocalcisomes 
are functionally linked to the contractile vacuole of Dictyostelium discoideum. J 
Biol Chem. 277: 8146-8153. 
Menniti, F. S., R. N. Miller, J. W. Putney and S. B. Shears (1993). Turnover of 
inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem. 268: 
3850-3856. 
Michell, R. H. (2011). Inositol and its derivatives: their evolution and functions. 
Adv Enzyme Regul. 51: 84-90. 
Mitchell, J., X. Wang, G. Zhang, M. Gentzsch, D. J. Nelson and S. B. Shears 
(2008). An expanded biological repertoire for Ins(3,4,5,6)P4 through its 
modulation of ClC-3 function. Curr Biol. 18: 1600-1605. 
Moreno, S. N. J. and R. Docampo (2013). Polyphosphate and its diverse 
functions in host cells and pathogens. PLoS Pathog. 9: e1003230. 
	   270 
Morrison, B. H., R. Haney, E. Lamarre, J. Drazba, G. D. Prestwich and D. J. 
Lindner (2009). Gene deletion of inositol hexakisphosphate kinase 2 predisposes 
to aerodigestive tract carcinoma. Oncogene. 28: 2383-2392. 
Morrissey, J. H., S. H. Choi and S. A. Smith (2012). Polyphosphate: an ancient 
molecule that links platelets, coagulation, and inflammation. Blood. 119: 5972-
5979. 
Müller, F., N. J. Mutch, W. A. Schenk, S. A. Smith, L. Esterl, H. M. Spronk, S. 
Schmidbauer, W. A. Gahl, J. H. Morrissey and T. Renné (2009). Platelet 
polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 
139: 1143-1156. 
Mulugu, S., W. Bai, P. C. Fridy, R. J. Bastidas, J. C. Otto, D. E. Dollins, T. A. 
Haystead, A. A. Ribeiro and J. D. York (2007). A conserved family of enzymes 
that phosphorylate inositol hexakisphosphate. Science. 316: 106-109. 
Muramoto, T., D. Cannon, M. Gierlinski, A. Corrigan, G. J. Barton and J. R. 
Chubb (2012). Live imaging of nascent RNA dynamics reveals distinct types of 
transcriptional pulse regulation. Proc Natl Acad Sci USA. 109: 7350-7355. 
Nagata, E., H. R. Luo, A. Saiardi, B.-I. Bae, N. Suzuki and S. H. Snyder (2005). 
Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol 
Chem. 280: 1634-1640. 
Nichols, J. M., D. Veltman and R. R. Kay (2015). Chemotaxis of a model 
organism: progress with Dictyostelium. Current opinion in cell biology. 36: 7-12. 
Norbis, F., M. Boll, G. Stange, D. Markovich, F. Verrey, J. Biber and H. Murer 
(1997). Identification of a cDNA/protein leading to an increased Pi-uptake in 
Xenopus laevis oocytes. J Membr Biol. 156: 19-24. 
	   271 
O'Neill, E. M., A. Kaffman, E. R. Jolly and E. K. O'Shea (1996). Regulation of 
PHO4 nuclear localization by the PHO80-PHO85 cyclin-CDK complex. Science. 
271: 209-212. 
Ohashi, K., S. Kawai and K. Murata (2012). Identification and characterization of 
a human mitochondrial NAD kinase. Nat Commun. 3: 1248. 
Onnebo, S. M. N. and A. Saiardi (2009). Inositol pyrophosphates modulate 
hydrogen peroxide signalling. Biochem J. 423: 109-118. 
Pilu, R., D. Panzeri, G. Gavazzi, S. K. Rasmussen, G. Consonni and E. Nielsen 
(2003). Phenotypic, genetic and molecular characterization of a maize low phytic 
acid mutant (lpa241). Theor Appl Genet. 107: 980-987. 
Pisani, F., T. Livermore, G. Rose, J. R. Chubb, M. Gaspari and A. Saiardi (2014). 
Analysis of Dictyostelium discoideum inositol pyrophosphate metabolism by gel 
electrophoresis. PLoS ONE. 9: e85533. 
Pollard, T. D. and G. G. Borisy (2003). Cellular motility driven by assembly and 
disassembly of actin filaments. Cell. 112: 453-465. 
Posternak, S. (1921). Sur la synthèse de l'acide inosito‐hexaphosphorique. 
Helvetica Chimica Acta. 
Raboy, V. (2007). The ABCs of low-phytate crops. Nat Biotechnol. 25: 874-875. 
Rashid, M. H., K. Rumbaugh, L. Passador, D. G. Davies, A. N. Hamood, B. H. 
Iglewski and A. Kornberg (2000). Polyphosphate kinase is essential for biofilm 
development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proc 
Natl Acad Sci USA. 97: 9636-9641. 
	   272 
Resnick, A. C., A. M. Snowman, B. N. Kang, K. J. Hurt, S. H. Snyder and A. 
Saiardi (2005). Inositol polyphosphate multikinase is a nuclear PI3-kinase with 
transcriptional regulatory activity. Proc Natl Acad Sci USA. 102: 12783-12788. 
Reyland, M. E. (2009). Protein kinase C isoforms: Multi-functional regulators of 
cell life and death. Front Biosci (Landmark Ed). 14: 2386-2399. 
Rohatgi, R., H. Y. Ho and M. W. Kirschner (2000). Mechanism of N-WASP 
activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J Cell Biol. 
150: 1299-1310. 
Ruiz, F. A., C. R. Lea, E. Oldfield and R. Docampo (2004). Human platelet dense 
granules contain polyphosphate and are similar to acidocalcisomes of bacteria 
and unicellular eukaryotes. J Biol Chem. 279: 44250-44257. 
Saiardi, A. (2012). How inositol pyrophosphates control cellular phosphate 
homeostasis? Adv Biol Regul. 52: 351-359. 
Saiardi, A., R. Bhandari, A. C. Resnick, A. M. Snowman and S. H. Snyder (2004). 
Phosphorylation of proteins by inositol pyrophosphates. Science. 306: 2101-
2105. 
Saiardi, A., J. J. Caffrey, S. H. Snyder and S. B. Shears (2000). The inositol 
hexakisphosphate kinase family. Catalytic flexibility and function in yeast 
vacuole biogenesis. J Biol Chem. 275: 24686-24692. 
Saiardi, A., H. Erdjument-Bromage, A. M. Snowman, P. Tempst and S. H. 
Snyder (1999). Synthesis of diphosphoinositol pentakisphosphate by a newly 
identified family of higher inositol polyphosphate kinases. Curr Biol. 9: 1323-
1326. 
	   273 
Saiardi, A., E. Nagata, H. R. Luo, A. Sawa, X. Luo, A. M. Snowman and S. H. 
Snyder (2001). Mammalian inositol polyphosphate multikinase synthesizes 
inositol 1,4,5-trisphosphate and an inositol pyrophosphate. Proc Natl Acad Sci 
USA. 98: 2306-2311. 
Saiardi, A., E. Nagata, H. R. Luo, A. M. Snowman and S. H. Snyder (2001). 
Identification and characterization of a novel inositol hexakisphosphate kinase. J 
Biol Chem. 276: 39179-39185. 
Saiardi, A., A. C. Resnick, A. M. Snowman, B. Wendland and S. H. Snyder 
(2005). Inositol pyrophosphates regulate cell death and telomere length through 
phosphoinositide 3-kinase-related protein kinases. Proc Natl Acad Sci USA. 
102: 1911-1914. 
Saiardi, A., C. Sciambi, J. M. McCaffery, B. Wendland and S. H. Snyder (2002). 
Inositol pyrophosphates regulate endocytic trafficking. Proc Natl Acad Sci USA. 
99: 14206-14211. 
Sarbassov, D. D., D. A. Guertin, S. M. Ali and D. M. Sabatini (2005). 
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. 
Science. 307: 1098-1101. 
Schell, M. J., A. J. Letcher, C. A. Brearley, J. Biber, H. Murer and R. F. Irvine 
(1999). PiUS (Pi uptake stimulator) is an inositol hexakisphosphate kinase. FEBS 
letters. 461: 169-172. 
Seeds, A. M., R. J. Bastidas and J. D. York (2005). Molecular definition of a 
novel inositol polyphosphate metabolic pathway initiated by inositol 1,4,5-
trisphosphate 3-kinase activity in Saccharomyces cerevisiae. J Biol Chem. 280: 
27654-27661. 
	   274 
Seeds, A. M., J. C. Sandquist, E. P. Spana and J. D. York (2004). A molecular 
basis for inositol polyphosphate synthesis in Drosophila melanogaster. J Biol 
Chem. 279: 47222-47232. 
Seidlmayer, L. K., L. A. Blatter, E. Pavlov and E. N. Dedkova (2012). Inorganic 
polyphosphate--an unusual suspect of the mitochondrial permeability transition 
mystery. Channels (Austin). 6: 463-467. 
Shah, Z. H., D. R. Jones, L. Sommer, R. Foulger, Y. Bultsma, C. D'Santos and N. 
Divecha (2013). Nuclear phosphoinositides and their impact on nuclear functions. 
FEBS J. 280: 6295-6310. 
Shears, S. B. (2001). Assessing the omnipotence of inositol hexakisphosphate. 
Cell Signal. 13: 151-158. 
Shears, S. B. (2009). Diphosphoinositol polyphosphates: metabolic 
messengers? Mol Pharmacol. 76: 236-252. 
Shears, S. B. (2009). Molecular basis for the integration of inositol phosphate 
signaling pathways via human ITPK1. Adv Enzyme Regul. 49: 87-96. 
Shears, S. B., S. B. Ganapathi, N. A. Gokhale, T. M. H. Schenk, H. Wang, J. D. 
Weaver, A. Zaremba and Y. Zhou (2012). Defining signal transduction by inositol 
phosphates. Phosphoinositides II: The Diverse Biological Functions. 
Shi, X. and A. Kornberg (2005). Endopolyphosphatase in Saccharomyces 
cerevisiae undergoes post-translational activations to produce short-chain 
polyphosphates. FEBS Lett. 579: 2014-2018. 
	   275 
Skorko, R. (1989). Polyphosphate as a source of phosphoryl group in protein 
modification in the archaebacterium Sulfolobus acidocaldarius. Biochimie. 71: 
1089-1093. 
Stephens, L., T. Radenberg, U. Thiel, G. Vogel, K. H. Khoo, A. Dell, T. R. 
Jackson, P. T. Hawkins and G. W. Mayr (1993). The detection, purification, 
structural characterization, and metabolism of diphosphoinositol 
pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s). J Biol 
Chem. 268: 4009-4015. 
Stephens, L. R. and R. F. Irvine (1990). Stepwise phosphorylation of myo-inositol 
leading to myo-inositol hexakisphosphate in Dictyostelium. Nature. 346: 580-
583. 
Stokoe, D., L. R. Stephens, T. Copeland, P. R. Gaffney, C. B. Reese, G. F. 
Painter, A. B. Holmes, F. McCormick and P. T. Hawkins (1997). Dual role of 
phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. 
Science. 277: 567-570. 
Streb, H., R. F. Irvine, M. J. Berridge and I. Schulz (1983). Release of Ca2+ from 
a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-
trisphosphate. Nature. 306: 67-69. 
Suh, B.-C. and B. Hille (2005). Regulation of ion channels by 
phosphatidylinositol 4,5-bisphosphate. Curr Opin Neurobiol. 15: 370-378. 
Szijgyarto, Z., A. Garedew, C. Azevedo and A. Saiardi (2011). Influence of 
inositol pyrophosphates on cellular energy dynamics. Science. 334: 802-805. 
Trilisenko, L. V., N. A. Andreeva, T. V. Kulakovskaya, V. M. Vagabov and I. S. 
Kulaev (2003). Effect of inhibitors on polyphosphate metabolism in the yeast 
	   276 
Saccharomyces cerevisiae under hypercompensation conditions. Biochemistry 
Mosc. 68: 577-581. 
Van Dijken, P. and P. J. Van Haastert (2001). Phospholipase Cdelta regulates 
germination of Dictyostelium spores. BMC Cell Biol. 2: 25. 
Vanhaesebroeck, B., L. Stephens and P. Hawkins (2012). PI3K signalling: the 
path to discovery and understanding. Nat Rev Mol Cell Biol. 13: 195-203. 
Voglmaier, S. M., M. E. Bembenek, A. I. Kaplin, G. Dormán, J. D. Olszewski, G. 
D. Prestwich and S. H. Snyder (1996). Purified inositol hexakisphosphate kinase 
is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy 
phosphate donor. Proc Natl Acad Sci USA. 93: 4305-4310. 
Wang, H., E. F. DeRose, R. E. London and S. B. Shears (2014). IP6K structure 
and the molecular determinants of catalytic specificity in an inositol phosphate 
kinase family. Nat Commun. 5: 4178. 
Wang, H., J. R. Falck, T. M. T. Hall and S. B. Shears (2012). Structural basis for 
an inositol pyrophosphate kinase surmounting phosphate crowding. Nat Chem 
Biol. 8: 111-116. 
Wang, H., V. S. Nair, A. A. Holland, S. Capolicchio, H. J. Jessen, M. K. Johnson 
and S. B. Shears (2015). Asp1 from Schizosaccharomyces pombe Binds a [2Fe-
2S](2+) Cluster Which Inhibits Inositol Pyrophosphate 1-Phosphatase Activity. 
Biochemistry. 54: 6462-6474. 
Watson, P. J., L. Fairall, G. M. Santos and J. W. R. Schwabe (2012). Structure of 
HDAC3 bound to co-repressor and inositol tetraphosphate. Nature. 481: 335-
340. 
	   277 
Weber, S., C. U. Stirnimann, M. Wieser, D. Frey, R. Meier, S. Engelhardt, X. Li, G. 
Capitani, R. A. Kammerer and H. Hilbi (2014). A type IV translocated Legionella 
cysteine phytase counteracts intracellular growth restriction by phytate. J Biol 
Chem. 289: 34175-34188. 
Williams, J. G. (2006). Transcriptional regulation of Dictyostelium pattern 
formation. EMBO Rep. 7: 694-698. 
Williams, J. G. (2010). Dictyostelium finds new roles to model. Genetics. 185: 
717-726. 
Wilson, M. S. C., S. J. Bulley, F. Pisani, R. F. Irvine and A. Saiardi (2015). A novel 
method for the purification of inositol phosphates from biological samples 
reveals that no phytate is present in human plasma or urine. Open Biol. 5: 
150014. 
Wilson, M. S. C., T. M. Livermore and A. Saiardi (2013). Inositol pyrophosphates: 
between signalling and metabolism. Biochem J. 452: 369-379. 
Worley, J., X. Luo and A. P. Capaldi (2013). Inositol pyrophosphates regulate cell 
growth and the environmental stress response by activating the HDAC Rpd3L. 
Cell Rep. 3: 1476-1482. 
Wundenberg, T. and G. W. Mayr (2012). Synthesis and biological actions of 
diphosphoinositol phosphates (inositol pyrophosphates), regulators of cell 
homeostasis. Biol Chem. 393: 979-998. 
Wurst, H. and A. Kornberg (1994). A soluble exopolyphosphatase of 
Saccharomyces cerevisiae. Purification and characterization. J Biol Chem. 269: 
10996-11001. 
	   278 
Yoko-o, T., Y. Matsui, H. Yagisawa, H. Nojima, I. Uno and A. Toh-e (1993). The 
putative phosphoinositide-specific phospholipase C gene, PLC1, of the yeast 
Saccharomyces cerevisiae is important for cell growth. Proc Natl Acad Sci USA. 
90: 1804-1808. 
York, J. D., A. R. Odom, R. Murphy, E. B. Ives and S. R. Wente (1999). A 
phospholipase C-dependent inositol polyphosphate kinase pathway required for 
efficient messenger RNA export. Science. 285: 96-100. 
York, S. J., B. N. Armbruster, P. Greenwell, T. D. Petes and J. D. York (2005). 
Inositol diphosphate signaling regulates telomere length. J Biol Chem. 280: 
4264-4269. 
Zhang, C., P. W. Majerus and M. P. Wilson (2012). Regulation of inositol 1,3,4-
trisphosphate 5/6-kinase (ITPK1) by reversible lysine acetylation. Proc Natl Acad 
Sci USA. 109: 2290-2295. 
Zhang, H., M. R. Gómez-García, M. R. W. Brown and A. Kornberg (2005). 
Inorganic polyphosphate in Dictyostelium discoideum: influence on 
development, sporulation, and predation. Proc Natl Acad Sci USA. 102: 2731-
2735. 
Zhang, H., M. R. Gómez-García, X. Shi, N. N. Rao and A. Kornberg (2007). 
Polyphosphate kinase 1, a conserved bacterial enzyme, in a eukaryote, 
Dictyostelium discoideum, with a role in cytokinesis. Proc Natl Acad Sci USA. 
104: 16486-16491. 
Zhang, H., K. Ishige and A. Kornberg (2002). A polyphosphate kinase (PPK2) 
widely conserved in bacteria. Proc Natl Acad Sci USA. 99: 16678-16683. 
	   279 
Zhu, Y., W. Huang, S. S. K. Lee and W. Xu (2005). Crystal structure of a 
polyphosphate kinase and its implications for polyphosphate synthesis. EMBO 
Rep. 6: 681-687. 
 
